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Abstract 
The Macular Society 2013 survey (MSQ 2013) formed study 1 of the thesis. This 
nationwide survey was sent to 4000 members of the Macular Society. The main 
purpose was to investigate the healthcare experiences of people with macular 
conditions and determine whether a previous survey and Royal College of 
Ophthalmologist (RCOphth) management guidelines brought improvements. Results 
showed that patients diagnosed with age-related macular degeneration (AMD) since 
the previous 1999 survey reported better experiences at diagnostic consultation. 
Overall satisfaction with the diagnostic consultation improved following publication of 
the RCOphth guidelines. However information and support provision at diagnosis 
remained low.  
Of the MSQ 2013 respondents, 53% reported receiving care from family or friends 
because of their AMD. Respondents who received care reported poorer quality of life 
and well-being than those who didn’t receive care, despite controlling for degree of 
visual impairment. Reasons for the relationship between poor well-being and receiving 
care were investigated using a mixed-methods approach. Two studies explored the 
impact of receiving and providing support for wet and/or dry AMD using a dyadic 
perspective (i.e. including both person with AMD and their caregiver). Previous 
research has often neglected to take into account the close relationship between 
caregiver/s and person/people with AMD (pwAMD). This mixed-methods study filled 
this gap. Quantitative study 2 investigated 72 such dyads using structural equation 
modelling to examine predictors of well-being in the pwAMD and caregiver, caregiver 
general health and caregiver reactions towards providing support. Qualitative study 3 
reports interviews with eight dyads exploring experiences in greater depth. This 
research provides information to enhance our understanding of how pwAMD and their 
caregivers adapt to living with AMD. It highlights the similarities and differences 
between pwAMD/caregiver pairs where the caregiver was the spouse of the pwAMD, 
and those where the caregiver was the adult-offspring of the pwAMD.  
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Chapter 1: Introduction and Literature review 
INTRODUCTION 
This thesis presents a series of studies which investigate the information and support 
received by people with age-related macular degeneration (AMD) from health and 
social care services, the voluntary sector, and friends and family. It includes the first 
study to examine the impact of receiving and providing care for AMD both from the 
perspective of people with AMD (pwAMD) and their caregivers. Chapter 1 provides 
background information on AMD including a critical review of the literature on the 
experience of living with AMD, and what is known about the help and support 
reported to be received by pwAMD. A review of the research on receiving care 
because of vision loss, and on caregivers of pwAMD is presented in Chapter 5. 
LITERATURE REVIEW  
Age-related macular degeneration (AMD) is a progressive chronic eye condition 
affecting people aged 50 years and above (RCOphth, 2009). AMD is one of many eye 
conditions affecting the macular. The macular is the central part of the retina used for 
activities requiring fine vision (e.g. reading, writing and recognising faces). Central 
vision deteriorates while peripheral vision is usually retained. Other types of macular 
condition include (for example): juvenile macular dystrophies, myopic maculopathy, 
macular hole, diabetic macular oedema, and retinal vein occlusion.  
AMD is the leading cause of blindness in developed countries (Bourne et al., 2014). 
There were approximately 513,000 people living with late AMD in the UK in 2012, and 
numbers are expected to grow by a third by 2020 with the increasing age of the 
population (Owen et al., 2012). 
Types of AMD 
In the early stages of the condition, drusen (yellow or white extracellular deposits) 
form between the retinal pigment epithelium (RPE) and Bruch’s membrane 
(Ratnapriya & Chew, 2013). There may also be areas of hypopigmentation of the RPE, 
and/or hyperpigmentation in the outer retina or choroid associated with drusen. AMD 
may be asymptomatic in the early stages. 
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Late or advanced stage AMD can be ‘wet’ or ‘dry’. Exudative or neovascular AMD (also 
known as wet AMD) usually involves choroidal neovascularisation (CNV). This is where 
new blood vessels have formed in the choroid and may be leaking blood or fluid into 
the retina leading to fibrous scarring. Geographic atrophy or non-neovascular AMD 
(also known as dry AMD) is characterised by the progressive atrophy of the RPE, 
choriocapillaris and photoreceptors (Lim, Mitchell, Seddon, Holz, & Wong, 2012).  Dry 
AMD can convert to, or be associated with, wet AMD in the same or contralateral eye. 
Advanced AMD is more likely to cause more pronounced central vision loss (Lim et al., 
2012). Dry AMD accounts for 80-85% of cases of AMD, whilst wet AMD accounts for 
15-20% (Bonastre et al., 2002).  
Symptoms of AMD 
Geographic atrophy (dry AMD) may not produce noticeable symptoms at first and is 
usually detected during a routine fundus examination. When geographic atrophy is 
bilateral (involving both eyes), a deterioration in central vision is more noticeable. 
Patients may have difficulty reading small print, and later on, large print (RCOphth, 
2013). 
Symptoms typical of onset of exudative (wet) AMD include central vision blurring and 
distortion. Straight lines may appear crooked or wavy. Vision loss caused by a 
haemorrhage or fluid accumulation secondary to CNV may produce sudden and 
profound vision loss (Jager , Mieler , & Miller 2008). Other symptoms typical of wet 
AMD include a dark central patch in the visual field (scotoma) (Mitchell, Annemans, 
White, Gallagher, & Thomas, 2011; RCOphth, 2013).  
Charles Bonnet Syndrome  
PwAMD may experience a common side effect of vision loss known as Charles Bonnet 
Syndrome (CBS). CBS is the experience of visual hallucinations which can take the form 
of, for example: people, trees, plants, patterns, animals or objects. 
Visual hallucinations may not be reported for fear of being labelled as having a serious 
mental illness (Menon, 2005). The experience of hallucinations has been linked to 
poorer well-being (Mitchell, 2003),  higher emotional distress and decreased functional 
ability (Scott, Schein, Feuer, & Folstein, 2001). Although there is currently no cure for 
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hallucinations, informing patients that hallucinations are usually benign has been 
shown to ease distress (Menon, 2005). 
A large-scale nationwide survey sent to members of the Macular Society found a 39% 
prevalence of CBS in people who reported diagnosis of a macular condition (Cox & 
ffytche, 2014). Of those experiencing hallucinations, 75% had had CBS for 5 years or 
more (Cox & ffytche, 2014). Respondents who reported that hallucinations had a 
negative effect on their lives were more likely to report more frequent hallucinations, 
hallucination episodes of longer duration, fear-inducing hallucinations, hallucinations 
which affected daily activities, having attributed hallucinations to mental illness and 
not knowing about CBS at the onset of symptoms (Cox & ffytche, 2014). Whilst 47% 
had spoken to a healthcare professional about their hallucinations, 7% had not spoken 
to anyone about their hallucinations (Cox & ffytche, 2014). Thus suggesting that many 
people experiencing CBS are not being given information on them (either at diagnosis 
or later on) and that this might affect their reactions to the hallucinations.  
Prevalence of AMD 
Several epidemiological studies have investigated the incidence and prevalence of 
AMD.  In the UK, overall prevalence of late stage AMD in those aged over 50 was 2.4% 
which is equivalent to 513,000 cases (Owen et al., 2012). Prevalence rates increased 
with age. Estimated prevalence of AMD in people aged over 65 years was 4.8%, 
increasing to 12.2% in those aged over 80 (Owen et al., 2012). The authors estimated 
an increase of 71,200 new cases of late AMD per year. 
A recent meta-analysis combining global data from population-based studies of AMD 
patients estimated pooled prevalence rates of: early AMD (8.01%, 95% credible 
intervals (Crl), 3.98%-15.49%), late AMD (0.37%, 95% Crl, 0.18%-0.77%) and any AMD 
(8.69%, 95% Crl, 4.26%-17.40%).  The projected number of pwAMD worldwide in 2020 
is 196 million (95% Crl, 140-261), increasing to 288 million in 2040 (95% Crl, 205-399) 
(Wong et al., 2014).  
Risk factors  
The exact causes of AMD are still being investigated (Ratnapriya & Chew, 2013). Both 
genetic and non-genetic factors are thought to play a role in causing AMD. Non-genetic 
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risk factors such as smoking and older age are consistently linked with increased risk 
for any form of AMD (e.g. Chakravarthy et al., 2010; Klein, Klein, Tomany, Meuer, & 
Huang, 2002; Smith et al., 2001; Thornton et al., 2005). A review by Chakravarthy et al. 
(2010) found no significant association between gender and AMD risk. 
Chakravarthy et al. (2010) noted inconsistent associations between risk of AMD and 
both cardiovascular factors (e.g. hypertension and hyperlipidaemia) and greater Body 
Mass Index. 
There is mixed evidence to suggest an increased prevalence of AMD in white 
compared to other ethnic groups (e.g. Chakravarthy et al., 2010; Klein et al., 2013). A 
recent meta-analysis of global data from patients with AMD found higher prevalence 
of early stage AMD in people with European ancestry than in those with Asian 
ancestry, but rates of late stage AMD were similar (Wong et al., 2014). Both early and 
late AMD were more prevalent in those with European ancestry than African ancestry 
(Wong et al., 2014). 
Family history of AMD is inconsistently associated with risk of AMD (Chakravarthy et 
al., 2010). Research is on-going into the identification of genes linked to susceptibility 
to AMD (Ratnapriya & Chew, 2013). 
There has been inconsistent evidence for an association between lighter iris 
pigmentation (i.e. blue vs brown eyes) and development of late AMD (Chakravarthy et 
al., 2010). Eye-related risk factors with consistent associations with late AMD include 
previous cataract surgery (Chakravarthy et al., 2010) and clinical signs such as drusen 
and pigmentary irregularities (Age-Related Eye Disease Study Research, 2005). 
Knowledge of macular conditions 
A US study found one third of a sample taken from the general population (i.e. 
including people either at high or low risk of developing AMD) had never heard of AMD 
(Cimarolli, Laban-Baker, Hamilton, & Stuen, 2012). Of those who had heard of AMD 
before, most reported becoming aware of AMD through knowing someone with the 
condition. Knowledge of AMD risk factors and perceived risk of AMD was low 
(Cimarolli et al., 2012). Just over a third of those at high risk of developing AMD (due to 
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older age, having smoked and white ethnicity) believed they had a small risk of 
developing AMD (Cimarolli et al., 2012). 
Cimarolli et al. (2012) suggested that people may not go for eye tests if they are 
unaware of AMD and their potential risk of AMD. A UK study investigated reasons why 
older adults do not go for eye tests and found poor knowledge of eye disease (Shickle 
& Griffin, 2014). Respondents were unaware of the purpose of different elements of 
the eye examination. Eye tests were perceived to be predominantly for correcting for 
refractive error and assessing the need for spectacles. Other barriers included: feeling 
vulnerable about getting their answers to the tests ‘wrong’ and looking foolish, the 
perception that wearing spectacles made them look old and frail, fear of being told 
that they would lose their driving license or being told that they would go blind, and 
having previously experienced ‘hard sell’ in opticians (Shickle & Griffin, 2014). 
Improving awareness of the need for eye tests to test for other causes of preventable 
sight loss might improve attendance at screening, but other factors such as informing 
patients about the need for different tests and explaining the procedure may also be 
important. 
There is evidence to show that timely treatment given at the onset of CNV secondary 
to AMD with anti-vascular endothelial growth factor (VEGF) injections leads to better 
visual outcomes (e.g. Real et al., 2013). Thus early detection, diagnosis and treatment 
may prevent unnecessary sight loss. Despite this, an international survey sent to 
people who had experienced symptoms of wet AMD found that a quarter of 
respondents waited more than a month to seek help for their symptom(s) (Varano et 
al., 2015). The main reason for delaying seeking help was due to thinking that the 
symptom(s) would resolve itself (themselves). The authors suggested that this may be 
due to a lack of awareness about eye health and the impact of a delayed diagnosis.  
Medical and surgical treatment 
At present, there is no cure for AMD. There are no proven treatments for dry AMD to 
date although progression may be reduced with the Age-Related Eye Disease Study 2 
(AREDS 2) formula nutritional supplements (Age-Related Eye Disease Study 2 Research, 
2013; Age-Related Eye Disease Study Research, 2001). Significant advances have been 
made in treatment for wet AMD with intravitreal injections of anti-VEGF drugs. 
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Ranibizumab (Lucentis, Genentech/Novartis) was approved for use in the UK by the 
National Institute for Health and Care Excellence (NICE) in August 2008 (NICE, 2008), 
and has been successful in preventing vision loss (Brown  et al., 2006; Brown et al., 
2009; Martin, 2011; Rosenfeld et al., 2006). More recently, aflibercept (Eylea, 
Regeneron/Bayer), was approved by NICE in July 2013 (NICE, 2013). In addition, the 
off-license use of bevacizumab (Avastin, Roche/Genentech) has been advocated by 
some specialists for the same indication since 2006 (Amoaku, 2008) and has been 
found to have similar efficacy to Ranibizumab (Chakravarthy et al., 2013).   
Estimates suggest there may be 26, 000 people with wet AMD now eligible for 
treatment in the UK each year (NICE, 2008). Evidence suggests that the number of 
patients eligible for blindness certification has decreased since the introduction of anti-
VEGF injections (e.g. Bloch, Larsen, & Munch, 2012).  
Anti-VEGF treatment is injected directly into the eye and works to inhibit the 
production of vascular endothelial growth factor (VEGF); a secreted endothelial-
specific mitogen which plays a key role in promoting neovascularisation in wet AMD.  
Patients receiving injections usually start with a ‘loading phase’ of one injection per 
month for three months.  At which point they are either monitored through monthly 
visits to assess the need for re-treatment (for Ranibizumab), or receive injections every 
two months for a year followed by monitoring (for aflibercept). The introduction of 
anti-VEGF treatment has led to financial and service capacity pressures on the NHS, 
with some clinics struggling to provide monthly treatment reviews where applicable 
(Amoaku et al., 2012).  
Laser treatment and photodynamic therapy are other treatments available for wet 
AMD but are only used in a minority of cases where patients present with particular 
clinical factors, e.g. laser treatment may be given to patients with lesions far away 
from the fovea (RCOphth, 2013). Submacular surgery, macular translocation and 
radiotherapy treatment have been provided in the past however they are no longer 
recommended by the Royal College of Ophthalmologists (RCOphth, 2013).  
Anti-VEGF treatment has revolutionised the treatment of wet AMD however no 
effective therapy exists to treat those with dry AMD which accounts for the majority of 
cases of AMD. Nevertheless, new understandings of AMD and recent technological 
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breakthroughs have led to new clinical trials aiming to find a cure for AMD (e.g. stem 
cell-based therapy involving regenerating RPE cells in geographic atrophy (Hanus, 
Zhao, & Wang, 2016)).  
The impact of anti-VEGF treatment on patients 
A recent study found that 12% of patients receiving treatment for wet AMD reported 
clinical levels of depression, and 17% reported symptoms of anxiety (Senra, Balaskas, 
Mahmoodi, & Aslam, 2017). The majority were not receiving appropriate psychological 
or psychiatric treatment (Senra et al., 2017). Clinical levels of depression were higher 
in patients who were in the early stages of receiving treatment, however the authors 
suggested this may be due to these patients being recently diagnosed with wet AMD 
and subsequent concern about their prognosis rather than being due to treatment 
specifically. Anxiety was caused by fear of going blind because of the injections (e.g. 
the needle doing damage to the eye), concern about treatment effectiveness, and 
anticipatory anxiety (waiting in the waiting room) rather than due to treatment-related 
pain (Senra et al., 2017). 
It has been argued that patient experiences of receiving treatment should be taken 
into account when creating guidelines to improve ophthalmology practice (Burton, 
Shaw, & Gibson, 2013). There have been several qualitative studies investigating 
patients’ experiences of receiving anti-VEGF treatment (e.g. Henriksen & Adhami, 
2010; McCloud, Khadka, Gilhotra, & Pesudovs, 2014; Thetford, Hodge, Harding, Taylor, 
& Knox, 2013). Similar to the findings reported above from Senra et al. (2017), 
Thetford et al. (2013) found that patients reported “anxiety and fear of the unknown” 
and were apprehensive about receiving injections. Anxiety about and discomfort from 
having the injections have been reported for various aspects of the treatment 
including the application of eye drops, the use of surgical drapes and needle entry, 
long waiting times, fear of losing their sight, fear of side effects and prior experiences 
of pain when receiving previous injections (Senra, Ali, Balaskas, & Aslam, 2016; 
Thetford et al., 2013). 
Despite the anxiety related to treatment, patients report that receiving anti-VEGF 
treatment is worth the initial distress so that future vision loss can be prevented, and 
would recommend the treatment to others (Burton et al., 2013; Thetford et al., 2013). 
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Burton et al. (2013) reported that patients described building relationships with nurses 
to help manage distress. Holding hands with the nurse during the procedure was 
considered a physical reassurance. Others reported using humour as a distraction. 
Making sure patients are adequately informed may help to ease their concerns and 
reduce unnecessary worry prior to treatment. Many patients reported not receiving 
explanations for tests and scans (Burton et al., 2013). This lack of information provision 
raises questions about the adequacy of informed consent for the procedure. Clearer 
communication with patients is needed to help them to develop realistic expectations 
about prognosis following treatment. Some patients reported difficulty understanding 
hospital appointment letters and information leaflets (Burton et al., 2013). 
Subsequently, it has been recommended that information about the procedure should 
be delivered verbally (as well as in written format), and that explanatory videos or peer 
support may help to ease pre-treatment anxiety (Burton et al., 2013; Thetford et al., 
2013).   
An international survey conducted in nine countries (Australia, Brazil, Canada, France, 
Germany, Italy, Japan, Spain and the UK) found that, for respondents receiving 
treatment for wet AMD and who had a caregiver, 60% of these caregivers always 
attended appointments with the person with AMD (Varano et al., 2015). Many 
caregivers reported that frequent appointments were inconvenient. However for many 
patients, treatment resulted in a temporary improvement or stabilisation in their 
vision, and caregivers reported this enabled them to reduce the level of domestic 
assistance provided. The majority of patients attended every clinic appointment (84%). 
The main reason for non-attendance was due to their caregiver being unable to take 
them, followed by fear of having the injection and patient illness.  
(Further research findings on the impact of providing care for someone with AMD, 
including caregiver burden associated with anti-VEGF treatment, are presented in 
Chapter 5.) 
Monitoring vision 
There is evidence to suggest that people diagnosed with an untreatable eye condition 
such as dry AMD and who are discharged from the eye clinic with the message that 
nothing more can be done for them, stop attending routine eye tests in the future 
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(Thetford, Robinson, Knox, Mehta, & Wong, 2009). A lack of information in the 
diagnostic consultation meant that people often had little understanding of their 
condition and the importance of continuing to get their eyes tested to monitor for 
deterioration (Thetford et al., 2009). The RCOphth guidelines (RCOphth, 2013) 
recommended that patients should be advised to go for eye tests at least every two 
years and to monitor their AMD at home using an Amsler Grid (a square arrangement 
of vertical and horizontal lines that helps to assess a person’s central visual field by 
identifying if there are any gaps, waviness or missing portions of the lines in the grid). 
Early detection of changes and timely treatment may lead to better visual outcomes. 
Recently, there has been interest in moving the monitoring of treatable wet AMD away 
from eye clinics and into community settings (with a referral back to the hospital for 
treatment if needed). The primary aim is to reduce the pressure on hospital eye clinics. 
Trials are currently being carried out to assess feasibility and acceptability of this new 
model. (For an example, see the Effectiveness of Community vs Hospital Eye Service 
(ECHoES) trial (Taylor et al., 2016; Townsend et al., 2015)). Additionally, to help meet 
service demands for the number of people requiring treatment, there have been trials 
to train nurse practitioners in delivering anti-VEGF injections. This has been shown to 
be safe and effective (Hasler et al., 2015; Li, Greenberg, & Krzystolik, 2015; Simcock, 
Kingett, Mann, Reddy, & Park, 2014). Therefore, in the near future there may be major 
changes to the way people with AMD are seen for diagnosis and treatment. 
Impact of AMD  
First, when reviewing the literature on the impact of AMD, it is important to be vigilant 
in noting the measures used in research studies so that appropriate conclusions are 
drawn from the study findings. For instance, a variety of different measures have been 
referred to as measures of quality of life (QoL) including measures of anxiety and 
depression (e.g. Hospital Anxiety and Depression Scale, HADS, Zigmond and Snaith 
(1983)), life satisfaction (e.g. Life satisfaction index, James, Davies, and Ananthakopan 
(1986)), health status (e.g. SF-36, Ware, Snow, Kosinski, and Gandek (1993)), functional 
status (e.g. Instrumental Activities of Daily Living, IADL, Williams, Brody, Thomas, 
Kaplan, and Brown (1998)) and vision-specific functional status measures (e.g. National 
Eye Institute Vision Function Questionnaire, NEI-VFQ, Mangione et al. (1998)). These 
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measure phenomena that may be related to QoL but are not in themselves measures 
of QoL (Mitchell & Bradley, 2006). QoL has been defined as how good or bad an 
individual feels his or her life to be (Joyce, 1994; McGee, O'Boyle, Hickey, O'Malley, & 
Joyce, 1991). It is a subjective perception that means different things to different 
people. Mitchell and Bradley (2006) argued that in order to be relevant to pwAMD, 
measures of QoL should include aspects of life impacted by AMD and allow patients to 
rate the importance of these aspects of life for their QoL. For instance, the NEI-VFQ 
measure has vision-specific items which enables the measurement of the impact of 
AMD on activities that may be affected by vision (e.g. ability to play card games), 
however it does not measure the importance or relevance of these items to the 
person’s QoL. For people who regularly play card games, AMD would impact on their 
QoL in this respect but there would be no such impact on someone who does not play 
card games. This difference in importance would not be picked up by measures of 
visual function alone (Covert, Berdeaux, Mitchell, Bradley, & Barnes, 2007). 
If measures of health status are used as if they are measures of QoL, the results can be 
misleading. Health may be good while QoL may be greatly affected by vision loss and 
worry about future visual impairment. Additionally, the EuroQoL (EQ-5D, Brooks 
(1996)), a commonly-used 6-item measure of health status, contains items that may 
not be relevant to AMD (e.g. overall health, pain, mobility) (Mitchell, 2007). 
The MacDQoL (Mitchell & Bradley, 2004) has been developed as an individualised 
measure of the impact of macular conditions on QoL. It contains two overview items: 
generic ‘present QoL’ and MD-specific ‘impact of MD on QoL’, plus a further 23 items 
identified as affected by MD and of importance to the QoL of many people with 
macular conditions (e.g. difficulties with household tasks). Respondents are asked to 
rate the impact of AMD on these domains as well as the importance of that domain for 
their QoL. Using this measure, Mitchell et al. (2005) found the domains most impacted 
by AMD were independence, leisure activities, dealing with personal affairs and getting 
out and about. The negative impact of AMD increased with more severe vision loss 
(Mitchell et al., 2008). 
Current guidelines focus on the use of objective measures (e.g. visual acuity) to guide 
treatment decisions (e.g. NICE, 2008). However Burton et al. (2013) argued that 
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patients may make different treatment decisions based on their daily experiences (i.e. 
whether they are able to see to do hobbies that are important to them). Thus it is 
important to consider patient experiences when guiding treatment decisions. The use 
of individualised measures of QoL are becoming more commonplace (e.g. the 
MacDQoL, used in the Inhibit VEGF in Age-related choroidal Neovascularisation (IVAN) 
trial to compare efficacy of Ranibizumab and Bevacizumab treatment (e.g. 
Chakravarthy et al. (2013)), is now linguistically validated into 25 languages as well as 
English for the UK).  
Medical decision makers such as NICE currently rely on the EQ-5D health status tool 
(often wrongly referred to as a QoL measure) to calculate utility values. Techniques 
such as Time Trade Off (TTO) are used to elicit preferences for different health states 
measured by the EQ-5D or similar tools and in turn are used to calculate Quality 
Adjusted Life Years (QALYs). The cost of a QALY gained from treatment is used to make 
decisions about which treatments to provide on the National Health Service (NHS). 
TTO measures have been criticised for being too hypothetical, ridiculous, and 
objectionable due to religious reasons (Brown et al., 2006). TTO questions ask patients 
to consider how much of their remaining life they would be willing to give up in return 
for normal vision. This has been criticised as elderly people may find this difficult to 
answer due to their limited life expectancy and indeed some question whether it is 
even ethical to ask such a question (Mitchell, 2007). Additionally the data sets used to 
calculate utility values are often collected from members of the general public who are 
given descriptions of the health condition being assessed but have no personal 
experience of the condition. Studies have shown that the general public tend to 
underestimate the impact of AMD on QoL (Stein, Brown, Brown, Hollands, & Sharma, 
2003). Thus treatments for AMD may be found to be less cost-effective in comparison, 
because of the public’s underestimation of the impact of AMD on QoL (Mitchell & 
Bradley, 2006).  
Functional limitations 
Visual impairment can impact on the day-to-day lives of pwAMD. Hochberg et al. 
(2012) found AMD patients experienced difficulty preparing meals, doing food 
shopping and travelling. These became more difficult with more severe vision loss. 
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Studies suggest that between 39-45% of AMD patients require help with at least one 
activity of daily living (e.g. Taylor, Hobby, Binns, & Crabb, 2016). Experiencing falls is 
twice as common in the population with wet AMD compared to elderly controls and 
people with wet AMD have a quadrupled need for assistance with daily activities 
(Soubrane et al., 2007). Vision-specific functioning has been found to be significantly 
worse in people with late AMD than early AMD (Lamoureux et al., 2011), and in people 
with both eyes affected as opposed to one eye (Dong et al., 2004; Marback, Maia 
Junior, Morais, & Takahashi, 2007). 
Whilst most research uses quantitative measures to examine the impact of AMD on 
non-vision specific functioning such as the Activities of Daily Living scale (ADL) and 
Instrumental activities of daily living (IADL), or vision-specific functioning such as the 
National Eye Institute-Vision Function Questionnaire (NEI-VFQ), other research has 
used qualitative methods. For instance, Bennion, Shaw, and Gibson (2012) reported a 
meta-synthesis of qualitative research on the experience of living with AMD. Whilst 
qualitative research can be used to confirm quantitative study findings (e.g. this review 
also found that pwAMD reported difficulties with everyday tasks such as cooking), it 
can provide a more complete picture of how people cope with these changes 
emotionally and the means by which they have adapted, which might not be picked up 
by using quantitative measures. For instance, many pwAMD reported that difficulties 
carrying out tasks and loss of ability to drive led them to fear losing their independence 
and increased worry about becoming a burden to family and friends. Indeed, loss of 
the ability to drive due to AMD has been cited as one of the main threats to 
independence (Weaver Moore & Miller, 2003).  
Psychological impact 
AMD has a considerable impact on psychological aspects of life. It has been linked to 
an increased risk for depression (e.g.Brody et al., 2001; Dawson, Mallen, Gouldstone, 
Yarham, & Mansell, 2014; Mathew et al., 2011; Soubrane et al., 2007), anxiety (e.g. 
Soubrane et al., 2007), poor quality of life (e.g. Mitchell & Bradley, 2006), poor 
psychosocial adjustment (e.g. Stanford, Waterman, Russell, & Harper, 2009), poor life 
satisfaction (e.g. Davis, Loviekitchin, & Thompson, 1995) and emotional distress (e.g. 
Williams et al., 1998). People with VI have a higher risk of committing suicide 
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compared to elderly controls (Johnson, Rovner, & Haller, 2014; Waern et al., 2002). 
People with vision loss were more likely than those without vision loss to be diagnosed 
with agoraphobia and social phobia, suggesting that anxiety may arise from the impact 
of vision loss on functioning related to specific places or social situations such as being 
on a bus or eating at a restaurant (van der Aa, Comijs, Penninx, van Rens, & van 
Nispen, 2015). Indeed, symptoms of depression have been found to be associated with 
loss of vision-specific functioning, independent of level of visual acuity (e.g. Banerjee, 
Kumar, Kulhara, & Gupta, 2008; Rovner & Casten, 2001, 2002). AMD patients who 
reported they were dissatisfied with performance of valued activities were 2.5 times 
more likely to become depressed than those satisfied with their ability to carry out 
valued activities (Rovner, Casten, Hegel, Hauck, & Tasman, 2007).  
The qualitative literature highlights individual differences in patients’ experiences with 
some reacting more positively to an AMD diagnosis than others (Bennion et al., 2012). 
Those who had not experienced much vision loss reported that AMD had little impact, 
however there was concern about future vision loss (Bennion et al., 2012). A variety of 
reactions to AMD have been reported including negative reactions such as uncertainty 
and fear about the future, frustration, sadness and inadequacy as well as positive ones 
such as hope, optimism (for the development of a cure for AMD or that vision would 
not deteriorate further) and an enthusiasm to hold onto independence (Owsley et al., 
2006; Weaver Moore & Miller, 2003). 
There is conflicting evidence on the impact of unilateral or bilateral AMD on emotional 
health.  Some results suggest a greater impact when both eyes are affected (e.g. 
Mitchell, 2003; Wong, Guymer, Hassell, & Keeffe, 2004). This may be due to poor 
visual acuity leading to difficulties carrying out vision-specific tasks, resulting in poorer 
psychological health. Others suggest poorer psychological health when only one eye is 
affected (e.g. Williams et al., 1998); perhaps due to fear of losing sight in the second 
eye (Slakter & Stur, 2005). Other factors associated with depression in AMD patients 
include neuroticism (Rovner & Casten, 2001), and time since diagnosis with more 
recently diagnosed patients reporting higher levels of emotional distress (Williams et 
al., 1998). 
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Social impact 
A meta-synthesis of the qualitative literature on the impact of AMD found that vision 
loss caused by AMD can lead to feelings of isolation (Bennion et al., 2012). People with 
AMD report barriers to social engagement including; feeling embarrassed because 
they are unable to see and recognise faces, and difficulty getting to places to see 
friends and family. In addition, public knowledge of AMD appears to be limited, and 
this led participants to feel that some family and friends lacked an understanding of 
their condition and were consequently unaware of their needs. Some participants 
were concerned that they would be labelled as a fraud due to their ‘invisible disability’. 
Whilst certification as SI or SSI gave some affirmation of their vision loss, some 
participants remained reluctant to disclose their sight loss to others. The decision to 
conceal their AMD led some people to refuse low-vision aids. Sometimes, concealment 
of AMD from friends and family was to avoid unwanted sympathy (Bennion et al., 
2012).  
(A comprehensive review of the impact that AMD has on people who provide support 
to someone with AMD is presented in Chapter 5.) 
Support for living with AMD 
Registration as severely sight impaired (blind) or sight impaired (partially sighted) 
In England and Wales, registration as sight impaired (SI) or severely sight impaired (SSI) 
is initiated with certification from a consultant ophthalmologist at the consent of the 
patient (Bunce, Xing, & Wormald, 2010). Data from April 2007 to March 2008 estimate 
that AMD accounts for over half of all registrations as SI or SSI in the UK (Bunce et al., 
2010). This may be an underrepresentation of the true number of people eligible for 
registration. Thetford et al. (2009) reported that some patients eligible for registration 
may not be registered. People already registered as SI and who have experienced a 
deterioration in sight since registration may also experience barriers and delays to 
registration as SSI including: having to be referred to see an ophthalmologist and other 
health conditions taking precedence (Hodge, Thetford, Knox, & Robinson, 2015).  
When sight loss has deteriorated to a point where patients can receive a Certificate of 
Visual Impairment from an ophthalmologist, the council will receive a copy of the 
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certificate. They should then contact the patient to ask if they would like to be 
registered and if they would like a vision rehabilitation needs assessment. Otherwise, 
people with VI can contact their council directly and ask for an assessment. Referral 
can also be via another organisation or service.  
Low-vision rehabilitation services 
Given the impact of AMD, what support is available to help pwAMD manage the 
changes associated with vision loss? All councils in England should offer vision 
rehabilitation services to people with VI (RNIB, 2016b). This may either be provided by 
the council or the council may contract a sight loss charity or organisation to provide 
this service. Vision rehabilitation provides training and advice to help people learn 
daily living skills to maintain independence. This may include, for example: tips, advice 
and training on how to cook, clean and maintain the home safely, advice on lighting, 
and mobility training (e.g. building confidence to move around safely both inside and 
outside the home). 
Excluding financial support, most services are available to people with VI regardless of 
registration status. The latest Royal College of Ophthalmologist guidelines (RCOphth, 
2013) recommend that eye-care professionals should not wait to refer a patient to 
low-vision services until all treatment options have been exhausted or until a patient’s 
vision has deteriorated to the point when registration becomes appropriate. It may be 
easier to make changes that may help activities of daily living when a patient’s vision is 
still good. However there is evidence to suggest that many people do not receive 
support until after registration, and even then, support may be limited (Hodge et al., 
2015; Thetford et al., 2009). People with VI reported being seen for an initial 
assessment, but were then left to contact services for further help if needed (Hodge et 
al., 2015). However many reported barriers to accessing this help, such as not knowing 
who to contact (Thetford et al., 2009). Others were unaware of what support was 
available or did not know what help to ask for (Thetford et al., 2009). Additionally, 
offers of help soon after diagnosis or registration may be rejected if people with VI are 
unable to accept support at a time when they are still coming to terms with their 
diagnosis (Thetford et al., 2009). The Royal National Institute of Blind People (RNIB) 
report that many people with vision loss are unaware that vision rehabilitation services 
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are available and that these services can be used at any point; they are not restricted 
to people who have just been diagnosed or registered, or have experienced recent 
vision loss (RNIB, 2016b) . Thus people with VI should be made aware of the ongoing 
availability of these services and who to contact for help (RNIB, 2016b). 
Vision rehabilitation support is provided free-of-charge, however a financial 
assessment is usually required if social care is needed (e.g. having someone to help 
with domestic tasks). Minor aids and adaptations, up to the value of £1000, are also 
provided for free. If the person with VI has an unpaid carer who helps to meet some of 
their needs, they have the right to request a carer’s assessment. Following this, carers 
may receive help from the council, such as equipment to help with caring duties or 
being offered support (e.g. respite breaks). They may also be eligible for specific 
benefits (e.g. Carer’s Allowance). 
A freedom of information request found that, in England, just under half of people 
registered as SI or SSI and who are in contact with their council have not received a 
vision rehabilitation assessment for their support needs (RNIB, 2016a). Of those who 
did receive an assessment, many felt they did not receive an assessment sensitive to 
their particular needs (RNIB, 2016a). Similarly, the Network 1000 survey found that 
half of the survey respondents had never been to a low-vision clinic despite being 
registered as SI or SSI (Douglas, Pavey, Corcoran, & Eperjesi, 2010). Referral to vision 
rehabilitation varied widely across comparable local authorities in England (RNIB, 
2016a). The variable distribution of low-vision services across the UK have been 
reported elsewhere (Culham et al., 2002). For instance, eye clinic liaison officers 
(ECLOs) provide patients with much-needed information about their eye condition, the 
services available in eye clinics and the community, emotional support and referral to 
social services. They are said to bridge the gap between health and social care (RNIB, 
2015). However this service has not been widely-implemented. It is thought that only 
around 30% of eye clinics in the UK have an ECLO (RNIB, 2015).  There is wide variation 
on how this role is set up; some clinics employ someone full-time to fill this position, 
whilst in other clinics the role is undertaken by volunteers. The role has not been 
established as a statutory element of eye health care, despite evidence suggesting that 
the service can provide health and social care budgets with a financial return of £10.57 
for every one pound invested (Sital Singh, 2013).  
 37 
 
Dickinson et al. (2011) suggested a template model of a comprehensive low-vision 
service would include ophthalmological care (diagnosis, treatment and monitoring), 
social care needs (review of the home environment, self-care and benefits), low-vision 
aids (optical aids, lighting), and emotional support (counselling). The LOVSME project 
(LOw-Vision Service Model Evaluation) profiled seven UK low-vision services. No 
standard model of delivery existed in the UK. The seven services profiled had different 
formats for how they provided low-vision services (Dickinson et al., 2011). The services 
were multi-disciplinary but none fulfilled all the components of the comprehensive 
‘template’ model (Dickinson et al., 2011). Only one of the seven services performed 
clinical audits of effectiveness in the form of QoL evaluations, but these data had not 
been published at the time of the evaluation, and it was unclear how the results were 
used. Thus low-vision services provided in the UK vary across the country and their 
effectiveness has not yet been shown in published studies. 
Binns et al., (2012) conducted a systematic review of low-vision rehabilitation (LVR) 
evaluations from around the world. Fifty eight articles reporting the results of 52 
studies met the inclusion criteria of having included people with a visual impairment in 
a rehabilitation service, and with the study design including a comparison (between 
groups or over time). Only 7 studies were RCTs. The authors examined potential 
sources of bias including the robustness of the study design (e.g. RCT vs before and 
after), whether the study included a wait list control, whether details were provided on 
randomisation and masking procedures (if relevant to the study design), the use of 
validated outcome measures, whether the outcome data were collected by someone 
independent of the providers running the service and the detail of the results provided 
(e.g. reporting of data to allow effect sizes to be calculated). Only studies that included 
over ten participants were included in the review. The synthesis of the evidence 
provided in the studies found provision of LVR improved functional outcomes (e.g. in 
ADLs) in people with VI but the evidence for effects on mood, QoL and health status 
were conflicting (Binns et al., 2012). A variety of measures were used to assess QoL. 
Many studies included in the review stated an increase in vision-related QoL after the 
intervention, however upon closer inspection, Binns and colleagues suggest that these 
results were due to improvements in the items from these measures that assess 
functional abilities, and that these showed greater sensitivity to the intervention. 
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The lack of consensus of the impact of LVR on symptoms of depression may be due to 
selection bias. Patients with depression have been found to be less likely to use low-
vision services (Tolman, Hill, Kleinschmidt, & Gregg, 2005). Thus it may be difficult to 
detect the effect of these services on depression.  
According to Binns and colleagues, the studies on LVR to date were poorly designed 
(e.g. few studies included a comparison group). There were difficulties making 
between-study comparisons as there was seemingly a lack of consensus on the best 
outcome measures to use for evaluation (the authors reported that 47 different 
outcome measures were used).  Lack of follow-up made it difficult to establish the 
long-term effectiveness of interventions (Binns et al., 2012). The evidence included in 
the review was not sufficient to provide recommendations on what type of service 
produces the best outcomes for people with VI. More high-quality RCTs of LVR are 
needed, plus a clearer focus on the cost-effectiveness of interventions (Binns et al., 
2012). More research is needed to ascertain the benefits of LVR on the QoL of pwAMD. 
Several barriers to LVR uptake have been reported. These include difficulty accepting 
vision loss, a reluctance to use services that were perceived as being geared towards 
the SSI, a lack of information about low-vision services from eye specialists, fear of 
being stereotyped and difficulty travelling to the clinic (Pollard, Simpson, Lamoureux, 
& Keeffe, 2003; Southall & Wittich, 2012). 
Many clinics in the UK do not routinely provide emotional support to people with VI 
despite the psychological impact of AMD (Gillespie-Gallery, Conway, & Subramanian, 
2012). Cimarolli et al. (2016) suggested that rehabilitation professionals should refer 
patients to specialist mental health services if depression and anxiety symptoms do 
not respond to rehabilitation. Furthermore, more needs to be done to encourage 
patients who are depressed to attend LVR. 
In conclusion, the development of an evidence-based intervention that can be used 
within existing care systems has been hindered by a lack of research into the cost-
effectiveness of interventions. Additionally the use of a variety of components in 
interventions (e.g. teaching problem-solving skills, LVA provision) and the variety of 
outcome measures used in evaluation have prevented between-study comparisons. 
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Many people with VI receive information and support from sight loss voluntary and 
charitable organisations. Indeed Hodge et al. (2015) reported that people with VI were 
more likely to receive support from the voluntary sector than the statutory sector 
(although this may be due to the method of recruitment used and area from which 
their participants were recruited: participants were recruited through a voluntary 
organisation which played a significant role in the area in which the participants lived). 
Services provided by the RNIB and the Macular Society include, for instance, emotional 
support and provision of information on eye conditions and treatments available. 
These services can be received over the phone or internet and thus may be more 
accessible than locally provided services run at the hospital or social services if patients 
have difficulty getting to these places. 
If people with VI are able to get out and about, local support groups may provide 
additional support. An evaluation was run on one of the many peer support groups run 
by members of a UK charity (the Macular Society), for patients newly diagnosed with 
AMD (Bradley, Mitchell, & Bradley, 2005). The peer support programme consisted of 
six weekly discussion groups.  Participants also received leaflets on the topics discussed 
in the sessions. Using the Well-being questionnaire (W-BQ12), participants who 
reported poorer negative well-being at baseline experienced greater improvements in 
well-being post-intervention than those who reported better well-being at baseline. A 
course evaluation form designed for the study found that participants thought the 
leaflets were informative, and that the aims of the programme had been met (to 
provide information about MD, to provide friendship and support, and to promote 
adjustment to MD).  Attendance rates were high suggesting acceptance of the 
programme. 
Information and support provision to patients with AMD 
The diagnostic consultation is, for many people, the first opportunity to receive 
information, support and advice on their macular condition and ways of managing 
their condition. If there is no treatment available for the patient’s AMD, they are often 
discharged and this consultation may be the only time that patients are seen in clinic 
unless they experience a deterioration in vision or are referred for registration as SI or 
SSI. 
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The first study presented in this thesis follows a previous survey carried out in 1999 by 
Dr Mitchell and Professor Bradley at Royal Holloway, University of London, in 
collaboration with the Macular Society (previously called the Macular Disease Society). 
This study formed part of the PhD thesis by Dr Jan Mitchell (Mitchell, 2003). The 
Macular Society is a British charitable organisation who support people with a macular 
condition. The Macular Disease Society Questionnaire (henceforth referred to as 
“MDSQ 1999”) used in the survey was designed in response to reports of 
unsatisfactory healthcare experiences from members of the Leicester local group of 
the Society, chaired by Peggy Bradley who undertook an initial pilot study. The 
subsequent postal survey was sent to 2000 randomly selected members of the 
Macular Society in 1999, and received a 71% response rate (1421 completed 
questionnaires were returned). The majority of respondents reported having AMD 
however the data included respondents with other macular conditions including 23 
with macular dystrophy, 15 with macular hole, 8 with pseudoxanthoma elasticum and 
3 with diabetic macular retinopathy. 
Results of the MDSQ 1999 were published in the British Journal of Ophthalmology 
(Mitchell, Bradley, Anderson, Ffytche, & Bradley, 2002), and Jan Mitchell’s thesis 
(Mitchell, 2003). Key findings from the survey included: over 50% of respondents 
thought that the eye specialist who first diagnosed their macular condition was not 
interested in them as a person, and 41% reported being dissatisfied with the diagnostic 
consultation. Respondents were asked to give their reasons for dissatisfaction. The 
most common reason was the attitude of the eye specialist; they were commonly seen 
as being dismissive, patronising, brusque or unfeeling. The second most cited reason 
for dissatisfaction was lack of information provision to patients about their condition 
and/ or what further help was available.  
Experiences with general practitioners (GPs) were not much better. Twice as many 
respondents reported that their GP was “not at all well-informed” about their macular 
condition compared with those who said their GP was “very well-informed”. About 
equal numbers reported that their GP was “very helpful and supportive” about their 
macular condition, or “not at all helpful and supportive”. There was a significant 
correlation between perceived GP knowledge and perceived GP supportiveness 
(Mitchell et al., 2002). This is important because early consultations with healthcare 
 41 
 
professionals may affect future help-seeking. Unsatisfactory experiences with GPs may 
result in patients being reluctant to consult GPs when further help and support is 
needed (e.g. referral to an ophthalmologist for registration).  
The survey also found that 1247 respondents were told that nothing could be done to 
help with their macular disease (Mitchell et al., 2002). Understandably this provoked 
an emotional reaction. The most commonly cited reactions were anxiety and / or 
depression (60.7%) and resignation (60.3%). Worryingly, as many as 54 respondents 
(4.3%) reported feeling suicidal. Other research has found that people with VI who 
were discharged with the message that ‘nothing can be done’ were less likely to go for 
eye tests (Thetford et al., 2009). Continual monitoring of eyesight is important in case 
dry AMD turns to treatable wet AMD, or if wet AMD develops in the second eye. Early 
detection and treatment is likely to lead to better visual outcomes. In addition, 
although it may be the case that nothing can be done in terms of medical treatment 
for the macular condition, there are ways in which pwAMD can be supported such as 
through low-vision aid provision and training that can help patients to manage their 
condition. Patients should be made aware of the availability of such support and that 
they have not been left to manage their condition alone. However previous research 
suggests they are not given information about further support available (Mitchell et 
al., 2002; Thetford et al., 2009; Thetford, Robinson, Knox, Mehta, & Wong, 2011). 
The majority of respondents to the 1999 survey reported experiencing visual changes 
since the onset of their macular condition, such as blurred vision, flashing lights or 
difficulty seeing at night (n=1111, 78.2%) (Mitchell et al., 2002). Of these respondents, 
a quarter reported experiencing visual hallucinations as a result of their macular 
condition (n=282, 25.4%). Only 122 (43.3%) had talked about these hallucinations with 
a healthcare professional (HCP), and of these, only 59 had been given a cause for the 
hallucinations (48.4%). The explanations given were not always accurate or reassuring. 
They included being due to age (n=3), stress (n=2), brain confusion (n=1), the 
environment (n=1), having nothing to do with their macular condition (n=1) or being 
due to psychological reasons (n=1). Mitchell et al. (2002) suggested that lack of 
information provision about visual hallucinations may lead to hallucinations being 
attributed to a serious mental illness such as dementia. Indeed not knowing about CBS 
at the onset of symptoms and having attributed symptoms to mental illness were 
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associated with people reporting that CBS had a negative effect on their lives (Cox & 
ffytche, 2014). Thus lack of information provision or information that is delivered in an 
unhelpful manner, may affect pwAMDs’ understanding of their condition, their well-
being and future help-seeking behaviour.   
Leventhal’s Self-regulation model of illness (e.g. Leventhal et al., 1997) suggested that 
patients form cognitive and emotional representations of their illness by comparing 
their own ideas about their illness with the information they receive. Misconceptions 
about their illness and inappropriate information provision may lead to maladaptive 
response to the illness. For instance, believing that one’s illness is uncontrollable leads 
to more passive coping (Moss-Morris, Petrie, & Weinman, 1996). In AMD, this may 
lead to patients not adopting behaviours that could prevent further deterioration such 
as protecting eyes from bright sunlight, taking AREDS 2 nutritional supplements and 
stopping smoking. Believing that one is to blame for their condition can lead to 
emotional distress (e.g. Newsom, Knapp, & Schulz, 1996). PwAMD have reported 
incorrect causes for their AMD including ‘wear and tear’ due to having watched ‘too 
much TV’ or reading (Burton, Shaw, & Gibson, 2013). If these incorrect causes are not 
addressed, this may lead to poorer emotional outcomes and unnecessary avoidance of 
previously-enjoyed activities. 
Patient satisfaction has been consistently associated with better patient outcomes. 
Stewart (1995) reviewed the literature and found that the quality of physician-patient 
communication in the history taking segment of the consultation and during discussion 
of the management plan, was found to influence patient health outcomes including 
emotional health, symptom resolution, function, physiologic measures (e.g. blood 
pressure and blood sugar level) and pain control. A more recent review found 
consistent links between patient experience, clinical effectiveness and patient safety 
(Doyle, Lennox, & Bell, 2013). Positive patient experiences were associated with better 
self-rated and objectively measured health, adherence to recommended treatment 
and medication, preventative care (such as use of screening services and 
immunisations) and healthcare resource use (Doyle et al., 2013). 
Patient experiences are an important indicator of quality of healthcare and are 
routinely collected in the NHS using large-scale surveys, e.g. General Practice Patient 
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Survey (https://gp-patient.co.uk/), Care Quality Commission national patient 
experience surveys (http://www.nhssurveys.org/), National Cancer Patient Experience 
survey (https://www.quality-health.co.uk/surveys/national-cancer-patient-experience-
survey).    
Best practice guidelines 
Following the publication of the 1999 survey results, the Royal College of 
Ophthalmologists (RCOphth) produced guidelines for management of AMD.  Whereas 
initial guidance focussed on possible treatment options (Amoaku, 2008; RCOphth, 
2000), the guidelines first published in February 2009 (RCOphth, 2009) (updated 
September 2013, RCOphth, 2013), set standards for best practice and included 
recommendations about information to be communicated to patients within the 
diagnostic consultation. The steering group involved in writing the guidelines included 
a Macular Society representative who used the MDSQ 1999 survey results and the 
Mitchell et al. (2002) paper to assist the development of the recommendations. 
The RCOphth 2009 guidelines stated that all patients require: a clear diagnosis 
(ensuring patients know the name of their condition), the prognosis and what to do if 
vision deteriorates, written information for patient and relatives, and signposting to 
other organisations such as the Macular Society for further help and support. The 
guidelines also highlighted the importance of an awareness of the impact of a 
diagnosis of this progressive eye condition, and the need to show empathy with 
patients. Moreover, the guidelines emphasised that patients require information 
about the possibility of experiencing visual hallucinations (Charles Bonnet Syndrome 
[CBS]) in order to avoid distress resulting from incorrectly attributing the cause of 
these hallucinations to, for example, dementia (RCOphth, 2009).  
There has yet to be an investigation of whether healthcare experiences have improved 
for pwAMD following the introduction of the 2009 RCOphth guidelines and the 
publication of the 1999 survey results in 2002 (Mitchell et al., 2002). A recent 
qualitative study found gaps in information provision to pwAMD (Burton et al., 2013). 
These included the benefits of registering as SI or SSI and details of how to register, 
causes of AMD, reasons for, and explanations of, medical processes and eye 
procedures, how to monitor eyes for changes in vision and the impact of smoking, 
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healthy diet and vitamin supplements on eye health. The most common source of 
information provided was verbal information given in hospital appointments however 
participants reported difficulty in understanding what was being said, and trouble 
recalling the information (Burton et al., 2013). It was also noted that many participants 
had not heard of AMD before diagnosis and as a result, diagnosis came as a shock. This 
lack of prior knowledge meant that participants lacked a frame of reference which 
they could use to make sense of their condition, and thus the information provided in 
consultations was all the more important in terms of helping participants understand 
their condition (Burton et al., 2013). A large-scale quantitative study may be able to 
establish whether information and support issues for pwAMD are widespread.  
Whilst information provision in the diagnostic consultation may be key, it is recognised 
that diagnosis of a condition causing vision loss can be a shock (Beverley, Bath, & 
Barber, 2007; Hodge, Barr, Bowen, Leeven, & Knox, 2013; Thurston, Thurston, & 
McLeod, 2010). Information may be difficult to take in at the time of diagnosis and this 
points to the need for ongoing support and information provision (Beverley et al., 
2007). Thus the first study presented in this thesis will also examine sources of 
information and support after the initial diagnostic consultation.  
Statement of epistemological stance 
Crotty (1998) argued that in order to justify the use of specific methods and 
methodologies in research, researchers must be clear on the assumptions they bring to 
their work. This includes the philosophical assumptions they bring to the research and 
their resulting worldview. 
Briefly, a post-positivist worldview argues that research can be a value-free process 
where objective knowledge (the ‘truth’) can be gained through empirical methods 
such as direct observation and measurement, and that the world exists independently 
from the individual’s perception of it. This worldview is typically associated with 
quantitative research. In contrast, the constructivist worldview, which is typically 
associated with qualitative approaches, uses individuals’ views and perspectives to 
inform the understanding or meaning of a phenomenon. 
Throughout this thesis, a pragmatic approach is taken. Pragmatism provides a 
philosophical basis for research which is not committed to a specific theory about 
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reality and acknowledges that there are many different ways of making sense of the 
world. This might mean combining both deductive and inductive thinking, typically 
associated with post-positivism and constructivism, respectively (Creswell & Plano 
Clark, 2011). 
In pragmatism, the focus is on using the most suitable methods for answering the 
research question/s. This means that it can advocate the use of multiple methods of 
data collection to inform the problem/s under study; if this is the best way to answer 
the research question. Its epistemology is focused on practicality; the researcher 
collects data using a ‘what works’ approach to answering the research question.  
Literature review search strategy 
The purpose of the literature reviews reported in this Chapter and in Chapter 5 were to 
give a comprehensive overview of the current state of knowledge on the topic and 
identify gaps in the research in order to help define the research questions. Thus a 
narrative review was chosen over a more in-depth systematic review methodology 
which is used to answer a specific research question. Systematic reviews should 
provide enough information about the search strategy used to enable replication. 
Whilst this is not normally reported for a narrative review, an overview of the search 
strategy used in Chapter 1 is presented in Appendix 1, and in Appendix 8 for Chapter 5, 
for information. 
Overarching research questions of the thesis 
1. To investigate whether healthcare experiences of patients with age-related 
macular degeneration have improved since the first survey in 1999. To 
determine whether significant improvements have been made since 
publication of the 1999 survey results in 2002, and/ or the Royal College of 
Ophthalmologists (RCOphth, 2009) management guidelines in 2009. (Methods 
in Chapter 2, results and discussion are in Chapter 3.) 
2. To examine other sources of information and support used by people with 
AMD (pwAMD) after the diagnostic consultation, in particular support from 
friends and family. (Methods in Chapter 2, results and discussion in Chapters 3 
and 4.) 
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3. To explore the impact of receiving and providing care for AMD from the 
perspectives of pwAMD and their caregivers. (Literature reviewed in Chapter 5, 
methods in Chapter 6, results and discussion in Chapters 7 (quantitative study) 
and 8 (qualitative study).) 
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Chapter 2: The Macular Society 2013 survey: Methodology. 
AIMS AND OBJECTIVES 
The main aim of the first study presented in this thesis was to establish whether 
healthcare experiences have changed for people diagnosed with macular conditions 
since a similar survey was carried out in 1999 (see Mitchell et al., 2002). A summary of 
the findings from the 1999 survey appear in Chapter 1.  
Following publication of the 1999 survey results in 2002, the Royal College of 
Ophthalmologists (RCOphth) produced guidelines for the management of age-related 
macular degeneration (AMD) (RCOphth, 2009). The guidelines published in February 
2009 (updated September 2013) set standards for best practice and included 
recommendations about information to be communicated within the diagnostic 
consultation to people with AMD (RCOphth, 2009, 2013). (See Chapter 1 for a 
summary of these recommendations.) This study aimed to investigate whether 
significant improvements in information and support provision in the diagnostic 
consultation had been made since publication of the 1999 survey results in 2002, 
and/or the RCOphth AMD guidelines in 2009.  
An additional objective of this study was to investigate sources of information and 
support for people with macular conditions after the diagnostic consultation, e.g. from 
eye-care professionals (ECPs), low-vision clinics (LVCs) and friends and family.  
METHOD 
Research design 
The present study used survey methodology in order to make direct comparisons with 
responses from the 1999 Macular Disease Society Questionnaire (MDSQ 1999). Using 
cross-sectional survey methodology is a time- and resource- efficient way to collect 
data from a large sample. Many people with macular conditions experience difficulties 
with reading and writing, hence telephone survey completion with the researcher was 
offered. 
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Participants 
A total of 4000 members of the Macular Society who joined after 1st January 2000 
were selected from the membership database using campaign management software 
(NFP CARE, Advance Computer Software Group). In order to achieve an adequate 
sample size to investigate the impact of the RCOphth guidelines, the sample was 
stratified based on date of joining the Macular Society (as a proxy for date of 
diagnosis). Two thousand of the total 4000 members sampled were randomly selected 
from a total sample of 4879 members who had joined within three years prior to the 
2013 survey being undertaken (i.e. between the 1st October 2010 and 30th September 
2013) (referred to as ‘recently joined’). A further 2000 members were randomly 
selected from the 7845 members who had joined the Society between 1st January 2000 
and 30th September 2010. Further selection criteria and the number of respondents 
included/excluded are summarised in Figure 2.1.  
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Figure 2.1. Flowchart of respondents included in the analyses.
 50 
 
The MDSQ 1999 (following pilot testing and clarification as required) was sent to 2000 
randomly selected members of the Macular Society in 1999, and 1421 completed 
surveys were received (71% response rate). The Macular Society has since sent other 
surveys to its members, and response rates have fallen (e.g. Cox & ffytche, 2014 
obtained a response rate of 31%, n=1254). A total of four thousand 2013 surveys were 
mailed in order to achieve a comparable sample size with the MDSQ 1999. 
The inclusion criteria were that participants must be over the age of 18, be currently 
residing in the UK, have been diagnosed with a macular condition, were not a 
professional member of the society nor a supporter of someone with a macular 
condition, and must be able to read, write and understand the English language1. In 
order to investigate the impact of the RCOphth 2009 guidelines which focus on AMD, 
only respondents who were diagnosed with AMD were selected for analysis. Other 
macular conditions have different prognoses and treatments available, thus 
respondents with these conditions may have significantly different healthcare 
experiences. AMD is the most common macular condition and participants with AMD 
formed the majority of the sample. For continuity, the results presented in this thesis 
are from respondents who were diagnosed with AMD. 
Materials 
Updating the Macular Disease Society Questionnaire 1999 (MDSQ 1999) 
In response to reports of unsatisfactory experiences with healthcare professionals 
(HCPs) among members of the Macular Society, members of the Leicester local 
Macular Society group instigated the design and piloting of the MDSQ 1999. This 
survey included questions derived from the literature whilst others were newly-
designed and were based on experiences with HCPs at the time of diagnosis and 
thereafter. A copy of the MDSQ 1999 is provided in Appendix 2. 
Updating the 1999 survey involved collaboration between the author, Prof Clare 
Bradley (CB), Dr Jan Mitchell (who managed the MDSQ 1999), Helen Jackman (the 
                                                          
1 Participants were asked if English was their first language and if not, to rate their level of English 
comprehension on a 7-point scale (with 7 being ‘very fluent’). All respondents whose first language was 
not English self-rated their fluency as 5 or above. The author checked the hard copy survey responses of 
respondents with scores of 5 or 6, and concluded that they were able to understand and respond to the 
survey questions without difficulty. Thus all respondents were included in analysis. 
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Chief Executive Officer (CEO) of the Macular Society at the time), and Cathy Yelf (the 
Head of External Relations at the Macular Society at the time, now CEO).  This involved 
careful consideration, discussion and compromise across all parties to include 
questions that would investigate the aims of the study and that were of importance to 
stakeholders including the Macular Society, HCPs, researchers and members of the 
Macular Society.  
A copy of the Macular Society 2013 survey (MSQ 2013) is provided in Appendix 3. 
Table 1 in Appendix 4 provides details of the survey questions including: the MDSQ 
1999 questions which were omitted from the MSQ 2013, changes to the wording of 
questions replicated from the MDSQ 1999, and the newly-designed questions for the 
MSQ 2013. The results presented in Chapter 3 focus on information and support 
provision in the diagnostic consultation and thereafter. Chapter 4 presents findings on 
support received for AMD from family and friends. Details of question design for these 
topics are presented below. Details of questions from the MSQ 2013 that are not 
reported in this thesis are provided in Table 1, Appendix 4, for information.  
Three key questions on experiences in the diagnostic consultation from the MDSQ 
1999 were replicated to enable comparison over time. These asked respondents 
whether they were given the name of their macular condition at the time of diagnosis, 
if they felt the HCP who diagnosed them was interested in them as a person, and their 
overall satisfaction with the diagnostic consultation. In the MDSQ 1999, respondents 
were asked to provide reasons for dissatisfaction with the consultation only. The MSQ 
2013 used a modified version of this question which asked respondents to provide 
reasons for dissatisfaction or satisfaction with the diagnostic consultation. The wording 
of the questions were changed from experiences with the ‘eye specialist’ (in the 1999 
survey) to ‘healthcare professional’ (in the 2013 survey) to reflect the fact that 
optometrists can now diagnose macular conditions (whereas in 1999 this was not the 
case). 
Seven new questions were designed to assess the incorporation of the RCOphth 
guidelines into practice, and focus on information and support provision around the 
time of diagnosis (see rows 16-21 of Table 1, Appendix 4). Respondents were asked 
which HCP they considered as the first to diagnose their macular condition.  
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Two questions on experiences with GPs were replicated from the 1999 survey. These 
asked about respondents’ perception of their GPs’ knowledge of their condition and 
how supportive they felt their GP was about their condition. Responses were made on 
a Likert scale of 0 (not at all) to 3 (very). In the 1999 survey, missing data on responses 
to the two GP questions were considerable. Many wrote on the survey that they had 
not seen their GP about their macular condition (Mitchell et al., 2002).  A “not 
applicable” option was therefore added in the 2013 survey to investigate how many 
had not visited their GP about their AMD.  
In order to investigate help and support received after the diagnostic consultation, 
several questions were replicated from the MDSQ 1999 to enable comparison over 
time. This included questions on whether or not respondents had experienced visual 
hallucinations and whether they had spoken to a HCP about them (see row 53 of Table 
1, Appendix 4), attendance at a low-vision clinic (LVC) (see rows 41-43 of Table 1, 
Appendix 4), and membership of a local group for people with macular conditions (see 
row 39 of Table 1, Appendix 4). A newly-designed question investigated whether 
respondents had received psychological support for AMD since diagnosis and if not, 
whether they would have liked to have received this support now or at the time of 
diagnosis. A new question was designed to assess whether respondents had recently 
seen an eye-care professional (ECP), and if not, whether they felt they had needed to. 
If respondents had ticked that they had not seen a ECP but had needed to, they were 
asked to provide reason/s why. 
A new question was designed to investigate how many respondents received unpaid 
care, support or assistance for their macular condition, who provides this support and 
how much support they receive per week.  
The MSQ 2013 included the 16-item Well-Being questionnaire (W-BQ16). This contains 
four subscales: negative well-being, positive well-being, energy, and stress. For all 
scales/ subscales, higher scores represent more of the type of well-being indicated by 
the name of the scale/ subscale. Scores for the total scale range from 0-48. The MDSQ 
1999 included the 12-item Well-Being questionnaire (see row 32 of Table 1, Appendix 
4). The W-BQ12 but not the W-BQ16, has been psychometrically evaluated with a 
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sample of people with macular conditions (Mitchell & Bradley, 2001). The W-BQ16 was 
included to enable psychometric evaluation of this longer version.   
Quality of life was measured using two overview items from the MacDQoL (Mitchell et 
al., 2005). One item assessed general quality of life (QoL) and was measured on a 
7-point scale (excellent/ very good/ good/ neither good nor bad/ bad/ very bad/ 
extremely bad). The other assessed the impact of MD on their QoL. It was measured 
on a 5-point scale scored from -3 which indicates their QoL would be ’very much 
better’ (if they did not have their macular condition), through to 0 (the same), to +1 
(where it would be ‘worse’). Higher scores indicate better quality of life. The MDSQ 
1999 contained the same two QoL questions, with some differences to the response 
options for the MD-specific QoL item and stem for the general QoL item (see row 31 of 
Table 1, Appendix 4). In a previous version of the MacDQoL used in the MDSQ 1999, 
there were three positive response options for the MD-specific QoL item (‘a little 
worse’, ‘much worse’ and ‘very much worse’). This was reduced to one option 
(‘worse’). This change was made because few people use this end of the scale, as it 
would indicate benefits of having a macular condition, which are usually perceived as 
being few if any (see Mitchell & Bradley, 2004). 
Socio-demographic information (age, gender, living circumstances (alone or with 
other/s)) were collected. Eye-related information (wet or dry AMD, registration status, 
AMD in one or both eyes, date of first diagnosis, self-assessed change in vision since 
diagnosis) were also gathered.  A single-item was used to measure self-rated health 
status (see row 75 of Table 1, Appendix 4). 
Questionnaire package presentation 
Similar to the MDSQ 1999, the 2013 survey was designed for self-completion by people 
with a macular condition and pilot tested. 
Macular conditions are characterised by central vision loss. Central vision is used to 
process fine details, therefore many participants would have difficulty reading a 
regular paper survey. Prof Clare Bradley and other researchers at the Health 
Psychology Research Unit have considerable experience in formatting questionnaires 
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for people with macular conditions, and the Macular Society have a knowledge base of 
acceptable fonts and layouts that they use in their publications.  
Based on this expertise, the following design principles were followed:  
 Use of size 16 Arial font.  
 Text was justified to the left to give a strong vertical line down the page to 
make the questions easier to follow. (Questions are more likely to be missed by 
people with vision loss if they start mid-page or are indented.)  
 The use of upper case letters was avoided except where dictated by grammar. 
Words formed of lower case letters are differentiated more easily than those 
with upper case letters. They also give the reader a better indication of word 
shape which helps visually impaired people to anticipate, to some extent, what 
the word might be. 
 Response boxes were placed immediately after the end of a question, where 
possible. Where response boxes where placed away from the question, a 
heavily dotted line guided the reader to the boxes.  
 Boxes with solid black lines were provided for free-text responses. People with 
macular conditions may find it difficult to write along lines, as these lines can 
appear wavy. Therefore writing in boxes may be less difficult. 
 Where a question had a yes/ no answer that led to a different pathway of 
responses, a solid black arrow from the yes/ no tickbox indicated the pathway 
for respondents to take. This was included to make it easier for respondents to 
follow the question.  
 Careful consideration was taken to ensure that questions weren’t split across 
pages. 
 The anchors for the W-BQ16 and questions on experiences with GPs were 
specified in the instructions as well as at the top of the scale, as the anchors 
above the scale could not be left-justified and might be missed by someone 
with a visual impairment. 
The questionnaire booklet, including a single-page consent form, consisted of 31 
pages. Questions were printed double-sided on A3 sheets and stapled down the 
middle to create a booklet. Please see Appendices 3, 5 and 6 for all materials sent to 
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participants. The survey packs included (in the following order): a covering letter 
(designed by Helen Jackman, former CEO of the Macular Society, checked by the 
author), a participant information sheet, the survey booklet (containing the consent 
form, the MSQ 2013, a contact details sheet, a sheet requesting the contact details of 
the participant’s caregiver, and blank pages for continuation of survey responses), a 
sheet asking participants to provide their reason/s for not taking part (if applicable) 
and a freepost envelope addressed to the author. The contact details sheet asked 
participants to provide their name, telephone number, postal and email address if they 
agreed to be contacted by the researcher for clarification of their responses (if 
needed). This sheet also asked respondents if they would be interested in taking part 
in future research. A ‘yes’ or ‘no’ tickbox response was provided. The second study 
presented in this thesis investigates the impact of receiving and providing support for 
AMD from the perspective of people with AMD and their caregivers. Thus, in the MSQ 
2013 questionnaire booklet, respondents were asked to provide the contact details 
(name, telephone number, postal and/or email address) if they knew a caregiver who 
they felt might be interested in taking part in this research. (It was stated that they 
would be under no obligation to take part.) 
The researchers’ (EB and CB) contact details (telephone number, email and postal 
addresses) were provided for enquiries about the research. 
Seven hundred and twenty-four of the 4000 members selected to take part had opted 
to receive information from the Macular Society on audio CD. The Macular Society 
recorded the information from the cover letter and information sheet (including the 
author’s contact details), onto an audio CD. This was included in the questionnaire 
pack for the members who had opted to receive information on audio CD. 
Ethics 
Ethical approval was obtained from the ethics committee of Royal Holloway, University 
of London (Ref: 05-13). The committee requested that we make an attempt to debrief 
the participants prior to publishing material in a publication. The costs of creating and 
sending a debriefing newsletter (and audio CD) to all the participants that were sent 
the survey were estimated to be £1404.57. These costs were not budgeted for in the 
project grant. We put forward this explanation to the ethics committee and suggested 
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a summary of the results in the Macular Society’s journal, Digest, (which is sent to 
members of the society) would be sufficient in informing participants of the results of 
the survey. The ethics committee agreed to this. A summary of the results appeared in 
Digest 2015 (Boxell & Bradley, 2015). 
To preserve the Macular Society members’ confidentiality, the surveys were sent from 
the Macular Society. The researchers did not have access to participants’ personal 
details unless they were provided by the participant (either by requesting telephone 
completion of the survey or by writing their contact details on the relevant page of the 
survey). To preserve anonymity, when surveys were received by the author, the 
consent form and contact details forms were removed from the completed survey. 
These details were put into a password-protected computer file. A unique identifier 
code was written at the top of the completed survey, the contact details sheet and the 
consent form. These were stored in locked cabinets separately. Hard copies of the data 
will be kept for up to five years. Electronic copies of the database will be stored for 
longer (max 15 years) to allow for long-term follow up if needed. Hard copies of the 
completed surveys will be disposed of as confidential waste. A similar protocol was 
used for participants who completed the survey over the phone with the researcher 
(they were assigned a unique identifier code). The audio-recordings were used to write 
the respondents’ answers onto a paper copy of the survey. As they also included the 
respondents’ consent to take part, the recordings are being kept until a year after full 
publication of the project, at which point they will be destroyed. We did not ask 
participant’s permission for data sharing, thus the data are only accessible to the 
author and CB. 
Procedure 
The Macular Society sent the postal surveys to members in November 2013. Both the 
1999 and 2013 surveys provided freepost return envelopes. Adverts informing 
members that the surveys would be sent to randomly-selected members of the 
Macular Society appeared in SideView (the membership magazine).  
Twenty six respondents requested telephone survey completion: all were conducted 
by the author.  Verbal consent was taken. All telephone interviews were audio-
recorded.  
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No reminders were sent for either the 1999 or 2013 survey. Preserving confidentiality 
was the main reason for this as well as the cost. It was also to minimise any confusion 
that may result from members who had already completed the survey being sent a 
reminder to fill in the survey (if we had sent out a blanket reminder to everyone 
selected to take part in the survey). 
 
Data entry 
Data entry was initially conducted by the author and seven undergraduate Psychology 
students as part of the Royal Holloway Passport Award scheme. This scheme enables 
students to gain recognition for taking part in work placements. Data entry and 
checking took longer than anticipated, thus the author sought funding for a specialist 
company to continue with data entry. Dajon Data Management were selected and 
employed to enter closed tick-box response data. Three of the seven placement 
students were employed on a temporary basis to complete free-text data entry from 
the remaining surveys, and conduct checks on the closed tick-box response data 
entered by Dajon Data Management.  Data were entered into an SPSS file designed by 
the author before data entry began. All those responsible for data entry were given 
guidelines for data entry produced by the author, and signed a confidentiality 
agreement before being given access to the completed questionnaires. 
All data entries were double-checked by either the author or a student. The author 
was on hand to answer queries regarding data entry. Any recurrent problems with 
data entry were discussed with all those involved in data entry until the issue was 
resolved. 
Participant identifying information (including contact details) were removed before 
anyone other than the author and her supervisor had access to the surveys, and were 
stored in a separate database to which only the author and her supervisor had access.  
Data analysis  
Experiences in the diagnostic consultation 
To explore the impact of the RCOphth guidelines published in February 2009 and the 
publication of the MDSQ 1999 results in July 2002, a new variable was created based 
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on the 2013 survey respondents’ date of diagnosis (before or after each of these 
dates). Socio-demographic differences between these three groups within the 2013 
survey data and between the 1999 and 2013 samples, were explored using Pearson 
Chi-squared analyses (χ2), one-way independent ANOVA’S or t tests (or the non-
parametric equivalent, Mann Whitney test, where required). Significant results were 
followed up with post-hoc evaluation of results (e.g. examining adjusted residuals for 
χ2 analyses). Effect sizes are reported for significant results. 
The outcome variables of interest were the ten questions (3 replicated and 7 new) on 
healthcare experiences relating to the diagnostic consultation (e.g. “overall, did you 
feel that the diagnostic consultation with this healthcare professional was 
satisfactory?”). Responses were always binary (‘yes’/‘no’). First, differences on these 
outcomes were explored using χ2 analyses; between the 1999 and 2013 samples (for 
the 3 replicated questions), and across the three sub-groups within the 2013 survey 
sample (for all ten questions). Then binary logistic regressions were used to assess 
factors associated with satisfactory healthcare experiences. Separate logistic 
regressions were carried out for each healthcare-experience question.  Independent 
variables were the socio-demographic data, information on the respondent’s eye 
condition, and the main variable of interest – the survey groups (1999 vs 2013 samples 
for the three replicated questions, or the three sub-groups of the 2013 survey sample 
for all 10 questions). Separate unadjusted logistic regressions explored the relationship 
between each predictor and the outcomes; then multivariable analyses with all 
predictors entered were conducted. The sample size fulfilled the requirement of >10 
respondents for the lesser reported outcome event (i.e. satisfaction or dissatisfaction) 
per predictor variable for multivariable logistic regression analyses (i.e. events per 
predictor variable) (Peduzzi, Concato, Kemper, Holford, & Feinstein, 1996). 
Preliminary analyses indicated a general trend of increasing satisfaction with 
healthcare experiences over time. In order to assess the impact of the interventions,  
this increasing trend was controlled for by creating a continuous variable that ranked 
the respondents’ year of diagnosis (e.g. the first year of diagnosis in the dataset was 
1980 and was coded as 1, and the last was 2013 and coded as 30). This variable was 
entered into the logistic regression analyses. It is referred to in Chapter 3 as the ‘year 
rank’ variable.  
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No problems with multicollinearity or linearity of the logit were observed. 
Reasons for satisfaction or dissatisfaction with the diagnostic consultation (free-text 
responses) 
Respondents were asked to give reasons why they were satisfied or dissatisfied with 
the diagnostic consultation, in their own words. The responses were coded using 
content analysis (Elo & Kyngäs, 2008; Hsieh & Shannon, 2005), and were quantified. A 
coding framework was designed by the author and refined with the help of a research 
assistant. Both completed the coding of responses. Where multiple reasons were 
given, multiple codes were allocated. The ten reasons for dissatisfaction from the 1999 
survey were used as codes in the coding framework. New codes were developed for 
responses which were not represented in the 1999 survey coding framework. In 
particular, the 1999 survey question asked respondents to provide reasons for 
dissatisfaction with the diagnostic consultation only. Therefore new codes were 
developed to reflect the reasons for satisfaction reported in the 2013 survey.  See 
Appendix 7 for coding framework. 
Visual hallucinations (Charles Bonnet syndrome) 
Respondents were asked if they had experienced visual hallucinations since diagnosis 
of AMD. A brief description of Charles Bonnet syndrome (CBS) was provided. 
Respondents could tick either “yes” or “no” and if yes, they were asked to provide a 
description of their experience. These descriptions were checked to exclude any 
responses that were clearly not CBS. Descriptions were included if they described 
simple repeated patterns including shapes, grids, dots of colour or straight lines, or 
more complex hallucinations such as detailed picture/s of people, animals, insects, 
landscapes and buildings. Where there was any uncertainty, descriptions were 
checked with an ophthalmologist. 
The number of respondents who had experienced hallucinations are reported, along 
with the type of hallucination reported (either simple/ complex/ both simple and 
complex hallucination/s). Pearson Chi-squared analyses (χ2) compared responses from 
the 1999 and 2013 samples on the number of respondents who had spoken to a HCP 
about their hallucinations, and whether respondents were given a cause for 
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hallucination/s. The latter were coded and quantified and compared with the causes 
reported in the 1999 survey.  
Within the 2013 sample, χ2 analyses explored differences in socio-demographic and 
eye-related factors between respondents who had experienced hallucinations and 
those who hadn’t. Mann-Whitney tests explored differences in quality of life (both 
MD-specific and general) and well-being between those who had experienced 
hallucinations and those who hadn’t. 
χ2 analyses explored associations between information provision on hallucinations 
around the time of diagnosis and experiencing hallucinations later on. χ2 analyses  
were used to see if there was an association between receiving information on 
hallucinations around the time of diagnosis and whether respondents later spoke to a 
HCP about their hallucinations. 
Mann-Whitney tests were used to investigate associations between information 
provision on hallucinations around the time of diagnosis and QoL and well-being at the 
time of survey completion. These analyses were conducted separately for people who 
had experienced hallucinations and those who hadn’t. Mann-Whitney tests were also 
used to explore associations between talking to a HCP about hallucinations after their 
onset and QoL and well-being at survey completion (conducted separately for those 
who were told around the time of diagnosis about hallucinations and those who 
weren’t). 
For bivariate analysis, non-parametric tests were used due to significant skewness (at 
p<0.001) for the variables of MD-specific QoL, general QoL and well-being. The MD-
specific QoL and general QoL items also showed significant kurtosis. 
Information and support after the diagnostic consultation 
Mann-Whitney tests or χ2 analyses were used to explore differences between the 1999 
and 2013 sample groups in experiences with GPs, attendance at a low-vision clinic, 
membership of a local support group for people with a macular condition, and 
whether respondents received more information about their macular condition post-
diagnosis. 
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Frequencies are reported for the 2013 survey respondents who had been to see an 
ECP within the past year, and if they hadn’t, whether they had needed to. The reasons 
why they hadn’t been but had needed to, were coded and quantified. The number of 
respondents who reported being offered psychological support for their macular 
condition, or who would have liked to have received/ currently receive psychological 
support, are also reported. Frequencies are reported for the 2013 survey respondents 
who had attended a LVC and rated their level of satisfaction with the LVC on a 5-point 
scale (satisfied, slightly satisfied, neither satisfied nor dissatisfied, slightly dissatisfied, 
dissatisfied). The number of respondents who had not attended a LVC but who 
reported that they would have liked to are stated along with those who indicated they 
did not need to attend a LVC.  
All analyses were conducted in SPSS version 21.0. 
Correcting for the use of multiple testing in the same sample 
It has been argued that experiment-wise error correction should be used in such cases 
of multiple testing to correct for the increased risk of type I error (i.e. concluding that a 
significant difference is present when it is not) (Dunn, 1961). A commonly used 
method to correct for this error is the use of Bonferroni correction. In practice, this 
involves using an adjusted significance level of α / T (where α = the critical p level, and 
T= the number of tests performed). However there have been several criticisms of this 
method, most notably that the probability of a type I error cannot be decreased 
without increasing the risk of type II error, such that real differences may not be 
detected (Perneger, 1998).  
It has been recommended that where analyses are to be carried out in an exploratory 
context with an aim to see what findings might be worthy of further study, a 
correction should not be applied to avoid the possibility of type II error. However when 
it is imperative to avoid type I error or when a large number of tests are being carried 
out without a pre-planned hypothesis in an attempt to establish if any results are 
significant, then corrections should be applied (Armstrong, 2014). 
On a practical level, there is no guidance on what constitutes the population of tests 
for which the correction should be applied. For example, should corrections be applied 
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to all tests in an article (or in this case, this thesis) or a subset of them, tests performed 
but not included in the article (thesis), or tests of the same data that are included in 
other reports (Perneger, 1998). The analysis of data presented in this thesis required 
use of multiple different tests (Mann Whitney, Kruskal Wallis, chi-square, etc). It has 
been suggested that applying corrections to multiple tests that use different statistical 
procedures based on different statistical models may result in conflicting conclusions 
from the same data (Armstrong, 2014). 
The author chose not to apply corrections to the tests presented in this thesis to be 
able to investigate potential relationships between variables where they existed (i.e. to 
reduce the chance of type II error). However one must be wary that this may increase 
the risk of type I error when making firm conclusions from the results. The exact p 
values are reported throughout the thesis for transparency.  
Missing data and variables 
There was a total of 289 respondents from the 1999 and 2013 surveys with missing 
data for age at first diagnosis (10.3%). The analyses reported in this thesis focus on 
AMD, therefore only those who were over the age of 50 at diagnosis and who had a 
diagnosis of AMD were included. Figure 2.1 explains how missing data were imputed 
to aid sample selection.  
In the 1999 survey, 709 respondents (58%) had missing data on whether they had wet 
or dry AMD. There were no questions with responses that correlated highly with this 
variable from the 1999 survey, so these data were not imputed, and this variable was 
not used as a predictor in the analyses comparing the healthcare experiences of the 
1999 and 2013 samples. Additionally, there was no question in the 1999 MDSQ on 
which HCP had first diagnosed the AMD, so this variable was not entered into the 
analyses comparing experiences at diagnosis for the 1999 and 2013 samples. 
There were varying amounts of missing data on other independent variables, the 
greatest being for date of diagnosis (missing n=300, 11.4%). There were no suitable 
variables to allow imputation of these missing values.  
Analyses comparing the 1999 and 2013 datasets are for those respondents with 
complete data on all the independent variables included in the analysis of experiences 
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in the diagnostic consultation: 1187 from 1999-, and 1169 from 2013-survey 
respondents (see Figure 2.1). For continuity, only these respondents were selected for 
the analyses used in the rest of the thesis. 
Sample size for each analysis will vary slightly depending on item non-response and 
missing data on additional independent variables included in the particular analysis. 
For example, the questions on experiences in the diagnostic consultation for the 2013-
survey-only analyses- which included additional independent variables (some with 
missing data)- left 1118 respondents (see Figure 2.1). Further information on missing 
data for each analysis is provided either in the relevant results tables or in the text 
alongside the results. 
Additional information on the hallucinations analyses 
There were 119 respondents who wrote descriptions that were not consistent with 
visual hallucinations but were consistent with symptoms of AMD such as wavy lines, or 
objects being distorted. These participants were removed from the analysis of 
responses on hallucinations. Thirty nine respondents left the answer missing in the 
2013 survey. The 1999 survey asked whether respondents had experienced any visual 
changes generally and not hallucinations specifically. Two hundred and thirty-nine 
respondents reported having experienced visual changes but did not specify what type 
(i.e. hallucination, flashing lights, blurred vision), thus they were coded as missing.  This 
left 1011 respondents for analysis in the 2013 sample, and 948 respondents in the 
1999 sample. 
Conclusion 
The present chapter describes the design and development of the Macular Society 
2013 survey that was used to investigate the experiences of people with macular 
conditions for comparison with the 1999 survey. Chapter 3 presents the results and 
discussion of experiences of information and support provision in the diagnostic 
consultation and thereafter. Chapter 4 reports the impact of receiving unpaid care, 
support or assistance for AMD.  
  
 64 
 
Chapter 3: 
The Macular Society 2013 survey: Experiences in the healthcare system and 
thereafter, for people with age-related macular degeneration. Results and 
discussion. 
RESULTS 
Sample characteristics 
Completed postal surveys were returned by 1545 respondents out of the 4000. 
Telephone completions by 26 gave a total sample size of 1571 for the 2013 sample (a 
39% response rate). A further 267 uncompleted surveys were returned, with reasons 
for non-completion, giving a gross response rate of 46%. The most common reason 
given for non-completion was ‘old age’, followed by ‘ill health’. The MDSQ 1999 had 
been completed and returned by 1421 participants, including four telephone 
interviews (71% response rate).  
For characteristics of the 1999 and 2013 survey samples, see Table 3.1. Respondents to 
the 2013 survey were significantly older and less likely to be registered as either sight 
impaired (SI) or severely sight impaired (SSI) than the 1999 survey respondents. The 
two samples did not differ in gender, whether one or both eyes were affected by AMD 
or the time between diagnosis and survey completion. 
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Table 3.1. Respondent characteristics in the 1999 and 2013 survey groups. Values 
are frequencies (valid percentage %) unless otherwise stated. 
Variables  1999 
sample 
(n= 1187) 
2013 sample 
(n= 1169)b 
Statistic, p 
value, effect 
size and n. 
Gender Male  368 
(31.0%) 
358 (30.6%) χ2 (1)=0.04, 
p=0.84: 
n=2356. 
Female  819 
(69.0%) 
811 (69.4%) 
Age at survey 
completion 
(years) 
Mean (SD) 78.34 (7.10) 80.15 (7.99) t (2313.83)= -
5.79, 
p<0.001***: 
r= - 0.02, 
n=2356. 
Median 78.66 81.00 
Registration 
status 
Not registered 469 (39.5%)  790 (67.6%) χ2 (2)=206.53, 
p<0.001***: 
Cramer’s V= 
0.30, n=2356. 
Registered sight 
impaired (SI)/ 
partially sighted 
379 (31.9%)  256 (21.9%) 
Registered severely 
sight impaired 
(SSI)/ blind 
 339 
(28.6%) 
123 (10.5%) 
Number of 
eyes affected 
One eye 223 (18.8%) 226 (19.3%) χ2 (1)=0.11, 
p=0.74: 
n=2356. 
Both eyes 964 (81.2%) 943 (80.7%) 
Years since 
diagnosisa  
Mean (SD) 5.91 (4.92) 5.55 (3.77) U=635, 839.00, 
z= 0.30, 
p=0.77: 
n=2249. 
Median 5.00 5.00 
aFor information. Not included in further analyses.  bThe majority of the 2013 survey 
respondents self-reported their ethnicity as “white” (99.5%). No question on ethnicity was 
included in the 1999 survey. *p<0.05, **p<0.01, ***p<0.001.  
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To explore the impact of the RCOphth guidelines published in February 2009, and the 
publication of the MDSQ 1999 results in July 2002, a new variable was created based 
on the 2013 survey respondents’ date of diagnosis (before or after each of these 
dates). Within these 2013 survey sub-groups, respondents diagnosed after the 2009 
RCOphth publication were younger, less likely to be registered, less likely to have both 
eyes affected by AMD, and more likely to have been first diagnosed by an optometrist 
(Table 3.2). Those diagnosed before the publication of the 2002 paper were more likely 
to have dry AMD and less likely to have wet AMD. Those diagnosed after the 
publication of the 2009 RCOphth guidelines were more likely to have wet AMD. There 
were no differences in gender balance within the 2013 sub-groups. 
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Table 3.2. Respondent characteristics in the 2013 survey sub-groups. Values are frequencies (valid percentage %) unless otherwise stated. 
Variables  Before MDSQ 1999 
paper results 
publication (July 2002) 
(n=194) 
Between 2002 and 
2009 
(n=448) 
After RCOphth 
publication (February 
2009) 
(n=476) 
Statistic, p value: 
effect size. 
Gender Male 72 (37.1%) 135 (30.1%) 153 (32.1%) χ2 (2)=3.02, p=0.22. 
Female 122 (62.9%) 313 (69.9%) 323 (67.9%) 
Age at survey 
completion 
(years) 
Mean (SD) 82.12 (7.26) 80.56 (7.68) 79.37 (8.16) F (2, 1115)= 8.86, 
p<0.001***: 
ω2=0.01Ϯ. 
Median 83.00 82.00 80.00 
Registration 
status 
Not registered 87 (44.8%) 269 (60.0%) 390 (81.9%) χ2 (4)=108.67, 
p<0.001***: 
Cramer’s V=0.22. Registered sight impaired 
(SI)/ partially sighted 
62 (32.0%) 117 (26.1%) 67 (14.1%) 
Registered severely sight 
impaired (SSI)/ blind 
45 (23.2%) 62 (13.8%) 19 (4.0%) 
Number of 
eyes affected 
One eye 19 (9.8%) 61 (13.6%) 132 (27.7%) χ2 (2)=42.76, 
p<0.001***: 
Cramer’s V=0.20. 
Both eyes 175 (90.2%) 387 (86.4%) 344 (72.3%) 
Wet AMD 
only v dry 
AMD only v 
mixed wet 
and dry AMD 
Wet AMD only 43 (22.2%) 175 (39.1%) 195 (41.0%) χ2 (4)=26.22, 
p<0.001***: 
Cramer’s V=0.11. Dry AMD only 108 (55.7%) 176 (39.3%) 201 (42.2%) 
Both wet and dry AMD 43 (22.2%) 97 (21.7%) 80 (16.8%) 
HCP who first 
diagnosed 
AMD 
Hospital eye specialist 131 (67.5%) 258 (57.6%) 230 (48.3%) χ2 (2)=22.07, 
p<0.001***: 
Cramer’s V=0.14. 
 
Optometrist 63 (32.5%) 190 (42.4%) 246 (51.7%) 
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Ϯ ω2=0.01 represents a small effect size, 0.06 a medium effect size and 0.14 a large effect size. 
*p<0.05, **p<0.01, ***p<0.001. 
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Experiences in the diagnostic consultation: 1999 vs 2013 samples 
Respondents from the 2013 survey were significantly more likely than the 1999 survey 
respondents to report feeling that the HCP who diagnosed their condition was 
interested in them as a person (71% compared with 47%- see Table 3.3). They were 
also more likely to report being given the name of their condition at diagnosis (91% v 
78%) and being generally more satisfied with the diagnostic consultation (76% v 61%).  
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Table 3.3. Comparison of responses to questions on experiences within the diagnostic consultation across survey sample groups. Values are 
frequencies of ‘yes’ responses (valid percentage %) unless otherwise stated. 
 1999 survey 
sample 
 
2013 survey 
sample 
χ2 , p-value: 
effect size and 
n. 
2013 survey sample sub-groups χ2, p-value: 
effect size 
and n.  Before MDSQ 
1999 paper results 
publication (July 
2002) 
Between 
2002 and 
2009 
After 
RCOphth 
guidelines 
publication 
(February 
2009) 
Interested in you as a 
person?a 
537 (46.9%) 805 (71.2%) χ2 (1)= 138.58, 
p<0.001***: 
phi= 0.25,  
n=2276. 
126 (67.0%) 
 
302 (70.1%) 
 
351 (74.8%) 
 
χ2 (2)= 4.86, 
p=0.09: 
n=1088. 
Given the name of 
your condition?b 
906 (77.6%) 1045 (91.0%) χ2 (1)= 78.34, 
p<0.001***: 
phi= 0.18, 
n=2315. 
 
165 (86.4%) 
 
401 (91.1%) 
 
435 (92.6%) 
 
χ2 (2)= 6.30, 
p=0.04*: 
Cramer’s V= 
0.08,  
n=1101. 
Generally satisfied 
with diagnostic 
consultation? c 
698 (61.0%) 856 (75.8%) χ2 (1)= 57.59, 
p<0.001***: 
phi= 0.16,  
n=2273. 
129 (70.1%) 
 
320 (73.7%) 
 
382 (82.0%) 
 
χ2 (2)= 
13.85, 
p=0.01*: 
Cramer’s V= 
0.11,  
n=1084. 
Given written 
information?d 
- - - 34 (17.7%) 
 
133 (30.4%) 
 
193 (41.9%) 
 
χ2 (2)= 
37.98, 
p<0.001***: 
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Cramer’s V= 
0.19,  
n=1090. 
Given appropriate 
support, help or 
advice?e 
- - - 86 (45.7%) 
 
 
229 (52.2%) 
 
 
302 (64.1%) 
 
 
χ2 (2)= 
23.25, 
p<0.001***: 
Cramer’s V= 
0.15,  
n=1098. 
Information about the 
Macular Society?f 
- - - 28 (15.1%) 
 
106 (24.0%) 
 
150 (31.9%) 
 
χ2 (2)= 
21.07, 
p<0.001***: 
Cramer’s V= 
0.14, 
n=1097. 
Information on action 
if sudden deterioration 
in your vision?g 
- - - 80 (42.3%) 
 
227 (51.4%) 
 
262 (56.3%) 
 
χ2 (2)= 
10.67, 
p=0.005**: 
Cramer’s V= 
0.10,  
n=1096. 
Given information 
about likely progress 
of macular condition?h 
- - - 84 (43.5%) 
 
203 (46.2%) 
 
190 (40.6%) 
 
χ2 (2)= 2.94, 
p=0.23: 
n=1100. 
Other contacts for help 
and support?i 
- - - 29 (15.4%)  
 
75 (17.1%) 
 
90 (19.5%) 
 
χ2 (2)= 1.75, 
p=0.42: 
n=1088. 
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Told about visual 
hallucinations?j 
- - - 26 (13.5%) 
 
66 (15.4%) 
 
80 (17.2%) 
 
 
χ2 (2)= 1.47, 
p=0.48: 
n=1085. 
 
a “Did you feel that this healthcare professional (who first diagnosed your macular condition), was interested in you as a person?” (Response ‘Yes’ or ‘No’ 
here and to all questions listed below.) 
b “Were you given the name of your condition at the time of diagnosis?” (This question was included in the MDSQ 1999 but the responses were not reported 
in the 2002 paper.)  
c “Overall, did you feel that the diagnostic consultation with this healthcare professional was satisfactory?” 
d “Were you given any written information about your macular condition at the time of diagnosis?” 
e “Do you feel you were given appropriate support, help or advice at the time of diagnosis?”  
f “Were you given information about the Macular Society (or the Macular Disease Society, as it was previously called) at the time of diagnosis?” 
g“Were you given any information around the time of diagnosis about what to do if you were to have a sudden deterioration in your vision?” 
h“Around the time of diagnosis, were you given information about the likely progress of your macular condition?”  
i “Were you given any other contacts for help and support at the time of diagnosis?” 
j “Were you told by a healthcare professional, around the time of diagnosis, of the possibility of experiencing visual hallucinations as a side effect of sight 
loss?” 
*p<0.05, **p<0.01, ***p<0.001. 
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Binary logistic regressions controlling for differences in socio-demographic and eye-
related factors, confirmed that being a 2013 survey respondent was a significant 
predictor of satisfaction with these aspects of healthcare (see Table 3.4 for Odds 
Ratios).  
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Table 3.4. Predictors of healthcare experiences in comparable questions from the 1999 and 2013 surveys; unadjusted (univariable analyses) 
and multivariable analysis adjusting for all other predictors. 
  Interested in you as a person?a  
(n=2276) 
Given name of condition?b 
(n=2315) 
Overall satisfaction?c 
(n=2273) 
Predictor  Unadjusted OR 
(95% CI) 
Adjusted OR 
(95% CI)  
Unadjusted OR 
(95% CI) 
Adjusted OR 
(95% CI) 
 
Unadjusted OR 
(95% CI) 
Adjusted OR 
(95% CI)  
Sample (1999 or 
2013) 
1999 1.00 1.00 1.00 1.00 1.00 1.00 
2013 2.80 (2.35 to 
3.33)*** 
2.75 (2.28 to 
3.31)*** 
2.92 (2.29 to 
3.73)*** 
2.78 (2.14 to 
3.61)*** 
2.00 (1.67 to 
2.40)*** 
1.90 (1.56 to 
2.31)*** 
Gender Male 1.00 1.00 1.00 1.00 1.00 1.00 
Female 0.73 (0.61 to 
0.87)** 
0.71 (0.59 to 
0.86)*** 
0.80 (0.63 to 
1.03) 
0.77 (0.60 to 
1.00)* 
0.68 (0.55 to 
0.82)*** 
0.67 (0.55 to 
0.82)*** 
§Age at survey completion 1.02 (1.01 to 
1.03)** 
1.01 (1.00 to 
1.02)  
0.99 (0.97 to 
1.00)  
0.98 (0.97 to 
1.00)* 
1.03 (1.01 to 
1.04)*** 
1.02 (1.01 to 
1.04)*** 
Registration status       
Contrast 1 Not registered 1.00 1.00 1.00 1.00 1.00 1.00 
 Registered as SI 
or SSI 
0.50 (0.36 to 
0.70)*** 
0.95 (0.64 to 
1.42)  
0.30 (0.19 to 
0.47)*** 
0.60 (0.36 to 
1.02)  
0.62 (0.44 to 
0.89)**  
0.89 (0.59 to 
1.35)  
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Contrast 2 Registered SI 1.00 1.00 1.00 1.00 1.00 1.00 
Registered as SSI  0.87 (0.68 to 
1.10) 
0.97 (0.75 to 
1.25)  
0.65 (0.48 to 
0.88)** 
0.72 (0.53 to 
0.97)* 
0.70 (0.55 to 
0.91)** 
0.74 (0.57 to 
0.96)  
Number of eyes 
affected 
one eye affected 1.00 1.00 1.00 1.00 1.00 1.00 
both eyes 
affected 
0.78 (0.63 to 
0.97)* 
0.77 (0.60 to 
0.97)* 
0.78 (0.58 to 
1.06)  
0.92 (0.66 to 
1.28)  
0.78 (0.62 to 
0.99)* 
0.74 (0.58 to 
0.96)* 
Adjusted Model 
statistics  
 - χ2 (6)= 
160.91, 
p<0.001***. 
- χ2 (6)= 
100.80, 
p<0.001***. 
- χ2(6)=97.05, 
p<0.001***. 
ϮAdjusted 
Model 
Nagelkerke’s R2 
 - 0.09 - 0.07 - 0.06 
Abbreviations: OR= Odds ratio; CI= confidence interval.  
a “Did you feel that this healthcare professional (who first diagnosed your macular condition), was interested in you as a person?” (Response was yes=1, 
no=0 for this and all questions below.) 
b “Were you given the name of your condition at the time of diagnosis?” 
c “Overall, did you feel that the diagnostic consultation with this healthcare professional was satisfactory?” 
§In logistic regression, for continuous variables such as age at survey completion, an odds ratio over 1 indicates increasing likelihood of the outcome as 
the predictor increases (i.e. as age increases). 
ϮNagelkerke’s R2 is a measure of model fit, where 0 indicates the predictors poorly predict the outcome and 1 is where the model predicts the outcome 
perfectly. 
*p<0.05, **p<0.01, ***p<0.001.  
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Impact of 2002 publication of MDSQ (the 1999 survey) results and 2009 RCOphth 
guidelines on healthcare experiences 
Within the 2013 sample, a general pattern of increase in information provision and 
satisfaction with the diagnostic consultation was observed over the three time periods 
studied (pre-publication of the 1999 survey results in 2002, between 2002 and when 
the RCOphth guidelines were published in 2009, and post-2009 RCOphth guidelines) 
for all aspects of the consultation, apart from provision of information on the likely 
progress of the macular condition (see percentages in Table 3.3). Unadjusted logistic 
regressions using the ‘year rank’ variable found an increasing trend in information and 
support provision across time for six of the ten aspects of healthcare experiences (see 
Table 3.5). These were for being given: the name of the macular condition, written 
information on the condition, Macular Society information, information on what to do 
if they experienced a sudden deterioration in vision, receiving appropriate help and 
support at the time of diagnosis, and overall satisfaction with the diagnostic 
consultation. Further unadjusted analyses using the 2013 survey sub-groups found 
significant increases in the same six aspects of information and support provision after 
the 2002 paper publication compared with pre-publication in 2002 (indicative of a 
combined effect of both interventions; see Table 3.5). However, there were significant 
improvements made after the 2009 RCOphth guidelines publication only for four of 
these namely: information on the Macular Society (p<0.01), provision of written 
information (p<0.001), receiving appropriate support, help or advice at the time of 
diagnosis (p<0.001), and overall satisfaction with the diagnostic consultation (p<0.01). 
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Table 3.5. Unadjusted odds ratios from binary logistic regressions investigating changes in information and support provision since the 2002 
publication of the 1999 survey results and the 2009 RCOphth guidelines. 
 Interest 
as a 
person? 
OR  
(95% CI) 
n=1088 
Overall 
satisfactn? 
OR  
(95% CI) 
n=1084 
Name of 
condition?  
OR  
(95% CI) 
n=1101 
Written 
informatn? 
OR  
(95% CI) 
n=1090 
Info on 
deterior- 
ation? 
OR  
(95% CI) 
n=1096 
Help & 
support? 
OR  
(95% CI) 
n=1098 
Macular 
Society 
contact? 
OR  
(95% CI) 
n=1097 
Other 
contacts? 
OR  
(95% CI) 
n=1088 
Likely 
progress? 
OR 
(95% CI) 
n=1100 
Hallucin- 
ation? 
OR  
(95% CI) 
n=1085 
Socio-demographic          
Gender           
Male 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
Female 0.73 
(0.54 to 
0.97)* 
0.67 (0.49 
to 0.91)* 
0.99 (0.64 
to 1.54) 
0.79 (0.60 
to 1.03) 
0.78 
(0.61 to 
1.01) 
0.68 
(0.52 to 
0.88)** 
1.05 
(0.79 to 
1.40) 
0.90 (0.65 
to 1.25) 
0.63 (0.49 
to 
0.81)*** 
0.98  
(0.70 to 
1.39) 
Age at survey 
completion§ 
1.01 
(1.00 to 
1.03) 
1.03 (1.01 
to 1.05)** 
0.96 (0.93 
to 0.98)** 
0.98 (0.96 
to 0.99)** 
0.97 
(0.95 to 
0.98)*** 
1.01 
(1.00 to 
1.03) 
0.99  
(0.97 to 
1.01) 
1.01 (0.99 
to 1.03) 
1.00 (0.99 
to 1.02) 
1.03 
(1.00 to 
1.05)* 
Eye-related variables         
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Number of eyes affected         
One eye 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
Both eyes 0.58 
(0.40 to 
0.83)** 
0.57 (0.38 
to 0.85)** 
0.87 (0.50 
to 1.50) 
0.60 (0.44 
to 0.81)** 
0.77 
(0.57 to 
1.04) 
0.58 
(0.42 to 
0.80)** 
0.55 
(0.40 to 
0.75)*** 
0.93 (0.63 
to 1.38) 
0.82 (0.61 
to 1.11) 
0.89 
(0.60 to 
1.33) 
Registration status          
Contrast 1           
Not registered 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
Registered as SI or 
SSI 
0.52 
(0.30 to 
0.92)* 
0.65 (0.36 
to 1.19) 
0.16 (0.07 
to 
0.38)*** 
0.58 (0.33 
to 1.02) 
0.29 
(0.17 to 
0.49)*** 
0.31 
(0.18 to 
0.53)*** 
0.89  
(0.49 to 
1.62) 
4.13  (2.16 
to 
7.91)*** 
0.82 (0.48 
to 1.38) 
2.92 
(1.14 to 
4.61)* 
Contrast 2           
Registered as SI 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
Registered as SSI 1.11 
(0.69 to 
1.76) 
0.63 (0.38 
to 1.03) 
0.48 (0.26 
to 0.87)* 
0.86 (0.53 
to 1.40) 
0.93 
(0.60 to 
1.44) 
0.55 
(0.35 to 
0.85)** 
1.15 
(0.70 to 
1.90) 
1.11 (0.67 
to 1.83) 
1.05 (0.68 
to 1.63) 
0.82 
(0.47 to 
1.44) 
wet or dry AMD          
Contrast 1           
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Wet AMD only and 
mixed wet and dry 
AMD 
1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
dry AMD only 0.44 
(0.26 to 
0.75)** 
0.48 (0.27 
to 0.84)* 
2.27 (0.94 
to 5.51) 
0.59 (0.35 
to 1.01) 
0.57 
(0.35 to 
0.92)* 
0.29 
(0.17 to 
0.47)*** 
0.65 
(0.37 to 
1.15) 
0.67 (0.35 
to 1.28) 
0.59 (0.36 
to 0.97)* 
0.44 
(0.22 to 
0.89)* 
Contrast 2           
Wet AMD only 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
Mixed wet and dry 
AMD 
0.67 
(0.46 to 
0.98)* 
0.60 (0.40 
to 0.90)* 
1.17 (0.68 
to 2.03) 
0.76 (0.54 
to 1.09) 
0.82 
(0.59 to 
1.14) 
0.62 
(0.44 to 
0.87)** 
0.84 
(0.58 to 
1.22) 
0.85 (0.56 
to 1.31) 
0.98 (0.71 
to 1.37) 
0.88  
(0.57 to 
1.36) 
Healthcare-related variables        
HCP who first diagnosed         
Hospital eye 
specialist 
1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 n/aa 
Optometrist 2.49 
(1.88 to 
3.30)*** 
2.40 (1.77 
to 
3.26)*** 
0.63 (0.42 
to 0.96)* 
0.73 (0.57 
to 0.95)* 
0.86 
(0.68 to 
1.10) 
1.28 
(1.01 to 
1.63)* 
0.94 
(0.71 to 
1.23) 
0.91 (0.67 
to 1.25) 
1.11 (0.88 
to 1.42) 
n/aa 
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Year of diagnosis 
(rank) § 
1.02 
(1.00 to 
1.05) 
1.03 (1.01 
to 1.06)* 
1.06 (1.03 
to 1.10)** 
1.10 (1.07 
to 1.14)*** 
1.04 
(1.02 to 
1.07)*** 
1.07 
(1.04 to 
1.09)*** 
1.08 
(1.05 to 
1.11)*** 
1.02 (0.98 
to 1.05) 
0.99 (0.97 
to 1.01) 
1.02 
(0.99 to 
1.06) 
Survey time group          
Contrast 1           
Before July 2002 
publicatn of MDSQ 
1999 results  
1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
After the 2002 
publicatn (combined 
intervention effect) 
1.58 
(0.80 to 
3.14) 
2.24 (1.10 
to 4.59)* 
3.47 (1.33 
to 9.02)* 
7.31 (3.25 
to 
16.42)*** 
2.58 
(1.36 to 
4.91)** 
2.84 
(1.50 to 
5.38)** 
4.74 
 (1.99 to 
11.29)**
* 
1.37 (0.58 
to 3.25) 
0.96 (0.51 
to 1.81) 
1.41 
(0.57 to 
3.48) 
Contrast 2           
Time between the 
2002 paper publicatn 
- 2009 RCOphth 
guidelines publicatn 
1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
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After RCOphth 
guidelines publicatn 
(February 2009) 
1.29 
(0.96 to 
1.72) 
1.63 (1.19 
to 2.24)** 
1.19 (0.74 
to 1.92) 
1.64  (1.25 
to 2.16)*** 
1.22 
(0.94 to 
1.59) 
1.63 
(1.25 to 
2.13)*** 
1.49  
(1.11 to 
1.99)** 
1.19 (0.85 
to 1.67) 
0.80 (0.62 
to 1.04) 
1.16 
(0.81 to 
1.65) 
§In logistic regression, for continuous variables such as age at survey completion, an odds ratio over 1 indicates increasing likelihood of the outcome as the 
predictor increases (i.e. as age increases). a This question was not specific to the diagnostic consultation, but asked if they were told “around the time of 
diagnosis”. *p<0.05. **p<0.01. ***p<0.001. 
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Figures 3.1a-j below show the adjusted odds ratios for logistic regressions controlling 
for the impact of socio-demographic, eye-related and healthcare-related variables.
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Figure 3.1a and 3.1b. Adjusted odds ratios for binary logistic regressions of satisfaction with healthcare experiences for respondents’ reports of 
whether ‘the HCP who diagnosed them was interested in them as a person’ and ‘overall satisfaction with the diagnostic consultation’.  
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Figure 3.1c and 3.1d. Adjusted odds ratios for binary logistic regressions of satisfaction with healthcare experiences for respondents’ reports of 
whether they were given ‘the name of their macular condition’ and ‘written information about their macular condition’ at the time of diagnosis.   
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Figure 3.1e and 3.1f. Adjusted odds ratios for binary logistic regressions of satisfaction with healthcare experiences for respondents’ reports of 
whether they were given ‘information on what to do if they were to have a sudden deterioration in vision’ and ‘appropriate help, support and advice’ 
at the time of diagnosis.   
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Figure 3.1g and 3.1h. Adjusted odds ratios for binary logistic regressions of satisfaction with healthcare experiences for respondents’ reports of 
whether they were given ‘information about the Macular Society’ and ‘other contacts for help and support’ at the time of diagnosis.   
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Figure 3.1i and 3.1j. Adjusted odds ratios for binary logistic regressions of satisfaction with healthcare experiences for respondents’ reports of 
whether they were given information around the time of diagnosis on the ‘likely progress of their macular condition’ and on ‘the possibility of 
experiencing visual hallucinations as a side effect of sight loss’. 
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In the multivariable analyses presented in Figures 3.1a-j, the trend for increasing 
satisfaction with healthcare experiences across time remained significant for the 
following three aspects of healthcare: provision of written information (p<0.01), 
information about the Macular Society (p<0.05), and being given appropriate support, 
help or advice at the time of diagnosis (p<0.05). Once this trend was adjusted for, of 
the ten aspects of care, only overall satisfaction with the diagnostic consultation 
significantly improved, and only after the 2009 RCOphth guidelines publication 
(p<0.01). There were no significant improvements associated with the 2002 
publication of the MDSQ 1999 results (ps>0.05).   
Women were less likely than men to report receiving information and support on five 
aspects of care: provision of written information, information on what to do if they 
have a sudden deterioration in vision, receiving appropriate help, support and advice 
at diagnosis, information on the likely progress of their macular condition and overall 
satisfaction with the diagnostic consultation (see Figures 3.1b, d, e, f and i). Older 
respondents were more likely to report overall satisfaction with the diagnostic 
consultation (p<0.01), and receiving appropriate help, support and advice at diagnosis 
(p<0.05), but were less likely than younger respondents to report receiving 
information on what to do if they have a sudden deterioration in their vision (p<0.01).  
Respondents who were registered as sight impaired (SI) or severely sight impaired (SSI) 
were less likely than those not registered to report being told the name of their 
condition at diagnosis, being given information on what to do if they experience a 
sudden deterioration in vision, and report receiving appropriate help and support at 
diagnosis (ps<0.01). However they were more likely to report being given other 
contacts for help and support (p<0.001), and information on visual hallucinations 
(p<0.01). Respondents who were first diagnosed by an optometrist were more likely 
than those diagnosed by an eye specialist to report feeling that the HCP who 
diagnosed them was interested in them as a person and overall satisfaction with the 
consultation (ps<0.001). Whereas, those first diagnosed by an eye specialist were more 
likely to report being given the name of their condition at diagnosis and written 
information on the condition (ps<0.01).  There were no significant differences between 
eye specialists and optometrists on the other five aspects of information and support 
provision studied. (See Figures 3.1a-j.) 
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Reasons for satisfaction or dissatisfaction with the diagnostic consultation (free-text 
responses) 
Table 3.6 shows a comparison between the 1999 and 2013 survey samples’ responses 
for the ten most commonly cited reasons for dissatisfaction with the diagnostic 
consultation from the 1999 survey. For a detailed descriptions of codes, see Appendix 
7 for the coding framework.  
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Table 3.6. A comparison of the number of 1999 and 2013 survey respondents reporting the same reasons for dissatisfaction 
with the diagnostic consultation (percentages are of those who reported being dissatisfied with the consultation within each 
survey group). 
Reason for dissatisfactionb 1999 responses 
(n=446)a 
2013 responses 
(n=273)a 
χ2 
 Yes (valid %) Yes (valid %)  
Specialist’s attitude (seen as dismissive, patronising, 
brusque, unfeeling, uninterested in patient/ condition, 
used jargon, talked to colleagues whilst ignoring the 
patient, made patient feel of no consequence because 
of their age)  
196 (45.4%) 74 (28.6%) χ2 (1)=19.20, p<0.001***, phi= 
-0.17, n=691. 
Lack of information or advice (about condition, 
prognosis, adjustment, low vision aids, self-help groups, 
counselling), lack of written information. 
193 (44.7%) 120 (46.3%) χ2 (1)=0.18, p=0.67, phi=0.02, 
n=691. 
Told nothing could be done 61 (14.1%) 60 (23.2%) χ2 (1)=9.17, p<0.01**, 
phi=0.12,  n=691. 
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Problems with management (delay in getting 
appointments, paperwork/ correspondence lost, seeing 
different doctors) 
45 (10.4%) 65 (25.1%) χ2 (1)=26.07, p<0.001***, 
phi=0.19, n=691. 
Shocked by what they were told 33 (7.7%) 13 (5.0%) χ2 (1)=1.83, p=0.18, phi= -0.05, 
n=689. 
Lack of time with the consultant 31 (7.2%) 13 (5.0%) χ2 (1)=1.31, p=0.25, phi = -0.04, 
n=688. 
Discharged after consultation 28 (6.5%) 21 (8.1%) χ2 (1)=.65, p=0.42, phi=0.03,  
n=691. 
Condition not named 21 (4.9%) 35 (13.5%) χ2 (1)=16.28, p<0.001***, 
phi=0.15, n=691. 
No opportunity for questions 17 (3.9%) 8 (3.1%) χ2 (1)=.33, p=0.56, phi= -0.02, 
n=691. 
Wanted second opinion 8 (1.9%) 10 (3.9%) χ2 (1)=2.58, p=0.11, phi=0.06, 
n=691. 
a There were 14 participants in each the 1999 and 2013 surveys who reported being dissatisfied with the diagnostic consultation but did 
not provide a reason why.b Reasons for dissatisfaction were coded using codes stated in the paper publishing the results of the 1999 
survey (Mitchell et al., 2002).  *p<0.05, **p<0.01, ***p<0.001. 
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The 2013 survey respondents’ top ten reasons for satisfaction or dissatisfaction with 
the diagnostic consultation are provided in Table 3.7.  
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Table 3.7. The ten most cited reasons for satisfaction or dissatisfaction with the diagnostic consultation by the 2013 survey respondents. 
Reason for 
satisfaction 
Yes (valid %)  
(total n=831)a 
Example quote: Reason for dissatisfaction  Yes (valid %) 
(total n=253)b 
  
Example quote: 
Information was 
provided  
163 (33.6%) “The consultant 
explained everything” 
 
Lack of information or 
advice Ϯ 
111 (45.7%) “…I was not given 
any information 
about [the] 
condition and had 
to ask several 
times before I felt 
I understood what 
was happening-
and that I wasn’t 
going to go blind!” 
Referred to or 
within a hospital  
150 (30.9%) “Referred me to eye 
specialist” 
 
Healthcare professional 
attitude Ϯ 
70 (28.8%) “Made no attempt 
to reassure 
me…very curt and 
abrupt”  
Prevention of delay 130 (26.8%) “Optician sent me 
straight to an eye 
centre” 
Problems with 
management Ϯ 
62 (25.5%) “Whole clinic 
experience was 
cold and staff 
omitted to always 
introduce 
themselves and 
explain each step 
of the process” 
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Healthcare 
professional’s 
attitude 
96 (19.8%) “He took an interest in 
me” 
Told nothing could be done 
Ϯ 
57 (23.5%) “I was told that I 
would go 
completely blind 
in that eye and 
nothing could be 
done” 
Treatment received 
or information on 
treatment 
76 (15.7%) “Receiving Lucentis 
Injections”  
 
Delay to diagnosis 
 
29 (11.9%) 
 
“He made an 
urgent plea for me 
to be seen by a 
hospital 
consultant, but I 
had to chase this 
up repeatedly to 
obtain an 
appointment & it 
was more than a 
month before I 
was successful!” 
Examination was 
thorough 
61 (12.6%) “Thorough examination 
included laser scans” 
 
Macular condition not 
named Ϯ 
28 (11.5%) “Did not give a 
name to my 
condition” 
 
Competence of 
healthcare 
professional (good) 
42 (8.7%) “She was an expert in 
the area” 
 
Negative comment on 
treatment received 
26 (10.7%) “It was in the early 
days of treatment 
and it wasn’t 
available on the 
NHS”  
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Referred to GPc 35 (7.2%) “She referred me to GP” 
 
Caused a delay to receiving 
treatment 
 
24 (9.9%) “I saw XXX at XXX 
who said it was far 
too late to treat 
my AMD. Optician 
should have 
bypassed GP.” 
Diagnosis made or 
confirmed 
31 (6.4%) “Pleased something 
being done, I had not 
imagined it” 
 
Discharged after 
consultation Ϯ  
18 (7.4%) “No follow-up 
given” 
 
Follow up received/ 
offered 
30 (6.2%) “I had a six month 
repeat consultation” 
 
Competence of healthcare 
professional (poor) 
18 (7.4%) “[Optician] Told 
me not to worry 
don’t need to see 
consultant. I went 
to doctor of my 
own volition and 
left eye was 
already wet so 
glad I did as then 
able to offer 
treatment.” 
a There were 346 respondents who didn’t write a reason for satisfaction. b There were 10 respondents who didn’t write a reason for dissatisfaction. c 
Please note that although some respondents viewed referral to a GP as positive, in practice it is unnecessary and may have delayed receipt of 
appropriate treatment. Ϯ  Indicates reasons for dissatisfaction reported in the paper publishing the MDSQ 1999 results. 
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For the 2013 survey respondents, the most common cause of satisfaction with the 
consultation was due to information provision within the consultation. The most 
common cause of dissatisfaction with the consultation was due to lack of information 
provision. Six of the top ten reasons for dissatisfaction with the consultation cited by 
the 1999 sample were cited in the top ten reasons for dissatisfaction by the 2013 
sample. The four reasons cited in the top ten reasons by the 1999 sample, but not in 
the top ten of the 2013 sample, were: being shocked by what they were told in the 
consultation, lack of time in the consultation, no opportunity given to ask questions, 
and the respondent wanting a second opinion. Nevertheless, they were still cited as 
reasons for dissatisfaction by the 2013 survey respondents (Table 3.6). The attitude of 
the healthcare professional who diagnosed them was the second most commonly 
cited reason for dissatisfaction (Table 3.7). A comparison of the proportion of 1999 and 
2013 survey respondents providing this reason in their free-text responses found that 
fewer 2013 respondents reported the healthcare professional’s attitude as a reason 
for dissatisfaction (Table 3.6). There was no significant difference in the proportion of 
1999 and 2013 survey respondents reporting a lack of information provision at 
diagnosis (Table 3.6). In both samples, nearly half of the respondents who were 
dissatisfied with the consultation reported this as a reason for dissatisfaction. 
The 2013 survey respondents were more likely than the 1999 respondents to cite the 
following reasons for dissatisfaction: being told that nothing could be done to help 
with their macular condition, problems with management (e.g. delay getting 
appointments, correspondence lost), and not receiving the name of their condition at 
diagnosis (Table 3.6). The reason for this may be partly explained by the HCP who 
diagnosed the condition. Optometrists are now able to diagnose AMD whereas in 1999 
only ophthalmologists were entitled to give this diagnosis. The 2013 survey asked 
respondents to state which HCP had first diagnosed them. Table 3.8 shows the reasons 
for dissatisfaction split between those diagnosed by an eye specialist and those 
diagnosed by an optometrist.  
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Table 3.8. Comparison of reasons for dissatisfaction by those first diagnosed by a hospital eye specialist or an optometrist from the 2013 
sample (only the ten most commonly cited reasons are included here). 
Reason for dissatisfaction Hospital eye specialist (n=180) 
Frequency of yes responses 
(valid %) 
Optometrist (n=73) 
Frequency of yes 
responses (valid %) 
Statistic, p value. 
Caused a delay to receiving treatment 17 (9.8%) 7 (10.0%) χ2 (1)=0.002, p=0.97, phi=0.003, 
n=243. 
Delay to diagnosis  20 (11.6%) 9 (12.9%) χ2 (1)=0.08, p=0.78, phi= 0.02, n=243. 
Competence of healthcare professional  13 (7.5%) 5 (7.1%) χ2 (1)=0.01, p=0.92, phi= -0.01, n=243. 
Lack of information or advice a 81 (46.8%) 30 (42.9%) χ2 (1)=0.32, p=0.57, phi= -0.04, n=243. 
Healthcare professional attitude a 55 (31.8%) 15 (21.4%) χ2 (1)=2.61, p=0.11, phi= -0.10, n=243. 
Told nothing could be done a 49 (28.3%) 8 (11.4%)** χ2 (1)=7.92, p=0.01**, phi= -0.18, 
n=243. 
Discharged after consultation a 14 (8.1%) 4 (5.7%) χ2 (1)=0.41, p=0.52, phi= -0.04, n=243. 
Condition not named a 14 (8.1%) 14 (20.0%)** χ2 (1)=6.93, p=0.01**, phi= 0.17, 
n=243. 
Management problems a 41 (23.7%) 21 (30.0%) χ2 (1)=1.04, p=0.31, phi= 0.07, n=243. 
Negative comment on treatment received 21 (12.1%) 5 (7.1%) χ2 (1)=1.30, p=0.25, phi= -0.07, n=243. 
a Indicates reasons for dissatisfaction reported in the paper publishing the MDSQ 1999 results. These were compared between Healthcare professional 
type. *p<0.05, **p<0.01, ***p<0.001. 
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Although there were no significant differences between those diagnosed by an eye 
specialist and those diagnosed by an optometrist in the proportion of respondents 
reporting problems with management, the results show that more respondents 
diagnosed by an optometrist stated dissatisfaction due to not being told the name of 
their condition, and that more respondents diagnosed by an eye specialist reported 
dissatisfaction due to being told that nothing could be done for their macular 
condition.  
There were several new reasons for dissatisfaction provided in the free-text responses 
by the 2013 survey respondents and that had not been given as reasons by the 1999 
survey respondents. Two reasons were a perceived ‘delay to diagnosis’ and ‘delay to 
receiving treatment’ (mentioned by 12% and 10% of the survey respondents who were 
dissatisfied, respectively; see Table 3.7). Other reasons include ‘negative comments 
made on the (medical) treatment received’ and ‘poor competence of the HCP’. There 
were no significant differences in the proportion of respondents reporting these as 
reasons for dissatisfaction by those diagnosed by an optometrist or an eye specialist 
(Table 3.8).  
The most commonly cited reason for satisfaction with the diagnostic consultation was 
having received information and advice (Table 3.7). Table 3.9 shows the reasons for 
satisfaction split between those diagnosed by an eye specialist and those diagnosed by 
an optometrist.  
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Table 3.9. Comparison of reasons for satisfaction by those first diagnosed by a hospital eye specialist or an optometrist (only the ten most 
commonly cited reasons are included here). 
Reason for satisfaction Hospital eye specialist (n=421)a 
Frequency of yes responses 
(valid %) 
Optometrist (n=410)b 
Frequency of yes 
responses  
(valid %) 
Statistic, p value. 
Information was provided  93 (38.9%) 70 (28.5%)* χ2 (1)=5.94, p=0.02*, phi= -0.11, n=485. 
Referred to or within a hospital  41 (17.2%) 109 (44.3%)*** χ2 (1)=41.84, p<0.001***, phi= 0.29, 
n=485. 
Prevention of delay 51 (21.3%) 79 (32.1%)** χ2 (1)=7.17, p=0.01**, phi= 0.12, n=485. 
Healthcare professional’s attitude 55 (23.0%) 41 (16.7%) χ2 (1)=3.08, p=0.08, phi= -0.08, n=485. 
Treatment received or received 
information on treatment 
57 (23.8%) 19 (7.7%)*** χ2 (1)=23.86, p<0.001***, phi= -0.22, 
n=485. 
Examination was thorough 34 (14.2%) 27 (11.0%) χ2 (1)=1.17, p=0.28, phi= -0.05, n=485. 
HCP competent 19 (7.9%) 23 (9.3%) χ2 (1)=0.30, p=0.58, phi= 0.03, n=485. 
Referred to GP c 0 (0%) 31 (12.6%)*** χ2 (1)=21.62, p<0.001***, phi= 0.21, 
n=485. 
Diagnosis made or confirmed 14 (5.9%) 17 (6.9%) χ2 (1)=0.23, p=0.64, phi= 0.02, n=485. 
Follow up received/offered 17 (7.1%) 13 (5.3%) χ2 (1)=0.70, p=0.40, phi= -0.04, n=485. 
a  182 respondents did not provide a reason for satisfaction with the consultation with the hospital eye specialist. b 164 respondents did not provide a 
reason for satisfaction with the consultation with the optometrist. c Please note that although some respondents viewed referral to a GP as positive, in 
practice it is unnecessary and may have delayed receipt of appropriate treatment.  *p<0.05. **p<0.01. ***p<0.001. 
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Satisfaction due to information provision was reported by a greater proportion of 
respondents first diagnosed by an eye specialist than those diagnosed by an 
optometrist (Table 3.9). The healthcare professional’s attitude was the fourth most 
commonly stated reason for satisfaction, reported by nearly a fifth of those satisfied 
with the diagnostic consultation (Table 3.7). There was no significant difference in the 
proportion of respondents first diagnosed by an eye specialist or an optometrist who 
reported this as a reason for satisfaction (Table 3.9). Other reasons for satisfaction 
included: being offered a follow-up consultation, having the diagnosis made or 
confirmed, the competence of the healthcare professional (good), and having received 
a thorough examination. There were no significant differences between respondents 
diagnosed by an eye specialist or an optometrist on these reasons. The second most 
commonly cited reason for satisfaction was receiving a referral to the hospital or 
within a hospital that led to the diagnosis being confirmed (Table 3.7). Significantly 
more of the respondents who were first diagnosed by an optometrist stated this as a 
reason for satisfaction (Table 3.9). As expected, only respondents who were first 
diagnosed by an optometrist reported satisfaction due to being referred to a GP. 
A ‘prevention of delay’ was the third most common reason for satisfaction. This was 
reported by significantly more respondents first diagnosed by an optometrist than an 
eye specialist. Seventy six respondents reported satisfaction due to having received 
treatment for their condition or receiving information on treatment. This was, as 
expected, mentioned by more respondents first diagnosed by an eye specialist than an 
optometrist.  
Experiences with general practitioners (GPs) around the time of diagnosis 
Figures 3.2 and 3.3 show a comparison of the 1999 and 2013 survey responses on 
respondents’ views of GP knowledge about AMD, and help and support received from 
GPs in relation to their macular condition.  
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Figure 3.2. Comparison of the 1999 and 2013 survey responses to the question 
“Around the time you were first diagnosed with your macular condition, to what 
extent was your GP well-informed about your condition?”a 
a “not applicable” responses are excluded. The responses of the remaining 684 respondents in the 2013 
survey group and 957 in the 1999 survey are reported here.  
 
 
Figure 3.3. Comparison of the 1999 and 2013 survey responses to the question “To 
what extent has your GP been helpful and supportive about your macular condition?”a 
a “not applicable” responses are excluded. The responses of the remaining 742 respondents in the 2013 
sample and 1064 in the 1999 sample are reported here.  
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In the 2013 survey, 163 respondents felt that their GP was “very well-informed” about 
their condition (23.8% of responses). However, many more said that their GP was “not 
at all well-informed” (n=269, 39.3%). Additionally, only 139 respondents (18.7%) 
reported that their GP was “very helpful and supportive” about their AMD, and almost 
half of the survey respondents (47.8%) reported that their GP was “not at all 
helpful/supportive” (n=355).  
Mann-Whitney tests found no significant differences between the 1999 and 2013 
samples in reported GP knowledge of AMD (U= 321, 207.00, z= -0.67, p=0.50, n=1641), 
but there was a significant difference in reports of GP supportiveness. Respondents 
from the 2013 survey were more dissatisfied with the support provided by GPs (U= 
314, 740.00, z= -7.66, p<0.001, n=1806). 
Experiences of visual hallucinations (Charles Bonnet Syndrome) 
Comparing the 1999 vs 2013 survey responses 
Visual hallucinations were reported by 225 respondents (22.3%) from the 2013 
sample. A similar number reported experiencing visual hallucinations in the 1999 
sample (n=244, 25.7%). The figures do not differ significantly between the surveys, (𝜒2 
(1)= 3.26, p= 0.07, n=1959). Of the hallucinations described by the 2013 survey 
respondents, 49 reported having hallucinations of simple repeated patterns and 110 
reported more complex hallucinations e.g. of figures, plants or animals. Sixty two 
respondents reported descriptions consistent with both types of hallucinations. Four 
respondents provided descriptions of their hallucinations for which it was difficult to 
determine whether they were simple or complex hallucinations. Among those 
reporting visual hallucinations, only 76 (33.8%) reported talking to a HCP about them. 
A significantly smaller proportion of the 2013 survey respondents talked to a HCP 
about hallucinations than the 1999 survey respondents (n in 2013 sample=76, 33.8% vs 
n in 1999 sample=106, 43.4%; χ2 (1)= 5.62, p=0.02, n=461; Cramer’s v= 0.11). Of the 
respondents who spoke to a HCP about hallucinations, 45 of the respondents from the 
2013 survey (59.2%) reported receiving an explanation for the visual hallucinations, 
compared to 42 respondents (39.6%) from the 1999 survey. This difference is 
significant; a greater proportion of the 2013 survey respondents were given a cause for 
the hallucinations (χ2 (1)= 6.51, p= 0.01. n=173; Cramer’s v= 0.19). The causes given to 
 103 
 
respondents from the 1999 survey included being due to age (n=3), stress (n=2), 
psychological reasons (n=1), brain confusion (n = 1), having nothing to do with AMD (n 
= 1), or being attributed to the environment (n = 1). In the 2013 survey, the majority of 
respondents reported being given an accurate explanation for the hallucinations. 
These explanations included simply being told they were due to CBS (n=4), or were a 
side effect of AMD (n=12), and 23 reported receiving more detailed explanations such 
as it is “the brain compensating for lack of vision”. However one participant noted, “a 
total dismissal when discussed with health officials, as though they had never heard of 
it”. Despite being told that the hallucinations were due to AMD, some respondents did 
not feel this was an adequate explanation of the cause of CBS, e.g. one respondent 
wrote, “I was told it happens to us VIPs [visually impaired persons] not the cause”. 
 
Factors associated with experiencing hallucinations 
The 2013 survey respondents who reported having experienced hallucinations were 
more likely to be living alone, be registered as SI or SSI, have both eyes affected by 
AMD, have a caregiver, be older and have been diagnosed longer ago (see Table 3.10). 
There were no differences between those who had or had not experienced 
hallucinations for type of AMD (wet AMD, dry AMD or both wet and dry AMD), and 
sex. 
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Table 3.10. Factors associated with experiencing hallucinations. Values are 
frequencies (valid percentage %) unless otherwise stated. Adjusted standardised 
residuals are shown in square bracketsϮ. 
Variables  Respondents 
reporting 
hallucinations 
(n= 225) 
Respondents 
who haven’t 
experienced 
hallucinations 
(n= 786) 
statistic, p 
value, effect 
size. 
Gender Male 59 (26.2%) 
[-1.6] 
250 (31.8%) 
[1.6] 
χ2 (1)=2.57, 
p=0.11: phi= 
0.05; n=1011. Female 166 (73.8%) 
[1.6] 
536 (68.2%) 
[-1.6] 
Age at 
survey 
completion 
(years) 
Mean (SD) 83.56 (7.01) 79.12 (8.03) U=117, 572.00, 
z= 7.55, 
p<0.001***; 
n=1011. 
Median 84.00 80.00 
Registration 
status 
Not 
registered 
85 (37.8%) 
[-11.6] 
614 (78.1%) 
[11.6] 
χ2 (2)=138.32, 
p<0.001***: 
Cramer’s V= 
0.37; n=1011. 
Registered 
sight 
impaired 
(SI)/ 
partially 
sighted 
88 (39.1%) 
[7.5] 
125 (15.9%) 
[-7.5] 
Registered 
severely 
sight 
impaired 
(SSI)/ blind 
52 (23.1%) 
[7.6] 
47 (6.0%) 
[-7.6] 
Number of 
eyes 
One eye 19 (8.4%) 
[-4.9] 
183 (23.3%) 
[4.9] 
χ2 (1)=24.09, 
p<0.001***: 
Both eyes 206 (91.6%) 603 (76.7%) 
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Associations between experiencing hallucinations and QoL and well-being 
The 2013 survey respondents who reported having had experienced hallucinations 
since diagnosis were more likely to report poorer QoL (both general and MD-specific) 
and well-being at the time of survey completion (ps<0.001; Table 3.11). 
 
affected by 
AMD 
[4.9] [-4.9] phi= 0.15; 
n=1011. 
Receipt of 
care for 
AMD 
Have 
caregiver 
174 (79.1%) 
[8.7] 
355 (46.0%) 
[-8.7] 
χ2 (1)=75.11, 
p<0.001***: 
phi= 0.28; 
n=991. 
No 
caregiver 
46 (20.9%) 
[-8.7] 
416 (54.0%) 
[8.7] 
Wet, dry or 
both wet 
and dry 
AMD 
Wet AMD 73 (35.4%) 
[-1.3] 
301 (40.3%) 
[1.3] 
χ2 (2)=3.25, 
p=0.20; n=952. 
Dry AMD 86 (41.7%) 
[-0.1] 
313 (42.0%) 
[0.1] 
Wet and dry 
AMD 
47 (22.8%) 
[1.7] 
132 (17.7%) 
[-1.7] 
Live alone? No 112 (50.7%) 
[-2.0] 
454 (58.4%) 
[2.0] 
χ2 (1)=4.13, 
p<0.05*: phi= -
0.06; n=999. Yes 109 (49.3%) 
[2.0] 
324 (41.6%) 
[-2.0] 
Years since 
diagnosis  
Mean (SD) 6.68 (3.73) 5.10 (3.65) U=110, 676.50, 
z= 5.79, 
p<0.001***; 
n=1011. 
Median 7.00 4.00 
Ϯ Adjusted standardised residuals over 2 show where expected frequencies are significantly 
different from their observed frequencies and therefore indicate which cells are non-
independent of each other (i.e. the variables are significantly related to each other). 
Negative residuals indicate a lower observed frequency than expected given the null 
hypothesis of independence. Positive residuals indicate a higher observed frequency than 
expected. *p<0.05, **p<0.01, ***p<0.001. 
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Table 3.11. Comparison of QoL and well-being for the 2013 survey respondents 
reporting hallucinations vs no hallucinations (n=1011). 
 
Variables  Reported 
experienced 
hallucinations 
Reported not 
experienced 
hallucinations 
Statistics, p value 
General 
quality of 
lifea 
Mean (SD) 0.62 (1.17) 1.24 (1.04) U=60, 450.50, z= -
7.26, p<0.001***: 
n=1004. 
 Median 1.00 
 
1.00 
MD-
specific 
quality of 
lifeb 
Mean (SD) -2.44 (0.74) -1.82 (1.06) U=58, 905.00, z= -
7.84, p<0.001***: 
n=1005. 
 Median -3.00 
 
-2.00 
Well-
beingc 
Mean (SD) 28.35 (9.63) 33.16 (8.67) U=51, 360.50, z= -
6.41, p<0.001***: 
n=914. 
 Median 30.00 
 
35.00 
a Quality of life is measured on a 7-point scale scored from +3 (excellent) through 0 (neither 
good nor bad) to -3 (extremely bad). b MD-specific quality of life is measured on a 5-point 
scale scored from -3 which indicates their quality of life would be ‘very much better’ (if they 
did not have their macular condition), through to 0 (the same), to +1 (where it would be 
‘worse’).  c  General well-being (W-BQ16) is on a scale of 0 to 48 where higher scores indicate 
higher well-being. *p<0.05, **p<0.01, ***p<0.001. 
 
 
Associations between information provision on hallucinations around the time of 
diagnosis and experiencing hallucinations  
Overall, respondents who had experienced hallucinations were significantly more likely 
to report having received information on them around the time of diagnosis than 
those who hadn’t experienced hallucinations (χ2 (1)= 20.99, p< 0.001; n=986; phi= 
0.15). Examination of the adjusted standardised residuals indicate that of the 2013 
survey respondents who reported having had experienced hallucination/s, they were 
more likely to report not having received information on hallucinations around the 
time of diagnosis (n=162, 74%) than having received this information (n=56, 26%). 
Those who hadn’t experienced hallucinations were also more likely to report that they 
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hadn’t received information on them around the time of diagnosis (n=669, 87%) than 
having received this information (n=99, 13%).  
Associations between information provision on hallucinations around the time of 
diagnosis and talking to a HCP about their hallucinations later on (for people who had 
experienced hallucinations) 
Of the 2013 survey respondents who had experienced hallucination/s, there was a 
significant association between having received information on hallucinations around 
the time of diagnosis and talking to a HCP about their hallucinations later on (χ2 (1)= 
6.22, p= 0.01; n=217; phi= 0.17). Those who had received information on 
hallucinations around the time of diagnosis were more likely to see a HCP about them 
later on. 
Associations between information provision on hallucinations around the time of 
diagnosis and QoL and well-being 
For the 2013 survey respondents who had experienced hallucinations, there were no 
significant differences between respondents who were given information on 
hallucinations around the time of diagnosis and those who weren’t given this 
information in their QoL, MD-specific QoL and well-being at the time of survey 
completion (see bottom half of Table 3.12). For the respondents who hadn’t reported 
hallucinations, there were no significant differences in QoL, MD-specific QoL and well-
being between respondents who were given this information around the time of 
diagnosis and those who weren’t (see top part of Table 3.12).  
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Table 3.12. Quality of Life and well-being of the 2013 survey respondents who were or were not given information on hallucinations 
around the time of diagnosis (split by those who reported later experiencing hallucinations and those who didn’t). 
Variables  Told about hallucinations 
around the time of 
diagnosis 
Not told about 
hallucinations around the 
time of diagnosis 
Statistics, p value 
Respondents not reporting hallucinations 
 
General quality of 
lifea 
Mean (SD) 1.39 (1.00) 1.22 (1.04) U=36, 230.50, z= 1.66, p=0.096: 
n=765. 
 Median 1.00 1.00 
MD-specific 
quality of lifeb 
Mean (SD) -1.97 (1.01) -1.80 (1.07) U=29, 868.00, z= -1.46, p=0.15: 
n=766. 
 Median -2.00 -2.00 
Well-beingc Mean (SD) 33.90 (9.17) 33.09 (8.61) U=28, 574.50, z= 1.03, p=0.30: 
n=696. 
 Median 36.00 34.42 
Respondents reporting hallucinations 
General quality of 
lifea 
Mean (SD) 0.50 (1.19) 0.67 (1.16) U= 4, 224.00, z= -0.73, p=0.46: 
n=217. 
 Median 1.00 1.00 
MD-specific 
quality of lifeb 
Mean (SD) -2.48 (0.76) -2.41 (0.74) U=4, 225.50, z= -0.86, p=0.39: 
n=218. 
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 Median -3.00 -3.00 
Well-beingc Mean (SD) 27.50 (9.25) 28.51 (9.88) U=3, 465.50, z= -0.87, p=0.38: 
n=199. 
 Median 27.00 30.00 
a Quality of life is measured on a 7-point scale scored from +3 (excellent) through 0 (neither good nor bad) to -3 (extremely bad). b MD-specific 
quality of life is measured on a 5-point scale scored from -3 which indicates their quality of life would be ‘very much better’ (if they did not have 
their macular condition), through to 0 (the same), to +1 (where it would be ‘worse’).  c General well-being (W-BQ16) is on a scale of 0 to 48 where 
higher scores indicate higher well-being. 
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Associations between QoL and well-being and talking to a HCP about hallucinations 
after their onset 
For respondents not told about hallucinations around the time of diagnosis, there 
were no significant differences in QoL, MD-specific QoL and well-being between those 
who later spoke to a HCP about their hallucinations and those who didn’t (see top part 
of Table 3.13). Of those who spoke to a HCP about their hallucinations, there were no 
significant differences between respondents who were and were not given a cause for 
the hallucinations in QoL, MD-specific QoL and well-being (U=192.00, z= -1.31, p=0.19: 
n=45; U=264.00, z= .45, p=0.66: n=45; U=240.50, z= 1.08, p=0.28: n=41, respectively). 
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Table 3.13. Quality of Life and well-being of the 2013 survey respondents who did or didn’t talk to a HCP about hallucinations after their onset 
(split by those who were told or not told about hallucinations around the time of diagnosis). 
Variables  Spoke to a HCP about 
hallucination/s after onset 
Didn’t speak to HCP about 
hallucination/s after onset 
Statistics, p value 
Respondents not told about hallucinations around the time of diagnosis 
General quality of 
lifea 
Mean (SD) 0.65 (1.44) 0.68 (1.03) U=2, 784.50, z= 0.38, p=0.71: n=160. 
 Median 1.00 1.00 
MD-specific 
quality of lifeb 
Mean (SD) -2.48 (0.71) -2.39 (0.75) U=2, 534.00, z= -0.74, p=0.46: n=161. 
 Median -3.00 -3.00 
Well-beingc Mean (SD) 27.68 (11.02) 28.84 (9.44) U=2, 170.50, z= -0.40, p=0.69: n=147. 
 Median 29.50 30.00 
Respondents told about hallucinations around the time of diagnosis 
General quality of 
lifea 
Mean (SD) 0.07 (1.21) 0.90 (1.05) U= 235.50, z= -2.67, p=0.008**: n=56. 
 Median 0.00 1.00 
MD-specific 
quality of lifeb 
Mean (SD) -2.48 (0.85) -2.48 (0.69) U=374.50, z= -0.32, p=0.75: n=56. 
 Median -3.00 -3.00 
Well-beingc Mean (SD) 22.83 (8.16) 32.36 (7.80) U= 128.00, z= -3.72, p<0.001***: n=51. 
 112 
 
 Median 21.00 33.67 
a Quality of life is measured on a 7-point scale scored from +3 (excellent) through 0 (neither good nor bad) to -3 (extremely bad). b MD-specific quality of life is 
measured on a 5-point scale scored from -3 which indicates their quality of life would be ‘very much better’ (if they did not have their macular condition), 
through to 0 (the same), to +1 (where it would be ‘worse’).  c General well-being (W-BQ16) is on a scale of 0 to 48 where higher scores indicate higher well-
being. *p<0.05, **p<0.01, ***p<0.001. 
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For respondents who reported being given information on hallucinations around the 
time of diagnosis and who also later spoke to a HCP about their hallucinations, they 
were more likely to have poorer QoL and well-being than those who didn’t speak to a 
HCP about them, but not poorer MD-specific QoL (see Table 3.13). Those who talked to 
a HCP about their hallucinations and were told a cause for them did not have 
significantly different QoL, MD-specific QoL and well-being to those not given a cause 
(U=78.50, z= -0.14, p=0.90: n=27; U=58.50, z= -1.36, p=0.25: n=27; U=76.50, z= 0.25, 
p=0.81: n=26, respectively). 
 
Further information and support 
A number of questions were included in the 2013 survey to establish whether 
respondents sought further support after diagnosis, or if they felt further help was 
needed but not received. 
Recent experience with eye care professionals (ECPs) 
The majority of respondents reported having seen an eye specialist or optometrist 
about their macular condition in the past 12 months (n=946, 81%). Two hundred 
people reported not seeing anyone (17.1%), and no response was given for 23 people. 
Of those who had not seen an ECP, 175 (87.5%) did not feel the need to see anyone, 
whilst 25 did want to see an eye specialist or optometrist. Of the 25 who had not seen 
an ECP but felt they needed to, some were waiting for booked appointments. Others 
had been to see their GP or optometrist but were waiting for a referral to an eye 
specialist. Of note, there were two respondents who had noticed a deterioration in 
their vision, had been to see their GP and were awaiting referral. 
Two respondents reported barriers to getting appointments. One of these respondents 
reported feeling that they “needed to see someone, but no-one can be of help or are 
interested enough to help”. This suggests this respondent experienced two barriers to 
seeking help- the perception that nothing can be done to help, with the added 
perception that ECPs aren’t “interested enough” to help. The other respondent felt 
that their doctor had “blocked- but not clearly refused” a referral to the eye specialist. 
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Four respondents specified that they had noticed a deterioration in vision which 
precipitated their need to seek help. Another four respondents hadn’t noticed a 
change in vision but felt that they ‘needed’ to see their ECP for reassurance that their 
sight hadn’t become worse, for instance one respondent wrote, “I am only checked for 
glaucoma. It would be reassuring to know how my MD was.” One respondent stated ill 
health was the reason for not seeking help with their macular condition when needed. 
Information on AMD received after diagnosis 
Both the 1999 and 2013 survey respondents were asked if they received information 
about their macular condition after diagnosis, and where this information came from. 
A similar proportion of respondents from the 1999 survey (n=949, 79.9%) and the 2013 
survey (n=931, 79.6%) reported receiving information elsewhere. The number of 
respondents reporting not having received further information had only reduced very 
slightly (n=193, 16.5% of the 2013 survey respondents who reported not receiving any 
information on their macular condition since diagnosis compared to the number in the 
1999 survey, n=208, 17.5%).  
Local group membership 
Just over 40% of the 2013 survey respondents reported membership to a local group 
for people with a macular condition (n=483, 41.3%). This was significantly more than 
the proportion of respondents reporting local group membership in the 1999 survey 
(n=360, 30.3%; χ2 (1)= 30.19, p<0.001, phi=0.11, n=2324). 
Low-vision clinic (LVC) attendance 
Around 36% of the 2013 survey respondents reported having attended a low-vision 
clinic (LVC, n=415). Most respondents had not been to a LVC (n=717, 61%). Others had 
missing data (n=37, 3%). Significantly more of the 1999 survey respondents had been 
to a LVC (n=628, 53%; χ2 (1)= 67.88, p<0.001, phi= -0.17, n=2300). This may be partly 
explained by a greater proportion of the 1999 survey respondents being registered as 
SI or SSI (n=718, 60.5%) than the 2013 survey respondents (n=379, 32.4%).  
Registration status was significantly associated with LVC attendance in both samples. 
Those who were registered were more likely to have been to a LVC in both the 1999 
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sample (χ2 (2)= 337.77, p<0.001, Cramer’s V= 0.54, n=1168) and the 2013 sample (χ2 
(2)= 256.81, p<0.001, Cramer’s V= 0.48, n=1132).  
Of the 2013 survey respondents who hadn’t been to a LVC, 227 respondents reported 
that they would like to attend a LVC (33.5%). 451 respondents reported not having 
been to a LVC nor wanting to attend one (66.5%).  
For those who had been to a LVC, satisfaction was generally high. The majority 
reported being ‘satisfied’ (n=267, 63.4%), or were ‘slightly satisfied’ (n=59, 14%). 
However 54 respondents reported being ‘neither satisfied nor dissatisfied’ and 40 
respondents reported being ‘slightly dissatisfied’ or ‘dissatisfied’ (9.7%). 
Psychological support 
The 2013 survey respondents were asked if they had ever been offered any 
psychological support from the hospital or eye clinic. The majority of respondents 
answered ‘no’ (n=1120, 95.8%). Only 26 respondents reported being offered 
psychological support (2.2%). (There were missing data on this question for 23 
respondents.) Just over 30% of respondents reported that they would have liked to 
have been offered psychological support at the time of diagnosis of their AMD (n=289). 
There were 96 respondents who reported they would have liked to have been offered 
psychological support at the time of the 2013 survey completion (9.7%). 
 
DISCUSSION 
Information and support provision in the diagnostic consultation and with GPs 
Patient experiences are an important indicator of quality of healthcare. The Macular 
Society 2013 survey of people with AMD (pwAMD) found significant improvements 
since the 1999 survey in patients being given the name of their macular condition at 
diagnosis, feeling that the HCP who first diagnosed them was interested in them as a 
person and overall satisfaction with the diagnostic consultation. Of two interventions 
that might have influenced this increase in satisfaction (the publication of the 1999 
survey results and the 2009 publication of RCOphth recommendations for information 
and support provision to AMD patients) only the latter was associated with significant 
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improvements and this was only for overall satisfaction with the diagnostic 
consultation. Satisfaction with the three aspects of care measured in both surveys was 
high initially, reducing the scope for improvements which were nevertheless apparent 
over time.  
The 2013 survey included seven newly-designed questions based on RCOphth 
recommendations for information and support provision at diagnosis. Only three 
recommendations showed a significant trend of improvement over time (for written 
information on the macular condition, information on the Macular Society and for 
receiving appropriate help, support and advice at diagnosis).  However there were no 
additional improvements, over and above this general trend, following publication of 
the 2009 guidelines. The proportion of respondents reporting provision of this 
information and support remains low. For instance, receiving written information on 
the macular condition was reported by 18% of respondents diagnosed before the 
publication of the 1999 survey results, 30% diagnosed after their publication, and 42% 
in those diagnosed after publication of the RCOphth guidelines- showing that despite 
the increase in this information provision, 58% of those diagnosed after the RCOphth 
guidelines were still reporting not receiving written information. This pattern of low 
information provision is similar across other areas. For instance, after the publication 
of the RCOphth guidelines, only 32% of the survey respondents reported receiving 
information about the Macular Society and 20% reported receiving other contacts for 
help and support. 
This is the first large-scale survey to examine whether improvements in practice 
followed interventions designed to improve AMD patients’ experiences in the 
healthcare system. The survey is also unique in examining whether respondents felt 
they were receiving adequate support from their GPs for AMD. The multivariable 
analysis of experiences in the diagnostic consultation included several important socio-
demographic, eye-related and healthcare factors which were found to be linked to 
patients’ experiences. Of particular note is the association between registration as SI 
or SSI and lack of information provision at diagnosis on what patients need to do if 
they experience a sudden deterioration in vision. Although such an association in a 
cross-sectional study is not necessarily indicative of a causal relationship, this finding 
may suggest that lack of this information may cause subsequent sight loss sufficient to 
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warrant registration. Respondents with dry AMD were less likely than those with wet 
AMD to be given information at diagnosis on what to do if they experience a sudden 
deterioration in vision. This is despite current knowledge that if dry AMD turns to wet 
AMD, it is important that patients should seek help quickly as treatment is available 
that may prevent unnecessary sight loss.  
Previous research has consistently found that older patients tend to be more satisfied 
with their healthcare experiences (Croker et al., 2013; Heje, Vedsted, Sokolowski, & 
Olesen, 2008; Voutilainen, Pitkäaho, Vehviläinen-Julkunen, & Sherwood, 2015). There 
is some evidence also of women being less satisfied than men, although this finding 
has been less consistent (e.g.Heje et al., 2008). The results presented in this chapter 
show some similar findings and some differences. Women were less likely than men to 
report receiving information and support on five aspects of care. Older respondents 
were more likely to report overall satisfaction with the diagnostic consultation and 
receiving appropriate help, support and advice at diagnosis, but were less likely than 
younger respondents to report receiving information on what to do if they have a 
sudden deterioration in their vision. The present study did not investigate the cause of 
differences in reports of information and support provision, for example, whether they 
were due to differences in patient characteristics (e.g. expectations) or differential 
treatment from HCPs providing less information and support to women than men, and 
less information but more help, support and advice to older people than younger 
people. Nevertheless an awareness of these differences should prompt HCPs to check 
these particular ‘at risk’ groups have received and understood important information. 
It has been suggested that the gender differences found in the present study may be 
due to men bringing their female partners with them to diagnostic consultations, and 
that the women ask questions on their partner’s behalf (personal communication with 
W. Amoaku, 28th October 2016). Indeed there is evidence that women are more likely 
to receive information in GP consultations because they are more likely to ask for this 
information (Pendleton & Bochner, 1980). Nguyen Thi, Briançon, Empereur, and 
Guillemin (2002) suggested that women make the decisions about healthcare in the 
household for their children, spouse, and parents. Women tend to use more health 
services (Owens, 2008), and thus they may be more experienced or rehearsed in asking 
questions. That women were less likely to receive some aspects of information and 
 118 
 
support may be due to them being too shocked to ask questions when it comes to 
their own diagnostic consultations, and their male partners are less likely to elicit 
information on their behalf.  
Another explanation may be due to gender differences in expectations of healthcare. 
Analysis of free-text responses of reasons for dissatisfaction with inpatient hospital 
stays indicated that male patients’ responses were more likely to reflect a need to be 
taken care of whereas womens’ responses reflected a need to be respected and taken 
seriously (Foss & Hofoss, 2004). For instance, men were more likely to report 
dissatisfaction relating to maltreatment (e.g. staff incompetence, mistakes made 
during diagnosis/ treatment, long waiting times), and women described negative 
experiences due to poor staff attitude (feeling that they had not been listened to or 
regarded as important). In the present study however, there were no significant 
gender differences in whether respondents felt that the HCP seemed interested in 
them as a person, which might reflect perceptions of staff attitude. However women 
were more likely to report not receiving “appropriate support, help or advice at the 
time of diagnosis”.  
Thus there may be complex reasons for gender differences including differences in 
expectations and needs as well as the patient’s behaviour, such as eliciting information 
for themselves or on another’s behalf. It may be that there are different expectations 
and needs for information and support in different healthcare settings (e.g. GP 
consultations, diagnostic consultations in a hospital vs at an optometrists), and for 
different health conditions. The reasons for gender differences for some, but not all 
aspects of information and support provision in diagnostic consultations for AMD are 
beyond the scope of this study and could be investigated in future research. 
The 2013 survey respondents were more likely than the 1999 sample to report that 
their GP had not been helpful and supportive about their macular condition, and 
reported GP knowledge of AMD remains low. In contrast to the 1999 survey, the 2013 
survey included a ‘not applicable’ response for the questions on experiences with GPs. 
It could be argued that having this response option reduces the reliability of the 
comparison between the 1999 and 2013 survey responses because it may have 
changed the likelihood of non-response. A high number of the 2013 survey 
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respondents used the ‘not applicable’ option. For the question that asked for their 
opinion of their GPs knowledge of AMD, only 38 respondents left this answer blank 
and a large number used the ‘not applicable’ option (n=447). In comparison, 230 
respondents to the 1999 survey left their answer blank to this question. Respondents 
were told in both surveys that they could leave survey questions blank if they wished. 
That 38 of the 2013 survey respondents still left their answer blank suggests there may 
be other reasons for item non-response and respondents exercised their right to leave 
their answer blank if they wished.  
 
The large number of responders who used the ‘not applicable’ option in the 2013 
survey might be explained by the more recent removal of the need to refer patients 
with suspected AMD via their GP. The introduction of anti-VEGF injections in 2008 may 
also mean that more patients are being seen in the eye clinic and thus there may be 
fewer patients seeing their GP about AMD than in the 1999 survey.  Therefore it was 
felt that including the ‘not applicable’ option would more accurately investigate 
patients’ experiences given the reduction in the need for pwAMD to see their GP. 
It is important to note that the results reported here demonstrate changes in 
information and support provision that occurred around the time of the interventions 
(the publication of the 2002 paper and 2009 RCOphth guidelines): they do not 
demonstrate direct cause and effect. It would have been difficult to create control 
questions based on information and support provision outside of the guidelines, as the 
guidelines cover many aspects of information and support. Creating control questions 
that would be comparable to the recommendations in importance would have been 
difficult and subjective. If the questions were less important, then this may itself be a 
reason for differences in results and thus could not be used as a control. The inclusion 
of the questions on experiences with GPs (who are unlikely to have read the RCOphth 
guidelines) could be seen to act as a control to test whether patient experiences would 
have improved across time regardless of the RCOphth guidelines. The lack of 
improvement in reports of experiences with GPs lends weight to the view that the 
RCOphth guidelines may well have had a positive influence on ECPs which in turn may 
have improved overall patient satisfaction with the diagnostic consultation. 
Additionally, the multivariable analysis controlled for trends of improving satisfaction 
across time where they existed. 
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Anti-VEGF injections were approved by NICE in August 2008. It cannot be excluded 
that the improvement in patients’ overall satisfaction with the diagnostic consultation 
found after the RCOphth 2009 guidelines introduction may be due, directly or 
indirectly, to the introduction of anti-VEGF, and that ECPs may be more engaged with a 
condition, when one form of the condition is treatable. GPs would also be aware of the 
introduction of anti-VEGF injections but not the RCOphth guidelines; patient 
satisfaction with GPs did not show the same improvements found for ophthalmologists 
and optometrists.  
 
It should be noted that the adjusted r-squared values for the multivariable logistic 
regression analyses examining experiences in the diagnostic consultation were small, 
ranging from 0.03 to 0.12 (where 0 indicates a poorly fitting model and 1 indicates a 
perfectly fitting model). However the purpose of these analyses was to establish which 
variables had significant relationships with the healthcare experience variables, rather 
than determine a model that might perfectly explain differences in healthcare 
experiences.  
It will be important to investigate HCPs’ responses and explanations for the findings 
reported here on the lack of information and support provision to pwAMD in and 
around the time of diagnosis. Perhaps the introduction of anti-VEGF injections for wet 
AMD has meant eye specialists are hard-pushed to find the time to provide adequate 
information and support in their diagnostic consultations. Perhaps ECPs don’t currently 
feel confident in providing the information recommended e.g. on the likely progress of 
macular conditions. Rates of diagnosis of AMD are expected to increase in the future, 
putting more pressure on eye clinics. High quality written information for pwAMD, 
pertinent to the RCOphth guidelines, is provided to eye clinics free of charge by the 
Macular Society, but appears to be underused. This information might usefully be 
provided in community and primary care settings. Indeed the results indicate that 45% 
of respondents considered that it was their optometrist who first diagnosed their 
AMD, and many reported seeing their GP about their macular condition. Some eye 
clinics in the UK have volunteers or eye clinic liaison officers available to provide 
support to pwAMD and who could hand pwAMD this leaflet. Crucially, staff and 
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volunteers need to highlight and emphasise important points in the booklet (e.g. what 
to do if pwAMD experience a sudden deterioration in vision). 
Reasons for satisfaction or dissatisfaction with the diagnostic consultation 
What do the free-text responses add to the closed tick-box responses reported above? 
Respondents were asked to write their reasons for satisfaction or dissatisfaction with 
the diagnostic consultation in their own words. Patient satisfaction and experiences 
are subjective and it could be argued that free-text responses may more closely reflect 
the respondents’ perceptions of the consultation than the closed tick-box responses. 
That the most common reason for satisfaction and dissatisfaction was the provision or 
lack of provision of information and advice, reflects that patients regard this as 
important and supports the findings from the closed tick-box responses. The 
healthcare professional’s attitude was the second most commonly cited reason for 
dissatisfaction with the diagnostic consultation. The comparison of the 1999 and 2013 
survey responses suggested a decrease in respondents reporting the healthcare 
professional’s attitude as a reason for dissatisfaction in the free-text response, and this 
is also reflected in the closed tick-box question which found an increase in the number 
of respondents reporting that the healthcare professional who diagnosed them 
appeared interested in them as a person.  
Initial evidence from a recent systematic review found that in primary care 
consultations, affective reassurance through verbal and non-verbal communication, 
for example, showing empathy, and recognising and responding to patient distress, 
was associated with the short-term outcome of higher patient satisfaction, but poorer 
longer-term outcomes including poorer recovery and higher symptom burden (Pincus 
et al., 2013). The review included studies where patients had conditions causing pain 
and discomfort, where the cause is poorly understood and where further tests and 
investigations are not indicated (e.g. irritable bowel syndrome, low back pain). 
However it should be noted that the results of the review are limited by the duration 
of follow-up; the majority of studies included in the review followed participants up to 
a maximum of four months. In addition, only a few high quality studies could be found. 
AMD is also a condition for which the exact cause is unknown and treatment is not 
available for people with dry AMD or untreatable wet AMD. However AMD does not 
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tend to be associated with symptoms of pain and discomfort. There is currently no 
research which has investigated the impact of giving affective reassurance to people 
diagnosed with AMD. It is possible that being comforted and receiving sympathy from 
a HCP for a diagnosis of a condition that may cause significant vision loss, might lead 
pwAMD to feel more worried and negative about their future with AMD. These 
negative perceptions could impact on the individual’s beliefs about what they can and 
cannot do (their self-efficacy), their functioning and ultimately their well-being. 
Building a rapport with patients could be seen as distressing for people with 
untreatable AMD who are only seen once in the diagnostic consultation and are then 
discharged. However it must be noted that for many people being diagnosed with 
AMD comes as a shock (Beverley et al., 2007; Hodge et al., 2013; Thurston et al., 2010). 
Thus pwAMD are likely to benefit from seeing a HCP who is attentive to their 
emotional and information needs. The interaction between cognitive reassurance 
(giving information and checking patient’s understanding of the information) and 
affective reassurance is poorly understood (Pincus et al., 2013). It may be that showing 
empathy for the patient’s concerns as well as providing information on the likely 
progress of their macular condition and what they can do to prevent further 
deterioration, may be associated with high patient satisfaction and positive long-term 
outcomes such as better visual acuity and functioning. 
Compared to the 1999 survey responses, more 2013 survey respondents reported 
being told that nothing could be done to help with their macular condition and not 
being told the name of their macular condition. However, when prompted using the 
closed tick-box question, more 2013 survey respondents reported being given the 
name of their macular condition than the 1999 survey respondents. Further 
examination of the free-text responses indicated that those first diagnosed by an eye 
specialist were more likely to report that they had been told that nothing could be 
done to help with their macular condition compared with those diagnosed by an 
optometrist. Those first diagnosed by an optometrist were more likely to state that 
they had not been told the name of their macular condition. Some of these findings 
are supported by the results from the closed tick-box responses. Optometrists were 
less likely to give the name of the macular condition than hospital eye specialists. 
Optometrists may spot the signs of AMD but refer on to a hospital eye specialist for 
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confirmation of diagnosis, and therefore be reluctant to name the condition. Once 
confirmed by a hospital eye specialist, the specialist will have the equipment to be able 
to confirm the type of AMD and determine whether medical treatment is available for 
the condition. They are in a position to be able to inform patients that there is no 
medical treatment available for the patient’s type of AMD. Thus the responses are in 
line with the roles of these ECPs. Mitchell et al. (2002) report patients’ emotional 
reactions to being told that “nothing can be done”. Fifty four respondents to the 1999 
MDSQ reported feeling suicidal after being told this. It is worth noting that although 
medical treatment may be unavailable for some types of AMD, there are other types of 
resources that can be used to help adjustment to sight loss, including low-vision aid 
provision and training. Being given information on how to access low-vision services 
might prevent patients from leaving the consultation without hope or control over 
their future with AMD. Additionally, being told that “nothing can be done” may cause a 
delay to help-seeking for people who notice changes in their vision that might be 
associated with untreatable dry AMD changing to treatable wet AMD. Thetford et al. 
(2009) report that people who were told that there was nothing that could be done for 
their sight loss were less likely to go to future eye tests as it was assumed that there 
was no reason to go to the tests. Indeed the 2009 RCOphth guidelines recommend 
avoiding using the phrase “nothing can be done” in consultations. 
The 2013 survey respondents reported similar reasons for dissatisfaction with the 
diagnostic consultation as those surveyed 14 years before. The reasons why ECPs still 
appear not to be providing information and support remain to be investigated. Some 
of the new reasons for satisfaction and dissatisfaction found in the 2013 survey may 
reflect the introduction of anti-VEGF treatment for some types of wet AMD. 
Respondents reported being dissatisfied due to delays to diagnosis or starting 
treatment, thus they may be aware of the urgency of receiving a diagnosis so that 
medical treatment, if available, can begin as soon as possible to reduce sight loss. The 
third most commonly cited reason for satisfaction was the prevention of delay. These 
findings suggest that patients appreciate their condition being taken seriously. There 
was no indication that urgency increased anxiety or worry. Although some 
respondents reported satisfaction due to being referred to a GP, it is possible that 
patients are unaware that this is an unnecessary step in referral for confirmation of 
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diagnosis and causes delays that may result in serious sight loss. Clearly there is still a 
need to inform optometrists that such a referral to a GP is no longer necessary and 
may cause dangerous delays that threaten sight. It may also be beneficial to inform 
patients and the general public so that they are empowered to contest referral back to 
their GP if their optometrist suggests this is required for diagnosis. 
One reason for dissatisfaction provided in both the 1999 and 2013 surveys was the lack 
of a follow-up consultation. The RCOphth 2009 guidelines recommend that 
ophthalmologists avoid ‘diagnose and immediate discharge’. Some of the 2013 survey 
respondents reported satisfaction due to being offered a follow-up consultation. The 
responses do not provide information on whether these follow-up appointments were 
offered for treatment, but it is clear that respondents were pleased that this had been 
offered to them. Now that there is treatment available for some forms of AMD, 
patients may be wary of deterioration in sight and understand the need to monitor 
their sight for changes. A follow-up consultation may help to reassure patients that 
their sight will be monitored and may also provide the opportunity to ask for further 
information post-diagnosis. The surveys did not ask respondents directly if they had 
received a follow-up appointment following diagnosis. It is possible that respondents 
received important information and support in this second consultation, and that the 
results reported here are an underestimation of the information provided by ECPs.  
There has yet to be a study which examines the psychological impact of diagnosis of 
early AMD. Evidence exists to show that patients diagnosed with treatable wet AMD 
are more likely to have better visual outcomes if treated earlier on (Ying, Huang, Jaffe 
et al., 2013; Rauch, Weingessel, Maca et al., 2012), and thus spotting wet AMD at an 
earlier stage is likely to lead to better visual outcomes. There is currently no evidence 
to show the benefit of early diagnosis for dry or untreatable wet AMD. However, as 
discussed, providing information and support both at diagnosis and after diagnosis 
may help patients to implement behaviours that could help maintain vision (stopping 
smoking, taking AREDS 2 supplements) and ADLs (by being referred early to low-vision 
services), as well as being educated in how to monitor for changes in vision so that 
they can detect deterioration and seek medical treatment quickly if necessary. 
Whether the benefits of this outweigh possible negative psychological impacts 
(increased worry about whether they will go blind) have yet to be investigated, but it is 
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likely that information and support will help patients with early AMD to feel more in 
control and able to manage their condition. Evidence from the present study suggests 
that pwAMD valued early detection as they appreciated the speed with which they 
were referred for diagnosis and thus establishing whether AMD is treatable with anti-
VEGF may be paramount. 
A greater proportion of respondents who were satisfied with the diagnostic 
consultation than those who were dissatisfied left the free-text response for reasons 
for satisfaction or dissatisfaction missing. Whilst the 1999 survey asked for reasons for 
dissatisfaction only, the 2013 survey asked for reasons for satisfaction as well as 
dissatisfaction and this question was added to explore causes of satisfaction. The lack 
of written reasons for satisfaction may show that respondents did not have a particular 
reason for satisfaction, but there was nothing in particular that caused them to be 
dissatisfied with the consultation. It may be easier to leave a response blank when one 
might not be required- reporting being dissatisfied might be perceived as needing 
justification whereas satisfaction may not. It is possible that adding this response 
option may have caused some participants who remember being dissatisfied with the 
consultation but could not think of a particular reason why, to change their response 
to reporting satisfaction with the diagnostic consultation. Thus there may be a falsely 
high number of people reporting satisfaction in the 2013 survey. That there was a high 
number of respondents reporting not receiving information and support in the closed 
tick-box responses suggests that when prompted, respondents can recall aspects of 
the consultation that are linked to reasons for dissatisfaction. 
The comparisons between the 1999 and 2013 samples or within the 2013 sample 
between those diagnosed by an optometrist or hospital eye specialist, must be 
interpreted with caution since these were free-text box responses and respondents 
were unprompted for specific reasons for satisfaction or dissatisfaction with the 
consultation. The closed tick-box responses may provide a more valid comparison 
between these groups. 
A further note of caution to make in the comparisons between the 1999 and 2013 
survey responses: the survey responses were coded by different coders and it is 
possible that the coders may have had different interpretations of the responses. The 
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free-text responses from the 1999 survey were unfortunately not available for 
checking that similar responses would be coded similarly; only the codes representing 
how the responses had been coded were available.   
Hallucinations 
The publication of the RCOphth guidelines in 2009 were not associated with an 
increase in pwAMD being informed, around the time of diagnosis, about the possibility 
of experiencing visual hallucinations as a side effect of sight loss. Of respondents who 
experienced hallucinations, 74% reported not having received information about 
hallucinations around the time of diagnosis. Against expectations, the respondents 
who weren’t given information on hallucinations around the time of diagnosis and who 
later experienced hallucinations, were less likely to have talked to a HCP about their 
hallucinations than those who had received information about them around the time 
of diagnosis. Perhaps respondents who had previously discussed hallucinations with a 
HCP felt more comfortable raising the issue with them at a later point. Concern that 
the cause of the hallucination/s may be due to a serious mental illness (e.g. dementia) 
may be a barrier to people with CBS seeking help (Menon, 2005). Alternatively it may 
be that respondents who had unsatisfactory experiences with HCPs and who didn’t 
receive information from them around the time of diagnosis were less likely to seek 
information and support from them later on.  
Many researchers have found that people experiencing hallucinations derive 
reassurance from being told about CBS and its cause (e.g.Abbott, Connor, Artes, & 
Abadi, 2007; Cox & ffytche, 2014; Menon, 2005; Teunisse, Cruysberg, Hoefnagels, 
Verbeek, & Zitman, 1996), and indeed the RCOphth guidelines recommend that 
information on hallucinations should be provided to patients with AMD. In the present 
study, respondents who experienced hallucinations and who were given information 
on them around the time of diagnosis were not more likely to report better general 
QoL, MD-specific QoL, or well-being at the time of survey completion, than those who 
didn’t receive this information. Thus information provision about hallucinations around 
the time of diagnosis may not make a difference to these patient-reported outcomes 
(PROs) an average of six years later. Of the respondents who didn’t receive information 
on hallucinations at diagnosis, those who later spoke to a HCP about them were also 
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not more likely to have better QoL or well-being than respondents who didn’t speak to 
a HCP about their hallucination/s. This suggests that information provision around the 
time of experiencing hallucinations may also not be beneficial. Further investigation to 
see if receiving a cause for the hallucination affected QoL or well-being also found no 
difference between those given and those not given a cause.  
Given that the research described above found that people tend to be reassured by 
receiving information on CBS, it is a surprising finding from this study that respondents 
who reported receiving information on hallucinations around the time of diagnosis and 
who also later spoke to a HCP about them, were more likely to report poorer QoL and 
well-being than those who didn’t speak to a HCP about them later. Those who spoke to 
a HCP about hallucinations were not more likely to have better QoL or well-being if 
they were given a cause for the hallucinations. Thus the information provided in the 
consultation may not be the cause of the difference in QoL and well-being between 
those who spoke to a HCP about their hallucinations and those who didn’t.  
That the respondents who spoke to a HCP about their hallucinations even after being 
told about hallucinations at diagnosis, had poorer QoL and well-being than those who 
didn’t seek further help might be due to these respondents experiencing hallucinations 
which were having a more negative impact on their life. Indeed Cox and ffytche (2014) 
found that respondents who reported that hallucinations had a negative effect on 
their life were more likely to seek support. That there were no significant differences in 
MD-specific QoL between those who saw a HCP later on and those who didn’t may be 
due to them experiencing hallucinations that were causing poorer MD-specific QoL 
which improved after seeing the HCP, whereas the PROs that were not MD-specific 
were not able to show this improvement.  Alternatively, it may be that poorer general 
health drove the appointment to see a HCP in which hallucinations happened to be 
discussed. Poorer general health may be linked to poorer well-being and quality of life, 
but not MD-specific QoL, but it was not controlled for in the analyses reported here.  
The reasons for the findings reported here may be complex and warrant further study. 
Present QoL, MD-specific QoL and well-being were the main PROs used in this study. 
Perhaps more specific measures assessing changes in anxiety about hallucinations or 
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adjustment to coping with sight loss may be more sensitive to detect the impact of 
information provision.  
In this cross-sectional study it is impossible to determine cause and effect. One should 
be aware of the problems of making causal assumptions. Perhaps the information 
provided, or the interaction with the HCP led to poorer QoL and well-being. Perhaps 
the finding that those who were told by a HCP about the possibility of experiencing 
hallucinations were more likely to talk to a HCP about them later when experiencing 
hallucinations themselves, may be due to not having initially received a satisfactory 
explanation for them, and this is the cause of poorer QoL and well-being. For the 
respondents who later spoke to a HCP about the hallucinations, almost all causes for 
hallucinations given were accurate and one might hypothesise that receiving an 
accurate explanation for the hallucinations would lead to better PROs. However there 
were no significant differences in QoL or well-being between respondents who stated 
they received an explanation and those who didn’t. Perhaps those who didn’t receive 
an explanation from a HCP were more likely to seek information elsewhere, however 
this was not measured in the current study. The source of the information may 
therefore be an important indicator of how patients cope with CBS. As mentioned 
above, we only measured PROs at the time of survey completion. Assessing changes in 
PROs before and after information seeking may provide a clearer picture of how 
discussions on hallucinations with HCPs impact on patient’s understanding and 
adjustment to experiencing hallucinations. 
A strength of this study is the inclusion of pwAMD who hadn’t experienced 
hallucinations and being able to see the effect of information provision on those not 
yet affected by personal experience of hallucinations. Of respondents who hadn’t 
reported hallucinations, those who were informed about them around the time of 
diagnosis did not have significantly different QoL or well-being at the time of survey 
completion than those not informed about them. Therefore, although the results 
suggest that information provision on hallucinations around the time of diagnosis may 
not have beneficial long-term effects on QoL and well-being, the results may also 
provide evidence that provision of this information does not lead to negative effects in 
those who haven’t yet experienced them, such as increased worry or anxiety about 
hallucinations.  
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There are limitations that require noting. The survey respondents were Macular 
Society members and had sought out the society for further help and support after 
diagnosis. They may be more proactive in seeking further information than the general 
AMD population or have read about CBS in Macular Society publications, and thus be 
more informed about them. The survey did not measure respondent’s knowledge of 
CBS and if they received information on them from elsewhere. Thus we do not know if 
respondents received accurate information on CBS from other sources after diagnosis. 
Those who sought and/or received accurate information on hallucinations may be 
reassured and this may have impacted on the PROs.  
There are other factors that may have influenced information seeking or the PROs and 
that weren’t controlled for in the analysis. In addition to the factors mentioned above 
(i.e. experiencing more distressing hallucinations linked to information seeking, poorer 
general health), the analyses did not take into account the severity of sight loss, which 
may be associated with the likelihood of experiencing hallucinations, QoL and well-
being.  
Similar to Cox and ffytche (2014), the survey method used here asked respondents to 
self-report whether they experienced hallucinations. Respondents provided 
descriptions of their hallucinations which were reviewed by the author who consulted 
an ophthalmologist about the range of manifestations of CBS. Respondents whose 
descriptions were not consistent with CBS were filtered out of the analyses, and this 
was determined, in part, by the choice of words used by the respondent to describe 
their CBS. Thus there may have been some respondents who experienced 
hallucinations but were removed from the analyses. ECPs may face a similar problem 
in their consultations. At present, there is no formal criteria available to help ECPs to 
recognise and formally diagnose CBS (personal communication with W. Amoaku, 20th 
March 2017). Diagnosis is based on the patient’s description and the ECP’s knowledge 
of CBS. This point shows the similarities between the method used in the survey and 
practice in real-life consultations. It helps to highlight how the language used to 
describe hallucinations in a consultation may determine HCPs recognition of CBS and 
how they discuss it thereafter. 
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The self-report survey method meant that the cause of the hallucinations may not 
have been confirmed by a HCP as being due to CBS. Hallucinations may instead be due 
to other causes, such as dementia.  
The present study found that respondents who lived alone were more likely to report 
CBS. This supports previous findings that those who live alone are more predisposed to 
hallucinations, and this has been explained by low levels of arousal and sensory 
deprivation being a trigger for CBS (e.g.Teunisse et al., 1996). The present study was 
the first to find that respondents who reported having a caregiver were more likely to 
report hallucinations. Perhaps respondents who experience hallucinations and are 
distressed by them are more likely to ask for or receive support from friends and 
family. A cautionary note, however, that it may be that registration status is associated 
with both hallucinations and receiving care for AMD and this wasn’t adjusted for in the 
analysis of the results reported here. 
Previous research suggests that people may be reluctant to admit experiencing visual 
hallucinations for fear of being labelled as ‘insane’ or ‘psychiatrically unstable’ 
(e.g.Menon, 2005; Mosimann et al., 2008). Despite assurance of the anonymity of the 
surveys, some respondents may have been reluctant to admit having experienced 
hallucinations. Thus there may be under-reporting of hallucinations in the results 
presented here.  
Fewer of the 2013 survey respondents than the 1999 respondents spoke to a HCP 
about hallucinations and this finding may suggest that the more recent survey 
respondents are more informed about hallucinations. This seems unlikely to be due to 
HCPs providing information about them as the results show no significant increases in 
provision of this information around the time of diagnosis, since the 2002 paper or 
2009 RCOphth guidelines. As mentioned above, the sample were Macular Society 
members who may have found out about hallucinations from membership magazines, 
local support groups and/or the national conference and may therefore have not 
needed to seek information from a HCP. However there may be other reasons why 
fewer of the 2013 survey respondents than the 1999 sample spoke to a HCP about 
hallucinations. The 2013 sample were, on average, older than the 1999 sample. 
Dementia is associated with older age (van der Flier & Scheltens, 2005). It is possible 
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that the 2013 sample may have been more concerned about the cause of visual 
hallucinations being due to dementia and were worried about receiving a diagnosis of 
dementia if they sought medical help. Alternatively it could be that greater pressure on 
eye clinics since the introduction of anti-VEGF injections in 2008 meant that patients 
were reluctant to seek help from ECPs, for example, because of worry about taking up 
their time. 
The present study did not ask which HCP the respondent had seen about 
hallucinations, and this may have affected whether respondents were given a cause for 
the hallucinations and the accuracy of the explanation given. For example, 
ophthalmologists who may have read the RCOphth 2009 guidelines and are aware of 
CBS, may be in a position to recognise hallucinations when they occur and provide an 
accurate explanation for them as well as reassurance as to their benign cause. On the 
other hand, GPs may not have heard of CBS and thus may not have been able to give 
an accurate and reassuring explanation.  
The survey did not ask if the explanations provided for hallucinations were satisfactory. 
This might be inferred from one respondent’s response, who wrote, “I was told it 
happens to us VIP's [visually impaired persons] not the cause”. Whether respondents 
received a satisfactory explanation for the hallucination/s may impact on their 
adjustment to them, leading to better QoL and well-being. Future research might 
usefully examine how information on hallucinations is discussed in consultations to see 
if HCPs are able to diagnose CBS accurately and give information in a way that is 
acceptable to patients. 
Further information and support 
The majority of the results reported above were for experiences in or around the time 
of the diagnostic consultation. Many patients may not be offered a follow-up 
appointment after the initial diagnostic consultation, particularly if no medical or 
surgical treatment is available for their macular condition. Thus it was important to 
investigate if patients are receiving further information and support, the sources of 
this support, and whether this support met their needs. There were some positive 
findings. Ninety six percent of respondents reported having seen a ECP about their 
macular condition in the past year, or not having a need to see one. A greater 
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proportion of 2013 survey respondents than the 1999 respondents, reported 
membership of a local group for people with macular conditions. The benefits of 
membership of a peer support group have been reported elsewhere (e.g.Bradley et al., 
2005).  
However there is still room for improvement for many aspects of help and support for 
pwAMD post-diagnosis. Some respondents reported barriers to seeking help from a 
ECP about their macular condition. This included feeling that ECPs were not interested 
in their condition or that nothing could be done to help. Some reported having to wait 
for a referral from the GP to access the eye clinic. Some respondents stated specifically 
that they would like reassurance from a ECP who continued to monitor their sight. 
Previous research has also found that AMD patients expressed a desire for regular 
monitoring by HCPs (Burton et al., 2013). Knowing that they were under the care of a 
hospital may give a sense of security that their sight is being monitored, and perhaps 
indicates patients’ lack of confidence in noticing changes in their vision. 
Although a high proportion of respondents reported receiving further information 
about their macular condition after diagnosis, there were still 17% of respondents who 
did not receive any information on their condition. This is despite these respondents 
being members of the Macular Society. This may indicate that these respondents 
aren’t receiving information and support to meet their needs. 
Around 60% of the 2013 survey respondents had not been to a LVC. This may be due in 
part to a low proportion of the respondents being registered as SI or SSI. Registration 
triggers an assessment of needs from the local social services. However it is advised 
that HCPs should not wait until an individual’s sight has deteriorated enough to 
warrant registration before referring to low-vision and rehabilitation services 
(RCOphth, 2009). Two hundred and twenty-seven respondents reported that they 
would like to attend a LVC. The reasons why respondents had not been to a LVC were 
not investigated in this study. Perhaps individuals did not know about the low- vision 
services available to them, or they do not know how to access these services. Perhaps 
they had tried to access the services but they were unavailable. The majority of 
respondents who had been to a LVC reported being ‘satisfied’ or ‘slightly satisfied’ with 
the clinic. This may suggest that these respondents’ needs were met by this service, 
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and that those who reported wanting to go to a LVC could also benefit from this 
service. The reasons why 40 respondents felt dissatisfied with the LVC remain to be 
examined, and suggest there may be some room for improvement in the service 
provided. 
Around 96% of respondents reported that they had never been offered psychological 
support from the hospital or eye clinic. This is despite many pwAMD reporting being 
shocked and worried after a diagnosis of AMD (Hodge et al., 2013). Indeed, just over 
30% of respondents reported that would have liked to have received psychological 
support at the time of diagnosis, and this emphasises the impact of diagnosis of AMD 
on mental health. There were considerably fewer respondents who reported having 
liked to have received psychological support at the time of survey completion (10%), 
however this is still a considerable number of people and shows the longer-term 
effects of AMD. It is possible that these figures reflect an under-reporting of the actual 
number of respondents needing psychological support. Some respondents may have 
been completing the questionnaire with a friend or family member and may not have 
wanted them to be aware of their need for psychological support. The availability of 
formal services that provide emotional support for people with low-vision are not 
generally provided in a hospital eye clinic, but may be available through low-vision 
services. Ophthalmologists, optometrists and GPs should be in a position to inform 
their patients about how to contact these services if the need arises. 
General methodological points on the survey  
The response rate to the 2013 survey was low, but was not dissimilar to that of other 
surveys including the last nationwide General Practice patient survey (35.7% for 
2015,Ipsos, 2016) and the Macular Society’s survey the previous year (31% response 
rate, Cox & ffytche, 2014). One might question the representativeness of the survey 
sample. Individuals may have joined the Macular Society because they had 
unsatisfactory experiences in their diagnostic consultations and sought information 
and support elsewhere. Conversely, this sample may have received information about 
the Macular Society in the diagnostic consultation more often than the general AMD 
population and thus be more satisfied. Members may have higher expectations of 
information and support than the general AMD population and be more likely to 
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request information at diagnosis, if it is not offered. There has yet to be a large, 
geographically representative population study of AMD in the UK that could be used to 
estimate the representativeness of the sample. Additionally, no socio-demographic 
information was available on the non-responders to the survey to help estimate the 
representativeness of the final sample. As the most common reason stated by the 
‘non-responders’ who returned paperwork was ‘old age’, followed by ‘ill health’, it is 
possible that those younger and in better general health are over-represented in the 
2013 survey. However the 2013 sample were on average older than the 1999 sample, 
and thus there seems not to be an over-representation of younger people in this 
sample. In comparison, non-responders to the 1999 survey cited ‘ill health’ or ‘visual 
impairment’ as the most common reasons for non-response. There were significantly 
fewer respondents registered as SI or SSI in the 2013 sample compared to the 1999 
sample, perhaps due to the introduction of treatment for some forms of AMD in 2008 
leading to better visual outcomes. Consequently, age and registration status were 
controlled for in the multivariable analyses comparing responses from the 1999 and 
2013 samples.  
Respondents were asked to reflect on their experiences at diagnosis and this may be 
subject to recall bias. The use of survey methodology retrospectively to investigate 
patient experiences in consultations has been previously reported (Douglas et al., 
2010). Being diagnosed with a condition that could lead to sight loss was shown in the 
telephone survey completion interviews to be a particularly memorable event for most 
people. The literature on autobiographical memory suggests that women recall more 
details than men (Grysman, Fivush, Merrill, & Graci, 2016). In this study however, men 
were more likely to report receiving several aspects of information and support 
provision than were women. This suggests that recall bias was not the main problem 
here but, rather, women may have received less information and support than men. 
The information that patients recall from their diagnostic consultation, even if asked 
years later, may still be relevant and important particularly for AMD where only a small 
minority of patients are seen repeatedly – those receiving, or being monitored for anti-
VEGF treatment for wet AMD. 
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Summary 
The Macular Society 2013 survey results showed that patients diagnosed with AMD 
since the previous 1999 survey reported better experiences at diagnostic consultation. 
Overall satisfaction with the diagnostic consultation improved following publication of 
the RCOphth guidelines. However information and support provision at diagnosis 
remained low. There were also no significant improvements in information and 
support provision associated with the publication of the 1999 survey results. In free-
text responses, the top two reasons for dissatisfaction with the diagnostic consultation 
reported by the 1999 sample remained the same for the 2013 sample. Reasons for 
dissatisfaction included a lack of information or advice given (about condition, 
prognosis, further help) and poor HCP attitude (seen as dismissive, patronising, 
unfeeling). The top reason for satisfaction with the consultation was having received 
information on the condition, demonstrating the importance that pwAMD place on 
receiving information and support to help them manage their AMD. 
There were notable sex and age differences in provision of information and support. 
Women reported receiving less information and support than men, and older 
respondents reported receiving less information but more help and support, and were 
more likely to report overall satisfaction with the consultation. Importantly, a lack of 
information provision on what to do if one experiences a sudden deterioration in 
vision was associated with being registered as SI or SSI. This demonstrates the need for 
this information to be given to pwAMD.  
Experiences with GPs were not much better. Reports of GP knowledge of AMD remain 
low, and the 2013 survey respondents reported receiving lower levels of help and 
support from GPs than the 1999 sample. This chapter reports on several other areas 
where information and support provision to pwAMD could be improved after 
diagnosis, e.g. referral to psychological support or to a LVC. Thus the results reported 
in this chapter highlight the lack of information and support provided to pwAMD 
during and after the diagnostic consultation, and provide suggestions for how this 
could be improved. The next chapter investigates support received from other sources; 
pwAMDs’ family and friends.   
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Chapter 4 
Receiving support for AMD: results from the Macular Society 2013 survey. 
Introduction 
There has been very little research examining the receipt of informal care and support 
in people with AMD (pwAMD). Several questions in the Macular Society 2013 survey 
were designed to explore this. In particular, this study aimed to investigate how many 
pwAMD receive support for AMD, who provides this support, the amount of support 
received and the relationship between receiving this support and the patient-reported 
outcomes of general and MD-specific quality of life (QoL) and well-being. Chapter 2 
provides a description of the study methods including details of the survey design and 
procedure. Chapter 3 provides the 2013 survey respondent characteristics. The results 
from the 2013 survey on support received for AMD from family and friends are 
reported in this chapter. 
Data analysis 
Frequencies, means and medians were used to describe the socio-demographic, eye- 
and health-related characteristics, and support-related characteristics of the sample. 
Descriptive statistics were analysed for living circumstances (living alone or with 
other/s), age, gender, registration status (objective VI), self-assessed change in vision 
since diagnosis (better/ stayed the same/ worse, henceforth ‘subjective VI’), general 
health status, whether respondents received care or not and if so, who provided this 
care and the amount of care they received. The patient-reported outcome variables of 
interest were well-being and generic and MD-specific QoL. First I explored differences 
in respondent characteristics between respondents who reported receiving care with 
those who didn’t, and of the former we also examined differences between 
respondents who reported receiving different amounts of care. Then each 
independent variable was assessed to see if it was significantly associated with QoL 
and well-being. These analyses were run using Pearson Chi-squared analyses (χ2), 
Mann-Whitney, Kruskal-Wallis tests and Spearman’s or point-biserial correlations, as 
appropriate. Effect sizes are reported for significant results. Post-hoc tests were 
carried out to evaluate significant results. 
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A hierarchical multiple regression was conducted to test the hypothesis that the socio-
demographic, health- and eye-related variables were associated with QoL and well-
being. This analysis assessed the unique contribution that having a caregiver made to 
the QoL and well-being outcome variables, after covariates had been controlled for.  
The variables were entered in blocks, so that each block of variables could be 
examined for their additional contribution to the variance. First, separate regressions 
were carried out for each dependent variable (well-being, generic QoL and MD-specific 
QoL) to see if having a caregiver was associated with each dependent variable. Then 
those who reported receiving care were selected and entered into regressions to see if 
the amount of care received was associated with the three dependent variables. These 
analyses controlled for the relationship of the caregiver to the pwAMD (i.e. spouse, 
adult-offspring or ‘other’ type of relationship to the pwAMD). A multivariate analysis of 
covariance (MANCOVA), which would include the three dependent variables in one 
analysis and would control for type I familywise error, could not have been used since 
the independent variables were not independent of each other. 
The usual rule of thumb for multiple regression is a minimum of 15 cases per 
‘predictor’ (i.e. independent variable). A sufficient sample size is needed to have 
enough power to detect small effect sizes. The multiple regression with the largest 
number of variables had nine independent variables and thus would require a sample 
size of at least 135 participants.  
All analyses were conducted in SPSS version 21.0. 
Missing data 
For continuity with the results presented in Chapter 3, this study included only the 
2013 survey respondents who were diagnosed with AMD and were aged over 50 at the 
time of diagnosis. The same data imputation methods were used to assist the selection 
of respondents, as shown in Figure 2.1 in Chapter 2.  
First, there were missing data from 39 respondents (2.8%) for whether or not they had 
a caregiver. Twenty eight respondents had left this question and the following 
questions on the details of the caregiver completely blank. It was considered 
inappropriate to impute data for this variable as there were no other variables that 
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could be used to predict the missing data reliably. Eleven (0.8%) had chosen not to tick 
a response but wrote an answer instead. Of the 770 participants who reported 
receiving care, there were 86 (11.2%) with missing data on how much care they 
receive. Forty seven of these had left their answer blank. Twenty nine respondents 
instead chose to write an answer.  This included receiving help ‘when necessary’, 
‘occasionally’, ‘variable’ or ‘don’t know’. Ten wrote ‘not applicable’ despite having 
ticked the box to say that they receive care. Perhaps this was due to difficulty 
distinguishing support from care, for instance one participant wrote ‘All my friends & 
family are very supportive & helpful, but I have no designated carer.’ Imputation of 
missing data was considered to be guesswork. Since the sample size was sufficiently 
powered for the analysis, it was decided to avoid this guesswork and remove these 
participants from the analyses. 
The ‘self-assessed change in vision since diagnosis’ variable (subjective VI) had missing 
data for 75 (5.3%) respondents. A dummy variable was constructed, assigning a value 
of 1 to those data that were missing and a value of 0 to those not missing. Mann-
Whitney tests found no significant differences on the dependent variables of well-
being and QoL between those participants with and without missing data for 
subjective VI. Therefore missingness was not related to the dependent variables and 
decisions on how to proceed are not so critical (Tabachnick & Fidell, 2014). There was 
a significant relationship between the ‘change in vision since diagnosis’ and 
‘registration status’ variables (rs = 0.29, p<0.001) however this was not strong enough 
to assist with imputation of missing values. Since there were no appropriate variables 
to help predict values for imputation of missing data, those participants with missing 
data for the ‘change in vision since diagnosis’ variable were removed from the 
analyses. 
The W-BQ16 had the largest amount of missing data. The guidelines for the treatment 
of missing scores were followed (Mitchell & Bradley, 2001). If only one item was 
missing from a subscale, then this was imputed using the average score from the other 
scores in the subscale. If more than one score was missing, then the score and that 
subscale were left blank. Nevertheless there was still a large amount of missing data, 
the greatest being for the ‘energy’ subscale for which 107 participants had missing 
scores. There were smaller but still significant amounts of missing data for the 
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‘negative well-being’ subscale (n=93), the ‘stress’ subscale (n=87) and the ‘positive 
well-being’ subscale (n=72). In order that the reliability of the scale does not drop 
below an acceptable level, the guidelines suggest that a total well-being score should 
not be computed if participants have more than one subscale with an estimated score, 
or more than one item missing so that a subscale score cannot be computed. There 
were 158 (11.2%) participants with missing total well-being scores. There were no 
other variables that could be used to predict missing scores reliably. 
A dummy variable was constructed to see if those who had missing total well-being 
scores were different from those who had these scores. Those with missing scores 
were more likely to be older, be registered as sight impaired and be female. There 
were no significant differences on the other socio-demographic, eye- and health-
related variables. There was no significant difference in whether or not these 
respondents were more or less likely to report receiving care, the amount of care 
received or who provided the support. Bivariate analysis of the impact of the 
independent variables on the dependent variables was run with and without the 
respondents with missing data on well-being, generic QoL and MD-specific QoL. There 
were no differences in the results, and running the multivariate analysis with and 
without the respondents with missing data also showed no differences in the results.  
Respondents were asked to state their relationship with their caregiver (if applicable). 
There were missing data for 9 respondents. Respondents could identify more than one 
caregiver, in which case the first response stated was taken as the primary (main) 
person who provides care.  
There were small amounts of missing data for other variables, as follows: general 
health (n=11,0.8%), gender (n=2,0.1%), living circumstances (n=16,1.1%), and 
registration status (n=9, 0.6%). There were small amounts of missing data on the 
outcome variables of generic QoL (n=9, 0.6%) and MD-specific QoL (n=9, 0.6%) (both 
are single-item measures). 
The analyses included respondents who had data for all variables, which left 1067 
respondents for use in analysis. 
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Data screening 
For bivariate analysis, non-parametric tests were used due to significant skewness (at 
p<0.001) for the variables of age at survey completion (standardised skewness score=-
5.67) and the dependent variables of MD-specific QoL, general QoL and well-being 
(standardised skewness scores= 8.27, -6.21 and -8.39, respectively). The MD-specific 
QoL and general QoL items also showed significant kurtosis (standardised kurtosis 
scores of -5.40 and 3.27, respectively).   
Evaluation of the assumptions of multiple regression were tested through residual 
analysis. 
There were no correlations between independent variables that were over 0.7. There 
were no issues of multicollinearity as indicated by no variance inflation factors (VIF 
values) over 10 (scores ranged from 1.04 to 3.26), and no tolerance values under 0.1 
(scores ranged from 0.31 to 0.96). There were no indications of singularity. 
Partial regression plots and a plot of studentised residuals against the predicted values 
revealed no problems of nonlinearity. There was independence of residuals, as 
assessed by the Durbin-Watson statistic of around 2 for all analyses. Visual inspection 
of plots of studentised residuals against unstandardised predicted values showed 
homoscedasticity. The assumption of normality was met for the majority of analyses, 
as assessed by the aforementioned plots plus Q-Q plots of studentised residuals. The 
MD-specific QoL item showed positive skewness. Multivariate analyses were repeated 
with this variable transformed (using logarithmic, square root and inverse 
transformations), however this did not improve the model. No transformation 
improved both skewness and kurtosis values. Therefore the results presented below 
are for the MD-specific QoL item in its original form. 
Fewer than 1% of standardised residuals had standard deviations greater than ±3.3. 
These were checked for accuracy of data entry and it was concluded that scores were 
legitimate. In a large sample there are more likely to be a few outliers (Tabachnick & 
Fidell, 2014). These respondents were included in the analysis since no Cook’s distance 
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values were above 1 indicating that no respondents were exerting a disproportionately 
large influence on the model.   
RESULTS 
Sample characteristics 
Completed surveys were returned by 1545 respondents out of the 4000. Telephone 
completions by 26 gave a total sample size of 1571 for the 2013 sample (a 39% 
response rate). A further 267 uncompleted surveys were returned, with reasons for 
non-completion, giving a gross response rate of 46%. The most common reason given 
for non-completion was ‘old age’, followed by ‘ill health’. 
Descriptive results 
The majority of respondents reported receiving unpaid care, support or assistance for 
AMD (n= 558, 52.3%). For characteristics of the respondents who reported receiving 
care and those who didn’t, see Table 4.1. Large adjusted standardised residuals (over 
2) indicate where cells deviate from independence and provide evidence against the 
null hypothesis (see Beasley & Schumacker, 1995). 
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Table 4.1. Respondent characteristics for those who reported receiving care and 
those who didn’t. Values are frequencies (valid percentage %) unless otherwise 
stated. Adjusted standardised residuals are shown in square bracketsϮ. 
Variables  Respondents 
who don’t 
receive care 
(n= 509) 
Respondents 
who receive 
care 
(n= 558) 
statistic, p 
value, effect 
size. 
Gender Male  149 (29.3%) 
[-2.0] 
195 (34.9%) 
[2.0] 
χ2 (1)=3.92, 
p=0.048*: phi= 
-0.06. Female  360 (70.7%) 
[2.0] 
363 (65.1%) 
[-2.0] 
Age at survey 
completion 
(years) 
Mean (SD) 77.83 (8.32) 81.87 (7.23) U=183,005.00, 
z= 8.16, 
p<0.001***. 
Median 78.00 83.00 
Registration 
status 
Not registered 454 (89.2%) 
[14.5] 
265 (47.5%) 
[-14.5] 
χ2 (2)=214.25, 
p<0.001***: 
Cramer’s V= 
0.45. 
Registered 
sight impaired 
(SI)/ partially 
sighted 
45 (8.8%) 
[-9.8] 
187 (33.5%) 
[9.8] 
Registered 
severely sight 
impaired (SSI)/ 
blind 
10 (2.0%) 
[-8.9] 
106 (19.0%) 
[8.9] 
Self-assessed 
change in 
vision since 
diagnosis 
Better 62 (12.2%) 
[-0.3] 
71 (12.7%) 
[0.3] 
χ2 (2)=69.32, 
p<0.001***: 
Cramer’s V= 
0.26. 
Stayed the 
same 
215 (42.2%) 
[8.1] 
108 (19.4%) 
[-8.1] 
Worse 232 (45.6%) 
[-7.4] 
379 (67.9%) 
[7.4] 
Mean (SD) 2.72 (1.03) 3.10 (1.11) 
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Respondents who reported receiving care were more likely to be registered as SI or SSI 
than those not receiving care. Of the respondents who received care, 379 reported 
their sight was ‘worse’ since diagnosis compared to the expected count of 320 if the 
null hypothesis was true (that change in vision was unrelated to receiving care).  They 
were more likely to report their sight had become ‘worse’ since diagnosis and were 
less likely to report it had stayed ‘the same’ than those not receiving care. Male 
respondents were more likely than expected to report receiving care for AMD. Older 
respondents and those who were living with someone else were more likely to report 
receiving care. Those who received care for AMD were more likely than those not 
receiving care to report poorer general health. 
Of those respondents who reported receiving care, the majority reported receiving 
‘fewer than 7 hours per week’ of care (n=262, 47%). Almost half as many reported 
receiving ‘more than 35 hours of care per week’ (n=128). One hundred and twenty-
seven respondents reported receiving ‘7 to 14 hours a week’, whilst only 41 
respondents reported receiving ’15 to 35 hours’ of care a week. 
Table 4.2 shows the characteristics of the respondents who reported receiving 
different amounts of care for AMD. The adjusted standardised residuals indicate where 
the significant differences lie (i.e. where there are associations between the two 
variables that contribute to the significant chi-square result).
General 
health status≠ 
Median 3.00 3.00 U=169,055.50, 
z= 5.60, 
p<0.001***. 
Living 
circumstances 
Live with 
other/s 
255 (50.1%) 
[-4.1] 
349 (62.5%) 
[4.1] 
χ2 (1)=16.79, 
p<0.001***: 
phi= -0.13. Live alone 254 (49.9%) 
[4.1] 
209 (37.5%) 
[-4.1] 
*p<0.05, **p<0.01, ***p<0.001.  Ϯ Adjusted standardised residuals over 2 show where 
expected frequencies are significantly different from their observed frequencies and 
therefore indicate which cells are non-independent of each other (i.e. the variables are 
significantly related to each other). Negative residuals indicate a lower observed frequency 
than expected given the null hypothesis of independence. Positive residuals indicate a 
higher observed frequency than expected. ≠ Higher scores indicate poorer self-rated health. 
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Table 4.2. Comparison of respondent characteristics between each group reporting receiving different amounts of care for AMD. Values are 
frequencies (valid percentage %) unless otherwise stated. Adjusted standardised residuals are shown in square bracketsϮ. 
Variables  Fewer than 7 
hours per week  
(n=262) 
 7 to 14 hours 
(n=127) 
15 to 35 hours  
(n=41) 
More than 35 
hours per 
week (n=128) 
Statistic, p value: 
effect size. 
Gender Male 75 (28.6%) 
[-2.9] 
45 (35.4%) 
[0.1] 
18 (43.9%) 
[1.2] 
57 (44.5%) 
[2.6] 
χ2 (3)=11.24, p=0.01*. 
Cramer’s V=0.14. 
Female 187 (71.4%) 
[2.9] 
82 (64.6%) 
[-0.1] 
23 (56.1%) 
[-1.2] 
71 (55.5%) 
[-2.6] 
Age at survey 
completion 
(years) 
Mean (SD) 82.01 (7.39) 82.48 (7.05) 81.37 (7.66) 81.12 (6.92) H (3)= 3.55, p=0.31. 
  Median 83.00 84.00 83.00 82.00 
Registration 
status 
Not registered 162 (61.8%) 
[6.4] 
46 (36.2%) 
[-2.9] 
9 (22.0%) 
[-3.4] 
48 (37.5%) 
[-2.6] 
χ2 (6)=44.58, 
p<0.001***: 
Cramer’s V=0.20. Registered sight 
impaired (SI)/ 
partially sighted 
64 (24.4%) 
[-4.3] 
54 (42.5%) 
[2.4] 
20 (48.8%) 
[2.2] 
49 (38.3%) 
[1.3] 
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Registered severely 
sight impaired (SSI)/ 
blind 
36 (13.7%) 
[-3.0] 
27 (21.3%) 
[0.7] 
12 (29.3%) 
[1.7] 
31 (24.2%) 
[1.7] 
Self-assessed 
change in 
vision since 
diagnosis 
Better 51 (19.5%) 
[4.5] 
8 (6.3%) 
[-2.5] 
1 (2.4%) 
[-2.1] 
11 (8.6%) 
[-1.6] 
χ2 (6)=26.68, 
p<0.001***: Cramer’s 
V=0.16. Stayed the same 54 (20.6%) 
[0.7] 
26 (20.5%) 
[0.4] 
4 (9.8%) 
[-1.6] 
24 (18.8%) 
[-0.2] 
Worse 157 (59.9%) 
[-3.8] 
93 (73.2%) 
[1.5] 
36 (87.8%) 
[2.8] 
93 (72.7%) 
[1.3] 
General 
health status≠ 
Mean (SD) 2.95 (1.09) 3.09 (1.12) 3.41 (1.20) 3.34 (1.04) H (3)= 16.81, 
p=0.001**. 
J= 59,748.00, z= 
3.86, p<0.001***. 
Median 3.00 3.00 3.00 3.00 
Living 
circumstances 
Live with other/s 126 (48.1%) 
[-6.6] 
71 (55.9%) 
[-1.8] 
29 (70.7%) 
[1.1] 
123 (96.1%) 
[8.9] 
χ2 (3)=88.42, 
p<0.001***: 
Cramer’s V=0.40. 
 
Live alone 136 (51.9%) 
[6.6] 
56 (44.1%) 
[1.8] 
12 (29.3%) 
[-1.1] 
5 (3.9%) 
[-8.9] 
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Relationship 
of caregiver 
to the 
respondent 
Spouse 109 (41.6%) 
[-5.4] 
58 (45.7%) 
[-2.1] 
27 (65.9%) 
[1.6] 
106 (82.8%) 
[7.5] 
χ2 (6)=73.24, 
p<0.001***: 
Cramer’s V=0.26.  
 
Adult-offspring 96 (36.6%) 
[2.3] 
53 (41.7%) 
[2.8] 
13 (31.7%) 
[0.0] 
15 (11.7%) 
[-5.5] 
 
Other (including 
friend, neighbour, 
sibling etc) 
57 (21.8%) 
[4.6] 
16 (12.6%) 
[-0.7] 
1 (2.4%) 
[-2.3] 
7 (5.5%) 
[-3.3] 
*p<0.05, **p<0.01, ***p<0.001.  Ϯ Adjusted standardised residuals over 2 show where expected frequencies are significantly different from their 
observed frequencies and therefore indicate which cells are non-independent of each other (i.e. the variables are significantly related to each other). 
Negative residuals indicate a lower observed frequency than expected given the null hypothesis of independence. Positive residuals indicate a higher 
observed frequency than expected. ≠ Higher scores indicate poorer self-rated health. 
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There was a significant association between the amount of care received and 
registration status, self-assessed change in vision since diagnosis, gender, living 
circumstances, and general health. There was no significant difference in 
respondents’ age across the hours of care groups. 
The majority of respondents reported that their caregiver was their spouse (n= 300, 
53.8%). One hundred and seventy-seven reported their caregiver was their offspring, 
and 81 reported ‘other’ types of relationships to their caregiver (e.g. friend, 
neighbour, or other family member such as their sibling). There was a significant 
association between the pwAMD/caregiver relationship type and the amount of care 
received (see Table 4.2). Those whose spouse was their caregiver were more likely to 
report receiving ‘more than 35 hours per week’ of care than people whose adult-
offspring were supporting them or those with ‘other’ types of relationships to their 
caregiver. Those with ‘other’ types of pwAMD/ caregiver relationships were more 
likely to report receiving ‘fewer than 7 hours per week’ of care.  
The support-related variables were not independent of the socio-demographic, eye- 
and health-related variables and hence multiple regression was used to adjust for 
these variables in order to see the unique impact that the support-related variables 
had on the dependent variables. All variables included in the multivariate analysis 
were significantly associated with the dependent variables. The exceptions were for 
the relationship between living circumstances and MD-specific QoL, gender and MD-
specific QoL and the type of pwAMD/ caregiver relationship and MD-specific QoL 
(see Table 4.3). The bivariate results for the main variables of interest (whether or 
not respondents reported having a caregiver and how much care they received) are 
described below. The results for the other independent variables are presented in 
Table 4.3.  
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Table 4.3. Bivariate analysis of the relationships between the independent variables and quality of life and well-being outcomes (n=1067). 
  General quality of lifea MD- specific quality of lifeb Well-beingc 
Predictor  Mean 
(SD) 
Median statistic, p value, 
effect size. 
Mean 
(SD) 
Median statistic, p 
value, effect 
size. 
Mean 
(SD) 
Median statistic, p 
value, effect 
size. 
Gender Male 1.21 
(1.10) 
1.00 U=112,184.00, z= -
2.69, p=0.01**. 
-1.95 
(1.02) 
-2.00 U=121,184.00, 
z= -0.71, 
p=0.50. 
33.97 
(8.15) 
35.00 U=101,332.50, 
z= -4.90, 
p<0.001***. Female 1.04 
(1.12) 
1.00 -1.99 
(1.04) 
-2.00 30.98 
(9.23) 
32.00 
    rpb =-.07, p=0.02*.   rpb =-.02, 
p=0.56. 
  rpb = -.16, 
p<0.001***. 
Age at survey completion   rs = -.25, 
p<0.001***. 
  rs = -.22, 
p<0.001***. 
  rs = -.10, 
p<0.01**. 
Living 
circumstances 
Live alone 0.94 
(1.08) 
1.00 U=120,223.00, z= -
4.09, p<0.001***. 
-2.03 
(1.03) 
-2.00 U=132,184.50, 
z= -1.61, 
p=0.11. 
31.05 
(9.18) 
32.00 U=125,820.50, 
z= -2.81, 
p=0.005**. Live with 
other/s 
1.21 
(1.13) 
1.00 -1.94 
(1.04) 
-2.00 32.62 
(8.82) 
34.00 
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   rpb = -.12, 
p<0.001***. 
  rpb =-.05, 
p=0.13. 
  rpb =-.09, 
p=0.005**. 
 1.30 
(1.03) 
1.00 H (2)= 77.31, 
p<0.001***. 
 J= 97,777.00, z= -
8.84, p<0.001***.  
-1.70 
(1.04) 
-2.00 H (2)= 171.39, 
p<0.001***. 
 J= 79,784.00, 
z= -12.89, 
p<0.001***. 
33.12 
(8.61) 
34.00 H (2)= 37.95, 
p<0.001***. 
 J= 
108,773.00, z= 
-6.21, 
p<0.001***. 
Registration 
status 
Not 
registered 
 Registered 
as SI  
0.73 
(1.08) 
1.00 -2.54 
(0.76) 
-3.00 30.04 
(8.87) 
32.00 
 Registered 
as SSI 
0.53 
(1.27) 
1.00 -2.57 
(0.70) 
-3.00 28.45 
(10.13) 
29.00 
Self-assessed 
change in 
vision since 
diagnosis 
Better 1.52 
(0.97) 
2.00 H (2)= 108.45, 
p<0.001***. 
 J= 110,684.00, z= -
10.14, p<0.001***.  
-1.71 
(1.03) 
-2.00 H (2)= 88.74, 
p<0.001***. 
 J= 
117,573.00, z= 
-8.85, 
p<0.001***.  
34.88 
(8.61) 
36.33 H (2)= 57.50, 
p<0.001***. 
 J= 
121,946.00, z= 
-7.56, 
p<0.001***.  
Stayed the 
same 
1.50 
(0.99) 
2.00 -1.59 
(1.13) 
-2.00 34.09 
(8.19) 
35.00 
Worse 0.79 
(1.11) 
1.00 -2.24 
(0.89) 
-2.00 30.17 
(9.09) 
31.00 
General health status ≠   rs = -.60, 
p<0.001***. 
  rs = -.16, 
p<0.001***. 
  rs = -.54, 
p<0.001***. 
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Relationship 
of caregiver 
to person 
with AMD 
Spouse 0.96 
(1.06) 
1.00 H (2)= 18.54, 
p<0.001***. 
 J= 37,694.00, z= -
4.30, 
p<0.001***.n=558. 
-2.38 
(0.75) 
-3.00 H (2)= 1.49, 
p=0.47. 
 J= 43,725.00, 
z= -1.22, 
p=0.22. 
n=558. 
31.37 
(8.55) 
32.00 H (2)= 7.23, 
p=0.03*. 
 J= 40,603.50, 
z= -2.66, 
p=0.008**. 
n=558. 
Adult-
offspring 
0.64 
(1.14) 
1.00 -2.44 
(0.78) 
-3.00 29.33 
(9.28) 
30.67 
Other 0.41 
(1.14) 
0.00 -2.40 
(0.90) 
-3.00 28.67 
(9.78) 
29.00 
a Quality of life (QoL) is measured on a 7-point scale scored from +3 (excellent) through 0 (neither good nor bad) to -3 (extremely bad). b MD- specific 
quality of life is measured on a 5-point scale scored from -3 which indicates their quality of life would be ‘very much better’ (if they did not have their 
macular condition), through to 0 (the same), to +1 (where it would be ‘worse’). More negative scores for both QoL and MD-specific QoL indicate greater 
perceived negative impact on QoL.  cGeneral well-being (W-BQ16) is on a scale of 0 to 48 where higher scores indicate higher well-being. ≠ Higher scores 
indicate poorer self-rated health. 
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Previous research has found that subjective and objective vision impairment (VI) 
affect outcomes differently. For instance, Brennan et al. (2011) found that objective 
and subjective assessments of VI were independent predictors of the social support 
received in older adults with AMD. In the present study we used registration status 
as an objective assessment of VI, and self-assessed change in VI since diagnosis as a 
subjective assessment of VI. We hypothesised that they may have different effects 
on the need for care, thus controlling for both would provide a better indication of 
the additional impact that receiving care had on the QoL and well-being outcomes, 
over and above the need for care. 
Receiving care vs not receiving care 
Bivariate analyses found that respondents who reported receiving care for AMD 
were more likely to report poorer well-being (U = 109, 912.00, z = -6.39, p<0.001), 
general QoL (U = 94, 515.00, z = -9.83, p<0.001) and MD-specific QoL (U = 76, 485.50, 
z = -13.72, p<0.001) than those not receiving care (see Table 4.4 for descriptive 
statistics).  
 
Table 4.4. Descriptive statistics of outcome variables for respondents who 
reported receiving care and those who didn’t (n=1067). 
 Respondents who don’t 
receive care 
Respondents who receive care 
 Mean (SD) Median  Mean (SD) Median  
General 
quality of lifea 
1.44 (1.01) 1.00 0.78 (1.11) 1.00 
MD- specific 
quality of lifeb 
-1.51 (1.08) -2.00 -2.40 (0.78) -3.00 
Well-beingc 33.71 (8.65) 35.00 30.33 (9.02) 31.00 
a Quality of life is measured on a 7-point scale scored from +3 (excellent) through 0 
(neither good nor bad) to -3 (extremely bad). b MD-specific quality of life is measured on a 
5-point scale scored from -3 which indicates their quality of life would be ‘very much 
better’ (if they did not have their macular condition), through to 0 (the same), to +1 
(where it would be ‘worse’). More negative scores for both QoL and MD-specific QoL 
indicate greater perceived negative impact on QoL.  cGeneral well-being (W-BQ16) is on a 
scale of 0 to 48 where higher scores indicate higher well-being. 
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The variables were entered into the multiple regression analyses in blocks so that 
each block of variables could be examined for their additional contribution to the 
variance. Independent variables were entered in the order suggested by Cohen and 
Cohen (1983), where variables that occur chronologically or temporally prior should 
go in the first step (such as socio-demographic variables). These are then followed by 
chronologically later variables such as vision and health-related variables (e.g. 
subjective and objective VI, and general health status.) Receipt of care was entered 
in the third and final step. (See Table 4.5.) 
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Table 4.5. Summary of Hierarchical Regression Analysis for the unique contribution of the receipt of care for AMD on quality of life (general 
and MD-specific) and well-being. 
 General quality of lifea MD-specific quality of lifeb Well-beingc 
Step and variable B SE B β B SE B β B SE B β 
Step 1          
Age -0.03 0.004 -.23*** -0.03 0.004 -.25*** -0.10 0.04 -.09** 
GenderΨ -0.20 0.08 -.09** -0.11 0.07 -.05 -3.05 0.61 -.16*** 
Living circumstances § -0.06 0.07 -.03 0.08 0.07 .04 -0.33 0.60 -.02 
Step 2          
Age -0.01 0.004 -.09*** -0.02 0.004 -.14*** 0.03 0.03 .03 
GenderΨ -0.05 0.06 -.02 -0.04 0.07 -.02 -1.98 0.51 -.10*** 
Living circumstances § -0.03 0.06 -.02 0.08 0.06 .04 -0.11 0.50 -.01 
Subjective VIα -0.27 0.04 -.17*** -0.23 0.04 -.16*** -1.49 0.33 -.12*** 
Objective VI¥ -0.18 0.04 -.11*** -0.40 0.05 -.27*** -1.18 0.36 -.09** 
General health status≠ -0.56 0.02 -.55*** -0.08 0.03 -.09** -4.27 0.21 -.52*** 
Step 3          
Age -0.01 0.004 -.06* -0.01 0.004 -.07* 0.05 0.03 .04 
GenderΨ -0.05 0.06 -.02 -0.04 0.06 -.02 -1.98 0.51 -.10*** 
Living circumstances § -0.11 0.06 -.05 -0.07 0.06 -.03 -0.42 0.51 -.02 
Subjective VIα -0.26 0.04 -.16*** -0.22 0.04 -.15*** -1.46 0.33 -.11*** 
Objective VI¥ -0.09 0.04 -.06* -0.23 0.05 -.15*** -0.81 0.38 -.06* 
General health status≠ -0.55 0.02 -.53*** -0.05 0.03 -.05 -4.20 0.21 -.51*** 
Whether or not receive care± -0.33 0.06 -.15*** -0.66 0.06 -.32*** -1.35 0.52 -.08* 
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SE: standard error. R2 is the proportion of variance explained by the model. ∆R2 is the change in R2 at each step as new variables are entered into the model, 
and the level of significance of R2 is assessed using the F- ratio. a R2= .06*** for step 1; ∆R2= .37*** for step 2; ∆R2= .02*** for step 3. b R2= .05 for step 1***; 
∆R2= .12 for step 2***; ∆R2= .08*** for step 3. c R2= .03*** for step 1; ∆R2= .31*** for step 2; ∆R2= .004* for step 3. *p<.05. ** p<.01.*** p<.001. n=1067. a 
Quality of life is measured on a 7-point scale scored from +3 (excellent) through 0 (neither good nor bad) to -3 (extremely bad). b MD- specific quality of life 
is measured on a 5-point scale scored from -3 which indicates their quality of life would be ‘very much better’ (if they did not have their macular condition), 
through to 0 (the same), to +1 (where it would be ‘worse’). More negative scores for both QoL and MD-specific QoL indicate greater perceived negative 
impact on QoL.  cGeneral well-being (W-BQ16) is on a scale of 0 to 48 where higher scores indicate higher well-being. Ψ Gender variable coded, 0=male, 
1=female. § Living circumstances variable coded, 0= live with other/s, 1=live alone. αSubjective VI measured by self-assessed change in vision since diagnosis. 
Coded as, 1= better, 2= the same, 3= worse. ¥ Objective VI measured using registration status. This was coded as, 1= not registered, 2= registered as sight 
impaired, 3= registered as severely sight impaired. ≠ Higher scores indicate poorer self-rated health. ±  Receipt of care. Coded as, 0= respondent does not 
receive informal care, 1= respondent receives informal care. 
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Quality of life 
Age, gender, living circumstances, subjective and objective VI, and general health 
status explained 43.3% of the variance in QoL. After the receipt of care variable was 
entered, the total variance explained by the model as a whole was 44.8%, (F(7, 
1059)= 124.75, p<0.001, R2 =.45 , Adj R2 =.45). The receipt of care variable was 
significantly associated with QoL over and above the other independent variables, 
and explained an additional 1.6% of variance in QoL (Finc (1, 1059)=30.83, p<0.001). 
In the final model, age, general health status, objective VI, subjective VI and the 
receipt of care were significantly associated with QoL (see Table 4.5). General health 
status recorded the highest beta value (standardised regression coefficient), 
followed by subjective VI, the receipt of care, age and objective VI. Those who were 
older, in poorer health, who were more likely to report that their vision was worse 
since diagnosis, who were registered as SI or SSI, and were receiving care for AMD 
were more likely to report poorer QoL. 
MD-specific Quality of Life 
The independent variables accounted for 25% of the variance in MD-specific QoL, (F 
(7,1059)= 51.69, p<0.001, R2=.26, Adj R2= .25). The receipt of care variable explained 
an additional 7.5% of the variance in MD-specific QoL after controlling for the other 
independent variables, (Finc (1, 1059) = 106.98, p<0.001). In the final model, older 
age, a greater perceived deterioration in vision since diagnosis, registration as SI or 
SSI, and receiving care for AMD were all significantly associated with poorer MD-
specific QoL. The receipt of care recorded the highest beta weight.  
Well-being 
The regression of well-being on the independent variables accounted for 34% of the 
variance, (F (7,1059) = 79.45, p<0.001, R2=.34, Adj R2= .34). The receipt of care 
variable contributed an additional 0.4% of the variance in well-being after controlling 
for the other independent variables, (Finc (1, 1059)= 6.70, p=0.01).  In the final model, 
age and living circumstances were not significant variables in the model. The 
strongest associations with well-being came from (in order of decreasing beta 
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weights): general health status (β = -.51, p<0.001), subjective VI (β = -.11, p<0.001), 
gender (β = -.10, p<0.001), the receipt of care (β = -.08, p<0.01), and objective VI (β = 
-.06, p<0.05). 
The amount of care received for AMD 
Bivariate analyses found that the amount of care received for AMD was significantly 
associated with general QoL, MD- specific QoL and well-being (see Table 4.6). 
Jonckheere’s test showed significant trends in the data: in general, those who 
received more care were more likely to report poorer QoL and well-being.  
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Table 4.6. Comparison of patient-reported outcome variables for respondents receiving different amounts of care for AMD (n=558). 
Variables  Fewer than 7 
hours per week 
7 to 14 hours per 
week 
15 to 35 hours 
per week 
More than 35 
hours per week 
Statistics, p value 
General quality of 
lifea 
Mean (SD) 0.98 (1.04) 0.65 (1.11) 0.44 (1.03) 0.61 (1.24) H (3)= 17.01, 
p<0.001***. 
 J= 44,868.00, z= -
3.68, p<0.001***.  
 Median 1.00 1.00 0.00 1.00 
MD-specific quality 
of lifeb 
Mean (SD) -2.24 (0.88) -2.45 (0.73) -2.63 (0.54) -2.60 (0.62) H (3)= 19.50, 
p<0.001***. 
 J= 44,123.50, z= -
4.37, p<0.001***. 
 Median -2.00 -3.00 -3.00 -3.00 
Well-beingc Mean (SD) 31.56 (8.75) 31.21 (8.59) 27.32 (8.94) 27.92 (9.43) H (3)= 19.98, 
p<0.001***. 
 J= 44,084.50, z= -
3.92, p<0.001***. 
 Median 32.83 32.00 27.00 28.00 
a Quality of life is measured on a 7-point scale scored from +3 (excellent) through 0 (neither good nor bad) to -3 (extremely bad). b MD-specific quality of life 
is measured on a 5-point scale scored from -3 which indicates their quality of life would be ‘very much better’ (if they did not have their macular condition), 
through to 0 (the same), to +1 (where it would be ‘worse’). More negative scores for both QoL and MD-specific QoL indicate greater perceived negative 
impact on QoL. cGeneral well-being (W-BQ16) is on a scale of 0 to 48 where higher scores indicate higher well-being. 
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Further examination of the means and median scores on the QoL and well-being 
variables found an exception to this trend (see Table 4.6). The ‘15 to 35 hours of care 
a week’ group reported lower mean and median QoL and well-being scores plus a 
lower mean score for MD-specific QoL than the ‘more than 35 hours of care a week’ 
group. These results prompted further examination of the characteristics of the 
sample who reported receiving ‘15 to 35 hours of care a week’. This group were not 
more or less likely to be male or female, or be living alone or with other/s (see Table 
4.2). In contrast, the ‘more than 35 hours a week’ group were more likely to be male 
than female, and report living with someone else vs living alone.  The ‘more than 35 
hours of care a week’ group were more likely to report their caregiver was their 
spouse than their offspring or ‘other’ type of relationship.  The ‘15 to 35 hours of 
care a week’ group were not more or less likely to report that their caregiver was 
their spouse or their offspring, but were less likely to report it was an ‘other’ type of 
relationship. 
In Table 4.2, the adjusted standardised residual for the description of vision as being 
‘worse’ since diagnosis was larger for the ‘15 to 35 hours of care a week’ group than 
for the ‘more than 35 hours of care a week’ group; indicating that more respondents 
than expected gave this response. Additionally, the residuals indicate that the ‘15 to 
35 hours of care a week’ group were less likely to not be registered as SI or SSI and 
were more likely to be registered as SI. The means also suggest that this group were 
more likely to report poorer general health than those receiving ‘more than 35 hours 
of care a week’. 
Hierarchical multiple regressions were run for each QoL and well-being dependent 
variables using the same independent variables included in steps one and two of the 
analysis above. The pwAMD/caregiver relationship type was added in step three. The 
amount-of-care-received variable was entered into the fourth and final step. (See 
Table 4.7.) 
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Table 4.7. Summary of Hierarchical Regression Analysis for the unique contribution of the amount of care received for AMD on quality of life 
(general and MD-specific) and well-being. 
 General quality of lifea MD-specific quality of lifeb Well-beingc 
Step and variable B SE B β B SE B β B SE B β 
Step 1          
Age -0.03 0.01 -.16*** -0.01 0.01 -.10* -0.13 0.06 -.10* 
GenderΨ -0.29 0.10 -.12** -0.01 0.07 -.003 -3.65 0.84 -.19*** 
Living circumstances§ -0.10 0.11 -.04 0.02 0.08 .01 -0.06 0.88 -.003 
Step 2          
Age -0.01 0.01 -.08* -0.01 0.01 -.05 -0.04 0.05 -.03 
Gender Ψ -0.14 0.09 -.06 0.02 0.07 .01 -2.57 0.73 -.14*** 
Living circumstances § -0.03 0.09 -.01 0.06 0.08 .03 0.40 0.76 .02 
Subjective VIα -0.32 0.06 -.20*** -0.14 0.05 -.13** -1.58 0.48 -.12** 
Objective VI¥ -0.09 0.05 -.06 -0.22 0.04 -.21*** -0.56 0.45 -.05 
General health status≠ -0.50 0.04 -.49*** -0.02 0.03 -.03 -3.81 0.30 -.47*** 
Step 3          
Age -0.01 0.01 -.08* -0.01 0.01 -.06 -0.04 0.05 -.03 
Gender Ψ -0.13 0.09 -.05 0.02 0.07 .01 -2.51 0.75 -.13** 
Living circumstances § 0.07 0.14 .03 0.06 0.08 .03 0.76 1.17 .04 
Subjective VIα -0.31 0.06 -.20*** -0.14 0.05 -.13** -1.58 0.48 -.12** 
Objective VI¥ -0.09 0.05 -.06 -0.22 0.05 -.21*** -0.55 0.45 -.05 
General health status≠ -0.50 0.04 -.49*** -0.02 0.03 -.03 -3.80 0.30 -.47*** 
Adult offspring caregiver 
(spouse)# 
-0.06 0.15 -.03 0.05 0.12 .03 -0.37 1.25 -.02 
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‘Other’ caregiver relationship 
(spouse)# 
-0.28 0.16 -.09 0.09 0.13 .04 -0.71 1.36 -.03 
Step 4          
Age -0.01 0.01 -.08* -0.01 0.01 -.05 -0.03 0.05 -.02 
GenderΨ -0.13 0.09 -.06 0.004 0.07 .003 -2.58 0.74 -.14** 
Living circumstances § 0.01 0.14 .002 -0.09 0.12 -.05 -0.10 1.20 -.01 
Subjective VIα -0.30 0.06 -.19*** -0.13 0.05 -.11** -1.42 0.48 -.11** 
Objective VI¥ -0.06 0.06 -.04 -0.18 0.05 -.18*** -0.23 0.46 -.02 
General health status≠ -0.48 0.04 -.48*** -0.002 0.03 -.003 -3.63 0.30 -.45*** 
Adult offspring caregiver 
(spouse)# 
-0.07 0.15 -.03 0.03 0.12 .02 -0.51 1.24 -.03 
‘Other’ caregiver relationship 
(spouse)# 
-0.30 0.16 -.10 0.05 0.13 .02 -1.08 1.36 -.04 
Amount of care receivedα -0.07 0.04 -.07 -0.10 0.03 -.16** -0.91 0.31 -.12** 
SE: standard error. R2 is the proportion of variance explained by the model. ∆R2 is the change in R2 at each step as new variables are entered into the model, 
and the level of significance of R2 is assessed using the F- ratio. a R2= .04*** for step 1; ∆R2= .31*** for step 2; ∆R2= .005 for step 3; ∆R2= .004 for step 4. b R2= 
.003 for step 1; ∆R2= .08*** for step 2; ∆R2= .001 for step 3; ∆R2= .02** for step 4. c R2= .04*** for step 1; ∆R2= .25*** for step 2; ∆R2= .00 for step 3; ∆R2= 
.01** for step 4. *p<.05. ** p<.01.*** p<.001. n=558. a Quality of life is measured on a 7-point scale scored from +3 (excellent) through 0 (neither good nor 
bad) to -3 (extremely bad). b MD-specific quality of life is measured on a 5-point scale scored from -3 which indicates their quality of life would be ‘very 
much better’ (if they did not have their macular condition), through to 0 (the same), to +1 (where it would be ‘worse’).  More negative scores for both QoL 
and MD-specific QoL indicate greater perceived negative impact on QoL. cGeneral well-being (W-BQ16) is on a scale of 0 to 48 where higher scores indicate 
higher well-being. Ψ Gender variable coded, 0=male, 1=female. § Living circumstances variable coded, 0= live with someone else, 1=live alone. αSubjective VI 
measured by self-assessed change in vision since diagnosis. Coded as, 1= better, 2= the same, 3= worse. ¥ Objective VI measured using registration status. 
This was coded as, 1= not registered, 2= registered as sight impaired, 3= registered as severely sight impaired. ≠ Higher scores indicate poorer self-rated 
health. # Relationship of caregiver to the respondent. Nominal variable (caregiver was spouse, adult-offspring or ‘other’ relationship to the respondent) was 
converted into a set of dichotomous variables using dummy coding. α  Amount of care received per week. Coded as, 1= fewer than 7 hours, 2= between 7 
and 14 hours, 3= between 15 and 35 hours, 4= more than 35 hours. 
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Quality of life 
Age, gender, living circumstances, subjective and objective VI and general health status 
explained 35% of the variance in QoL. The addition of the pwAMD/ caregiver 
relationship type variable did not reliably improve R2 (Finc (2, 549)=2.09, p=0.13).  After 
the amount-of-care-received variable was entered, the total variance explained by the 
model as a whole was 35.5%, (F(9, 548)= 35.06, p<0.001, R2 =.37 , Adj R2 =.36). The 
amount-of-care-received variable was not significantly associated with QoL over and 
above the other variables included in the regression (Finc (1, 548)=3.14, p=0.08). In the 
final model, age, general health status and subjective VI were significantly associated 
with QoL (see Table 4.7). General health status recorded the highest beta value, 
followed by subjective VI, and age. Respondents who were older, in poorer health, and 
who reported their vision was ‘worse’ since diagnosis were more likely to report 
poorer QoL. 
MD-specific Quality of Life 
The independent variables accounted for 8.9% of the variance in MD-specific QoL, (F 
(9,548)= 7.05, p<0.001, R2 =.10, Adj R2 =.09). The addition of the pwAMD/ caregiver 
relationship type variable did not significantly improve the model (Finc (2, 549) = 0.22, 
p=0.80).  The amount-of-care-received variable explained an additional 1.8% of the 
variance in MD-specific QoL after controlling for the other independent variables, (Finc 
(1, 548) = 10.77, p<0.01). In the final model, socio-demographic variables and general 
health status were not significant.  The vision-related variables (objective and 
subjective VI) and the amount-of-care-received variable were significantly associated 
with MD-specific QoL. 
Well-being 
The regression of well-being on the independent variables accounted for 29.2% of the 
variance, (F (9,548) = 26.54, p<0.001, R2 =.30, Adj R2 =.29). Adding the 
pwAMD/caregiver relationship type variable did not improve the model (Finc (2,549)= 
0.14, p=0.87). The amount-of-care-received variable contributed an additional 1.1% of 
the variance in well-being after controlling for the other independent variables, (Finc 
(1,548)= 8.47, p<0.01).  In the final model, age, living circumstances and objective VI 
were not significant variables in the model. The strongest associations with well-being 
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came from (in order of decreasing beta weights): general health status (β= -.45, 
p<0.001), gender (β = -.14, p<0.001), the amount-of-care-received (β = -.12, p<.01), 
and subjective VI (β = -.11, p<0.01). Respondents who were in poorer health, were 
female, who reported their vision was ‘worse’ since diagnosis and who received higher 
amounts of care for AMD were more likely to report poorer well-being. 
DISCUSSION 
This study found that for pwAMD, the receipt of informal care and support received 
from others was significantly associated with QoL, MD-specific QoL and well-being, 
over and above socio-demographic variables such as age and gender, and vision- and 
health-related variables. Those who reported receiving higher amounts of informal 
care and support from others were more likely to report lower MD-specific QoL and 
lower well-being, but not lower general QoL. 
This study used data from questionnaires sent to a nationwide sample of members of 
the Macular Society. The analyses were not restricted to people using care-related or 
rehabilitation services and thus may be more generalisable to pwAMD, however it is 
possible that participants may have been looking for support when they joined the 
Macular Society and thus may be receiving less support than non-members of the 
Macular Society. Nevertheless, this is the first nationwide study to assess the number 
of pwAMD receiving informal support from others, as well as examining who provides 
this support and the associations between receiving this support and QoL and well-
being. 
The study adjusted for socio-demographic, health-, eye- and support- related factors 
that were associated with the dependent variables (QoL and well-being) and the main 
independent variables of interest (receipt of care and the amount of care received). In 
particular, bivariate analyses found the association between the amount-of-care-
received variable and the dependent variables to be non-linear. Further investigation 
found significant associations between the amount-of-care-received variable and 
socio-demographic, health-, eye- and support- related factors that may account for this 
non-linear pattern. There were no problems with linearity in the multiple regression, 
as assessed through residual analysis. Thus including these factors enabled the unique 
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relationship between the amount-of-care-received variable and the patient-reported 
outcomes to be examined. 
Both the receipt of care and the amount of care received were significantly associated 
with MD-specific QoL. Since the survey question asked about care received for AMD it 
might be expected that this would be more sensitive to the quality of life question 
specific to AMD. The vision-related variables (subjective and objective VI) were also 
significantly associated with MD-specific QoL. The receipt of care accounted for a 
larger proportion of the variance in MD-specific QoL than the vision-related variables, 
indicating its importance over the vision-related variables in explaining MD-specific 
QoL. However when the analysis was refined to assess the importance of the amount-
of-care-received in explaining MD-specific QoL, objective VI was more strongly 
associated with MD-specific QoL. Perhaps this suggests that there are factors other 
than the amount-of-support-received that are related to receiving support and might 
account for the relationship between the receipt of support and MD-specific QoL.  
The receipt of care was significantly associated with general QoL and well-being, and 
the amount-of-care-received was significantly associated with well-being, but not 
general QoL. These outcomes were not specific to AMD, thus showing the relationship 
between receiving support for AMD and broader patient-reported outcomes. The 
finding that the amount of care for AMD was not related to general QoL may be due to 
the broadness of the term ‘QoL’. QoL has been described as ‘a subjective perception’ 
that ‘means different things to different people’ (p7, Mitchell & Bradley, 2006). In this 
study, only the overview single-item from the MacDQoL was used to measure general 
QoL. Well-being was measured used the W-BQ16 which contains specific questions on 
feeling depressed or anxious, as well as positive well-being items concerned with 
enthusiasm for life (the energy and positive well-being subscales). As discussed above, 
the MD-specific QoL item is specific to AMD. Thus more specific or more detailed 
measures may be more sensitive to detect the impact of the amount of care received 
or the need for more support.  
The ‘change in vision status since diagnosis’ item was used as a subjective measure of 
VI. In the hierarchical regressions reported here, it was more strongly associated with 
general QoL and well-being than the objective measure of VI used in the study 
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(registration status). However objective VI was more strongly associated with MD-
specific QoL in the regression including the amount-of-care-received variable, and 
accounted for a similar amount of the variance in the regression when the receipt of 
care variable was included in the regression for MD-specific QoL. This highlights the 
difference between these two measures. It is not known why the subjective VI 
measure is more strongly associated than the objective VI measure with well-being 
and general QoL, but not MD-specific QoL. The subjective VI measure used in this 
study assessed a perceived change in vision since diagnosis. This will be dependent on 
both perceived level of VI at diagnosis and perceived change in vision since diagnosis. 
Respondents who experienced a bleed at diagnosis, for example, may perceive very 
poor vision at diagnosis but have an improvement in vision following treatment, and 
thus report their sight was ‘better’ since diagnosis. Nevertheless they may have 
experienced deterioration since diagnosis that may not be as bad as the bleed 
experienced at diagnosis, but may still lead to them being registered by the time of 
survey completion. It is this actual level of VI (i.e. reflected in their registration status) 
that may be more likely to reflect their present MD-specific QoL.  
The stronger relationship between subjective VI and QoL and well-being may be due to 
the perception of change in vision being more sensitive to mood; those who feel they 
have poor QoL or who are more depressed or anxious may be more likely to view their 
sight as having deteriorated. Whereas registration status, as an objective measure, is 
independent of differences in mood. The association between subjective and objective 
VI was small in this study and one might expect a stronger correlation if subjective VI 
was based on vision. It is important to note that this cross-sectional study was unable 
to determine causal associations between the variables studied. Whilst it may that 
subjective VI was a predictor of the patient-reported outcomes, it might be that poorer 
QoL and well-being predicted one’s perception of change in vision.  
Of the socio-demographic, eye-, health- and support- related variables included in the 
regressions, it was general health status that was most strongly associated with 
general QoL and well-being; poorer self-rated general health was associated with 
poorer QoL and well-being. However, general health status wasn’t significantly 
associated with MD-specific QoL. This supports other researchers’ arguments that 
health does not reflect the impact of AMD on QoL, and provides support to suggest 
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that health status measures e.g. SF-12, may not pick up on what is important to 
pwAMDs’ QoL (Mitchell & Bradley, 2006). 
Receiving more care for AMD was significantly related to poorer patient-reported 
outcomes over and above the type of relationship the caregiver had with the 
respondent (i.e. spouse, offspring or ‘other’). The type of pwAMD/ caregiver 
relationship was not significantly associated with QoL or well-being in the regression 
models. Thus whether care was received from a spouse, offspring or the ‘other’ types 
of pwAMD/ caregiver relationships, did not appear to affect the patient-reported 
outcomes included in this study. 
Conclusion 
In this study, receiving care for AMD was significantly associated with poorer QoL and 
well-being. That it was significantly associated with these dependent variables over 
and above subjective and objective VI shows its unique relationship with these patient-
reported outcomes. Receiving higher amounts of support for AMD was linked to 
poorer patient-reported outcomes. The amount of variance attributed to the amount-
of-care variable in the regressions were small but were similar to the variance 
predicted by the vision-related variables. Perhaps there are other aspects of receiving 
support that affect QoL and well-being since the regressions including the receipt of 
care variable accounted for a higher amount of the variance in the patient-reported 
outcome variables. This will be explored in the remaining studies that form this thesis. 
A discussion of the relevant literature on support as positive or problematic follows in 
the next chapter. This is followed by the rationale for the follow-on studies. 
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Chapter 5: 
The impact of providing and receiving support for AMD: Literature review. 
The Macular Society 2013 survey results presented in Chapter 4 state that for pwAMD, 
the receipt of informal care and support from others was significantly associated with 
poorer general quality of life (QoL), MD-specific QoL and well-being, over and above 
socio-demographic variables such as age and gender, and vision- and health-related 
variables. Receiving higher amounts of informal care and support from others was 
significantly related to poorer MD-specific QoL and lower well-being, but not lower 
general QoL. The type of relationship between pwAMD and their caregivers (i.e. 
spouse, adult-offspring/ parent, other) wasn’t significantly associated with these 
patient-reported outcomes.  
A literature review found that the majority of research has used an individual rather 
than a dyadic perspective to investigate the experience of supporting someone living 
with AMD or vision loss. Research has examined the impact of receiving care from the 
perspective of the person with vision loss (but none have focused specifically on 
pwAMD), or the ‘burden’ caregivers report from supporting someone living with AMD. 
In the caregiving research literature, there has been very little research exploring the 
caregiving role in the context of the interactive relationship between the support 
recipient and provider. I present the relevant research below and argue why the 
experience of receiving support for AMD should be investigated using a dyadic 
approach. (Details of the methodology of the review are provided in Appendix 8.) 
The impact of receiving support for the person with low vision. 
Most of the social support literature suggests that receiving support is considered to 
have positive effects on well-being (e.g. Wang, 2016), physical health (e.g. Reblin & 
Uchino, 2008; Spiegel, Kraemer, Bloom, & Gottheil, 1989; Uchino, Cacioppo, & Kiecolt-
Glaser, 1996) and mortality (Uchino, 2006). Within the vision impairment (VI) 
literature, support received from others has been linked to both positive and negative 
outcomes. 
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First, it is important to be aware of several definitions: 
 Instrumental support-also referred to as tangible support or practical support- 
is defined as providing assistance with tasks of everyday living or provision of 
material goods. 
 Emotional support (or affective support) involves the verbal and non-verbal 
communication of caring and concern. 
 Informational support is the provision of information and advice. 
 Support can be broken down into receipt of support (received support). This 
might be measured, for example, by asking respondents to state how often 
over the past month they have received support e.g. with housework (taken 
from Cimarolli, Reinhardt, & Horowitz, 2006). Perceived support (the 
perception that support would be available if needed)  may also be examined 
(Helgeson & Cohen, 1996). This may be measured with a question such as: “In 
times of trouble, can you count on at least some of your family or friends most 
of the time, some of the time, or hardly ever?” (taken from Sheffler & Sachs-
Ericsson, 2016). A more accurate term for this maybe ‘perceived availability of 
support’, which clarifies that this refers to the potential for support to be 
provided or perceived availability of support rather than the participant’s 
perception of whether or not they have received actual support. 
 Furthermore, another way of investigating social support is to examine the size 
of the person’s social support network. 
In a study of working age adults living with VI, instrumental support was the most 
common type of support received (Cimarolli & Boerner, 2005). Instrumental support 
may be important to people with VI because the majority have some degree of 
functional limitation associated with vision loss. Reinhardt, Boerner, and Horowitz 
(2006) found that greater receipt of instrumental support was linked to experiencing 
more symptoms of depression, but was unrelated to adaptation to vision loss. In 
contrast, perceived instrumental support was linked to better adaptation to vision loss, 
but unrelated to depressive symptoms. Both received and perceived emotional support 
had beneficial effects on adjustment to vision loss. Support was measured using self-
report questionnaires commonly used in the social support literature. To measure 
received support, participants were asked to list the persons in their social network 
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who they had received affective and instrumental support from over the past month. 
Perceived support was assessed via a single item with a 4-point scale: ‘have support 
from family and friends if needed: most of the time, some of the time, only 
occasionally or not at all’. The findings highlight that receiving support for vision loss 
may not lead to better outcomes. Rather it is the perception that help would be there 
if needed that leads to positive outcomes. It also highlights the importance of 
emotional as well as instrumental support for people with VI. The results point to the 
importance of measuring different types of support given their different impact on 
psychological outcomes.   
One type of support that has been studied in detail for people with VI is 
overprotectiveness. Individuals who perceive the support they receive as 
overprotective may have the feeling of being helped unnecessarily or being overly 
restricted by their support providers (Thompson & Sobolew-Shubin, 1993). Some 
researchers suggest that ‘negative’ support such as overprotection is independent of 
whether or not support receivers perceive it to stem from the supportive intent of the 
support providers (e.g. Shiozaki et al., 2011).  Therefore although it may not 
necessarily be perceived as negative support by the recipient, it is generally considered 
to lead to poorer outcomes.  
Overprotection has been argued to be a particularly salient issue for people with VI 
because of the increased risk of falls and injuries associated with this condition 
(Cimarolli, Boerner, Reinhardt, & Horowitz, 2013). It is possible that some support 
providers may have difficulty providing the appropriate balance of instrumental 
support to enable a person with VI to live as independently as possible. Greater 
independence may have a knock-on effect on patient-reported outcomes such as well-
being. A lack of knowledge of the person’s visual acuity and the impact of this on their 
functional abilities, as well as concern for their safety, may contribute to 
overprotection.  
In working age adults with VI, overprotection was linked to a greater number of  
depressive symptoms and higher levels of anxiety, even after controlling for vision loss 
severity, functional disability and perceived social support (Cimarolli, 2006). In people 
with age-related vision loss, overprotection was associated with poorer adjustment to 
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vision loss, and lower scores on measures of vision-specific adaptation and 
environmental mastery (Cimarolli et al., 2006).  Results indicated that higher levels of 
functional disability were related to greater instrumental support received, and both 
were related to greater perceived overprotection in adults with age-related vision loss. 
The researchers suggested that further research needs to identify other pathways that 
contribute to overprotection, such as negative interactions between the support 
recipient and provider. Cimarolli and colleagues also suggested future research could 
look at perceived satisfaction with instrumental and emotional support, and include 
support providers as well as people with VI to determine antecedents to 
overprotection and the dynamics of perceived overprotection.  
Cimarolli et al. (2013) conducted further exploration of the relationship between 
overprotection and the amount of support received for VI. In a longitudinal study 
carried out over a year, they found that although perceived overprotection increased 
over time, it was only related to instrumental support initially. This lends further 
support to the investigation of other factors influencing the perception of 
overprotection, other than the amount of support received.  
Three models of overprotection were proposed by Thompson, Galbraith, Thomas, 
Swan, and Vrungos (2002). They hypothesised that overprotective caregiving may 
result from either: a caregiving style that is overly intrusive and involved but not based 
on negative attitudes towards the patient (the “involved” model), or that 
overprotection arises from caregiver resentment and this is expressed through over-
controlling care and negative behaviours and attitudes towards the care recipient (the 
“resentment” model).  Alternatively it might be that caregiver’s overprotective style 
might arise from a reaction to the low level of autonomy and independence of the care 
recipient (the “patient source” model).  
Thompson et al. (2002) tested the three models (involved, resentment and patient 
source) in patient-caregiver dyads in which the patient had experienced a stroke 
(henceforth referred to as ‘stroke survivor’). They collected quantitative data from 
questionnaires and task observations. Some support was found for the ‘resentment’ 
model; that overprotective caregiving was related to an over-controlling caregiving 
style and behaviours that resulted from resentment and negative affect toward the 
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stroke survivor.  However caregivers’ expressions of criticisms and frustration were not 
related to perceived overprotection. The researchers also investigated equity within 
the patient-caregiver relationship. Thompson et al. (2002) refer to Exchange theory 
which suggests that satisfaction in a relationship arises from the perceived balance of 
resources given and received in the relationship. For instance, if caregivers perceive 
themselves to be under-benefitting in a relationship, and the patient to be over-
benefitting, this may result in caregiver resentment. Thompson et al. (2002) found 
evidence to support this theory; caregivers who reported under-benefitting from the 
relationship had higher resentment. Resentment partly mediated the relationship 
between caregivers’ perception of under-benefitting and the stroke survivors’ feeling 
of being overprotected. This further supports their “resentment” model.  
Thompson et al. (2002) report that perceptions of being overprotected came from 
several sources. First from caregiver resentment towards the stroke survivor and 
towards the caregiving role. Secondly through the dependency of the stroke survivor. 
In addition, stroke survivors’ dependent attitudes were associated with caregiver 
resentment.  
Thompson et al. (2002) findings suggest that it may not be over-helping itself that 
resulted in the stroke survivors feeling overprotected, but other factors such as 
negative affect and resentment. The results may suggest that caregiver dissatisfaction 
with the caregiving role may lead to ‘burden’ and resentment and this could result in 
overprotective behaviours towards the stroke survivor. Additionally the dependence of 
the stroke survivor was associated with overprotection and with caregiver resentment, 
providing partial support for the “patient source” model. Longitudinal research would 
need to confirm the pathways to overprotection. These findings are in contrast to 
Fiske, Coyne, and Smith (1991) who found that overprotection was unrelated to 
caregiver hostility. This difference in findings may be due to the researchers 
contrasting definitions of overprotection and the different instruments used to 
measure overprotection. Arguably the most important difference may be that patient 
perceptions of overprotectiveness were measured in the Thompson et al. (2002) study 
whereas spousal perceptions were measured by Fiske et al. (1991) and may not be 
reflective of patient perceptions.  
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In the Thompson et al. (2002) study, both physical and mental health functioning of 
the patient were unrelated to overprotection. The authors suggest future research 
could explore further causes of caregiver resentment including the quality of the pre-
caring relationship and lack of support for the caregiver. These aspects are taken into 
account in some models of caregiver burden which will be described below (e.g. 
Pearlin, Mullan, Semple, & Skaff, 1990 stress-process model).   
The majority of the social support literature for people with VI has focused on 
overprotective support as a negative consequence of receiving support, however other 
types of negative support have been identified. A number of other types of negative 
support were reported by adults of working age with VI (Cimarolli & Boerner, 2005). 
These included: their social network underestimating or overestimating their 
capabilities, their social network not understanding their need for independence, 
conflict with members of their social network, their support network not being able to 
provide adequate help, and the perception that their support provider neglects 
themselves. More symptoms of depression and reduced life satisfaction were more 
likely in people who reported receiving only negative support or who reported a lack of 
support. Those who reported receiving both positive and negative support had better 
psychological health. The social network underestimating their capabilities was the 
most frequently reported type of negative help received (Cimarolli & Boerner, 2005).  
Cimarolli et al. (2006) recommended that future research could explore the receipt of 
negative support in more detail by including support providers and observing negative 
interactions within dyads to investigate the causes of negative support. With regards 
to the study of overprotection in people with VI, longitudinal research is needed to 
examine the antecedents to overprotection, its association with the dependency of the 
person with VI and its impact on disability. 
Introduction to research on caregivers 
Many developed countries have an aging population and a common response is to 
delay residential care by enabling older people to live in the community for longer. The 
emphasis is on the community, friends and family of older adults to provide unpaid 
care and support (Aggar, Ronaldson, & Cameron, 2011). Of the care required to 
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support people at home, 80% is reported to be provided by family caregivers (Parveen 
& Morrison, 2012). 
A caregiver has been defined as someone who provides emotional and physical 
support for an individual who is experiencing difficulties due to physical, cognitive, or 
emotional impairments, and often does this without financial compensation (Bridges, 
1995). A report by Carers UK (2016) estimated that there are around 6.5 million 
caregivers in the UK saving the National Health Service (NHS) approximately £132 
billion per year. Around 39% of the UK population are estimated to provide unpaid 
care at some point in their lives (Carmichael & Ercolani, 2016). 
Caregiver stress is a strong predictor of an older person entering residential care 
(Spillman & Long, 2009). There is a need to assess the impact of caregiving in order to 
create healthcare initiatives and strategies to support caregivers to enable them to 
stay in their caregiving role. 
The impact of caring in the general population 
The Carers UK 2014 survey reported that 80% of the 4924 carers surveyed felt caring 
impacted negatively on their health. Health and well-being were affected in a variety 
of ways for instance, through a lack of sleep, a reduction in physical activity, and not 
having enough time to take care of one’s own health; including having a well-balanced 
diet and making timely health appointments (Carers UK, 2014). Psychological health 
was also impacted with 82% of caregivers reporting feeling more stressed because of 
their caregiving role, and 73% feeling more anxious. Half of respondents stated that 
they were affected by depression after taking on the caregiving role (Carers UK, 2014). 
Caregiving affected carers’ employment (Carers UK, 2014). Some carers reported 
having to cut their working hours, retire early or give up work entirely in order to 
provide care. This impacted on their income, career prospects and ability to save for 
pensions or for their own care needs. Caregivers reported having to turn down 
opportunities for promotion or a better job elsewhere in order to keep working flexibly 
to fit around their caregiving role. Fifty four percent of the caregivers surveyed 
reported struggling to pay for household bills or to make ends meet (Carers UK, 2014). 
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Seventy five percent of caregivers who completed the Carers UK 2014 survey reported 
difficulties maintaining relationships and social networks, and reported that this was 
due to other people not understanding the impact of caregiving (Carers UK, 2014).  
Similar findings appear elsewhere in the research literature. A review by Oyebode 
(2003) reports that one-third to one-half of caregivers experience psychological 
distress . Caregiving can bring direct stresses (e.g. reduced time and energy) as well as 
indirect stresses (e.g. an indirect effect on social life and work) (Oyebode, 2003). 
Given the impact on health, work and social relationships, it is concerning that many 
caregivers are still reporting struggling to get the support they need from health and 
social care services, despite the introduction of the Care Act 2014 and Children and 
Families Act 2014 (Carers UK, 2016). The authors stated, ‘The survey shows evidence of 
public services creaking under pressure- charging is up, the right services are harder to 
find and vital support is cut or under threat, leaving many carers anxious about the 
future and their ability to continue to care’ (p5, Carers UK, 2016). 
Models of caregiving 
Several models of the impact of caregiving appear in the literature, and include both 
patient and caregiver determinants of ‘caregiver burden’. Lazarus and Folkman (1984) 
described the ‘Transactional model of stress and coping’ when conceptualising the 
experience of caregiving. Within this framework, stress occurs when a person 
perceives their resources and capabilities to be insufficient to cope with the 
environment. Cognitive appraisal and coping are critical mediators of stressful person-
environment relationships and long-term outcomes (Folkman, Lazarus, Gruen, & 
Delongis, 1986). This model has been used in caregiving research as it has been found 
to have good predictive validity when applied to the caregiving situation, and it is 
applicable when examining both positive and negative caregiver outcomes (Parveen & 
Morrison, 2012).  
Other models build on this approach and apply it to the caregiving role. The stress-
process model of Pearlin et al. (1990) was guided by their research with caregivers of 
people with Alzheimer’s disease (see Figure 5.1). This model distinguishes four 
domains: background and contextual factors, stressors, mediators of stress, and 
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outcomes. Stressors are divided into three types: primary stressors which are directly 
connected with providing care (e.g. level of help required for everyday care), 
secondary role strains such as those caused by the conflicting roles of caring, work and 
family responsibilities, and secondary ‘intra-psychic’ strains including the caregiver’s 
level of confidence in their role. Mediators include coping strategies and social 
support. Finally, outcomes include caregiver physical and mental health, and yielding 
of the caregiver role. 
One issue with the Pearlin et al. (1990) stress process model is the grouping together 
of objective (e.g. Activities of Daily Living/ ADL) and subjective (e.g. role overload) 
indicators of burden as primary stressors (Bastawrous, 2013). The Yates, Tennstedt, 
and Chang (1999) stress model distinguishes between objective (‘stressors’) and 
subjective indicators (‘appraisals’) (see Figure 5.2). In this model, the primary stressors 
(e.g. ADL) predict the primary appraisal of care (number of hours spent caregiving) as 
well as secondary appraisals (burden) and outcomes (well-being).  As in the Pearlin et 
al. (1990) model, perceived social support acts as a mediator in addition to the 
frequency of getting a break, number of hours of formal care received and caregiver 
self-esteem. 
The common underlying principle of these models is the assumption that caregiving 
itself may not automatically cause stress; it is the caregiver’s appraisal of the ‘stressors’ 
that may lead to stress, and that this can be influenced by other factors such as social 
support.   
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Figure 5.1. Pearlin et al.’s Stress-process model. (Taken from Pearlin et al., 1990, used 
with permission from the publisher Oxford University Press.)  
 
Cognitive 
status
Functional 
dependency
Behavioural 
problems
Number of 
informal 
caregiving 
hours
Perceived social support
Frequency of getting a 
break
Formal service
Self-esteem
Burden
Well-being
Primary 
stressors
Primary 
Appraisal
Mediators Secondary 
Appraisal
Outcome
Figure 5.2. Yates et al., (1999) Stress-Process model. (Reproduced from Bastawrous, 
2013, used with permission from publishers Elsevier and Oxford University Press.) 
 
Although some stress theories take into account the impact of the caregiving role on 
the other roles the caregiver undertakes (for instance work or child caring 
responsibilities), role theory focuses specifically on how the various roles interact and 
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the implications this has for burden, in particular, the impact of role overload and 
conflict (Biddle, 1986).  
Measuring the impact of caregiving 
Oyebode (2003) highlighted the importance of distinguishing between objective and 
subjective burden. Objective burden refers to the additional practical support or 
assistance that is required. Subjective burden is the emotional and cognitive reaction 
to caregiving. Thus they are similar to the ‘stressors’ and ‘appraisals’ specified in the 
stress-process models described above. It is important to distinguish between them as 
two caregivers could perform the same tasks for their patients (i.e. objective burden), 
but one may feel differently about the impact of this than the other due to their 
personal interpretation of the situation (i.e. subjective burden). Failure to distinguish 
between the two has been argued to hinder the understanding about the source of 
burden which limits the ability to design interventions of benefit to caregivers 
(Bastawrous, 2013). 
The impact of providing support to someone with low-vision 
There has been very little research on the experiences of caregivers providing support 
to people with VI, particularly people with macular conditions. The results of the 
Macular Society Survey 2013 (herewith ‘2013 survey’) show that 52.3% of members 
perceive themselves to have a friend or family member who provides unpaid care, 
support or assistance to them because of their macular condition, yet this population 
has been relatively understudied. 
Other research suggests a high number of caregivers that provide support to people 
with VI. For example 20% of caregivers in the UK report looking after someone with a 
sensory impairment (The NHS Information Centre, 2010). 
The majority of research into the experiences of providing support to someone with 
AMD have focused on caregivers who support someone living with wet AMD. The 
Caregiver Reaction Assessment (CRA, Given et al., 1992) measure has been used to 
assess reactions to supporting someone receiving treatment for wet AMD. Gohil et al. 
(2015) found caregiver ‘burden’ was associated with caregiver activities related to 
treatment (e.g. taking pwAMD to eye clinics) and to disease impact (visual function 
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scores, visual acuity in better eye and the number of injections received). The level of 
caregiver ‘burden’ reported by the 250 caregivers studied, was similar to that reported 
for caregivers of people with atrial fibrillation who required regular hospital 
appointments for monitoring thromboprophylaxis (see Coleman et al., 2012). Around 
70% of caregivers reported attending 10 or more eye clinic appointments in the past 
year, with around 25% requiring time off work to support the pwAMD with their 
treatment. Ten percent reported this had led to a loss of income. The majority of 
caregivers recruited were women (63%).  Female caregiver gender was a significant 
predictor of caregiver burden. 
Although validated measures of caregiver or pwAMD psychological health were not 
included in the Gohil et al. (2015) study, there were indications that caregivers’ mental 
health was affected by caregiving. Caregivers reported specific health problems due to 
providing care, including anxiety (38.8% of caregivers), tiredness (39.6%) and 
depression (29.6%). Over half of the caregivers reported they had not received 
information about wet AMD, its treatment, potential loss of vision, or any further 
support that might be available to them to help them in their caregiving role. 
Similarly, Gopinath, Kifley, Cummins, Heraghty, and Mitchell (2015) focused on 
caregivers of people with wet AMD, however they designed a bespoke questionnaire 
instead of using validated measures. They found that caregivers who perceived the 
pwAMD was ‘highly dependent’ on them were more likely to report caregiver distress. 
Other predictors of caregiver distress included the pwAMDs’ severity of sight loss, 
male pwAMD gender and caregivers’ own health. More than half of the sample 
reported a ‘negative state of mind’ and having to make changes to their lives because 
of the impact of caregiving, including making changes to their retirement plans as well 
as their everyday plans. Caregivers who supported someone who was blind, compared 
to supporting someone with good vision, were more likely to provide daily or constant 
care, have a negative state of mind and have their lifestyle and retirement plans 
affected due to providing care. Interestingly, care providers who reported the pwAMD 
was currently receiving treatment for their eye condition, were less likely to report 
feeling that the pwAMD was dependent on them. The authors suggested that 
treatment may maintain the quality of life and independence of pwAMD, thereby 
potentially reducing the risk of caregiver burden. Alternatively it could be that 
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caregivers are convinced that treatment might prevent the pwAMD experiencing 
permanent vision loss and this hope could impact on caregiver outcomes. This study 
therefore adds to the findings of Gohil et al. (2015) who only included caregivers who 
were supporting pwAMD receiving treatment. The findings of Gopinath et al. (2015) 
suggest that caregivers of pwAMD not receiving treatment may have poorer caregiver 
outcomes than those who are looking after pwAMD receiving treatment. 
The free-text response questions included in the same survey sent to caregivers in the 
Gopinath et al. (2015) study were analysed using an ‘inductive’ grounded theory 
approach and reported separately (Vukicevic, Heraghty, Cummins, Gopinath, & 
Mitchell, 2016). The authors argued that the qualitative data provide an understanding 
of the reasons for caregiver distress that add to the predictors identified by Gopinath 
et al. (2015). Vukicevic et al. (2016) reported that caregivers were ‘compassionate and 
self-sacrificing’, and provided encouragement to the pwAMD whilst taking on the 
additional responsibility of caregiving. They reported that lack of outside help (either 
sought or received) had a negative impact on the relationship between the pwAMD 
and their caregiver. The researchers only analysed data from caregivers. The pwAMD 
perspective may help to validate the findings. The authors concluded ‘It is quite 
evident that caregivers are very special people and require more support than 
currently available to them to prevent or ease the known issue of distress experienced 
as a result of caring’ (p421, Vukicevic et al., 2016). They argued that the experience of 
providing care to someone with AMD doesn’t only involve stress and burden (as could 
be concluded from quantitative studies), as these aspects were not identified by 
participants as being the most important aspects of providing care. Instead the 
qualitative data found that altruistic personality traits and compassion, empathy and 
self-sacrifice were important in providing care. 
A global cohort of people with wet AMD and their caregivers took part in a survey in 
2012 that spanned nine countries including Australia, Brazil, Canada, France, Germany, 
Italy, Japan, Spain and the UK. The survey was developed through collaboration 
between members of an independent steering committee including ophthalmologists. 
The results have been reported in several papers (Varano et al., 2015, 2016). The 
respondents were all receiving anti-VEGF injections at the time of recruitment, or had 
received them recently. The majority of people with wet AMD reported receiving help 
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from a paid or unpaid caregiver (82%). Most caregivers were the child or grandchild of 
the pwAMD (47%). Sixty three percent of caregivers lived with the pwAMD.  
Varano et al. (2016) reported that 31% of caregivers felt providing support to the 
pwAMD had a negative impact on their lives, however 35% reported a positive impact. 
Thirty five percent of caregivers reported feeling sad and 24% reported depression. An 
increase in negative emotions was associated with longer duration of AMD and AMD in 
both eyes compared to one. The authors reported that the emotional impact of the 
diagnosis of AMD on the caregiver was similar to that on the pwAMD. However 
positive aspects of caregiving were also reported; 48% reported that it made them feel 
‘useful’.  
Caregiving impacted on the caregivers’ schedule; 27% of caregivers rated caregiving as 
‘inconvenient’ (Varano et al., 2016). This was linked to missed days of employment or 
personal obligations. The most frequent type of support provided by the caregiver was 
help with travelling to appointments. The level of support provided tended to increase 
with the duration of AMD. Fifty four percent of pwAMD reported being dependent on 
the person who provides them with care, which is slightly lower than the percentage 
of caregivers who reported that the pwAMD they provide support to was dependent 
on them (57%). PwAMD in one eye were more likely to report needing support on an 
‘as needed’ basis. Twenty six percent of pwAMD reported a fall in the previous two 
years due to VI, and just over a third (34%) of these had been hospitalised as a result of 
the fall. The majority of caregivers always attended treatment appointments with the 
pwAMD (60%) (Varano et al., 2015). Some reported being able to reduce the amount 
of domestic assistance provided after starting treatment (30%), with just over half 
reporting a temporary improvement or stabilisation in the pwAMD’s vision (Varano et 
al., 2015). Lack of information about the condition was cited as one obstacle to coping 
with the diagnosis of AMD by 11% of pwAMD and 16% of caregivers. Lack of 
understanding of AMD was also highlighted as an issue by 25% of caregivers (Varano et 
al., 2015). 
These studies provide some information about the demographic characteristics of 
caregivers of people who support someone living with wet AMD. They also provide 
information on the emotional impact of AMD and the types of support provided. 
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Analyses are mainly descriptive and although some studies recruited pwAMD/ 
caregiver pairs, these data have not yet been analysed as a dyad within the context of 
the shared impact of living together with AMD. Some results are suggestive of the 
dyadic nature of coping with AMD, e.g. Varano et al. (2016) found that caregivers and 
pwAMD reported similar emotional impact following diagnosis, however only 
descriptive data were reported. Additionally, validated measures were not used to 
measure patient-reported outcomes including depression or well-being. The findings 
reported by Vukicevic et al. (2016) indicate that qualitative research methods may be 
useful in highlighting both negative and positive aspects of providing support. 
Health outcomes in patient-caregiver dyad research 
What has been lacking, not just in AMD research, but more generally, is the study of 
support as a two-way process. Research typically considers the support recipient or 
provider in isolation and ignores their interactive relationship, leaving us with an 
incomplete picture. More recently, this has been changing.  
One recently proposed method for studying dyadic outcomes that is rising in 
popularity is the Actor-Partner Interdependence Model (APIM; Cook & Kenny, 2005). 
This model takes into account the effect of an individual’s own influence or 
characteristics on an outcome (referred to as actor effects), as well as the effect of 
their partner’s (referred to as partner effects). Actor effects are estimated after taking 
into account partner effects (and vice versa). This method has been used to 
investigate, for instance, the actor and partner effects of spouse health on marital 
satisfaction (Korporaal, van Groenou, & van Tilburg, 2013), the impact of chronic 
cardiovascular disease patients’ and their spouses’ illness cognitions on psychological 
symptoms (depression and anxiety), whilst controlling for marital quality (Karademas, 
2014), and the relationship between advanced cancer patients’ and their caregivers’ 
mental health, physical health and self-efficacy over time (Kershaw et al., 2015). 
There has been some research examining the influence of a person with VI’s outcomes 
on their caregiver, however none of which have used the APIM. For instance, Bambara 
et al. (2009) found 35% of their sample of family caregivers of people with VI were 
identified as being at risk for depression (using the Center for Epidemiologic Studies- 
Depression Scale, CES-D). Caregivers’ symptoms of depression and their life 
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satisfaction scores were associated with the person with VI’s own symptoms of 
depression.  
Strawbridge, Wallhagen, and Shema (2007) summarised three conceptual frameworks 
that might be appropriate for explaining why the person with VI might affect their 
caregivers’ physical and psychological health outcomes. First, communication theory 
states that VI may affect communication patterns between pairs. Although people with 
VI may still be able to interact verbally without problems, non-verbal communication 
may be affected. Non-verbal cues can indicate emotional content of communication, 
and so without being able to see these cues, the person with VI may misinterpret the 
meaning of what is being said (Heine & Browning, 2002). Strawbridge et al. (2007) 
argued that this could result in a feeling of lack of connectedness within pairs which 
could negatively affect pair’s well-being. 
Secondly, affect or emotional contagion refers to a process where an individual’s mood 
spreads to others who are in close contact (Bookwala & Schulz, 1996). According this 
theory, changes in an individual’s mood should be followed in time by similar changes 
in their partner’s mood. Studying this theory would require a longitudinal analysis. 
Lastly, Strawbridge et al. (2007) suggested that the stress-process model (Pearlin et al., 
1990, as described above) may be a relevant framework for explaining the impact of a 
person’s VI on their partner’s or caregiver’s outcomes. However, Strawbridge et al. 
(2007) acknowledged the model was designed for caregivers of people with dementia 
and so may contain illness-specific aspects not relevant to the study of VI.  
Strawbridge et al. (2007) conducted a longitudinal study to investigate the impact of VI 
within married couples where one has VI. They found that VI negatively impacted 
spouses’ depression, physical functioning, well-being and marital quality. These effects 
were similar to the impact of VI on the individual with VI’s own outcomes. There were 
gender differences. Husbands’ VI impacted more negatively on wives’ social 
involvement, well-being and marital quality than the impact of wives’ VI on husbands’ 
outcomes. The results were discussed in relation to each of the above frameworks. 
Strawbridge et al. suggested their results were in line with communication theory and 
with the Pearlin et al. (1990) stress-process model, however further work would need 
to be conducted to confirm this. Nevertheless, this suggests that models of caregiver 
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burden would be appropriate to assess the impact of AMD on both patient and 
caregiver outcomes.  
The only dyadic qualitative research study to explore the impact of AMD was 
conducted by Burton, Shaw, and Gibson (2015). They reported a longitudinal 
qualitative case study of a married couple who both had AMD. Three themes were 
discussed. The first, “the disruption of visual impairment”, described how the couple 
made ‘sense’ of the impact of AMD including impact on their activities. The second 
theme, “managing mutual deterioration”, describes the ebb and flow over time of 
changes in autonomy, dependency and increasing disability. It also refers to each 
member of the dyad using their partner’s AMD as a frame of reference with which to 
compare to their understanding of their own AMD. Finally, “resilience through 
togetherness” describes the joint experience of coping with AMD.  The researchers 
described how the couple’s lives were ‘knitted together’ (p1291) since having spent 
their adult lives together, and argued for the importance of understanding the 
experience of living with a long-term condition in old age within a wider context of 
‘home life, the interdependence between partners and the impact of co-morbidities’ 
(p1291) (Burton et al., 2015). 
Summary 
Research into positive and negative types of social support received for VI paints a 
complicated picture of the impact of receiving support for VI. Received instrumental 
support is related to negative outcomes such as higher risk for depression. However 
perceived instrumental support is related to better adaptation to VI. Perceived 
overprotection has been linked to a range of poorer psychological health outcomes for 
people with VI. The antecedents to overprotection have yet to be confirmed, but one 
study suggested it might arise from caregiver resentment and negative affect towards 
the patient (see Thompson et al., 2002), however others have suggested 
overprotection may be unrelated to hostility (Fiske et al., 1991). Additionally the 
impact of receiving support have yet to be investigated in pwAMD specifically. 
There is a wealth of both qualitative and quantitative research into the experience of 
caregiver burden for chronic conditions. However there has been much less research 
on caregivers of pwAMD. Several researchers have highlighted the emotional and 
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physical impact of supporting someone living with AMD. However the majority of 
studies have focussed on caregivers supporting pwAMD who have received treatment 
for wet AMD, and have yet to explore the experiences of people supporting someone 
with dry AMD or untreatable wet AMD. Nevertheless, the reported impact on 
caregivers indicate that this is an important research topic needed to determine how 
best to support caregivers of pwAMD. 
In the past few years, there has been a gradual increase in studying the dyadic 
response to illness. This research area benefits from more sophisticated statistical 
analysis techniques (e.g. the APIM) and the rising popularity of qualitative research. 
The field of coping with VI or AMD has yet to bring together research into caregiver 
burden, dyadic coping with illness, social support and overprotection to investigate 
coping with AMD as a dyadic and dynamic system.  
The next step in the research reported in this thesis is to investigate further the 
reasons why pwAMD who reported receiving care in the Macular Society 2013 survey 
were more likely to report poorer QoL and well-being even after controlling for degree 
of VI (using registration status and pwAMD-reported change in vision status since 
diagnosis). As discussed above, there are theoretical perspectives and models that 
suggest that patient/ caregiver pairs may affect each other’s psychological and physical 
health. Only one study has examined the impact of AMD using a dyadic approach 
(Burton et al., 2015), however both individuals were living with AMD and could be 
argued to have different experiences from people who support someone with AMD 
who do not themselves have any VI. In order to further the research in this area, both 
the well-being of the pwAMD and their caregiver will be investigated using a dyadic 
perspective.  
What is the difference between ‘providing support’ and being there for your loved one 
whilst they are coping with a chronic condition? Is there one? Evidence from 
qualitative literature suggests the label of ‘caregiver burden’ may be rejected by some 
caregivers (e.g. Greenwood & Mackenzie, 2010). Is there any benefit in perceiving 
support provided in a relationship to be ‘care’, with caregivers experiencing ‘caregiver 
burden’? The author believes that research might move forward by taking a holistic 
view of the impact of living with AMD and using a dyadic perspective.   
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Chapter 6: 
The impact of providing and receiving support for AMD: A mixed methods study of 
person with AMD/ caregiver dyads: Methodology. 
Introduction and rationale for this study  
Chapter 4 reported the findings from the Macular Society 2013 survey that suggested 
that receiving care for AMD was related to poorer well-being and quality of life (QoL), 
after controlling for degree of visual impairment (VI) using registration status and 
patient-reported change in vision status since diagnosis. Respondents who reported 
receiving more hours of care a week for their AMD, were more likely to report poorer 
well-being, after controlling for other factors including registration status, self-
reported vision loss since diagnosis, age, gender, whether they lived alone, general 
health status and whether their caregiver was their spouse, adult-offspring or ‘other’ 
type of pwAMD/caregiver relationship (friend, neighbour or other family member).  
The aim of the quantitative second study was to investigate reasons for the 
relationship between receiving more care for AMD and poorer well-being. The 
quantitative first study relied on registration status and patient-reported change in 
vision status since diagnosis as indicators of degree of VI. However previous research 
indicates that people with VI may not be appropriately registered (Thetford et al., 
2009). People with VI whose vision has deteriorated to a point where registration is 
applicable, may not be registered. Furthermore, people registered as SI who have 
experienced further vision loss may not be registered as SSI (see Chapter 1 for a 
discussion). The single-item question designed by the author that was used as a 
subjective measure to assess respondents’ change in vision status since diagnosis 
(whether vision is better, the same or worse), had a lower than expected correlation 
with registration status in the results presented in Chapter 4. It was considered that it 
may not accurately reflect level of VI (as discussed in Chapter 4). Subsequently, the 
quantitative second study used a validated measure of pwAMD difficulty carrying out 
vision-dependent tasks as an indicator of level of VI.  PwAMD ability to manage 
activities of daily living was also measured in order to assess the amount of help 
required. Replicating the first study, data were collected on pwAMDs’ perceptions of 
the amount of help received per week. It was hypothesised that the amount of help 
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required, would predict the amount of help received. The questionnaires used were 
expected to provide a more detailed picture of the pathways to the well-being and QoL 
of pwAMD.  
A review of the literature reported in Chapter 5 found that there was very little 
reported research on the experiences of people who provide help, support or 
assistance to pwAMD, and in particular, for people with dry AMD. The quantitative 
study to be reported here explores caregiver reactions to providing support for people 
with dry and wet AMD. It also examines the predictors of reactions to providing 
support and caregiver well-being and QoL. The Yates et al. (1999) stress model is used 
as a framework; combining pwAMD and caregiver factors into one model. 
The qualitative third study follows the quantitative second study and explores the 
findings of both quantitative studies in greater detail.  
The overall aim of this study was to explore the impact of receiving and providing 
support for AMD in more detail. A dyadic approach was used for both the quantitative 
and qualitative studies to take into account the interactive relationship between the 
support recipient and provider.  
Philosophical and methodological framework  
Taking a pragmatic approach, this study used a sequential mixed methods design to 
answer the research questions. The second quantitative study used quantitative 
research methods to build on the quantitative first study findings. This methodology 
was chosen given one of the reasons for carrying out the research was to explore the 
use of other quantitative measures to help explain the first study findings. However 
using quantitative measures provides a somewhat reductionist view of the impact of 
providing and receiving support for AMD that might not fully capture the individuals’ 
experiences. So in order to investigate this research aim more comprehensively, a 
qualitative third study was added to help explain and add to the quantitative study 
findings. Using more than one method or source of data in the study of social 
phenomena is referred to as triangulation. Triangulation is typically employed for three 
main reasons: confirmation, completeness and abductive inspiration (Risjord, 
Moloney, & Dunbar, 2001). In other words, a mixed methods approach was used in 
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order to maximise reliability and validity through using both qualitative and 
quantitative approaches to corroborate findings, to build a more comprehensive 
picture of the phenomena under study and to begin to make inferences about the 
causal mechanisms that account for the phenomena (Risjord et al., 2001). However 
Risjord et al. (2001) noted that there is still controversy as to whether quantitative and 
qualitative methods can together confirm study findings to a greater degree than 
either method alone. 
The quantitative second study was used to facilitate the sampling of participants for 
the qualitative third study. The two methods are given equal priority in this research 
study. It was felt that by using both quantitative and qualitative research methods to 
answer the research aims, one could gain a more complete understanding of the 
impact of receiving and providing support for AMD.  
Theoretical perspective, methodology and methods 
As discussed in the literature review in Chapter 5, several different theories have been 
proposed to explain the impact of providing support, however two theories that have 
been suggested to be most relevant to the field are stress theory and role theory 
(Bastawrous, 2013). 
Highlighted by several ‘stress’ theories (e.g. the stress process model of Pearlin et al. 
(1990) and the stress model of Yates et al. (1999)) is the importance of distinguishing 
between objective and subjective burden in assessing the impact on the caregiver.  
Objective burden indicators include the patient’s cognitive status, problematic 
behaviour and difficulties with activities of daily living (ADL) and/or instrumental 
activities of daily living (IADL). The models differ on the perception of whether 
subjective burden is perceived as a primary stressor alongside the objective indicators 
(as stated in the Pearlin et al. (1990) model) or whether subjective burden is seen as 
part of a secondary appraisal of providing care (Yates et al. (1999)). Whilst the Yates et 
al. (1999) model views only mental health as a caregiver ‘outcome’, the Pearlin et al. 
(1990) model includes several outcomes including both mental and physical health.  
The measures section in this chapter explains which objective and subjective burden 
measures were chosen. The model proposed by Yates et al. (1999) was used as a 
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framework given that the ‘primary appraisal’ included in the model was in line with the 
measure used in the first quantitative study (number of hours of care provided), and 
this is also included in the second study. Additionally, the hypothesis that objective 
burden (primary appraisals) would predict subjective burden (secondary appraisals) 
seemed plausible.  
Previous research on the impact of receiving support for VI has mainly focused on the 
risk of overprotection (e.g. Cimarolli, 2006). However, as described in the literature 
review, there may be other appraisals of the impact of receiving support that help to 
explain well-being and QoL. There are currently no validated questionnaires measuring 
the impact of receiving support for AMD/ VI that could be used in the quantitative 
study. Therefore both negative and positive appraisals of receiving support were 
explored in the qualitative study. 
Whilst the theories discussed so far have focussed on patient- or caregiver-specific 
explanations for impacts on well-being or QoL outcomes, there has been less research 
looking at the experience within the patient-caregiver dyad. Thus the choice of 
measures of predictors of patient or caregiver outcomes could not be informed by any 
existing theoretical frameworks.  
This research used methods and analysis specific to dyad-based research (as far as 
possible). They will be described in the relevant sections in this chapter. 
QUANTITATIVE STUDY 
Aims 
The aims of this study were to investigate further the impact of receiving support for 
AMD, and to assess the impact that providing support for someone with AMD has on 
their caregiver. The main aims were to confirm the 2013 survey findings, examine the 
predictors of: pwAMD and caregiver hours of care received/ provided, caregiver 
reactions to providing support, and pwAMD and caregiver outcomes. The direction of 
relationships between predictors and outcomes were informed by the stress model of 
Yates et al. (1999). 
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Research design 
The above aims were investigated in the quantitative strand of the mixed method 
study used postal questionnaires. 
Participants and procedure 
At the end of the Macular Society 2013 survey, respondents were asked to provide 
their own and their caregiver’s contact details if they were interested in receiving 
information about taking part in future research. Of the 1413 respondents to the 2013 
survey who had AMD, 137 provided their contact details and those of their caregivers 
(9.7%). They were sent questionnaire packages in October and November 2015 
containing an information sheet explaining both stages of the research study (the 
quantitative and qualitative parts), a consent form, the questionnaires (detailed in the 
‘materials’ section) and a stamped addressed return envelope. Participants were asked 
to contact the researcher if they would prefer to go through the questionnaires over 
the phone. The researcher audio-recorded verbal consent from participants before 
going through the questionnaires.  
Included in the questionnaire pack was a response slip. Participants were asked to 
complete and return this if they did not want to take part in the research. Participants 
who had not returned this response slip or a completed questionnaire were contacted 
once more via email (if they had provided an email address) or by telephone to check 
they had received the questionnaire pack. 
There were some instances where questionnaires were returned with pages 
uncompleted. It was considered that these pages may have been unintentionally 
missed out. Photocopies of the blank pages were sent back to participants to ask them 
to either complete and return these pages using the stamped addressed envelope 
provided, or to complete and return a reply slip stating they had intentionally left 
these responses blank. This was done to reduce missing data. 
The exclusion/ inclusion criteria were as follows: participants were required to have a 
good standard of spoken and written English and be over the age of 18. Caregivers 
needed to be the primary caregiver, and not be formally paid for this role. All 
participants met these criteria. 
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Ethics 
This study was approved by Royal Holloway, University of London ethics committee 
(Application number: 04/15).  
MEASURES 
Questionnaire Package Design 
So that the results from the respondents with AMD from this study could be compared 
with the results from the Macular Society 2013 survey, several of the same measures 
were used (for more detail on these measures, see Chapter 2). It was important that 
pwAMD and caregivers completed the same measures for the appraisal of the number 
of hours of care received/ provided and well-being so that the non-independence of 
the dyads could be controlled for in multivariate analysis. 
Questionnaires sent to pwAMD and their caregivers (these match the measures used 
in the Macular Society 2013 survey): 
 Well-being, using the 16-item Well-Being questionnaire (W-BQ16). This 
contains four subscales: negative well-being, positive well-being, energy, and 
stress. For all scales/ subscales, higher scores represent more of the type of 
well-being indicated by the name of the scale/ subscale. Scores for the total 
scale range from 0-48.  
 Quality of life, using two overview items from the MacDQoL (Mitchell et al., 
2005). One item assessed general quality of life (QoL). The other assessed the 
impact of AMD on their QoL. The latter was adapted for caregivers. Caregivers 
were asked, ‘If I did not provide care to my friend or relative with a macular 
condition, my quality of life would be:…’ The response options for this item for 
the pwAMD were unchanged, and on a 5-point scale (very much better/ much 
better/ a little better/ the same/ worse). As the adapted question for caregivers 
had not been tested before, the ‘worse’ option was split into three response 
options in order to add balance to the scale. These were: ‘a little worse/ much 
worse/ very much worse’. Higher scores indicate less negative (or more 
positive) impact of caring for someone with MD on the caregiver’s QoL. 
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 General health status (single-item self-assessment of their general health). 
Participants were asked, ‘In general, my health is:’ followed by a 7-point scale 
scored as: 7=excellent, 6= very good, 5= good, 4= neither good nor bad, 3= bad, 
2= very bad, 1= extremely bad. Higher scores indicate better general health. 
 Self-reported registration status (for pwAMD only). Response options were ‘not 
registered/ registered as sight impaired (visually impaired) or registered as 
severely sight impaired (blind)’. 
 Amount of care received/ provided for AMD (‘primary appraisal’ of caregiving). 
PwAMD were asked to state the person who ‘most often’ provided them with 
help, support or assistance. Their response was compared with the details of 
the caregiver we had on record, to check they were their main caregiver. 
Participants were then asked: ‘Please tick how many hours per week this 
person spends helping you (on average)’. Caregivers were asked: ‘Please tick 
how many hours per week you spend helping them (on average)’. Both the 
questions to the pwAMD and caregiver had the same 4-point ordinal response 
options: fewer than 7 hours per week/ 7 to 14 hours/ 15 to 35 hours/ more 
than 35 hours per week. Higher scores indicate that the participant received/ 
provided more hours of care. 
The measures in this study that were not included in the Macular Society 2013 survey 
are described separately for the pwAMD and caregiver below. 
Additional questionnaires sent to pwAMD 
Amount and type of help required 
A review of the literature found no standardised questionnaire designed to measure 
the amount and/or type of support received/provided for AMD or for VI generally.  
Three different measures were therefore used to assess the amount and type of 
support that might be required, and to see if these would predict the amount of 
support received for AMD (the pwAMDs’ primary appraisal), the amount of support 
provided for AMD (the caregivers’ primary appraisal), caregivers’ reactions to providing 
support and pwAMD and caregiver outcomes. PwAMD general health status (as 
 192 
 
described above), difficulties with instrumental tasks of daily living and a vision 
function measure were used. 
Instrumental Activities of Daily Living (IADLs) 
Ability to carry out instrumental activities of daily living were assessed using a 8-item 
measure used in previous research with pwAMD (Hochberg et al., 2012). IADLs 
included eight activities: preparing meals, grocery shopping, managing one’s own 
money, using a telephone, heavy housework, light housework, getting to places 
beyond walking distance, and taking medications. Participants were asked to rate each 
IADL on a 4-item scale, where 1= ‘No difficulty’, 2= ‘with difficulty, but without help’, 
3=  ‘with help’, 4= ‘unable to perform task’.  In line with previous research, participants 
were considered to have a disability regarding a specific IADL if they reported doing 
the task with help or not doing the task at all (e.g. Hochberg et al., 2012; Shumway-
Cook et al., 2007). Therefore scores of 3 or 4 were recoded as 1 (to show an inability to 
complete this task alone), and scores of 1 or 2 were recoded as 0 (to show they were 
able to complete this task alone). Individual scores for each IADL were added together 
to give a total score which ranged from 0 (can perform all IADLs with or without 
difficulty) to 8 (inability to perform any of the IADLs alone). 
Daily Living Tasks Dependent on Vision (DLTV) 
The DLTV was included to assess the impact AMD had on vision-related tasks. This 
measure was developed, designed and tested in pwAMD (Hart, Chakravarthy, 
Stevenson, & Jamison, 1999). It consists of 24-items. Two items ask respondents to 
rate their overall distance and near vision on a scale of 1 (poor) to 4 (excellent). These 
two items are not normally included in the DLTV total score. The remaining 22-items 
cover a range of aspects of visual function including far distance, intermediate and 
near vision, binocularity, field of vision, light and dark adaptation and contrast 
sensitivity. Participants were asked to score each of these to reflect the level of 
difficulty they have with each task. The scoring reflects the following responses: 4= no 
difficulty, 3= a little difficulty, 2= a lot of difficulty, 1= cannot see to do. The total DLTV 
score can range between 22 and 88. Total scores were reverse coded so that higher 
scores indicated poorer visual function. 
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The DLTV was found to be able to distinguish between pwAMD and people with 
cataracts (Hart et al., 1999). It is also able to discriminate between different levels of 
severity of AMD (Schmier, Halpern, & Covert, 2006). The DLTV has been used in RCTs 
for subfoveal radiotherapy and shown sensitivity to changes in vision over time 
(Stevenson et al., 2005). 
The NEI-VFQ (Mangione et al., 1998) is more commonly used in AMD population 
studies and clinical research than the DLTV (Finger, Fleckenstein, Holz, & Scholl, 2008). 
However this measure was designed for people with vision loss (rather than AMD 
specifically), meaning that it may not contain items pertinent to pwAMD. It may also 
contain items not perceived as relevant to pwAMD (e.g. items on ocular discomfort). 
The DLTV was chosen over other measures of visual function for the following reasons: 
its appropriateness in measuring the intended construct (the items are more specific 
to tasks of daily living that might require help, and therefore had ‘face validity’ for the 
study aims), it’s applicability and relevance to the AMD population, the length of the 
questionnaire (it is shorter than the NEI-VFQ 25), and its ability to be used as a pen and 
paper questionnaire. 
One aspect of functioning not measured in the DLTV is driving status. It was considered 
that including a measure of this would be particularly relevant to this research topic 
given that this may be one of the activities caregivers undertake as part of providing 
support. Questions on driving status were added to the end of the DLTV.  
Participants were asked a series of questions on whether they had ever driven and 
whether they currently drive. For those who had stopped driving, they were asked 
whether this was due to their AMD. For those who still drive, they were asked if they 
felt able to drive under certain conditions: ‘to familiar places in daylight/ in the dark’, 
and ‘to unfamiliar places in daylight/ in the dark’. Responses were a yes/ no tickbox. 
Finally they were asked whether or not their caregiver currently drove, and if yes, 
whether they ‘drove them to places’. The above questions were designed to measure 
the level of pwAMDs’ functioning, i.e. whether or not they could drive and their ability 
to drive under certain conditions. It was also included to ask directly about a caregiver 
activity. 
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Additional questions for caregivers of pwAMD 
The Caregiver Reaction Assessment Instrument 
The Caregiver Reaction Assessment (CRA, Given et al., 1992) was used to assess the 
impact of providing support for the pwAMD. The CRA was developed and tested in 
caregivers of elderly people with physical impairments, Alzheimer’s disease and 
cancer. It is a 24-item scale assessing both positive and negative reactions to providing 
support. It consists of five subscales measuring caregiver esteem, family support for 
help with caring, and impact on finances, health and the caregiver’s schedule. 
The CRA has since been used in research with caregivers of people with other 
conditions (e.g. dementia, cancer, chronic obstructive pulmonary disease, multiple 
sclerosis) (e.g. Burton et al., 2012; Forbes, While, & Mathes, 2007; Persson, Wennman-
Larsen, Sundin, & Gustavsson, 2008). More recently it’s been used to assess the impact 
of supporting someone receiving treatment for wet AMD (Gohil et al., 2015). Deeken, 
Taylor, Mangan, Yabroff, and Ingham (2003) reviewed and recommended the CRA for 
use in caregiver research. In the original development paper, the CRA demonstrated 
good internal consistency (Cronbach’s alphas for the five subscales range from 0.80-
0.90), construct validity (it correlated as expected with measures of depression and 
activities of daily living), content validity and stability over time (Given et al., 1992). 
The CRA was chosen over a more well-known measure of ‘caregiver burden’- the Zarit 
Burden Interview (ZBI, Zarit, Reever, & Bach-Peterson, 1980). The review by Deeken et 
al. (2003) stated the ZBI had not yet undergone rigorous psychometric testing 
(including assessments of reliability). It has also been criticised for being 
unidimensional and not reflecting the impact of caregiving on multiple aspects of 
caregivers’ lives (Given et al., 1992). The measure has since been validated in diverse 
samples, undergone testing of its factor structure and been tested in various short-
form versions (e.g. Hébert, Bravo, & Préville, 2000; Higginson, Gao, Jackson, Murray, & 
Harding, 2010). However since the ZBI had been designed for caregivers of people with 
dementia, some of the items were not thought to be relevant to the caregivers in this 
study (e.g. ‘I feel embarrassed over my spouse’s behaviour’, ‘I feel uncomfortable 
when I have friends over’). Therefore the CRA measure was used. 
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In order to establish the applicability of the CRA to caregivers of pwAMD, two 
questions were added after the CRA. Caregivers were asked ‘Are there any other areas 
of your life that you feel have been impacted on by providing care for the person with 
a macular condition that were not asked about in these questionnaires?’ and ‘Were 
there any questions that you found particularly difficult to answer, or that you felt did 
not apply to you? If so, which question(s)?’  Text boxes were provided for the 
participants’ response. 
Global indicators of the impact of providing care 
Two overview items were designed to assess the impact of caregiving. The first asked 
about the negative impact: ‘In general, I feel that providing care to my relative or 
friend with a macular condition, has a negative impact on me and my life’. The other 
asked about the positive impact: ‘In general, I feel that providing care to my relative or 
friend with a macular condition, has a positive impact on me and my life’. Both 
questions had the same response scale, ranging from 1 (strongly disagree) to 6 
(strongly agree). These questions were included to see if they correlated with the CRA 
total or subscale scores. 
Additionally, a question on the level of dependency of the pwAMD was included. This 
question was based on a similar question used in the Gopinath et al. (2015) research 
study reported in Chapter 5 (the question stem was not included in the study report 
and thus could not be replicated). In the present work, caregivers were asked: ‘How 
dependent do you feel the person with the macular condition has been on you since 
diagnosis?’ Responses were on a 5-point scale: ‘not at all’/ ‘somewhat’/ ‘moderately’/ 
‘very’/ ‘extremely’ dependent. This question was included because caregivers’ 
perceptions of care recipient dependency were related to caregivers’ negative state of 
mind, changes to their lifestyle, and changes to their retirement plans (Gopinath et al., 
2015). An indicator of dependency as an appraisal of providing support is not included 
in the CRA. Given the potential impact of this on caregiver outcomes, this item was 
included in the present study. 
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Socio-demographic, and additional questions on care, and eye- and health-related 
characteristics 
Socio-demographic questions 
Participants were asked to complete a short questionnaire which included questions 
on socio-demographic variables (marital status, employment status, highest 
qualification obtained). Caregivers were asked to provide their date of birth, gender, 
ethnic group, whether English was their first language and if not, to rate their level of 
fluency in English on a scale of 1 (very basic) to 7 (very fluent). PwAMD had already 
been asked for this information in the Macular Society 2013 survey and so were not 
asked again. Caregivers were asked if their employment status had changed since they 
had started providing care for the pwAMD. Response options were (tickbox response): 
gave up work, reduced work hours, took paid leave, took unpaid leave, or none of the 
above. An ‘other’ response option was included, with a free-text box response where 
participants could state any other changes to their employment due to providing care. 
Caregivers were asked whether they had children, and if so, to state how many they 
had and their age/s.  
Details of caring 
Caregivers were asked to state what relationship they had to the pwAMD (i.e. 
husband, daughter). This was included to check they matched the pwAMD’s response 
on who was their main caregiver. A question on the length of caring was included: 
‘How long have you been providing care/ support/ assistance to the person with a 
macular condition, because of this condition?’ There were three response options: 
‘less than a year’, ‘between 1 and 5 years’ and ‘more than 5 years’.  Caregivers were 
asked if they had provided care to the pwAMD before the diagnosis of AMD (yes/ no 
response). If they ticked ‘yes’, they were asked to provide details.  
Caregivers were asked if they lived with the pwAMD (response was a yes/ no tickbox).  
Both pwAMD and their caregivers were asked: ‘Does anyone else provide you/ them 
with assistance (because of your/ their macular condition)?’ (Words in italics were 
used as appropriate.) This was followed by a yes/ no tickbox response. Participants 
were asked to give the name of the person(s) and their relationship to the pwAMD, if 
relevant. 
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Treatment for AMD 
PwAMD were asked if they had ever received treatment for their macular condition. 
This had a yes/ no tickbox response. They were also asked if they were currently 
receiving treatment for AMD and to state the name of the treatment, if known. These 
questions were added to explore the impact of receiving treatment.  
Comorbid health conditions 
PwAMD were asked whether they had any of the following medical conditions: 
diabetes, stroke, heart attack/ heart disease, kidney disease, asthma/ lung disease. 
Participants were asked to write down any other ‘serious or long-term condition(s)’ if 
they did not appear in this list. This question was included to establish whether 
participants might be receiving care or treatment for another condition. 
See Appendix 9 for the questionnaire package sent to the pwAMD, and Appendix 10 
for those sent to their caregiver. 
Questionnaire Package Presentation 
The same design and presentation guidelines for questionnaires designed for pwAMD 
were followed as those used in the Macular Society 2013 survey (see guidelines in 
Chapter 2). These guidelines were applied to the questionnaires for both the pwAMD 
and their caregivers. 
The order in which the questionnaires appeared in the booklet were considered 
carefully. In order to maximise the response rate, respondent fatigue and the potential 
impact of the sensitive and emotive nature of some of the questionnaires were taken 
into account. The potentially sensitive questions and questionnaires asking the 
pwAMD about their well-being and QoL were placed in the middle of the booklet 
instead of near the front of the booklet. It was hoped that this would avoid the 
perception that the entire booklet contained measures of an emotive nature which 
may have negatively influenced participants’ willingness to complete the rest of the 
questionnaire. Instead the IADL and DLTV measures were put at the front of the 
questionnaire package as these were perceived to be less sensitive, but still important 
for data analysis. Since caregivers were not asked to complete the IADL or DLTV, the 
CRA was placed at the front of their questionnaire booklet. The additional questions on 
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socio-demographic data etc., were placed at the end of the questionnaire as these 
were considered to be the least important for data analysis (in case respondent fatigue 
meant participants missed out questions).  
The questionnaire booklet, including a 2-page consent form, was 16 pages for the 
pwAMD, and 15 pages for caregivers. Pages were printed double-sided. 
Data analysis 
Frequencies and means were used to describe the sample. The characteristics of the 
sub-sample of 2013 survey respondents who took part in the second study were 
compared with the larger group of 2013 survey respondents included in the first study 
(who were included in the analysis of results presented in Chapter 4). Pearson Chi-
squared analyses (χ2), Mann-Whitney tests and Kruskal-Wallis tests were used, as 
required. Effect sizes are reported for significant results. The guidelines provided by 
Cohen (1988) were followed for determining the strength of size of correlations: r 
between 0.1 and 0.3 is a small association, r between 0.3 and 0.5 is a moderate 
association, and r>0.5 is a large or strong correlation. Post-hoc tests were carried out 
to evaluate significant results. 
Socio-demographic, eye- and health-related characteristics and support-related 
characteristics of the dyads were analysed descriptively. Bivariate analyses explored 
differences between dyads with different types of pwAMD/caregiver relationships (i.e. 
between spouse pairs or adult-offspring/parent pairs). Descriptive statistics were 
analysed for the ‘stressors’ (pwAMD DLTV score, IADL score and general health status), 
the ‘primary appraisal’ (amount of help provided/ received), the ‘secondary appraisal’ 
(caregiver reactions to providing support, CRA score) and ‘outcomes’ (well-being and 
general health). Then relationships were explored between these variables (and other 
variables of interest) using bivariate analyses. All analyses were conducted in SPSS 
version 21.0. 
Scoring of the CRA subscale and total scores vary between different studies. The 
present study followed the scoring used by Gohil et al. (2015) to enable comparison of 
scores. To facilitate comparison of scores with other studies, the author made some 
changes to scoring (e.g. reverse scoring subscale scores).  
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Structural equation modelling (SEM) using Mplus (version 7.4, Muthen & Muthen, 
1998-2015) investigated various direct and indirect pathways to pwAMD and 
caregivers’ outcomes. This statistical technique has a number of advantages over using 
ordinary regression analysis, including being able to test more than one equation 
simultaneously and modelling non-independence between dyads by making the dyad 
the unit of analysis (Cook & Kenny, 2005). PwAMD and caregiver scores for the 
‘amount of help received/ provided’ and their well-being scores had correlated error 
terms to account for other sources of non-independence (other than those predictors 
included in the model). The model tested is shown in Figure 6.1. It is based on the 
Yates et al. (1999) stress model shown in Figure 5.2 in Chapter 5. 
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Figure 6.1. Initial path model for the impact of receiving and providing support for age-related macular degeneration. DLTV denotes the Daily 
Living Tasks dependent on Vision scale. IADL is Instrumental Activities of Daily Living. CRA is the Caregiver Reaction Assessment. 
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For models which contain only measured variables and not latent variables (as in the 
present study), the sample size requirements are the same as for ordinary regression 
analysis (Kenny & Cook, 1999). The usual rule of thumb for multiple regression is a 
minimum of 15 cases per predictor. The model shown in Figure 6.1 has six predictors 
(pwAMD IADL score, pwAMD DLTV score, pwAMD general health, pwAMD amount 
of help received, caregiver amount of help provided, and caregiver CRA score). Using 
this rule of thumb a sample size of at least 90 dyads would be required. This rule of 
thumb (as with many others) takes into account the number of predictors in the 
model. Sufficient sample sizes are needed to have enough power to detect small 
effect sizes. Since there is little previous research in the field, we had no a priori 
estimates of the size of the effect we were looking for. Thus in order to have enough 
power for the analysis, the model contained the minimum number of predictors 
possible given that the maximum possible sample we could have achieved with the 
volunteer pool and limits to time and resources was 137 dyads. 
Missing data 
As noted in the ‘Participants and procedures’ section, blank pages were returned to 
participants with a request for completion or to return a reply slip ticking a box to 
say they had intentionally left these questions blank. 
There were missing data on the IADL measure for seven pwAMD (9.7%). These seven 
participants had missing data for either one or two items. For the DLTV, there were 
missing data for nine pwAMD (12.5%). Of these, 4 respondents had only one item 
missing, and 3 had two items missing. However 2 respondents had five items 
missing; suggesting there may have been some issues with content validity for these 
particular respondents. Generally speaking, the items ‘difficulty reading newspaper 
headlines’ and ‘enjoying the scenery if out for a drive’ had the most missing data 
(three people did not respond to each of these items).  
For the DLTV, IADL and CRA total and subscale scores, reliability analyses (Cronbach’s 
alpha) were carried out to calculate how many missing data could be tolerated 
before the reliability of the scale was reduced to an unacceptable level (a value of α 
≥ 0.70 was considered acceptable). If the reliability remained above this level, then it 
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was considered acceptable to calculate an average score using the answered items 
to impute missing subscale and total scores. This procedure has been reported using 
data on the W-BQ 12 (Mitchell & Bradley, 2001). 
Cronbach’s alpha for the IADL scale with 4 items removed was 0.78. The DLTV could 
be reduced to a five-item scale which had a Cronbach’s alpha of 0.74. Thus average 
scores were computed despite missing data. 
The CRA had the largest amount of missing data. The greatest amount of missing 
data was for the ‘lack of family support’ subscale where 6 participants had missing 
scores. There were smaller amounts of missing data for the ‘impact on health’ 
subscale (n=3) and ‘impact on finances’ subscale (n=2). The ‘schedule’ and ‘esteem’ 
subscales had no missing data. The total score was based on the average of the 
subscale scores. There were 8 participants with missing total CRA scores as they had 
too many missing data on the subscales in order for the subscales to be computed 
using the average score (reliability would have dropped below an acceptable level).  
The same procedure was used for caregiver and pwAMD scores on the W-BQ 16. 
One pwAMD and two caregivers had too many missing items for the total score to be 
computed.  
There were smaller amounts of missing data for other variables, as follows: pwAMD 
general health (n=1), pwAMD amount of help received (n=4), caregiver amount of 
help provided (n=4). There were no missing data for caregivers’ general health.  
The SEM analysis used the full information maximum likelihood (FIML) estimation 
available in Mplus. This allowed all 72 dyads to be included, which was important 
given the small sample size. Little’s Missing Completely at Random (MCAR) test was 
used to confirm that data were missing at random (so FIML techniques were valid). 
Data screening 
Prior to conducting the SEM, the variables that were to be included in the model 
were examined for accuracy of data entry, missing values and the assumptions of 
multivariate analysis. 
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Outliers 
Univariate outliers were checked for by looking for very large standardised scores. 
Scores over 3.29 are indicative of outliers (Tabachnick & Fidell, 2014). There were no 
scores in excess of 3.29 in the dataset. Multivariate outliers were examined using 
Mahalanobis distance. None were significant (p<0.001, Tabachnick & Fidell, 2014) so 
there was no cause for concern. 
Multicollinearity 
No correlations between independent variables were over 0.7, apart from between 
pwAMDs’ and caregivers’ responses for the amount of care they reported receiving/ 
providing. Chapter 7 explains the reasons why both variables were included in the 
model tested. Despite this, no VIF values were over 10, and no tolerance values were 
under 0.1. There were no indications of singularity. 
Normality 
All variables were checked for normality by visually assessing histograms and 
examining skewness and kurtosis statistics for each variable. Both caregiver and 
pwAMD hours of care had kurtosis values that were significant at the p<0.01 level 
(caregiver hours of care kurtosis z-score = -2.69, pwAMD hours of care kurtosis z-
score= -2.70). Negative kurtosis is indicative of peaked tails with a relatively flat 
distribution.  The majority of respondents in the sample reported providing/ 
receiving either the lowest or highest amount of support, resulting in peaked tails. 
The ‘hours of care’ variables only have four categories and therefore responses are 
restricted to a smaller range. These variables were left as they were and not 
transformed since some kurtosis might be expected for these variables and it was 
not significant at a higher level (i.e. p<0.001).  
All other variables had skewness and kurtosis z-scores below 1.96 (which would be 
indicative of significant skewness or kurtosis at p<0.05).  
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QUALITATIVE STUDY 
Aims 
The primary purpose of the qualitative study was to help corroborate, explain and 
add to the quantitative study findings.  
Research design 
The qualitative phase used telephone interviews with pwAMD/caregiver pairs. 
Since the research study was examining shared experiences of support for AMD, it 
was important to take into account the impact of the dyad on the research design. It 
was felt that interviewing pwAMD and their respective caregivers would deepen our 
understanding of the experience of providing and receiving support, by including 
both perspectives which could be compared and contrasted. The use of the dyad as 
the unit of analysis was taken into account in sampling, data collection, analysis and 
interpretation.  
Eisikovits and Koren (2010) identified five modes of dyadic data collection: separate 
interviews with each member of the dyad (either by one interviewer at separate 
times, or by two interviewers simultaneously), joint interviews with both members 
of the dyad, both separate and joint interviews with the same participants, and 
separate interviews with some dyads and joint interviews with others.  Joint 
interviewing has several benefits including participants being able to prompt each 
other which could lead to new insights, as well as potentially being quicker to 
conduct. However separate interviews were considered to be preferable in this 
study as the research topic meant that sensitive issues would be raised (e.g. impact 
on relationships, negative aspects of receiving/providing support) that individuals 
might not feel comfortable discussing in front of their partner. This could be an 
ethical issue if there is the potential to cause harm to relationships by revealing 
sensitive information. Separate interviews also allow participants to speak without 
being inhibited by the presence of their partner. In addition, both individual and joint 
perspectives can be gained from conducting separate interviews. Norlyk, Haahr, and 
Hall (2016) argued that the presence of a partner during an interview session might 
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influence data and favour expressions of shared experiences rather than individual 
experiences.  Therefore separate interviews were conducted for ethical and 
methodological reasons. However it must be noted that there are disadvantages to 
conducting separate interviews. One of which is the issue of maintaining internal 
confidentiality. This occurs when there is the potential for one member of a dyad to 
read and recognise information from the other member, by presenting it alongside 
information they are able to identify as their own (Ummel & Achille, 2016).  
The process of dyadic data analysis from separate interviews is a relatively under-
reported topic, however Eisikovits and Koren (2010) provided initial guidelines, 
derived through ‘trial and error’ (p1645).  The guidelines focus on comparing and 
contrasting the individuals’ perspectives on both descriptive and interpretive levels 
to move from “I-ness” to “we-ness”. They argued that this leads to ‘various 
reconstruction of the existing themes and the emergence of unique subthemes’ 
(p1645). The analysis of overlaps and contrasts between the individuals’ perspectives 
can indicate differing degrees of ‘togetherness or separateness’ and ‘awareness or 
unawareness’ (of how their partner thinks and feels) within the relationship. Thereby 
this process of dyadic analysis can be used to determine the nature of the dyadic 
relationship. The study of overlaps and contrasts in the interview data within 
respective pairs was used in this study to focus the analysis and indicate where pairs 
agreed or disagreed on topics. However the themes themselves were based on the 
overall content of the data. 
Telephone interviews were used instead of face-to-face interviews. Some argue that 
face-to-face interviews are preferable because they may help to build a rapport 
between interviewer and interviewee, which is particularly important for research 
investigating in-depth personal experiences (e.g. Opdenakker, 2006). This difficulty 
building rapport is partly caused by the lack of visual communication. However the 
absence of face-to-face contact may be advantageous in cases where interviews may 
benefit from this ‘anonymity’- particularly if participants feel more comfortable 
revealing sensitive information over the phone than face-to-face (Opdenakker, 2006; 
Sturges & Hanrahan, 2004). Vogl (2013) argued that telephone interviews may 
provide responses that are less socially desirable. The anonymous nature means 
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participants do not ‘lose face’, which may lead to more honest answers. This was 
thought to be an advantage in this research where respondents might feel 
uncomfortable revealing negative feelings on the care they receive or provide to 
their respective partner. There are mixed findings in the literature with regard to 
whether telephone interviews are as effective in being able to elicit sensitive 
information (e.g. Tourangeau & Yan, 2007). Some argue that there is actually very 
little difference between the two modes of interview (e.g. Sturges & Hanrahan, 
2004; Vogl, 2013).  
Additionally, telephone interviews were thought to provide other advantages. From 
an ethical viewpoint, it could be argued that the telephone potentially gives a 
greater sense of control for the interviewee; it is easier to end an interview by 
terminating a phone call than asking someone to leave their house (Vogl, 2013). 
Additionally, using a telephone may mean interviewees find it easier to resist talking 
to their partner if they are present, or it can act as protection from their partner 
overhearing the conversation, or from their partner interrupting the conversation 
(Holt, 2010). Telephone interviews were also chosen due to the desire to collect data 
from a geographically dispersed sample and limits on time and finances meant that 
travelling to participants’ homes was not feasible. 
Ethics 
Ethical approval was granted as above.  
Participants and procedure 
Respondents to the quantitative study were asked to tick a box on the consent form, 
to show their interest in taking part in telephone interviews. (Details of the 
qualitative study were included in the Participant Information Sheet sent with the 
questionnaires.)  
Of the 72 pairs who returned completed questionnaires and were eligible to take 
part, 32 (44.4%) volunteered to take part in the follow-up interviews. The primary 
aim of the qualitative study was to add to the quantitative study findings, where 
well-being was used as both a pwAMD and caregiver outcome. With this in mind, in 
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order to collect qualitative data on a range of different peoples’ experiences, I 
selected pairs who had: similar well-being scores (i.e. both had low well-being or 
high well-being scores), those who had discrepant scores (i.e. one person in the pair 
had high well-being, and the other had low well-being) and those for whom both the 
pwAMD and their caregiver had well-being scores around the mean score for the 
sample. The quantitative analysis found a large correlation between pwAMD and 
caregiver well-being scores, indicating the majority of pairs had similar well-being 
scores (rs =0.54, p<0.001, reported in Chapter 7). The pairs who had discrepant 
scores may be considered ‘outliers’, however it was important in this study to 
investigate a range of different peoples’ experiences. With this main selection 
criterion in mind, I also aimed to select people who had a range of scores on the 
DLTV and CRA measures and who had different relationships between the pwAMD 
and the caregiver (i.e. whether they were spouses or adult-offspring of the pwAMD). 
Following sample selection, I phoned participants using the contact number they 
provided, and reminded them of the details of the research study. I asked if they had 
any questions on the study and whether they were still interested in taking part in 
the interviews. All participants agreed to take part. I arranged a separate time and 
date to phone them back for the interview. Of the pairs that lived together, both 
interviews were arranged with the person who answered this initial phone call. At 
the beginning of each interview, I reminded participants of the research before 
asking them again if they would like to take part (this was done primarily to check 
whether the person who didn’t answer the initial phone call was informed of the 
study and agreed to take part). Participants were asked if they consented to the 
interview being audio-recorded; all participants agreed. Consent to take part was 
audio-recorded at the beginning of all interviews. I suggested that individuals might 
prefer being alone at the time of the interview, so that their responses wouldn’t be 
overhead. Interviews with the pwAMD and their respective caregiver typically took 
place on the same day, apart from one couple, where the caregiver asked the 
researcher to complete the interview at a different date. Interviews took place in 
February and March 2016. They lasted between 25 minutes (participant 120) and 90 
minutes (participant 37a). 
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Recruitment stopped at 16 individuals (8 pwAMD/caregiver pairs). This was because 
of time and resource constraints. There are no specific guidelines for the optimum 
number of interviews needed for a good quality thematic analysis. Instead, many 
researchers describe stopping interviewing when it is considered that no new 
information could be gained from doing more interviews. This is referred to as 
reaching ‘saturation’. When saturation is reached however, is a matter of debate 
(e.g. Francis et al., 2010; Guest, Bunce, & Johnson, 2006), with some researchers 
suggesting sample size can be determined a priori using methods typically associated 
with calculating sample sizes in quantitative studies (Fugard & Potts, 2015). It is 
important that researchers are clear on whether they feel saturation has been 
reached (Green & Thorogood, 2004; O’Reilly & Parker, 2013). When saturation 
hasn’t been reached, instead of interpreting findings as invalid, it may simply mean 
that the phenomenon hasn’t been fully explored yet (Morse, 1995). Indeed, some 
researchers argue that saturation may never be achieved as there are always new 
phenomenon to discover (Green & Thorogood, 2004; Wray, Markovic, & Manderson, 
2007). 
According to Morse (2015), indicators of saturation include: having adequate scope 
(the data should be comprehensive enough to show breadth and depth of the topic), 
and be replicable (participants report similar responses in situations which have 
features in common). For this to happen, the sample should be adequate (large 
enough for replication) and appropriate (be experts on the topic of interest). 
Saturation may also be achieved when the researcher’s questions are answered; this 
requires a circular process where researchers interpret the data and recognise 
‘holes’ which can be used to aid further sampling. This process allows the researcher 
to learn about the phenomenon and develop theory.  
Indicators that saturation hasn’t been reached include that there are too few 
examples in each theme to develop concepts or theory and that results are 
‘tentative, obvious, and uninteresting’ (p588, Morse, 2015). The present study took 
these indicators into consideration during the recruitment and analysis phases.  
 
 209 
 
Recording and transcribing 
Digitally recorded interviews were transcribed verbatim by two research 
administrators and the researcher, using Express Scribe Transcription Software v5.81 
(NCH software). All verbal and non-verbal (e.g. coughs) utterances were transcribed 
so that the transcript reflected the ‘true’ data. All transcripts were checked for 
accuracy by the researcher. Data were entered into NVivo v.10 (QSR International), 
for coding.  
MATERIALS 
Interview guide 
Separate interview guides were created for the pwAMD and their caregiver. They 
were designed to guide participants towards reflecting on their experiences of 
receiving or providing support for AMD, and their views on how their partner has 
coped. The topics in the interview guides for the pwAMD and their caregiver 
followed a similar pattern: the experience of diagnosis, impact of AMD on their own 
and their partner’s life, specific questions on the support provided including the 
types of support received, the impact of receiving or providing support (as relevant) 
including questions on support from others, and QoL. Copies of the interview guides 
are provided in Appendices 11 and 12. 
The interview questions were based on the research aims. The first question asked 
pwAMD to: ‘Tell me about your experience of diagnosis of AMD’. It was 
hypothesised that participants would give factually based answers (e.g. when they 
first recognised the symptoms), as well as emotional reflections on diagnosis. This 
question was asked at the beginning so that participants would have the chance to 
reflect on the impact of AMD from diagnosis, and it was thought that having this in 
mind might lead to richer answers later on. Caregivers were also asked to reflect on 
their memory of diagnosis of AMD, but before this they were asked for details about 
when they first started providing support for AMD and whether they had ever 
provided support to the pwAMD for another medical condition. 
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Following this, there were general questions on the impact of AMD diagnosis on 
their life as well as their partner’s. This was kept broad so that participants could 
interpret this as they wished, potentially leading to new insights on this research 
topic. Afterwards there were a series of questions that asked more specifically about 
the impact of providing or receiving support. These questions were guided by the 
research aims and the literature review. For instance, both the pwAMD and 
caregivers were asked about the negative and positive consequences of receiving or 
providing support. These open-ended questions were included to see if the 
responses might add to the literature on overprotection (Cimarolli, 2006), or 
reactions to providing care (e.g. Pearlin et al.,’s (1990) and Yates et al.,’s (1999) 
Stress process models; Given et al. (1992)), and might be specific to providing 
support for AMD. These were followed by more specific questions (if not already 
discussed in answer to the general questions). For instance, pwAMD were asked if 
they felt they received ‘the amount and kind of support or assistance you need from 
them [the caregiver], when you need it’. For caregivers, they were asked whether 
they felt the care they provided was ‘sufficient or more than sufficient’. These 
questions were added to help guide participants to talk about the amount of help 
provided, and it was hoped that this might lead them to bring up the topic of 
overprotection without using leading questions. The dyadic design is unique in 
getting both the patient and caregiver’s views on this potential issue. 
Given that previous research has found caring impacts on the patient-caregiver 
relationship, and this contributes to caregivers’ well-being (e.g. Bastawrous, Gignac, 
Kapral, & Cameron, 2014), a question was included that asked whether participants 
felt their relationship had changed since they started receiving or providing support.  
The author used the prompt ‘was there anything that helped or hindered this?’ 
throughout the interview to investigate facilitators and barriers to coping with AMD. 
The guide also included a question on whether outside help was used and whether 
this was perceived as helpful in adjusting to life with AMD. In addition, pwAMD were 
asked if they felt there was anything that could be done to help their caregiver 
provide support, and caregivers were asked if there was anything that could be done 
to help them provide support. This was added to establish need for outside support 
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and provided a direct, tangible way that pwAMD and their caregivers might be 
assisted.  
Other questions were added to help explain the quantitative study findings. For 
example, in order to investigate differences between the 2013 survey and the 
second quantitative study findings regarding the relationship between the amount of 
help received/ provided and other variables (see Chapter 7), we prompted 
participants with the answer they gave on how much support they 
received/provided in the second quantitative study and asked them if they 
remembered having difficulty answering this question. We asked participants about 
the types of support they provided/received. This was done for two reasons; to add 
to the quantitative study findings (as this wasn’t included as a measure), and to see if 
this would prompt participants to reconsider their response on how much care they 
received/provided.  
As there is currently no validated measure available to record the amount and type 
of support provided specifically for AMD, the quantitative study relied on the DLTV, 
IADL and general health status to provide a proxy of the amount and type of help 
required. Gopinath et al. (2015) created their own instrument of the activities 
caregivers of pwAMD provide help with. These activities included:  exercise and/or 
sport, cooking food, cleaning, gardening, making the bed, hanging laundry, reading, 
hobbies, playing with or caring for their grandchildren, getting dressed, personal 
grooming, leaving the house, travelling/holidays, using automated teller 
machines/electronic funds transfer at point of sale (ATMs/EFTPOS), and/or entering 
PIN number, playing/walking their pet, driving the car, managing their finances, 
climbing stairs and shopping. In order to assess the types of activities caregivers 
provide help with, both the pwAMD and their caregiver were asked if they received/ 
provided help with these activities described in the Gopinath et al. (2015) study. In 
addition to these activities, the following activities were perceived to be relevant to 
this research topic and were included: ‘booking GP or hospital appointments with 
them’, ‘attending GP or hospital appointments with them’, ‘washing laundry’, 
‘preparing food’ and ‘providing emotional support’. ‘Leaving the house’ was 
broadened to ‘getting out and about’. This list was used as a guide to facilitate 
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discussion on the types of activities they receive/provide help with rather than to be 
used as a quantitative, structured measure. 
The interviews were primarily guided by the set interview questions however 
participants were left free to direct the conversation to topics they felt were relevant 
to their experience.  
Towards the end of the interview guide, there was a question asking participants to 
rate their current QoL as either ‘excellent/ very good/ good/ neither good nor bad/ 
bad/ very bad/ extremely bad’. They were asked if there was anything affecting their 
QoL at the moment, that hadn’t already been discussed. This was to establish if 
there were other factors affecting the participants’ current QoL that could have 
affected their answers or were important to them. 
At the end of the interview, the researcher summarised what they understood to be 
the participants’ experience and invited participants to ‘step in’ if they felt the 
researcher had misunderstood their responses, or to confirm if they had understood 
correctly. Half of the sample had experienced vision loss, and so we felt it would be 
too onerous to ask these participants to check their interview transcripts. This 
therefore acted as a ‘check-point’ where participants could add to their responses 
and help aid the researcher’s interpretation of their responses, if required.    
ANALYSIS 
Thematic analysis 
The decision to use thematic analysis was guided by the pragmatic worldview used 
throughout this thesis. Unlike other qualitative analysis methods (e.g. grounded 
theory, interpretative discourse analysis), thematic analysis is not tied to a specific 
epistemology and can be used to answer a variety of research questions (Braun & 
Clarke, 2006).  It has been described as ‘a flexible and useful research tool, which can 
potentially provide a rich and detailed, yet complex account of data’ (p5, Braun & 
Clarke, 2006). Importantly, it was felt that this type of analysis would be more likely 
to provide information in an accessible format to those who may want to use it to 
inform services or policy for pwAMD and their caregivers.  
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Thematic analysis is a method for identifying patterns in one’s data whilst also going 
beyond this to a wider interpretation of the data.  
Data were coded following the procedure outlined by Braun and Clarke (2006). An 
inductive, ‘bottom-up’ approach was taken to analysis where themes were not 
driven by the researcher’s theoretical interest or the literature, but instead were 
strongly linked to the data.  First, I familiarised myself with the data. Finalised 
transcripts were read whilst listening to the audio-recording of the interview to 
check interpretations of the meaning applied to the data.  Then preliminary notes 
were made whilst re-reading the transcripts. The next phase involves identifying 
initial codes. Codes ‘identify a feature of the data (semantic content or latent) that 
appears interesting to the analyst’ (p18, Braun & Clarke, 2006). Once a list of codes 
have been collated, the next phase is to re-focus the analysis to a broader level of 
themes. This involves sorting the codes into themes. For this stage I created mind-
maps to sort the codes visually. The following phase involves the refinement of 
themes. For instance, some themes identified in the previous phase may be 
discarded if there is not enough data to support them, or if the codes are too 
diverse. One might find that two or more themes are similar and these could be 
combined to form a single theme. For this stage, I took into account the dual criteria 
for judging categories developed by Patton (1990); themes should have both internal 
homogeneity (data within themes should cohere together meaningfully) and 
external heterogeneity (themes should be distinct). The first step involves going back 
to the dataset to check all coded extracts for each theme form a coherent pattern. 
Once completed, the next part is stepping back and checking that the themes reflect 
the meaning in the whole dataset. The entire dataset is then re-read to check that 
the themes accurately represent the data and to code data that might have been 
missed previously. The process of refining themes should be stopped when 
refinements are not adding anything substantial. Once a satisfactory thematic map 
has been created, themes are then tested by assessing their ability to adequately 
define the “… ‘essence’ of what each theme is about (as well as the themes overall), 
and determining what aspect of the data each theme captures” (p22, Braun & 
Clarke, 2006). This is also the stage where themes are named. The final stage is 
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writing up. Braun and Clarke (2006) suggest that data extracts should illustrate the 
prevalence of a theme and be easily identifiable as an example of the issue. The 
analytic narrative that accompanies the extracts should go beyond description of the 
data, and make an argument in relation to the research question.  
One should note that movement through these stages is not linear; it is recursive, 
where one can move back and forth as needed. 
Rigour 
A basic requirement for the reporting of research is that it is presented in sufficient 
detail so that it can be evaluated. Criteria for the assessment of good quality 
qualitative research exist (e.g. Yardley, 2000), however concerns have been raised 
about rigid criteria stifling creativity in qualitative research (Elliott, Fischer, & Rennie, 
1999), and the validity of such criteria has been questioned given the diverse range 
of qualitative approaches (Reicher, 2000). Despite this, Elliott et al. (1999) argue that 
guidelines for qualitative research are necessary to help introduce rigour into 
qualitative research and to encourage researchers to be self-reflective in their 
research practices. 
For this research I took into account the guidelines for publishing qualitative 
research studies in psychology and related fields, created by Elliott et al. (1999). 
These include several judging criteria in common with quantitative approaches. For 
instance, the research should have clear research questions, the methods chosen 
should be appropriate, the researcher should collect informed consent from 
participants and the research should provide a strong contribution to the research 
field. In addition, Elliott et al. (1999) suggested further criteria specific to qualitative 
research. These include elements of transparency; the researcher should specify 
their theoretical orientations and attempt to recognise their thoughts and feelings 
that are relevant to the research to try to reduce or balance their influence (see 
‘reflexivity’ and ‘personal reflexivity’ sections below). They also suggested the 
researcher provides information on the participants to aid the reader in making 
judgements about the suitability of the sample and potential generalisability of the 
research (see ‘table of interview participants’ characteristics’ section below). Further 
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suggestions were: including extracts of the data, conducting credibility checks (e.g. 
‘triangulation’ with quantitative data or using multiple qualitative data analysts), 
reporting analysis in a coherent manner, using methods and samples in line with 
whether the researchers are aiming to gather data on the general experience of the 
topic under study or a more specific investigation, acknowledging the limitations to 
the generalisability of the results, and finally that the report is presented in such a 
way that the reader can judge it to represent the topic accurately or at least have 
expanded their appreciation and understanding of the topic. 
For assessment criteria specific to thematic analysis, I used guidelines produced by 
Braun and Clarke (2006). An important decision researchers make during the process 
of analysis is how they decide on what counts as a theme. According to the Braun 
and Clarke (2006) guidelines, a theme is ‘some level of patterned response or 
meaning within the data set’ (p10, italics are in text). Braun and Clarke (2006) argued 
that prevalence is left up to the researcher’s judgement, there are no strict cut-offs 
for how much presence a theme needs to have in a dataset before it can be labelled 
as a theme. What is important, Braun and Clarke (2006) argued, is that the theme is 
important in answering one’s research questions. This is the approach used in the 
analysis reported in the present study. In this research, I chose to provide a rich 
thematic description of the entire dataset by identifying the themes that were 
pertinent to answering the research questions.  
Reflexivity 
It is important that researchers are aware of the potential bias they bring to their 
research. With this in mind, it is suggested that instead of trying to control one’s 
influence on the research process, one should instead acknowledge it (Ortlipp, 
2008). In order to create transparency in qualitative research, one should make their 
experiences, values, opinions, thoughts and feelings visible and an acknowledged 
part of the research process (e.g. how these have influenced their research interests 
and the way they choose to do their research), by keeping a reflective journal or field 
notes and using them to write up the research (Ortlipp, 2008). 
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‘The process of reflection helps to bring the unconscious into consciousness 
and thus open for inspection’ (p703, Ortlipp, 2008). 
With this in mind, I kept a reflective journal throughout this research and added to it 
during all stages of the research process. In addition, I included field notes in the 
reflective journal. For instance, after each interview, I wrote up field notes on 
reflections and impressions from the interviews. This included notes on observations 
made during the interview (e.g. indications that the caregiver/pwAMD was in the 
background) and my interpretations (e.g. noting general impressions about the 
participant’s well-being). These notes were referred to during the analysis phase, 
although not always used. 
Personal reflexivity 
Given the importance of reflexivity and transparency in qualitative research I feel it is 
important to identify and share with the reader my relevant experiences, thoughts 
and feelings with regards to this research. First, my own experiences of observing my 
father provide support to his mother with AMD could be compared to that of the 
pwAMD/ caregiver pairs in the qualitative study, particularly as the adult-
offspring/parent pairs were similar in age to my father and his mother. Secondly, 
during the process of qualitative analysis of the interview data for this study, my 
mother was diagnosed with a serious condition for which I became her main 
caregiver. Throughout the research I continued to reflect on my thoughts related to 
my pre-conceived ideas of AMD and experiences of providing care by writing in the 
reflective journal. I hoped that this awareness allowed me to reflect on these 
preconceptions and base my interpretations as close as possible to the experiences 
of the pwAMD and caregivers included in this study.  
My determination to make sure that the research results made sense to pwAMD, 
their caregivers, HCPs and other professionals, and charitable bodies influenced the 
choice of research methods and methods of data analysis used in the study. I was 
driven by my wish for the research to be understood and incorporated into services. 
Thus this influenced the choice of a pragmatic approach to this research.  
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Ethical issues and considerations taken in reporting the results 
All identifiable information were removed from the transcripts. Participants were 
assigned ID numbers in place of their actual name. This is particularly an issue in 
dyadic research where individuals may be able to recognise their partner’s responses 
(i.e. the issue of ‘internal confidentiality’). I have therefore tried to strike a balance 
between leaving out information to safeguard confidentiality whilst leaving in 
information that helps to preserve the context of the situation described and 
analysed. Results are therefore presented at a more general, and therefore less 
identifiable level (Ummel & Achille, 2016). 
It is suggested that in order to preserve anonymity, data on demographic 
characteristics should not be presented line-by-line as this might enable an 
interested party to identify an individual (Morse & Coulehan, 2015). The authors 
suggested that where analysis is related to participants’ scores, that these individual 
scores should not be presented with quotes, but rather a ‘group label’ (e.g. high or 
low well-being) should be used. Overall they recommended only reporting data that 
are necessary to aid interpretation and understanding. A summary of the 
interviewee characteristics is provided in Table 6.1. 
 218 
 
 
 219 
 
Table 6.1. Table of interview participants’ characteristicsψ.   
Participant 
ID number 
Role  Daily Living Tasks 
Dependent on Vision 
scale (DLTV score)a 
(median=61.50) 
Living 
together? 
General well-being (W-BQ 16 
score)b (pwAMD mean=28.94, 
caregiver mean= 31.07) 
Caregiver 
Reaction 
Assessment 
score 
(CRA)c 
(mean =2.4) 
Self-reported 
number of hours 
of care received/ 
provided for AMD 
Adult offspring/ parent with AMD pairs     
1 Mother with 
AMD 
 Below median no 30 Above mean (although 
close to mean) (pwAMD and 
caregiver had similar general 
well-being) 
n/a 15-35 hours per 
week 
1a Daughter of 
mother with 
AMD 
 n/a 28 Below mean (although 
close to mean) 
Below 
mean 
7-14 hours a week 
19 Mother with 
AMD 
 Above median yes 26 Below mean (pwAMD had 
well-being just below the 
mean, whereas the caregiver 
had general well-being much 
above that of the mean and 
that of the pwAMD) 
n/a More than 35 
hours a week 
19a Daughter of 
mother with 
AMD 
 n/a 38 Above mean Missing 
data 
15 to 35 hours a 
week 
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37 Mother with 
AMD 
 Above median no 16 Below mean 
(pwAMD and caregiver had 
similar general well-being. 
Both were much below the 
mean for their respective 
group.) 
n/a 15 to 35 hours a 
week 
37a Daughter of 
mother with 
AMD 
 n/a 18 Below mean Above 
mean 
7 to 14 hours a 
week 
120 Mother with 
AMD 
 Above median yes 17 Below mean (pwAMD had 
much lower general well-
being than their caregiver) 
n/a Missing data 
120a Son of 
mother with 
AMD 
 n/a 33 Above mean Missing 
data 
Missing data 
Spouse person with AMD/caregiver pairs     
128 Wife with 
AMD 
 Above median yes 13 Below mean (Both the 
pwAMD and caregiver had 
well-being below the mean for 
their respective group. 
PwAMD had lower well-being 
than their caregiver.) 
n/a 15 to 35 hours a 
week 
128a Husband of 
Wife with 
AMD 
 n/a 23 Below mean Above 
mean 
7 to 14 hours a 
week 
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28 Husband with 
AMD 
 Below median yes 45 Above mean (PwAMD had 
much higher general well-
being than their caregiver) 
n/a 15 to 35 hours a 
week 
28a Wife of 
husband with 
AMD 
 n/a 26 Below mean Below 
mean 
15 to 35 hours a 
week 
121 Husband with 
AMD 
 Above median yes 26 Below mean (Both the 
pwAMD and caregiver had 
well-being below the mean for 
their respective group. 
Caregiver had lower well-
being than pwAMD.) 
n/a More than 35 
hours a week 
121a Wife of 
husband with 
AMD 
 n/a 16 Below mean Above 
mean 
More than 35 
hours a week 
81 Wife with 
AMD 
 Above median yes 39 Above mean (Both pwAMD 
and their caregiver had high 
general well-being) 
n/a More than 35 
hours a week 
81a Husband of  
Wife with 
AMD 
 n/a 45 Above mean Below 
mean 
More than 35 
hours a week 
Participant ID numbers with ‘a’ indicate the caregiver within the pair. ψ Means and median scores shown were calculated based on the 72 pairs who took 
part in the quantitative study. a DLTV was completed by PWAMD only. Possible score range: 22 to 88, lower score indicates better visual function. b Score on 
the W-BQ 16 ranged from: 0-48, higher scores indicate better well-being. c Caregiver Reaction Assessment was completed by caregivers only. Possible score 
range: 1-5, higher scores indicate more negative impact of providing care.  
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In conclusion, the above chapter describes the methods used in this mixed-methods 
study examining the impact of receiving and providing support for AMD. The 
quantitative study results and discussion are presented in Chapter 7. The results of the 
qualitative data analysis are presented in Chapter 8 with a discussion of how they add 
to and help explain the quantitative study findings. 
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Chapter 7: 
The impact of providing and receiving support for AMD: Results and discussion from 
the quantitative study. 
Of the 137 person with AMD/ caregiver dyads sent questionnaire packs, 81 caregivers 
and 83 people with AMD (pwAMD) returned completed surveys. Three pwAMD 
requested telephone completion of surveys, giving a total of 86 pwAMD who 
completed the survey. This was a 59% response rate for caregivers and 63% for 
pwAMD.  The results reported in this chapter are for 72 dyads where both the pwAMD 
and their respective caregiver returned completed questionnaires. 
SAMPLE CHARACTERISTICS 
Characteristics of the non-responders 
Of the 51 pwAMD who did not complete a questionnaire, 19 people provided reasons 
for not taking part (giving a gross response rate for pwAMD of 77%). Reasons for non-
response included poor health (n=8), feeling that the questionnaire was not applicable 
to them (n=3), or being too busy to take part (n=1). Eight people provided a reason 
under the ‘other’ textbox. The majority of ‘other’ responses were from family or 
friends who informed the researcher that the pwAMD had died. One person stated 
that they felt their responses would have been affected by the repercussions of a 
recent serious accident. One caregiver who was the daughter of the pwAMD replied 
saying that her mother ‘hates talking about her macular experiences’. 
Pearson Chi-squared analyses (χ2) and independent-samples Mann Whitney tests were 
conducted to examine differences and similarities between those who completed the 
questionnaires and those who didn’t. There were no significant differences between 
the pwAMD who completed the questionnaire (n=86) and those who didn’t take part 
(n=51), on their MSQ 2013 responses for the following: well-being, general quality of 
life (QoL), MD-specific QoL, the number of people who provided them with support for 
AMD, age at time of MSQ 2013 completion, number of eyes affected by AMD, self-
assessed change in vision status since diagnosis (better/ stayed the same/ worse), 
pwAMD/caregiver relationship type (spouse, adult-offspring or ‘other’ type of 
caregiver), the amount of support received per week for AMD, registration status, 
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gender and living circumstances (whether they lived alone). However non-responders 
were more likely to report poorer general health on the MSQ 2013 than responders 
(non-responders mean general health rating=3.50, responders mean general health 
rating= 2.95, U = 2721.00, z= 2.59, p <0.05). (On the MSQ 2013, higher general health 
ratings indicate poorer self-rated health.) 
Comparison between the quantitative second study participants and the Macular 
Society 2013 survey respondents with caregivers 
The MSQ 2013 responses between the 72 participants who took part in the second 
study and whose data are presented with their caregivers in this chapter, were 
compared with the 2013 survey respondents who had AMD only, were over the age of 
50 at diagnosis and who reported having a caregiver (and were included in the results 
presented in Chapter 4). This was done as a proxy for seeing how the respondents 
included in this chapter compare with a wider population of pwAMD who have a 
caregiver, and to investigate significant differences between the two samples included 
in the analyses presented in these chapters. Caution must be applied when 
interpreting the results due to differences in sample size between the groups (72 
participants for the present study and 558 from the 2013 survey). This occasionally 
resulted in expected cell counts below 5 for χ2 analysis.  
The analyses found that the participants in the quantitative second study were more 
likely than the MSQ 2013 respondents with caregivers to: be male, live with someone 
else (vs living alone), and were more likely to report receiving more support for AMD 
(measured in hours per week). The 2013 survey respondents who took part in the first 
study were more likely to report having more supporters (1.66 vs 1.36 supporters). 
(See Table 7.1.)  
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Table 7.1. Characteristics of the sub-sample of respondents who took part in the second study vs the comparative sample from 
the 2013 survey (i.e. 2013 survey respondents who had AMD only, were over age 50 years at the time of diagnosis, and who 
had a caregiver). Values are frequencies (valid percentage %) unless otherwise stateda. 
Variables  Second 
study 
participants 
(n=72)b 
Comparative 
respondents 
from 2013 
survey 
(n=558)  
Interpretation of results; statistic, p value, effect 
size and n. 
Gender of 
pwAMD 
Male 32 (50.8%) 195 (34.9%) Significant difference between groups; the second 
study participants were more likely to be men. 
χ2 (1)=6.13, p=0.013*: phi= -0.10. n=621. 
Female 31 (49.2%) 363 (65.1%) 
PwAMD Age at 
survey 
completion 
(years) 
Mean (SD) 82.30 (6.61) 81.87 (7.23)  No significant difference between groups. 
U=18,418.50, z= 0.62, p=0.53: n=621. Median 83.00 83.00 
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PwAMD 
Registration 
status 
Not registered 20 (31.7%) 265 (47.5%) No significant difference between groups. 
χ2 (2)=5.69, p=0.06: n=621.  Registered sight 
impaired (SI)/ 
partially sighted 
28 (44.4%) 187 (33.5%) 
Registered severely 
sight impaired 
(SSI)/ blind 
15 (23.8%) 106 (19.0%) 
Self-assessed 
change in vision 
since diagnosis 
Better 5 (8.5%) 71 (12.7%) No significant difference between groups. 
χ2 (2)=1.80, p=0.41: n=617.  Stayed the same 9 (15.3%) 108 (19.4%) 
Worse 45 (76.3%) 379 (67.9%) 
Number of eyes 
affected 
One eye 2 (3.2%) 53 (9.5%) No significant difference between groups. 
χ2 (1)=2.84, p=0.09: n=618.  Both eyes 61 (96.8%) 502 (90.5%) 
Wet or dry AMD 
or both 
Wet AMD (one or 
both eyes) 
22 (37.3%) 208 (39.9%) No significant difference between groups. 
χ2 (2)=0.24, p=0.89: n=580.  
Dry AMD (one or 
both eyes) 
25 (42.4%) 204 (39.2%) 
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Wet AMD in one 
eye, dry AMD in the 
other 
12 (20.3%) 109 (20.9%) 
Living 
circumstances 
Live with other/s 52 (82.5%) 349 (62.5%) Significant; respondents in the second study were 
more likely to report living with someone else than 
living alone (at the time of the 2013 survey). 
χ2 (1)=9.89, p=0.002**: phi = -0.13. n=621.  
Live alone 11 (17.5%) 209 (37.5%) 
PwAMD general 
healthc 
Mean 3.03 (1.02) 3.10 (1.11) No significant difference between groups. 
U=17,613.50, z= 0.25, p=0.81: n=620. Median 3.00 3.00 
Type of 
pwAMD/caregiver 
relationship  
Spouse 41 (66.1%) 300 (53.8%) No significant difference between groups. 
χ2 (2)=4.53, p=0.10: n=620.  Adult-offspring 17 (27.4%) 177 (31.7%) 
Other 4 (6.5%) 81 (14.5%) 
Number of 
caregivers 
Mean (SD) 1.36 (0.95) 1.66 (0.99) Significant; 2013 survey respondents reported 
having more caregivers. 
U=14, 519.50, z= -2.39, p=0.02*: n=620. 
Median 1.00 1.00 
PwAMD hours of 
care received 
Fewer than 7 hours 
per week 
16 (25.4%) 262 (47.0%) Significant; adjusted residuals indicate that the 
second study participants were less likely to report 
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7 to 14 hours per 
week 
15 (23.8%) 127 (22.8%) receiving care for fewer than 7 hours per week and 
more likely to report receiving care for more than 35 
hours a week. 
χ2 (3)=13.57, p=0.004**:  Cramer’s V=0.15. n=621. 
15 to 35 hours per 
week 
9 (14.3%) 41 (7.3%) 
More than 35 hours 
per week 
23 (36.5%) 128 (22.9%) 
PwAMD QoLd Mean (SD) 0.71 (1.16) 0.78 (1.11) No significant difference between groups. 
U=18,274.00, z= -0.72, p=0.47: n=627. Median  1.00 1.00 
PwAMD MD-
specific QoLe 
Mean (SD) -2.52 (0.78) -2.40 (0.78) No significant difference between groups. 
U=17, 328.000, z= -1.53, p=0.13: n=627. Median  -3.00 -3.00 
PwAMD GENERAL 
well-beingf  
Mean (SD) 30.32 (8.99) 30.33 (9.02) No significant difference between the two groups. 
U=15,017.50, z= -0.90, p=0.37: n=616. Median 31.00 31.00 
a Responses are from the Macular Society 2013 survey.b  Sample size for each analysis will vary slightly depending on item non-response for 
items on the Macular Society 2013 survey.  cHigher scores indicate poorer self-rated health. d Quality of life (QoL) is measured on a 7-point 
scale scored from +3 (excellent) through 0 (neither good nor bad) to -3 (extremely bad). eMD- specific quality of life is measured on a 5-
point scale scored from -3 which indicates their quality of life would be ‘very much better’ (if they did not have their macular condition), 
through to 0 (the same), to +1 (where it would be ‘worse’). More negative scores for both QoL and MD-specific QoL indicate greater 
perceived negative impact on QoL.  fGeneral well-being is on a scale of 0 to 48 where higher scores indicate higher well-being. *p<0.05, 
**p<0.01, ***p<0.001. 
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There were no differences between these two groups on: their age at the time of the 
MSQ 2013 completion, their well-being or general health, registration status, or their 
generic QoL or MD-specific QoL. There were no differences in the likelihood of them 
reporting their adult-offspring or spouse as their primary caregiver. There were no 
significant differences between the two groups in: the number of eyes that were 
affected by AMD, self-assessed change in vision status since diagnosis (better/ 
stayed the same/ worse), and whether they had wet AMD, dry AMD or both wet and 
dry AMD (see Table 7.1). 
Socio-demographic characteristics of the 72 pwAMD and their caregivers 
The socio-demographic characteristics of the 72 pwAMD and their caregivers whose 
data are used in the present study are presented in Table 7.2. All but one of the 
caregivers identified themselves as ‘white British’. The remaining one participant 
identified themselves as ‘white Irish’. All pwAMD identified themselves as ‘White’. 
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Table 7.2. Characteristics of the 72 caregivers and people with AMD. Values are 
frequencies (valid percentage %) unless otherwise stated. 
Variables  Participants 
with AMD 
Caregivers 
Genderb Male 35 (48.6%) 22 (30.6%) 
Female 37 (51.4%) 50 (69.4%) 
Missing 0 (0%) 0 (0%) 
Age at 
survey 
completion 
(years) 
Mean (SD) 84.39 (6.65) 73.46 (10.42) 
Median 85.00 77.00 
Missing 0 (0%) 0 (0%) 
Registration 
status 
Not registered 12 (16.7%) -a 
Registered sight impaired 
(SI)/ partially sighted 
26 (36.1%) -a 
Registered severely sight 
impaired (SSI)/ blind 
34 (47.2%) -a 
Missing 0 (0%)  
Number of 
eyes 
affected by 
AMDb 
One eye 3 (4.2%) -a 
Both eyes 69 (95.8%) -a 
Missing 0 (0%) -a 
Wet or dry 
AMD or both 
wet and dry 
AMDb 
Wet AMD (one or both 
eyes) 
24 (33.3%) -a 
Dry AMD (one or both 
eyes) 
31 (43.1%) -a 
Wet AMD in one eye, dry 
AMD in the other 
12 (16.7%) -a 
Missing 5 (6.9%) -a 
Years since 
diagnosisb 
Mean (SD) 11.43 (6.36) -a 
Median 10.00 -a 
Missing 5 -a 
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Marital 
status 
Married/living with 
partner 
49 (68.1%) 61 (84.7%) 
Widowed 20 (27.8%) 1 (1.4%) 
Divorced 2 (2.8%) 0 (0%) 
Separated 0 (0%) 1 (1.4%) 
Single 1 (1.4%) 9 (12.5%) 
Civil Partnership 0 (0%) 0 (0%) 
Missing 0 (0%) 0 (0%) 
Employment 
status 
Employed, full time 0 (0%) 2 (2.8%) 
Employed, part time 0 (0%) 5 (6.9%) 
Self-employed 0 (0%) 2 (2.8%) 
Looking after family 
and/or home 
0 (0%) 1 (1.4%) 
Retired 70 (97.2%) 59 (81.9%) 
Seeking work/ 
unemployed 
0 (0%) 1 (1.4%) 
Disabled or too ill to work 1 (1.4%) 1 (1.4%) 
Student 0 (0%) 0 (0%) 
Other 1 (1.4%) 1 (1.4%) 
Missing 0 (0%) 0 (0%) 
Highest 
qualification 
Degree or higher degree 17 (23.6%) 22 (30.6%) 
Higher Education 
qualification below 
degree level 
16 (22.2%) 9 (12.5%) 
A Levels or equivalent 3 (4.2%) 13 (18.1%) 
O Level or GCSE or 
equivalent 
10 (13.9%) 15 (20.8%) 
Still studying 0 (0%) 0 (0%) 
No formal qualification 18 (25.0%) 13 (18.1%) 
Other 5 (6.9%)c 0 (0%) 
Missing 3 (4.2%) 0 (0%) 
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The gender split for pwAMD was almost equal (51% were female). The majority of 
caregivers were women (69%). PwAMD tended to be older than the caregivers 
included in this study (Table 7.2).  
Over two-thirds of the pwAMD were married or living with a partner, whilst almost 
28% were widowed. Most caregivers were either married (85%) or single (13%). All 
but two of the pwAMD reported being retired. The majority of the caregivers also 
reported being retired. Some were still working whilst others were seeking work. 
Two reported not being in formal employment as they were looking after the home 
or were too ill to work. PwAMD most frequently stated they had no formal 
qualifications. Caregivers most frequently stated they had a degree or a higher 
degree. 
Eye- and health-related characteristics (general health, number of other medical 
conditions, treatment for AMD) 
The majority of pwAMD were registered as SSI (blind), and had both eyes affected by 
AMD (see Table 7.2). Only three pwAMD had only one eye affected by AMD. Just 
over 40% of the pwAMD had dry AMD. At the time of MSQ 2013 survey completion, 
pwAMD had been diagnosed on average 11 years ago. 
The number of pwAMD who reported having a medical condition in addition to AMD 
are reported in Table 7.3.The most common response was the reporting of one other 
condition (31.9%, n=23), however one participant reported having eleven conditions. 
The next highest number reported was seven (reported by only one participant).   
 
aQuestion was only asked to participants with AMD. b Responses are 
from the Macular Society 2013 survey. c ‘other’ qualifications include: 
nursing qualification, retired midwife and remedial massage, school 
certificate 1944, secretarial certificates/ qualifications. 
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There was a moderate-to-large association between caregivers’ ratings of their 
general health and pwAMDs’ ratings of general health (rs = 0.40, p<0.01). The 
pwAMD had a wider range of scores than caregivers; no caregivers said their general 
health was either ‘extremely bad’ or ‘very bad’ whereas pwAMD used these options 
(see Table 7.4). The median general health scores for both pwAMD and caregivers 
was 3.00 which indicated that on average, respondents felt their general health was 
‘good’.  
 
Table 7.3. Other medical conditions reported by the pwAMD. Values are 
frequencies of ‘yes’ responses (valid percentage %). 
 Participants with AMD 
(n=72) 
Diabetes 11 (15.3%) 
Stroke 8 (11.1%) 
Heart attack 22 (30.6%) 
Kidney disease 6 (8.3%) 
Asthma 11 (15.3%)  
Othera 38 (52.8%) 
a Participants were asked to write down the name of any other serious or long-
term conditions. Responses varied but were mainly physical health conditions, for 
example: prostate cancer, polymyalgia, arthritis, and Osteoporosis. Four 
participants reported having a hearing impairment.  
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The most common change in registration status was for participants who were 
registered as SI at the time of the 2013 survey, to be registered as SSI at the time of 
the second study. This might suggest that those already in the system, were more 
likely to be assessed to see whether they would qualify for registration as SSI.  
Thirteen participants who were not registered at the time of the 2013 survey, 
reported being registered at the time of the second study; eight as SI and five as SSI. 
This suggests that some of the respondents in the second study may have had a 
recent deterioration in vision. 
Around 57% (n=41) of pwAMD reported that they had received treatment for their 
AMD. Of these participants, fifteen reported they were currently receiving treatment 
for AMD. Twelve reported having eye injections. One respondent reported not 
knowing the name of the drug injected and another did not report the name. Eight 
participants reported receiving either Eylea injections (n= 6), or Lucentis injections 
(n=2). One respondent reported having Lucentis in one eye and Eylea in the other. 
One reported having both Avastin and Lucentis injections but did not report which 
Table 7.4. Self-reported general health status of the caregivers and people with 
AMDa. Values are frequencies (valid percentage %). 
General health descriptionb  Participants 
with AMD 
Caregivers 
 Excellent  3 (4.2%) 7 (9.7%) 
Very good  17 (23.6%) 17 (23.6%) 
Good  22 (30.6%) 19 (26.4%) 
 Neither good nor bad  17 (23.6%) 20 (27.8%) 
Bad  9 (12.5%) 9 (12.5%) 
Very bad  2 (2.8%) 0 (0%) 
 Extremely bad  1 (1.4%) 0 (0%) 
 Missing 1 (1.4%) 0 (0%) 
a There was a moderate-to-large association between caregivers’ ratings of 
their general heath and pwAMDs’ ratings of general health (rs = 0.40, 
p<0.01).b Participants were asked ‘In general, my health is:’ followed by the 
following list of responses ‘excellent/ very good/ good/ neither good nor 
bad/ bad/ very bad/ extremely bad’.  
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had been most recent. Two respondents did not report the type of treatment they 
were receiving. The remaining respondent reported taking nutritional supplements 
only. 
Support-related characteristics 
The majority of the caregivers in the second study were the spouse of the pwAMD 
(68%). The rest were adult-offspring of the pwAMD (29%), and two people were a 
neighbour or friend of the pwAMD (3%, see Table 7.5). The majority of caregivers 
were women (69%) (Table 7.2). This is in line with national statistics on the gender of 
caregivers which reports that 60% of the caregivers in England are women (The NHS 
Information Centre, 2010).  
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Table 7.5. Support-related characteristics of the caregivers and people with AMD. Values are frequencies (valid percentage %) unless 
otherwise stated. 
Variables  Participants with 
AMD 
Caregivers 
Relationship of caregiver 
to person with AMD 
Wife a 30 (41.7%) 
17 (23.6%) 
18 (25.0%) 
3 (4.2%) 
1 (1.4%) 
1 (1.4%) 
2 (2.8%) 
Husband 
Daughter 
 Son 
Friend 
Neighbour 
 Partner 
Person with 
AMD/caregiver 
relationship (combined 
groups) 
SpouseϮ 49 (68.1%) 
Adult-offspring/ parent§ 21 (29.2%) 
Other 2 (2.8%) 
Amount of care received/ 
provided 
Fewer than 7 hours per week 18 (25.0%) 18 (25.0%) 
7 to 14 hours per week 12 (16.7%) 15 (20.8%) 
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15 to 35 hours per week 14 (19.4%) 13 (18.1%) 
 More than 35 hours per week 24 (33.3%) 22 (30.6%) 
Missing 4 (5.6%) 4 (5.6%) 
Duration of caregivingb Less than a year - 0 (0%) 
Between 1 and 5 years - 23 (31.9%) 
More than 5 years - 49 (68.1%) 
Provide support for 
another condition before 
AMD diagnosis?b 
Yes - 24 (33.3%) 
No - 47 (65.3%) 
Missing - 1 (1.4%) 
PwAMD receive 
assistance from others 
for AMD? 
Yes 28 (38.9%) 22 (30.6%) 
No 42 (58.3%) 48 (66.7%) 
Missing 2 (2.8%) 2 (2.8%) 
Live with the person with 
AMD?b 
Yes - 57 (79.2%) 
No  - 12 (16.7%) 
Missing - 3 (4.2%) 
a PwAMD provided the same responses as caregivers. bQuestion was only asked to 
caregivers. Ϯ Combined ‘wives’/ ‘husbands’/ ‘partners’ caregiver groups. § Combined 
‘daughter’/ ‘son’ caregiver groups. 
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Some caregivers reported having to give up work (4.2%, n=3), and reduce their 
working hours (6.9%, n=5) as a consequence of providing support to the pwAMD. 
Only one person reported having to take unpaid leave to provide support. No 
participants reported taking paid leave to provide support. The majority (76.4%) 
reported having no change in their employment status due to providing support to 
the pwAMD; perhaps because the majority were already retired when they started 
providing support. Some caregivers provided comments that suggested they had 
experienced employment changes related to providing support. For instance, one 
person said they ‘retired early’. Another said they were ‘working part-time but had 
to stop’. Other responses suggested that some respondents had reflected that 
reducing their working hours had helped them to cope with providing support, for 
example: ‘I did not change [employment status], I find it less stressful since 
retirement in 2013’ and ‘It’s easier working part-time for self and time to give to 
mum’.  
The majority of caregivers reported having their own children (77.8%, n=56). Of 
these, the majority said they had two children (41.07%, n= 23), though the number 
ranged from one (5.36%, n=3) to six children (5.36%, n=3). Only around 31% of 
caregivers felt that others provided assistance to the pwAMD because of the AMD. 
The majority reported not receiving help from others. There were some 
discrepancies with pwAMD reports. 39% of pwAMD reported receiving help from 
others (see Table 7.5). 
Around a third of caregivers reported providing care to the pwAMD before diagnosis 
of AMD.  
We asked pwAMD for their own and their caregiver’s contact details at the time of 
the Macular Society 2013 survey (at the end of 2013/ early 2014), and we would 
therefore expect that there wouldn’t be any caregivers who reported providing 
support for less than a year. Indeed, no caregivers reported this. Just over two-thirds 
of caregivers reported having provided support for AMD for ‘more than 5 years’. 
Therefore caregivers and the pwAMD had provided/ received support for AMD for a 
relatively long period of time.  
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There was a large, significant association between caregiver and pwAMD 
perceptions of how much support they provided/received per week (rs = 0.81, 
p<0.01). The most commonly reported amount of care received per week for AMD 
was ‘more than 35 hours’. This option was the highest possible amount of care. The 
non-perfect correlation indicates there are some discrepancies. The majority of 
dyads (n=47, 72%) reported receiving/providing the same amount of care per week 
(i.e. within each dyad, pwAMD and caregivers both ticked the same response 
option). However there were eighteen pairs where the pwAMD and caregiver had 
ticked different options (plus seven pairs had missing data). For seven of the pairs 
who had reported different responses, the caregiver had reported they provided 
more care than the pwAMD reported receiving. However for eleven pairs, the 
pwAMD reported receiving more care than the caregiver said they provided.  
Impact of the person with AMD/ caregiver dyad relationship 
The sample size of the ‘other’ pwAMD-caregiver relationship group (n=2) was very 
small and this led to some violations of the assumptions for analysis (e.g. for χ2 tests, 
expected frequencies for each group should be greater than five). Therefore 
significant differences between the two most common pwAMD-caregiver 
relationship types were tested (for spouse (n=49) and adult-offspring/ parent 
relationships (n=21)). The results are presented in Table 7.6.  
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Table 7.6. Characteristics of spouse dyads and adult-offspring/ parent caregiver dyads. Values are frequencies (valid 
percentage %) unless otherwise stated. 
Variables  Spouse dyads 
(n=49) 
Adult-offspring/ 
parent dyads 
(n=21)  
statistic, p value, 
effect size and n. 
Gender of pwAMD Male 31 (63.3%) 4 (19.0%) χ2 (1)=11.50, 
p=0.001**: phi=0.41: 
n=70.  
Female 18 (36.7%) 17 (81.0%) 
Missing 0 0 
Gender of caregiver Male 18 (36.7%) 3 (14.3%) χ2 (1)=3.53, p=0.09: 
n=70.  Female 31 (63.3%) 18 (85.7%) 
Missing 0 0 
PwAMD age at survey 
completion (years) 
Mean (SD) 79.65 (5.99) 88.05 (3.31) U=936.00, z= 5.41, 
p<0.01**: n=70. Median 81.00 89.00 
Missing 0 0 
Caregiver age at survey 
completion (years) 
Mean (SD) 78.92 (6.26) 60.62 (5.84) U=19.50, z= -6.35, 
p<0.01**: n=70. 
Median 80.00 62.00 
Missing 0 0 
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PwAMD registration status Not registered 10 (20.4%) 2 (9.5%) χ2 (2)=1.15, p=0.58: 
n=70.  Registered sight impaired 
(SI)/ partially sighted 
17 (34.7%) 8 (38.1%) 
Registered severely sight 
impaired (SSI)/ blind 
22 (44.9%) 11 (52.4%) 
Missing 0 0 
Number of eyes affecteda One eye 2 (4.1%) 1 (4.8%) χ2 (1)=0.02, p=0.90: 
n=70. Both eyes 47 (95.9%) 20 (95.2%) 
Missing 0 0 
Wet or dry AMD or botha Wet AMD (one or both 
eyes) 
19 (40.4%) 5 (26.3%) χ2 (2)=1.43, p=0.55: 
n=66. 
Dry AMD (one or both eyes) 20 (42.6%) 11 (57.9%) 
Wet AMD in one eye, dry 
AMD in the other 
8 (17.0%) 3 (15.8%) 
Missing 2 2 
Years since diagnosisa Mean (SD) 10.53 (5.22) 14.56 (8.30) U=517.000, z= 1.71, 
p=0.09: n=63. Median 10.00 14.00 
Missing 4 3 
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PwAMD marital status Married/living with partner 49 0 b 
Widowed 0 19 
Divorced 0 2 
Separated 0 0 
Single 0 0 
Civil Partnership 0 0 
Missing 0 0 
Caregiver marital status Married/living with partner 48 12 b 
Widowed 0 1 
Divorced 0 0 
Separated 1 0 
Single 0 8 
Civil Partnership 0 0 
Missing 0 0 
PwAMD employment status Employed, full time 0 0 b 
Employed, part time 0 0 
Self-employed 0 0 
 243 
 
Looking after family and/or 
home 
0 0 
Retired 48 20 
Seeking work/ unemployed 0 0 
Disabled or too ill to work 1 0 
Student 0 0 
Other 0 1 
Missing 0 0 
Caregiver employment 
status 
Employed, full time 0 2 b 
Employed, part time 2 3 
Self-employed 0 2 
Looking after family and/or 
home 
1 0 
Retired 46 11 
Seeking work/ unemployed 0 1 
Disabled or too ill to work 0 1 
Student 0 0 
Other 0 1 
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Missing 0 0  
Living together? Yes 48 (100%) 8 (42.1%) χ2 (1)=33.25, 
p<0.01**: phi = 0.70: 
n=67. 
No 0 (0%) 11 (57.9%) 
Missing 1 2 
PwAMD general healthc Mean (SD) 4.59 (1.32) 4.81 (1.25)  U=488.50, z= - 0.21, 
p=0.84: n=69. Median  5.00 5.00 
Missing 1 0 
Caregiver general healthc Mean (SD) 4.73 (1.17) 5.38 (1.11) U=363.50, z= -1.99, 
p=0.046*: n=70. Median  5.00 5.00 
Missing  0 0 
PwAMD number of other 
medical conditions 
Mean (SD) 1.63 (1.88) 1.86 (1.77) U=564.50, z= 0.66, 
p=0.51: n=70. Median 1.00 2.00 
Missing 0 0 
PwAMD reported hours of 
care received 
Fewer than 7 hours per 
week 
15 (32.6%) 3 (15.0%) χ2 (3)=4.03, p=0.26: 
n=66. 
7 to 14 hours per week 6 (13.0%) 5 (25.0%) 
15 to 35 hours per week 8 (17.4%) 6 (30.0%) 
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More than 35 hours per 
week 
17 (37.0%) 6 (30.0%) 
Missing 3 1 
Caregiver reported hours of 
care provided 
Fewer than 7 hours per 
week 
15 (31.9%) 2 (10.5%) χ2 (3)=5.06, p=0.17: 
n=66. 
7 to 14 hours per week 8 (17.0%) 7 (36.8%) 
15 to 35 hours per week 10 (21.3%) 3 (15.8%) 
More than 35 hours per 
week 
14 (29.8%) 7 (36.8%) 
Missing 2 2 
Duration of caregiving Less than a year 0 (0%) 0 (0%) χ2 (1)=1.11, p=0.29: 
n=70. Between 1 and 5 years 18 (36.7%) 5 (23.8%) 
More than 5 years 31 (63.3%) 16 (76.2%) 
PwAMD level of dependency 
on caregiver (as reported by 
the caregiver)d 
Not at all dependent 3 (6.1%) 0 (0%) U=608.00, z= 1.23, 
p=0.22: n=70. Somewhat dependent 11 (22.4%) 5 (23.8%) 
Moderately dependent 16 (32.7%) 4 (19.0%) 
Very dependent 11 (22.4%) 6 (28.6%) 
Extremely dependent 8 (16.3%) 6 (28.6%) 
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Missing 0 0 
Mean (SD) 3.20 (1.15) 3.60 (1.16) 
Median 3.00 4.00 
PwAMD DLTV score e Mean (SD) 59.28 (16.43) 61.41 (14.31) U=553.00, z= 0.49, 
p=0.62: n=70. Median 59.00 63.00 
Missing 0 0 
PwAMD IADL scoref Mean (SD) 4.30 (2.80) 4.93 (2.27) U=573.50, z= 0.76, 
p=0.45: n=70. Median 4.00 5.00 
Missing 0 0 
PwAMD QoL Excellent 6 (12.2%) 2 (9.5%) U=435.500, z= -1.04, 
p=0.30: n=70. Very good 12 (24.5%) 3 (14.3%) 
Good 11 (22.4%) 3 (14.3%) 
Neither good nor bad 13 (26.5%) 11 (52.4%) 
Bad 4 (8.2%) 1 (4.8%) 
Very bad 1 (2.0%) 1 (4.8%) 
Extremely bad 2 (4.1%) 0 (0%) 
Missing 0 0 
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Median 1.00 (Good) 0 (Neither good 
nor bad) 
PwAMD MD-specific QoL g Very much better 32 (65.3%) 17 (81.0%) U=419.00, z= -1.50, 
p=0.14: n=70. Much better 10 (20.4%) 3 (14.3%) 
A little better 5 (10.2%) 1 (4.8%) 
The same 2 (4.1%) 0 (0%) 
Worse 0 (0%) 0 (0%) 
Missing 0 0 
 Median -3.00 (very much 
better) 
-3.00 (very much 
better) 
PwAMD negative well-being 
subscale of W-BQ16 h 
Mean (SD) 2.77 (2.66) 4.07 (3.16) U=640.50, z= 1.63, 
p=0.10: n=70. Median 2.00 4.00 
Missing 0 0 
PwAMD energy  subscale of 
W-BQ16 i 
Mean (SD) 6.30 (2.90) 5.79 (2.14) U=421.00, z= -1.21, 
p=0.23: n=70. Median 7.00 5.50 
Missing 0 0 
PwAMD positive well-being 
subscale of W-BQ16 h 
Mean (SD) 6.56 (3.41) 6.43 (3.03) U=475.50, z= -0.37, 
p=0.71: n=69. Median 7.50 6.00 
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Missing 1 0 
PwAMD stress  subscale of 
W-BQ16 i 
Mean (SD) 4.17 (2.65) 4.26 (2.51) U=533.50, z= 0.25, 
p=0.81: n=70. Median 4.00 4.50 
Missing 0 0 
PwAMD GENERAL well-being 
score (W-BQ16) j 
Mean (SD) 29.86 (10.14) 27.88 (9.00) U=428.00, z= -0.99, 
p=0.32: n=69. Median 30.00 26.00 
Missing 1 0 
Caregiver QoL Excellent 3 (6.1%) 2 (9.5%) U=539.00, z= 0.33, 
p=0.74: n=70. Very good 15 (30.6%) 8 (38.1%) 
Good 19 (38.8%) 4 (19.0%) 
Neither good nor bad 8 (16.3%) 6 (28.6%) 
Bad 4 (8.2%) 1 (4.8%) 
Very bad 0 (0%) 0 (0%) 
Extremely bad 0 (0%) 0 (0%) 
Missing 0 0 
Median 1.00 (Good) 1.00 (Good) 
Caregiver adapted MD-
specific QoL item g 
Very much better 3 (6.1%) 2 (9.5%) U=450.00, z= -0.57, 
p=0.57: n=69. Much better 6 (12.2%) 3 (14.3%) 
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A little better 21 (42.9%) 8 (38.1%) 
The same 18 (36.7%) 7 (33.3%) 
A little worse 0 (0%) 0 (0%) 
Much worse 1 (2.0%) 0 (0%) 
Very much worse 0 (0%) 0 (0%) 
Missing 0 1 
Median -1.00 -1.00 
Caregiver appraisal of 
positive impact k 
Mean (SD) 3.43 (1.63) 3.42 (1.50) U=430.00, z= -0.10, 
p=0.92: n=65. Median 3.50 3.00 
Missing 3 2 
Caregiver appraisal of 
negative impact k 
Mean (SD) 3.29 (1.72) 3.19 (1.69) U=502.00, z= -0.17, 
p=0.87: n=70. Median 4.00 4.00 
Missing 0 0 
Caregiver negative well-
being  subscale of W-BQ16 h 
Mean (SD) 1.96 (2.31) 2.52 (2.91) U=522.00, z= 0.39, 
p=0.70: n=68. Median 1.00 1.00 
Missing 2 0 
Caregiver energy  subscale of 
W-BQ16 i 
Mean (SD) 6.60 (2.67) 6.69 (2.25) U=517.50, z= 0.18, 
p=0.86: n=69. Median 6.50 7.00 
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Missing 1 0 
Caregiver  positive well-
being  subscale of W-BQ16 h 
Mean (SD) 6.69 (3.00) 6.67 (2.63) U=489.00, z= -0.20, 
p=0.84: n=69. Median 6.00 6.00 
Missing 1 0 
Caregiver  stress  subscale of 
W-BQ16 i 
Mean (SD) 4.08 (3.39) 4.52 (3.11) U=554.00, z= 0.66, 
p=0.51: n=69. Median 4.00 4.00 
Missing 1 0 
Caregiver  general well-being 
score (W-BQ16) j 
Mean (SD) 31.23 (9.03) 30.31 (9.62) U=462.00, z= -0.42, 
p=0.68: n=68. Median 32.00 32.00 
Missing 2 0 
CRA total scale score l Mean (SD) 2.31 (0.63) 2.46 (0.72) U=436.00, z= 0.62, 
p=0.54: n=62. Median 2.25 2.27 
Missing 5 3 
CRA ‘lack of family support’ 
subscale l 
Mean (SD) 2.23 (0.83) 2.51 (1.10) U=468.50, z= 0.82, 
p=0.41: n=64. Median 2.00 2.00 
Missing 3 3 
CRA ‘impact on finances’ 
subscale l 
Mean (SD) 2.01 (0.77) 2.18 (1.17) U=482.50, z= 0.03, 
p=0.97: n=68. Median 2.00 2.00 
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Missing 1 1 
CRA ‘impact on schedule’ 
subscale l 
Mean (SD) 2.85 (0.97) 3.20 (1.00) U=610.00, z= 1.23, 
p=0.22: n=70. Median 2.80 3.00 
Missing 0 0 
CRA ‘impact on health’ 
subscale l 
Mean (SD) 2.38 (0.86) 2.29 (0.76) U=445.50, z= -0.51, 
p=0.61: n=67. Median 2.25 2.00 
Missing 3 0 
CRA ‘caregiver esteem’ 
subscale l 
Mean (SD) 1.96 (0.72) 2.05 (0.59) U=603.00, z= 1.14, 
p=0.26: n=70. Median 1.86 2.14 
Missing 0 0 
*p<0.05, **p<0.01, ***p<0.001. a Responses are from the Macular Society 2013 survey. b Socio-demographic characteristics provided for 
information only.  c  Participants were asked ‘In general, my health is:’ followed by the following list of responses ‘excellent / very good/ 
good/ neither good nor bad/ bad/ very bad/ extremely bad’. Higher scores indicate better health. d Caregivers were asked: ‘How 
dependent do you feel the person with the macular condition has been on you since diagnosis?’ Responses were on a 5-point scale where 
higher scores indicate higher perceived dependency on the caregiver.  e DLTV is the Daily Living Tasks Dependent on Vision scale. Scale 
ranges from 22 to 88 where higher scores indicate poorer visual function.  f IADL is the Instrumental Activities of Daily Living. Scale ranges 
from 0 (no disability) to 8 (high disability).g  MD- specific quality of life is measured on a 5-point scale scored from -3 which indicates their 
quality of life would be ‘very much better’ (if they did not have their macular condition), through to 0 (the same), to +1 (where it would be 
‘worse’). More negative scores indicate greater perceived negative impact on QoL.  h The negative and stress well-being subscales are on a 
scale of 0 to 12 where higher scores indicate poorer well-being. i Positive and energy well-being is on a scale of 0 to 12, where higher 
scores indicate better well-being in these areas.  j  General well-being is on a scale of 0 to 48 where higher scores indicate better well-
being. k Caregiver appraisals of the positive and negative impact of providing support are on a scale of 1 to 6 where higher scores indicate 
more positive or negative impact (respectively).  l CRA is the Caregiver Reaction Assessment. The subscale and total scale ranges from 1 to 
5, where higher scores indicate more negative impact of providing support.  
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There were no significant differences between dyads who were spouses or adult-
offspring/parents in: the pwAMDs’ general health, pwAMD number of other medical 
conditions, pwAMDs’ reported hours of care received per week, caregiver reported 
hours of care provided per week, caregiver-reported level of dependence of the 
pwAMD on them, IADL scores, DLTV scores, pwAMDs’ registration status, pwAMDs’ 
time since diagnosis of AMD, pwAMD number of eyes affected by AMD, and whether 
the pwAMD had wet, dry or both wet and dry AMD. There were also no differences 
between these types of dyads in caregivers’ QoL, caregivers’ subscale scores on the 
W-BQ16, caregiver general W-BQ16 scores, caregivers’ CRA total and subscale 
scores, as well as the single-item measures of their appraisal of the positive and 
negative impact of caregiving. In line with the multivariable findings from the 2013 
survey (presented in Chapter 4), the type of pwAMD/caregiver relationship was not 
significantly associated with pwAMD QoL (generic or MD-specific) or their well-
being.  
Spouse caregivers were more likely to have poorer general health and be older than 
adult-offspring caregivers. Caregivers’ general health was significantly associated 
with their age (rs= -0.28, p=0.02, n=72), and this might account for the poorer health 
status of the older spouse caregivers than adult-offspring caregivers.   
The pwAMD whose adult-offspring was supporting them, were more likely to be 
older than pwAMD whose spouse was their caregiver. All spouse caregivers who 
responded to the question on living status reported they lived with the pwAMD, 
whereas only 42% of adult-offspring caregivers reported living with the pwAMD. Two 
adult-offspring caregivers (under ‘missing’ in the Table 7.6) noted that they had their 
own homes, but lived with the pwAMD a lot of the time. 
The pwAMD whose caregiver was their spouse were more likely to be male, whereas 
pwAMD in adult-offspring/parent pairs were more likely to be women than men. 
There were no significant differences in the proportions of male and female 
caregivers between spouse and adult-offspring/parent pairs. These differences may 
be accounted for by the trend of women having a longer life expectancy than men 
(ONS, 2016) and thus being more likely to require support from their children when 
 253 
 
their male partner has died. It is only to be expected that caregivers who are spouses 
of the pwAMD are more likely to be older than caregivers who are adult-offspring of 
the pwAMD. 
 ‘Stressors’ 
The ‘stressors’ included in the model tested in this study (shown in Figure 6.1) are 
pwAMD difficulties with vision-dependent tasks (measured using the DLTV), pwAMD 
difficulties with tasks of everyday living (their IADL score) and pwAMD self-reported 
rating of their general health. Details of pwAMDs’ general health are provided in 
Table 7.4. Descriptive statistics and internal consistency reliabilities for pwAMDs’ 
DLTV scores and IADL scores are presented in Table 7.7.  
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Table 7.7. Descriptive characteristics for ‘stressor’ variables (pwAMD 
responses). 
 
Variables    
IADL (IADL is the Instrumental Activities of 
Daily Living. Scale ranges from 0 (no disability) 
to 8 (high disability).)a 
Mean (SD) 4.55 (2.65) 
Median 4.79 
Minimum 0 
Maximum 8 
Missing 0 
DLTV (DLTV is the Daily Living Tasks 
Dependent on Vision scale. Scale ranges from 
22 to 88 where higher scores indicate poorer 
visual function.)a 
Mean (SD) 60.43 (15.83) 
Median 61.50 
Minimum 26.00 
Maximum 85.00 
Missing 0 
DLTV single item for near vision (Scores 
range from 1 (poor) to 4 (excellent).) 
Mean (SD) 1.26 (0.59) 
Median 1.00 
Minimum 1 (poor) 
Maximum 3 (good) 
Missing 3 
DLTV single item for distance vision  
Scores range from 1 (poor) to 4 (excellent). 
Mean (SD) 1.48 (0.68) 
Median 1.00 
Minimum 1 (poor) 
Maximum 4 (excellent) 
Missing 3 
Currently drive? Yes 4 
No 52 
n/a as have 
never driven 
13 
Missing 3 
Reason stopped driving Mainly 
because of my 
43 (82.7%) 
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The correlation matrix in Table 7.8 presents the results of Spearman’s correlations 
between the ‘stressors’ included in this study.  There were moderate-to-large 
significant correlations between the three ‘stressors’. 
There were significant associations between registration status and both IADL scores 
and DLTV scores (H (2)= 14.62, p=0.001; H (2)= 21.56, p<0.001, respectively). The 
trend was in the expected direction where more severe registration status was 
associated with more difficulties with activities of everyday living (IADL) and vision-
dependent tasks (DLTV) (ps<0.001).  
 
macular 
condition 
Partly due to 
AMD, partly 
other reasonsb 
5 (9.6%) 
Mainly other 
reasonsb 
4 (7.7%) 
Missing 0 
Caregiver drives for pwAMD? Yes 54 (75.0%) 
No 4 (5.56%) 
Not applicable 
as caregiver 
doesn’t drive 
11 (15.28%) 
Missing 3 (4.17%) 
a  Internal consistency was assessed using Cronbach’s alpha. This was 0.96 for the DLTV, 
and 0.92 for the IADL. b   Other reasons for stopping driving included being due to ‘age’, 
other health issues (e.g. a TIA), another member of the family wanting to drive, and 
lowered confidence in driving ability (unrelated to changes in eyesight). 
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Table 7.8. Intercorrelations between ‘stressors’, pwAMD and caregiver QoL, well-being and caregiver reactions to providing support. 
  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
1 IADL -                 
2 DLTV .69*** -         
       
3 PwAMD general 
health 
-.44*** -.38** -        
       
4 Caregiver appraisal 
of negative impact of 
caregiving 
.39*** .33** -.43*** -       
       
5 Caregiver appraisal 
of positive impact of 
caregiving 
-.05 -.03 .07 -.35** -      
       
6 Level of dependency 
of pwAMD on 
caregiver 
.70*** .63*** -.49*** .58*** -.15 -     
       
7 PwAMD QoL -.48*** -.65*** .54*** -.29* .21 -.51*** -    
       
8 PwAMD MD-specific 
QoL 
-.45*** -.54*** .19 -.33** .09 -.41*** .39*** -   
       
9 Caregiver QoL -.49*** -.53*** .47*** -.48*** .20 -.53*** .64*** .33** -  
       
10 PwAMD General 
well-being score (W-
BQ16) 
-.60*** -.64*** .62*** -.41*** .13 -.62*** .76*** .49*** .64*** - 
       
11 Caregiver General 
well-being score (W-
BQ16) 
-.31** -.37** .42*** -.51*** .32* -.50*** .38** .24* .69*** .54*** 
-       
12 CRA ‘lack of family 
support’ subscale 
.31* .33** -.41*** .45*** -.20 .42*** -.36** -.19 -.51*** -.35** -.56*** -   
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  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
13 CRA ‘impact on 
finances’ subscale 
.28* .36** -.36** .31** -.13 .28* -.39*** -.15 -.47*** -.48*** -.47*** .38** -  
   
14 CRA ‘impact on 
schedule’ subscale 
.53*** .47*** -.49*** .55*** -.24 .67*** -.45*** -.29* -.65*** -.54*** -.74*** .62*** .48*** - 
   
15 CRA ‘impact on 
health’ subscale 
.42*** .39*** -.37** .53*** -.20 .49*** -.40*** -.34** -.73*** -.60*** -.80*** .49*** .52*** .71*** 
-   
16 CRA ‘caregiver 
esteem’ subscale 
-.09 -.05 -.08 .21 -.31* .11 -.16 .03 -.09 -.08 -.14 .17 .20 .20 .01 -  
17 CRA total scale score .46*** .46*** -.55*** .65*** -.33* .64*** -.50*** -.29* -.74*** -.60*** -.82*** .78*** .66*** .89*** .78*** .33** - 
*** p<0.001, **p< 0.01, * p<0.05. 
 
 258 
 
Primary appraisal (hours of care variables) 
The ‘hours-of-care’ groups were compared to see if there were differences in health-
related, and eye-related variables, caregivers’ secondary appraisals of the impact of 
caregiving and both pwAMD and caregiver psychological health outcomes (well-
being and QoL). The results appear in Table 7.9. Descriptive statistics and 
frequencies are provided for pwAMD reported ‘hours-of-care’. Differences in the 
socio-demographic and support-related characteristics between the ‘hours-of-care’ 
groups are at the bottom of Table 7.9.   
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Table 7.9.  Differences between hours-of-care groups (pwAMD-reported) on characteristics of the caregivers and pwAMD. 
Values are means and medians unless otherwise stated. 
 
Variables  Fewer 
than 7 
hours per 
week 
(n=18) 
7 to 14 hours 
per week 
(n=12) 
15 to 
35 
hours 
per 
week 
(n=14) 
More than 
35 hours 
per week 
(n=24) 
Test for 
differences 
between pwAMD 
reported ‘hours 
of care’ groups: 
statistics, and p 
valueψ. 
Relationship in 
the expected 
direction? 
Does the 
analysis using 
the caregiver 
‘hours-of-
care’ variable 
(instead of 
pwAMD 
reported 
hours of 
care), show a 
similar 
pattern of 
results?  
Instrumental 
Activities of 
Daily Living  
(range 0 to 8)a 
Mean (SD) 1.91 (1.94) 3.80 (1.97) 4.91 
(2.38) 
6.67 (1.79) H (3)= 34.43, 
p<0.001***. 
 
Yes- in the direction 
of: more difficulties 
with IADL, the more 
support received. 
All pairwise 
comparisons are 
significant apart 
from between the 
7-14 hrs vs 15-35 
hrs groups.  
Yes. (Similar 
pattern of 
results.) 
 Median 1.50 4.00 5.50 7.00 
Missing 0 0 0 0 
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DLTV score 
(range 22 to 
88)b 
Mean (SD) 48.00 
(14.83) 
59.92 (13.32) 57.71 
(11.43) 
71.13 
(13.20) 
H (3)= 22.12, 
p<0.001***. 
  
Generally In the 
direction of: poorer 
VF, associated with 
more support 
received.  Only two 
pairwise 
comparisons are 
significant: 
between fewer 
than 7 hrs vs more 
than 35 hrs groups. 
Also between the 
15-35 hrs vs more 
than 35 hrs groups. 
 
N.B. The scores 
appear to follow a 
non-linear pattern. 
 
Yes. (Similar 
pattern of 
results.) 
In addition to 
the two 
comparisons 
stated in the 
pwAMD results, 
another 
pairwise 
comparison is 
significant: 
between the 7-
14 hrs vs more 
than 35hrs 
group is 
significant. 
Median 49.50 61.50 57.50 76.50 
Missing 0 0 0 0 
DLTV single-
item- distance 
vision (range 
from 1 (poor) 
to 4 
(excellent)) 
Mean (SD) 1.94 (0.89) 1.36 (0.51) 1.54 
(0.66) 
1.17 (0.38) H (3)= 11.77, 
p=0.008**. 
 
Generally In the 
direction of poorer 
distance vision, the 
more support 
received.  Only one 
significant pairwise 
comparison: for 
between the fewer 
than 7 hrs group vs 
more than 35hrs 
group. 
 
Yes. (Similar 
pattern of 
results.) 
In addition, 
more pairwise 
comparisons 
are significant. 
In addition to 
the one 
comparison 
stated in the 
pwAMD results, 
another one 
pairwise 
Median 2.00 1.00 1.00 1.00 
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N.B. The scores 
appear to follow a 
non-linear pattern. 
 
comparison is 
significant: 
between the 
fewer than 7 
hrs group vs 7-
14hrs groups.  
 
Missing 1 0 1 0   
DLTV single-
item- near 
vision (range 
from 1 (poor) 
to 4 
(excellent)) 
Mean (SD) 1.59 (0.80) 1.36 (0.81) 1.31 
(0.48) 
1.00 (0.00) H (3)= 11.19, 
p=0.011*. 
  
Generally in the 
direction of poorer 
near vision, the 
more support 
received. Only two 
significant pairwise 
comparisons: 
between the fewer 
than 7 hrs vs more 
than 35hrs groups. 
Also between the 
15-35 hrs vs more 
than 35hrs groups. 
 
 
Yes. (Similar 
overall 
pattern of 
results.) 
However the 
comparison 
between the 
15-35 hrs vs 
more than 35 
hrs groups is 
not significant.  
Median 1.00 1.00 1.00 1.00 
Missing 1 1 1 0 
Registration 
status 
(frequencies) 
Not 
registered 
8 (44.4%) Ϯ 2 (16.7%) 2 
(14.3%) 
0 (0%)  Ϯ χ2 (6)=16.73, 
p=0.009**: 
Cramer’s V= 0.35, 
n=68. 
Significant 
association 
between 
registration 
status and the 
amount of care 
χ2 (6)=15.83, 
p=0.013*: 
Cramer’s V= 
0.34, n=68. 
 
Registered 
as SI 
6 (33.3%) 4 (33.3%) 3 
(21.4%) 
11 (45.8%) 
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Registered 
as SSI 
4 (22.2%)  Ϯ 6 (50.0%) 9 
(64.3%) 
13 (54.2%) received. The   Ϯ  
indicates significant 
adjusted residuals. 
The fewer than 7 
hours per week 
group were more 
likely to not be 
registered, and less 
likely to be 
registered as SSI. 
The more than 35 
hrs group were less 
likely to be not 
registered.  
Same adjusted 
residuals were 
significant, 
indicating same 
pattern of 
results as with 
the pwAMD 
hours of care 
variable. 
 Missing 0 0 0 0   
PwAMD 
general health 
(range 1 to 7)c 
Mean (SD) 5.28 (0.89) 4.92 (1.24) 4.89 
(1.27) 
4.08 (1.35) H (3)= 8.95, 
p=0.03*. 
 
Generally in the 
direction of poorer 
general health, the 
more support 
received.  Only one 
significant pairwise 
comparison: 
between the fewer 
than 7 hrs vs more 
than 35hrs groups. 
 
 
Yes- same 
results as for 
pwAMD 
hours of 
care. 
 Median 6.00 5.00 5.00 4.00 
Missing 0 0 0 0 
PwAMD 
number of 
other 
conditions 
Mean (SD) 1.00 (1.03) 1.50 (1.24) 2.14 
(2.91) 
1.92 (1.77) H (3)= 3.18, 
p=0.37. 
 
Relationship 
was not 
statistically 
significant. 
No. This was 
significant: 
H (3)= 8.37, 
p=0.039*.  
There was an 
association 
Median 1.00 1.00 1.00 1.00 
Missing 0 0 0 0 
 263 
 
between the 
number of 
medical 
conditions the 
pwAMD had 
with the 
amount of 
care 
caregivers 
reported 
providing. 
No pairwise 
comparisons 
were 
significant.  
Care recipient 
dependency 
(range 1 to 5)d 
Mean (SD) 2.33 (0.77) 3.13 (0.68) 3.43 
(1.16) 
4.04 (1.08) H (3)= 23.61, 
p<0.001***. 
  
Generally in the 
direction of more 
pwAMD 
dependency on the 
caregiver, the more 
support received. 
There were four 
significant pairwise 
comparisons – 
between fewer 
than 7 hours per 
week and the other 
three groups. Plus 
between 7-14 hrs 
vs more than 35 hrs 
a week group.   
Yes-similar 
pattern to 
pwAMD hours 
of care. 
However the 
pairwise 
comparison 
between fewer 
than 7 hrs per 
week and 7-14 
hours a week 
groups was not 
significant. 
Median 2.00 3.00 3.00 4.00 
Missing 0 0 0 0 
 264 
 
Caregiver 
overall 
negative 
impact of 
caregiving 
(range 1 to 6)e 
Mean (SD) 2.61 (1.79) 2.50 (1.45) 3.07 
(1.39) 
3.96 (1.73) H (3)= 9.61, 
p=0.022*. 
  
Generally In the 
direction of more 
negative impact 
related to more 
support received.  
Only one significant 
pairwise 
comparison: 
between fewer 
than 7 hrs vs more 
than 35 hrs per 
week. 
 
N.B. there appears 
to be a non-linear 
pattern in the 
scores.  
Yes-similar 
pattern to 
pwAMD 
hours of 
care. 
Median 2.00 2.50 3.50 4.00 
Missing 0 0 0 0 
Caregiver 
overall 
positive 
impact of 
caregiving 
(range 1 to 6)e 
Mean (SD) 3.41 (1.66) 4.17 (1.34) 3.31 
(1.32) 
3.41 (1.68) H (3)= 2.74, 
p=0.433. 
 
Relationship 
was not 
statistically 
significant. 
Yes- 
relationship 
is not 
significant. Median 3.00 4.50 3.00 4.00 
Missing 1 0 1 2 
Caregiver 
impact of 
caregiving on 
Mean (SD) -0.61 
(0.61) 
-0.45 (0.69) -0.86 
(1.29) 
-1.13 (1.19) H (3)= 5.53, 
p=0.137. 
  
Relationship 
was not 
statistically 
significant. 
Yes- 
relationship 
is not 
significant. Median -1.00 0.00 -1.00 -1.00 
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QoL (range 3 
to -3)f 
Missing 0 1 0 0  
 
CRA ‘lack of 
family support’ 
subscale 
(range 1 to 5)g 
Mean (SD) 1.88 (0.83) 2.27 (0.71) 2.30 
(0.78) 
2.64 (1.06) H (3)= 8.43, 
p=0.04*. 
 
In the direction of: 
caregiver 
perceiving greater 
lack of family 
support with more 
support received. 
One significant  
pairwise 
comparison 
between: 
fewer than 7 hrs 
and more than 35 
hrs a week groups.  
 
Yes. 
An additional 
pairwise 
comparison 
was significant: 
between:   
fewer than 7 
hrs and 7-14 
hrs a week 
groups.  
 
Median 1.80 2.10 2.00 2.50 
Missing 2 0 0 2 
CRA ‘impact on 
finance’ 
subscale 
(range 1 to 5)g 
Mean (SD) 1.76 (0.79) 2.00 (0.90) 1.98 
(0.50) 
2.41 (1.11) H (3)= 4.97, 
p=0.17. 
 
Relationship is 
not significant.  
 
No.  There is 
a significant 
relationship 
(p=0.005); 
caregivers 
perceive 
greater 
impact on 
finance from 
providing 
more 
support.  
Median 1.67 2.00 2.00 2.33 
Missing 0 0 0 1 
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H (3)= 12.85, 
p=0.005**. 
There were 
significant 
pairwise 
comparisons 
between: 
fewer than 7 
hrs vs more 
than 35 hrs a 
week. Plus 
between 15-35 
hrs and more 
than 35 hrs 
groups. 
 
CRA ‘impact on 
schedule’ 
subscale 
(range 1 to 5)g 
Mean (SD) 2.08 (0.77) 2.95 (0.68) 3.20 
(0.66) 
3.46 (1.06) H (3)= 18.79, 
p<0.001***. 
  
There was a 
significant 
relationship: 
caregivers 
perceived greater 
negative impact on 
their schedule if the 
pwAMD reported 
receiving more 
care.  
There were 
significant  pairwise 
comparisons 
between: 
Yes- the 
relationship 
was 
significant. 
There was an 
additional 
significant 
pairwise 
comparison 
between:  
fewer than 7 
hrs and 7-14 
hrs of care a 
week group. 
 
Median 2.00 3.10 3.10 3.50 
Missing 0 0 0 0 
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-fewer than 7 hrs 
per week vs more 
than 35 hours 
-fewer than 7 hrs vs 
15-35hrs a week. 
 
 
CRA ‘impact on 
health’ 
subscale g 
Mean (SD) 1.92 (0.65) 2.13 (0.69) 2.55 
(0.76) 
2.67 (0.96) H (3)= 8.30, 
p=0.04*. 
  
There was a 
significant 
relationship: 
caregivers 
perceived greater 
impact on their 
health as a result 
of caregiving if 
the pwAMD 
reported 
receiving more 
care. There were 
no significant 
pairwise 
comparisons. 
  
Yes- there 
was a similar 
relationship. 
There was a 
significant 
pairwise 
comparison 
between: 
fewer than 7 
hrs and more 
than 35 hrs a 
week.  
 
 
Median 2.00 2.00 2.38 2.50 
Missing 0 0 0 2 
CRA ‘esteem’ 
subscale 
(range 1 to 5)g 
Mean (SD) 2.13 (0.95) 1.98 (0.46) 2.20 
(0.51) 
1.79 (0.52) H (3)= 4.43, 
p=0.22. 
  
Relationship 
wasn’t 
statistically 
significant. 
Yes- 
relationship 
wasn’t 
significant. 
 
Median 2.00 2.00 2.23 1.86 
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Missing 0 0 0 0 
CRA total scale 
score (range 1 
to 5)h 
Mean (SD) 1.92 (0.66) 2.26 (0.42) 2.45 
(0.43) 
2.67 (0.72) H (3)= 13.33, 
p=0.004**. 
  
There was a 
significant 
relationship: 
caregivers 
reported more 
negative impact 
of providing 
support with 
more support 
received by the 
pwAMD. There 
were two 
significant pairwise 
comparisons: 
between 
fewer than 7 hrs vs 
15-35 hrs groups. 
Plus between 
Fewer than 7 hrs vs 
more than 35 hrs 
groups. 
  
Yes- the 
relationship 
was 
significant.  
There were two 
significant 
pairwise 
comparisons:  
Between fewer 
than 7 hrs vs 7-
14 hrs a week. 
Plus between 
fewer than 7 
hrs per week vs 
more than 35 
hrs. 
 
 
Median 1.78 2.24 2.30 2.78 
Missing 2 0 0 4 
PwAMD 
overall QoL 
(range 3 to -3)i 
Mean (SD) 1.39 (1.15) 0.92 (1.44) 0.79 
(1.12) 
0.21 (1.59) H (3)= 6.31, 
p=0.098. 
  
Relationship 
was not 
significant.  
 
No. There 
was a 
significant 
relationship: Median 1.00 0.50 0.50 0.00 
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Missing 0 0 0 0  pwAMD who 
received more 
care (as 
reported by 
the caregiver), 
had poorer 
QoL. 
H (3)= 14.44, 
p=0.002**. 
 
One pairwise 
comparison is 
significant: 
between fewer 
than 7 hours of 
care vs more 
than 35 hours 
of care a week 
group. 
PwAMD MD-
specific QoL 
(range -3 to 1)j 
Mean (SD) -2.00 
(0.97) 
-2.33 (0.99) -2.89 
(0.29) 
-2.79 (0.51) H (3)= 13.83, 
p=0.003**. 
  
Generally In the 
direction of poorer 
MD-specific QoL 
related to more 
support received.  
Two pairwise 
comparisons were 
significant: 
between fewer 
than 7 hrs vs 15-35 
hrs. Plus between 
fewer than 7 hrs vs 
Yes-similar 
pattern to 
pwAMD 
hours of 
care.   
There was one 
additional 
significant 
pairwise 
comparison: 
between fewer 
than 7hr vs 7-
Median -2.00 -3.00 -3.00 -3.00 
Missing 0 0 0 0 
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more than 35 hrs 
groups. 
 
N.B. It appears that 
scores are in a non-
linear pattern. 
 
14 hrs a week 
groups.  
 
Caregiver 
overall QoL 
(range 3 to -3)i 
Mean (SD) 1.67 (0.84) 1.50 (0.80) 1.14 
(0.77) 
0.67 (1.20) H (3)= 10.61, 
p=0.014*. 
  
Generally In the 
direction of poorer 
caregiver QoL 
related to more 
support received.  
One pairwise 
comparison is 
significant: 
between fewer 
than 7 hrs vs more 
than 35 hrs groups. 
  Yes. (Similar 
pattern of 
results.) 
Two pairwise 
comparisons 
were 
significant, 
between: fewer 
than 7 hours 
per week vs 
more than 35 
hours a week, 
and between 
fewer than 7 
hours per week 
and 7-14 hours 
a week. 
  
Median 2.00 1.50 1.00 0.50 
Missing 0 0 0 0 
PwAMD 
negative well-
being subscale 
Mean (SD) 1.72 (1.67) 1.96 (1.96) 3.61 
(3.21) 
4.67 (2.96) H (3)= 12.53 
p=0.006**. 
  
Generally In the 
direction of greater 
negative well-being 
related to more 
support received.  
Yes. (Similar 
pattern of 
results.) 
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score of W-BQ 
16 (range 0 to 
12)k 
Median 1.00 1.50 2.50 5.00 One pairwise 
comparison is 
significant, 
between: fewer 
than 7 hrs vs more 
than 35 hrs groups.  
Only one 
pairwise 
comparison 
was significant-
between fewer 
than 7 hours 
per week and 
more than 35 
hours per week 
groups.  
Missing 0 0 0 0 
PwAMD 
energy 
subscale score 
of the W-BQ16 
(range 0 to 
12)k 
Mean (SD) 7.87 (2.11) 6.42 (2.43) 6.68 
(2.15) 
4.42 (2.80) H (3)= 15.27, 
p=0.002**. 
 
Generally in the 
direction of lower 
energy related to 
more support 
received.  Only one 
significant pairwise 
comparison: between 
fewer than 7hrs vs more 
than 35hrs. 
 
However, there 
was a non-linear 
trend in scores.  
Yes. (Similar 
results as 
when used 
pwAMD 
hours of 
care.) 
However an 
additional 
pairwise 
comparison 
was significant: 
between 15-35 
hours a week vs 
more than 35 
hours of care a 
week. 
Median 8.00 6.50 6.50 5.00 
Missing 0 0 0 0 
PwAMD 
positive well-
being subscale 
Mean (SD) 8.44 (2.41) 7.00 (2.80) 6.23 
(3.59) 
5.50 (3.15) H (3)= 9.02, 
p=0.029*. 
  
Generally In the 
direction of lower 
positive WB related 
to more support 
received.  Only one 
Yes. Same 
findings as 
with pwAMD 
Median 8.50 6.00 7.00 6.00 
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score of the W-
BQ16 (range 0 
to 12)k 
Missing 0 0 1 0 significant pairwise 
comparison: 
between fewer 
than 7hrs vs more 
than 35hrs. 
 
hours of care 
variable. 
PwAMD stress 
subscale score 
of the W-BQ16 
(range 0 to 
12)k 
Mean (SD) 2.94 (2.21) 3.96 (1.94) 4.67 
(2.25) 
5.00 (3.01) H (3)= 6.84, 
p=0.077. 
 
Relationship 
was not 
significant. 
No.  The 
Kruskal Wallis 
test was 
significant. 
H (3)= 8.24, 
p=0.04*. 
Generally In the 
direction of 
higher stress 
related to more 
support 
received.   
One pairwise 
comparison 
was significant: 
between fewer 
than 7 hours a 
week vs more 
than 35 hours a 
week groups.   
Median 3.00 3.50 5.00 5.00 
Missing 0 0 0 0 
PwAMD 
general well-
Mean (SD) 35.65 
(7.14) 
31.50 (7.97) 28.31 
(9.03) 
24.25 (9.82) H (3)= 13.89, 
p=0.003**. 
 
In the direction of 
lower general WB 
related to more 
support received.   
Only one significant 
Yes. Same 
results as 
with pwAMD 
Median 36.00 31.50 30.00 26.00 
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being (range 0 
to 48)l 
Missing 0 0 1 0 pairwise 
comparison: 
between fewer 
than 7hrs vs more 
than 35hrs groups. 
hours of 
care. 
Caregiver 
negative well-
being subscale 
score of the W-
BQ16 (range 0 
to 12)k 
Mean (SD) 0.71 (1.16) 1.50 (2.07) 3.10 
(2.74) 
2.92 (2.86) H (3)= 11.07, 
p=0.011*. 
 
Generally In the 
direction of greater 
negative WB 
related to more 
support received. 
Two significant pairwise 
comparisons:  between 
fewer than 7hrs vs more 
than 35hrs groups. 
Also between the fewer 
than 7hrs vs 15-35hrs a 
week groups. 
 
N.B. there appears 
to be a non-linear 
trend in scores. 
Yes. Similar 
results as 
with pwAMD 
hours of 
care. 
However only 
one pairwise 
comparison 
was significant: 
between fewer 
than 7 hours a 
week vs more 
than 35 hours a 
week groups.  
Median 0.00 1.00 3.50 2.50 
Missing 1 0 0 0 
Caregiver  
energy 
subscale score 
of the W-BQ16 
(range 0 to 
12)k 
Mean (SD) 7.39 (1.82) 6.75 (2.01)  6.89 
(1.62) 
6.04 (3.34) H (3)= 2.08, 
p=0.556. 
  
Relationship 
was not 
statistically 
significant. 
Yes. Results 
were also 
not 
significant 
using 
caregiver 
reported 
hours of care 
provided. 
Median 7.50 8.00 7.00 6.50 
Missing 0 0 0 0 
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Caregiver  
positive well-
being subscale 
score of the W-
BQ 16 (range 0 
to 12)k 
Mean (SD) 7.33 (2.85) 7.00 (2.76) 6.57 
(2.34) 
6.50 (3.12) H (3)= 0.98, 
p=0.81. 
 
Relationship 
was not 
statistically 
significant. 
Yes. Results 
were also 
not 
significant 
using 
caregiver 
reported 
hours of care 
provided. 
Median 8.00 7.50 6.00 6.00 
Missing 0 0 0 0 
Caregiver 
stress subscale 
score of the W-
BQ16 (range 0 
to 12)k 
Mean (SD) 2.56 (2.57) 3.08 (2.47) 4.86 
(2.80) 
5.63 (3.87) H (3)= 10.23, 
p=0.017*. 
 
Generally In the 
direction of higher 
stress related to 
more support 
received. One 
significant pairwise 
comparison:  
between fewer 
than 7hrs vs more 
than 35hrs a week 
groups.  
Yes. Same 
results was 
with pwAMD 
hours of care 
variable. 
Median 2.50 3.50 4.50 5.50 
Missing 0 0 0 0 
Caregiver 
general well-
being (range 0 
to 48)l 
Mean (SD) 35.59 
(5.67) 
33.17 (7.18) 29.51 
(7.88) 
28.00 
(11.47) 
H (3)= 7.65, 
p=0.054. 
  
Kruskal Wallis 
test was not 
significant, i.e. 
caregivers’ 
general well-
being was not 
significantly 
associated with 
pwAMD reported 
No. The 
Kruskal 
Wallis test 
was 
significant 
when the 
caregiver 
reported 
hours of care 
Median 35.00 32.50 27.50 26.00 
Missing 1 0 0 0 
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hours-of-care-
received.   
 
variable was 
used.  
H (3)= 10.88, 
p=0.012*. 
 
There was 
one 
significant 
pairwise 
comparison: 
between the 
fewer than 7 
hours group 
vs more than 
35 hours a 
week group. 
Caregiver 
general health 
(range 1 to 7)c 
Mean (SD) 5.39 (1.14) 4.92 (1.17) 5.21 
(1.05) 
4.42 (1.21) H (3)= 7.78, 
p=0.051. 
  
Kruskal Wallis 
test was not 
significant, i.e. 
caregivers’ 
general health 
was not 
significantly 
associated with 
pwAMD reported 
hours-of-care-
received.   
 
n.b. there 
appears to be a 
No. The 
Kruskal Wallis 
test was 
significant 
when the 
caregiver 
reported 
hours of care 
variable was 
used. 
H (3)= 12.24, 
p=0.007**. 
 
Median 5.50 5.00 5.00 4.00 
Missing 0 0 0 0 
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non-linear trend 
in scores across 
groups. 
There was one 
significant 
pairwise 
comparison: 
between the 
fewer than 7 
hours group vs 
more than 35 
hours a week 
group. 
Person with 
AMD/caregiver 
relationship 
(frequencies) 
Spouse 15 (83.3%) 6 (50%) 8 
(57.1%) 
17 (70.8%) χ2 (6)=6.35, 
p=0.38: n=68. 
Relationship 
was not 
statistically 
significant. 
Yes (same 
result as with 
pwAMD 
reported 
hours-of-care-
received).  
 
χ2 (6)=6.65, 
p=0.36: 
n=68. 
Adult-
offspring 
3 (16.7%) 5 (41.7%) 6 
(42.9%) 
6 (25.0%) 
Other 0 (0%) 1 (8.3%) 0 (0%) 1 (4.2%) 
Gender of 
pwAMD 
(frequencies) 
Male 8 (44.4%) 4 (33.3%) 8 
(57.1%) 
12 (50%) χ2 (3)=1.61, 
p=0.64: n=68. 
Relationship 
was not 
statistically 
significant. 
Yes (same 
result as with 
pwAMD 
reported 
hours-of-care-
received).  
χ2 (3)=2.71, 
p=0.45: 
n=68. 
Female 10 (55.6%) 8 (66.7%) 6 
(42.9%) 
12 (50%) 
Missing 0 0 0  0 
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Gender of 
caregiver 
(frequencies) 
Male 8 (44.4%) 4 (33.3%) 3 
(21.4%) 
6 (25.0%) χ2 (3)=2.50, 
p=0.50: n=68. 
Relationship 
was not 
statistically 
significant. 
Yes (same 
result as with 
pwAMD 
reported 
hours-of-care-
received).  
χ2 (3)=3.44, 
p=0.35: 
n=68. 
Female 10 (55.6%) 8 (66.7%) 11 
(78.6%) 
18 (75.0%) 
Missing 0 0 0 0 
Live with the 
person with 
AMD? 
(frequencies) 
Yes 14 (82.4%) 7 (58.3%)Ϯ 10 
(71.4%) 
22 (100%)Ϯ χ2 (3)=10.23, 
p=0.013*: 
Cramer’s V= 0.40, 
n=65. 
More than 
expected of those 
pairs who live 
together said ‘more 
than 35 hours per 
week’, and less 
than expected said 
the ‘7-14 hours a 
week’ option. Of 
those who didn’t 
live together, more 
than expected said 
the ‘7-14 hours a 
week’ option and 
less than expected 
said the ‘more than 
35 hours a week’ 
option.  
 
 
Yes. Similar 
findings 
however the 
adjusted 
residuals 
indicated 
different 
causes of the 
significant 
result (as 
detailed 
below). 
χ2 (3)=12.57, 
p=0.004**: 
Cramer’s V= 
.44. n=65. 
For caregivers, 
the cause of 
the significant 
result was 
mainly due to 
No  3 (17.6%) 5 (41.7%)Ϯ 4 
(28.6%) 
0 (0%) Ϯ 
Missing 1 0 0 2 
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more of the 
pairs who 
didn’t live 
together saying 
they provided 
‘7-14 hours of 
care a week’, 
and less than 
expected of the 
pairs that lived 
together saying 
they provided 
‘7-14 hours of 
care  a  week’. 
Length of time 
provided 
support for 
AMD 
(frequencies) 
Less than a 
year 
0 (0%) 0 (0%) 0 (0%) 0 (0%) χ2 (3)=3.93, 
p=0.28: n=68. 
Relationship 
was not 
statistically 
significant. 
Yes. 
(Relationship 
was not 
significant.) 
χ2 (3)=4.28, 
p=0.24: 
n=68. 
Between 1 
and 5 
years 
8 (44.4%) 5 (41.7%) 3 
(21.4%) 
5 (20.8%) 
More than 
5 years 
10 (55.6%) 7 (58.3%) 11 
(78.6%) 
19 (79.2%) 
Missing 0 0 0 0 
Time since 
diagnosis 
Mean (SD) 11.40 
(5.91) 
10.46 (6.12) 12.08 
(8.47) 
12.33 (6.37) H (3)= 0.99, 
p=0.80. 
Relationship 
was not 
Yes. 
(Relationship 
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Median 10.00 8.00 11.00 11.00   statistically 
significant. 
was not 
significant.) 
H (3)= 0.71, 
p=0.87. 
 
Missing 3 1 1 3 
* is p<0.05, ** is p<0.01, ***p<0.001.   Ϯ Adjusted residuals over 2.0- indicates cause of overall significant χ2  test result. ψKruskal Wallis tests were run to examine 
differences between the hours- of-care groups. Pairwise comparisons were performed using Dunn (1961) procedure with a Bonferroni correction for multiple 
comparisons.   
a IADL is the Instrumental Activities of Daily Living scale. Scale ranges from 0 (no disability) to 8 (high disability). b DLTV is the Daily Living Tasks Dependent on Vision 
scale. Scale ranges from 22 to 88 where higher scores indicate poorer visual function. c Self-rated health is measured using a single item. Higher scores indicate better 
health. d Caregivers were asked: ‘How dependent do you feel the person with the macular condition has been on you since diagnosis?’ Responses were on a 5-point 
scale where higher scores indicate higher perceived dependency on the caregiver. e Caregiver appraisals of the positive and negative impact of providing support are on 
a scale of 1 to 6 where higher scores indicate more positive or negative impact (respectively). f Higher scores indicated less negative/ more positive impact of caring for 
someone with MD on the caregiver’s quality of life. g Subscales of the Caregiver Reaction Assessment (CRA) are scored so that higher scores indicate more negative 
impact of caregiving for the topic of the subscale, e.g. higher scores on the ‘impact on finances’ subscale indicate more negative impact of caregiving on finances.  hCRA 
is the Caregiver Reaction Assessment. The total scale ranges from 1 to 5, where higher scores indicate more negative impact of providing support. i Quality of life (QoL) 
is measured on a 7-point scale scored from +3 (excellent) through 0 (neither good nor bad) to -3 (extremely bad).  jMD- specific quality of life is measured on a 5-point 
scale scored from -3 which indicates their quality of life would be ‘very much better’ (if they did not have their macular condition), through to 0 (the same), to +1 
(where it would be ‘worse’). More negative scores for both QoL and MD-specific QoL indicate greater perceived negative impact on QoL.   k Subscales of the W-BQ16 
are scored so that higher scores indicate more of the type of well-being for that subscale, e.g. higher score on the negative well-being subscale indicate greater 
negative well-being. l General well-being is on a scale of 0 to 48 where higher scores indicate better well-being.    
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Some of the findings from the bivariate analysis of the 2013 survey findings presented 
in Chapter 4 are replicated here in this sub-sample. The pwAMD who reported 
receiving more support for AMD were more likely to be registered as SI or SSI, have 
poorer general health status, and report living with their caregiver. In bivariate 
analyses of the 2013 survey responses, respondents who reported receiving more care 
for AMD were more likely to report poorer QoL (both general and MD-specific) and 
well-being. However in multivariate analyses, the relationship between general QoL 
and the amount-of-care-received was no longer significant. In the present study, 
pwAMD reported hours- of-care-received was not significantly associated with their 
general QoL, but it was with their MD-specific QoL and well-being. In the 2013 survey, 
pwAMD who were male and reported their caregiver was their wife were more likely 
to report receiving ‘more than 35 hours of care a week’. In the present study, there 
were no gender differences or differences in type of pwAMD/caregiver relationship 
across the hours-of-care groups.  
Further examination of the mean and median scores indicate the trends weren’t 
always linear. For instance, the 7-14 hours-of-care group reported higher DLTV scores 
(indicative of poorer visual function) than the 15-35 hours-of-care a week group. The 
fewer-than-7-hours-a-week group had the lowest scores, and the more-than-35-hours-
a-week group had the highest (as would be predicted).   
The quantitative second study added to the 2013 survey study findings by including 
the caregivers’ perspective. The amount of care provided to pwAMD was significantly 
associated with caregivers’ negative appraisals of the impact of caregiving. Caregivers 
who provided more care were more likely to rate the pwAMD as more dependent on 
them, perceive a more negative overall impact of providing support on their lives, have 
poorer general QoL and well-being, and perceive greater ‘burden’ as a result of 
providing support (i.e. a higher total CRA score). (See Table 7.9.) 
In contrast, providing more care for AMD was not significantly associated with 
caregivers perceiving a lower positive impact from providing support, and higher 
resentment and lower enjoyment from caregiving (i.e. their score on the esteem 
subscale of the CRA). The amount of care provided to the pwAMD was not associated 
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with caregivers’ scores on the energy and positive well-being subscales of the W-BQ16. 
(See Table 7.9.) 
The last column in Table 7.9 shows whether the bivariate analyses using caregivers’ 
appraisal of the amount of help they provide produced similar findings compared to 
when the pwAMDs’ appraisal of the amount of care received is used. There were some 
differences in the results. For instance, caregivers who provided more care reported 
poorer well-being. Whereas pwAMD reported hours-of-care-received was not 
significantly associated with caregiver well-being. Similarly caregivers’ general health 
was related to their own appraisal of the amount of care they provide, but not to the 
appraisal by pwAMD. This indicates (depending on the outcome under consideration), 
that it may be important to collect data from the ‘actor’ in order to determine how 
factors affect outcomes.  
Secondary appraisals (Caregiver reactions towards providing support) 
Table 7.10 presents the mean scores for the subscales and total score on the CRA. The 
mean scores of below 3 might indicate that caregivers (on average) reported little 
impact of caregiving in these areas of their lives. However there is huge variability in 
scores (as seen in the range of scores). Some caregivers report the maximum negative 
reaction whilst others report minimal negative reactions. The esteem subscale seems 
to be the least impacted (mean score= 2.0), whilst the schedule subscale is the most 
impacted (mean score= 3.0). The maximum negative reactions were recorded on both 
the schedule subscale and family support subscale.   
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Table 7.8 presents Spearman’s correlations between the ‘stressors’ and caregivers’ 
appraisals of the impact of providing support. In particular, pwAMD who reported 
greater difficulties with tasks of everyday living (IADL), vision-dependent tasks (DLTV) 
and poorer general health status were more likely to have caregivers who perceived 
greater negative impact of providing care (as measured by the total CRA score). 
There were no significant associations between IADL, DLTV scores, and pwAMD 
general health with caregivers’ appraisal of the positive impact of providing support on 
their lives. Neither was there an association between these ‘stressors’ with scores on 
the CRA subscale for caregiver esteem. (See Table 7.8.)  
None of the individual CRA subscales (all p>0.05) nor the total CRA scale score (H (2)= 
4.53, p=0.10) were significantly associated with registration status.  
Caregivers’ appraisal of the positive impact of caregiving had a moderate correlation 
with caregivers’ appraisal of the negative impact of providing support (rs= -0.35, 
p=0.004, n=67), suggesting that the two are not measuring two ends of the same 
spectrum.  
 
Table 7.10. Reactions to providing care, CRA subscale and total scoresa. 
CRA Mean (SD) Range n missing 
 Self-esteem 2.0 (0.67) 1.00-4.71 0 
Impact on finances 2.1 (0.89) 1.00-4.67 2 
Impact on health 2.4 (0.84) 1.00-4.50 3 
 Disrupted schedule 3.0 (0.98) 1.00-5.00 0 
Lack of family support 2.3 (0.91) 1.00-5.00 6 
CRA total 2.4 (0.65) 1.14-3.80 8 
aInternal consistency was assessed using Cronbach’s alpha. This was 0.92 for the CRA. The 
CRA is the Caregiver Reaction Assessment. The total and subscale scores range from 1 to 
5, where higher scores indicate more negative impact of providing support.  The subscale 
scores are the average score of the items on the subscale which are scored from 1 to 5, 
and where lower scores indicate respondents feel this area of life has not been affected 
by caregiving and higher scores indicate it has been greatly affected. A score of 3 is 
‘neither agree nor disagree.’ The total score is the average of all the subscales. 
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Well-being 
 
 
Caregiver mean and median general well-being scores were only slightly higher than 
pwAMD scores (caregiver general well-being mean score= 31.07, median=32.00, 
Standard deviation= 9.10; pwAMD general well-being mean score= 30.32, median= 
31.00, Standard deviation= 8.99). The descriptive statistics for the W-BQ12 and W-
BQ16 are presented in Table 7.11. The results of the W-BQ12 are presented here for 
comparison with other populations however the General well-being score from the W-
BQ16, which includes a subscale measuring stress, is used in the present study. 
There were significant correlations between the ‘stressors’ and general well-being. 
Fewer difficulties with tasks of everyday living (IADL), vision-dependent tasks and 
better general health were associated with better pwAMD general well-being scores. 
(See Table 7.8.) Caregivers’ well-being was significantly associated with pwAMDs’ IADL 
scores, DLTV scores and general health, in the same direction.  
Table 7.11. PwAMD and caregiver general well-being, W-BQ12a and W-BQ16b. 
General well-being Mean (SD) Range n missing 
 pwAMD General well-
being (W-BQ12) 
21.21 (7.69) 4.00-34.00 1 
pwAMD General well-
being (W-BQ16) 
28.94 (9.83) 6.00-45.00 1 
Caregiver General well-
being (W-BQ12) 
23.23 (6.42) 10.00-36.00 2 
 Caregiver General well-
being (W-BQ16) 
31.07 (9.10) 10.00-48.00 2 
a The W-BQ12 is on a scale of 0 to 36 where higher scores indicate better well-being.  b  
The W-BQ16 is on a scale of 0 to 48 where higher scores indicate better well-being.    
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Registration status was significantly associated with pwAMDs’ well-being (H (2)= 16.49, 
p<0.001), but not caregivers’ well-being (H (2)= 1.91, p=0.38). There were significant 
trends in the data for the more severe the registration status, the poorer pwAMD well-
being (for all well-being subscales p<0.01, and the general well-being score p<0.001). 
Both pwAMD and caregivers’ appraisal of the hours of care they receive/provide was 
associated with the pwAMD general well-being score. PwAMD who received more 
support were more likely to report poorer well-being. Caregivers’ appraisal of the 
amount of support they provide was related to their general well-being scores (in the 
same direction as for pwAMD). However pwAMDs’ appraisal of the amount of care 
they receive was not significantly associated with caregiver well-being.  
There was a strong correlation between caregivers’ appraisals of the impact of 
providing care (CRA total score) and their well-being (rs= -0.82, p<0.001, n=63). 
Caregivers who reported more negative reactions to providing support were more 
likely to report poorer well-being. There was also a strong correlation between 
caregivers’ health and their well-being (rs= 0.62, p<0.001). Poorer health was 
associated with poorer well-being. There was a significant association between 
caregiver health and pwAMD well-being (rs=0.51, p<0.001). There was a large 
significant correlation between pwAMD and caregiver well-being scores (rs= 0.54, 
p<0.001).  
Quality of life and MD-specific QoL 
PwAMD reported lower mean QoL scores than caregivers, however the median scores 
were the same (pwAMD QoL mean score= 0.71, median= 1.00, standard deviation= 
1.16; caregiver QoL mean score= 1.13, median=1.00, standard deviation= 1.05). 
PwAMD who reported fewer difficulties with tasks of everyday living (IADL) or vision-
dependent tasks were more likely to have better generic QoL and MD-specific QoL (see 
Table 7.8). In line with the findings from multivariable analyses of the 2013 survey 
responses, better pwAMD general health was associated with better pwAMD general 
QoL, but not pwAMD MD-specific QoL.   
There were significant correlations between caregivers’ QoL and pwAMD DLTV scores, 
IADL scores and general health ratings. Poorer caregiver QoL was related to poorer 
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pwAMD visual functioning, greater difficulties with IADL and poorer pwAMD health. 
(See Table 7.8.) 
Caregivers’ total CRA score (i.e. their reactions to providing support to the pwAMD), 
were significantly correlated with both pwAMDs’ QoL and caregivers’ QoL. A greater 
reported negative impact of providing support was related to poorer pwAMD and 
caregiver QoL. (See Table 7.8.) 
Caregiver health 
PwAMDs’ difficulties with IADL and visual functioning (DLTV) scores both had 
moderate correlations with caregivers’ general health (rs= -0.44, p<0.001, n=72; rs= -
0.42, p<0.001, n=72, respectively). It is interesting to note that there was a similar 
effect size for the correlation between pwAMDs’ own health and their difficulty with 
IADLs (rs= -0.44, p<0.001, n=71). Interestingly, the effect size for the correlation 
between pwAMDs’ DLTV score and caregivers’ health was larger than that with 
pwAMDs’ own health (rs= -0.42 vs rs= -0.38, respectively), perhaps suggestive of the 
effect of providing support related to pwAMDs’ level of visual functioning, on 
caregivers’ health. As mentioned above, pwAMDs’ general health and caregivers’ 
health were moderately correlated.  
Caregiver general health and pwAMD registration status were not significantly 
associated (H (2)= 4.88, p=0.09). 
Caregivers’ health was strongly correlated with their reactions towards providing 
support for the pwAMD (rs= -0.57, p<0.001, n=64). Caregivers who reported more 
negative reactions towards providing support were more likely to report poorer 
health. 
As stated above, caregivers’ appraisal of the amount of help they provided was 
significantly related to their health however pwAMDs’ appraisal of the amount of help 
received was not significantly related to caregiver health.  
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MULTIVARIATE ANALYSIS 
DEVELOPMENT OF THE STRUCTURAL MODEL 
Following bivariate analyses, structural equation modelling (SEM) was used to help 
assess direct and indirect pathways to pwAMD and caregiver outcomes.  
Figure 6.1 provides a conceptual overview of the initial structural model that was 
tested using MPlus (version 7). Observed or ‘manifest’ variables are presented as 
rectangles. Direct effects from one variable to another are indicated by a single-
headed arrow indicating the hypothesised direction of influence. A correlation is 
indicated by a double-headed curved arrow between variables. Each dependent 
variable has an associated error term, which represents measurement error. 
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Figure 6.1. Initial path model for the impact of receiving and providing support for age-related macular degeneration. 
DLTV denotes the Daily Living Tasks dependent on Vision scale. IADL is Instrumental Activities of Daily Living. CRA is the Caregiver Reaction 
Assessment. 
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Given that there are currently no theoretical models on the experience of living with 
AMD using a dyadic perspective, the initial model was designed based on the research 
literature considered to be relevant. The Yates et al. (1999) stress process model in the 
caregiver literature was used as a starting point. According to this model, the ‘primary 
stressors’ (in this study- pwAMDs’ visual functioning, their difficulties with IADLs, and 
their general health) would directly influence the primary appraisal variable of ‘hours 
of care per week’. It was hypothesised that these would predict both pwAMD and their 
caregiver’s primary appraisals (patients’ primary appraisal is not included in the Yates 
et al. (1999) model). The ‘stressors’ would also predict caregivers’ secondary appraisal 
of providing care (in this study- their total CRA score). In the stress process model, 
‘stressors’ directly affect the caregiver outcome of well-being. For this dyadic model, 
pwAMDs’ well-being was included in addition to caregivers’ well-being. Caregivers’ 
health is included as an outcome in the Stress Process Model designed by Pearlin et al. 
(1990), and this was included as an outcome here. Direct relationships were predicted 
between pwAMDs’ ‘stressors’ and their well-being, however for reasons of relevance 
and parsimony only two direct relationships between pwAMDs’ stressors and caregiver 
outcomes were predicted. First pwAMDs’ and caregivers’ health were predicted to be 
related, given their close proximity. In order to investigate indirect relationships 
between these variables, it was necessary to have a unidirectional arrow between 
them. Therefore it was predicted that pwAMDs’ health would impact on caregivers’ 
health. This is in line with the stress process models that suggest pwAMD health is a 
‘stressor’ that impacts on caregiver primary and secondary appraisals and outcomes. 
Based on the researcher’s interest, a pathway between pwAMDs’ DLTV score and 
caregivers’ well-being was included to investigate if there was a direct relationship 
between the impact of AMD on pwAMDs’ functioning (this ‘vision-specific’ measure) 
and caregivers’ well-being. Indirect relationships between caregivers’ well-being and 
health with pwAMDs’ ‘stressors’ were examined, via primary and secondary appraisals 
of providing care.  
Caregivers’ appraisal of the hours of support they provided was hypothesised to have a 
direct effect on their secondary appraisal (i.e. their CRA score) and both direct and 
indirect effects on their outcomes (caregiver well-being and caregiver health). 
PwAMDs’ appraisal of the amount of care received is not typically included in caregiver 
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‘stress process’ models, however, in line with the 2013 survey findings, it was 
predicted to influence their outcome directly (i.e. their well-being). It was also 
predicted to influence caregivers’ secondary appraisals of providing care (i.e. 
caregivers’ CRA score). 
It was hypothesised that caregivers who experience greater negative impacts from 
providing support (i.e. higher CRA scores) may have a negative impact on their 
pwAMDs’ well-being. A direct pathway tested whether caregivers’ CRA score might 
predict pwAMDs’ well-being. 
To account for the non-independence of the data, error terms were correlated for 
dependent variables where both the caregiver and pwAMD were asked to complete 
the same or potentially related measures (i.e. their appraisals of the amount of care 
received/ provided, and their well-being). The correlation between residuals controls 
for sources of non-independence not accounted for by the other variables in the 
model (Cook & Kenny, 2005). All independent variables were correlated since this is a 
requirement of SEM.  
The goal of SEM analysis is to determine the extent to which the proposed theoretical 
model is supported by the data. Three indices were used to evaluate the fit of the 
model: chi-square χ2 with an insignificant p value (p>0.05); a comparative fit index (CFI) 
value of above 0.95; and a root mean square error of approximation (RMSEA) value of 
less than 0.05, were considered to be indicative of good model fit (Hooper, Coughlan, 
& Mullen, 2008). SRMR (standardised root mean square residual) values below 0.08 
suggest an adequate model fit (Hu & Bentler, 1999). The chi-square test is sensitive to 
sample size, so multiple indices were used. Ullman (2013) stated a rough rule of thumb 
for a good-fitting model may be indicated when the ratio of the χ2 to the degrees of 
freedom is less than 2.  
Modification indices are provided by path analysis software packages after the model 
has been fitted. They are a list of paths that, if added, may improve model fit. However 
changes to the model should be theoretically justified and not purely data driven. Bias-
corrected bootstrapped confidence intervals were requested for indirect pathways.  
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FIT OF INITIAL MODEL 
The initial model showed a good fit to the data in three of the four indicators of model 
fit (χ2 (7)= 8.77, p = 0.27, CFI= 0.99, RMSEA= 0.06, SRMR= 0.02). The RMSEA value was 
slightly above the 0.05 level considered to be indicative of good model fit. 
Standardised parameters, their standard errors and p values are presented in Table 
7.12 for each specified pathway. Figure 7.1 shows the significant and non-significant 
pathways.  
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Table 7.12. Standardised parameter estimates for initial model (shown in Figure 6.1 and 7.1). 
 
Parameters  Standardised 
path 
coefficients 
Standard 
error 
p value 
DLTVa pwAMD hours of care 0.13 0.12 0.30 
Caregiver hours of care 0.18 0.12 0.14 
Caregiver CRA 0.17 0.14 0.21 
pwAMD well-beingf -0.29 0.10 0.01* 
Caregiver well-being 0.02 0.09 0.80 
IADLb pwAMD hours of care 0.60 0.12 <0.001*** 
Caregiver hours of care 0.55 0.12 <0.001*** 
Caregiver CRA 0.05 0.17 0.77 
pwAMD well-being -0.16 0.12 0.19 
pwAMD healthc pwAMD hours of care -0.04 0.10 0.66 
Caregiver hours of care -0.08 0.10 0.43 
Caregiver CRA -0.35 0.10 0.001** 
pwAMD well-being 0.36 0.08 <0.001*** 
Caregiver health 0.17 0.11 0.12 
pwAMD hours of cared  Caregiver CRA 0.01 0.17 0.96 
pwAMD well-being -0.02 0.11 0.88 
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Caregiver hours of cared Caregiver CRA 0.17 0.18 0.35 
Caregiver well-being -0.06 0.09 0.51 
Caregiver health -0.16 0.11 0.14 
Caregiver CRAe pwAMD well-being -0.17 0.10 0.07 
 Caregiver well-being -0.79 0.06 <0.001*** 
Caregiver health -0.35 0.12 0.002** 
Covariances     
pwAMD hours of care received and Caregiver 
hours of care provided 
 0.59 0.08 <0.001*** 
pwAMD well-being and Caregiver well-being  0.37 0.11 0.001** 
Caregiver well-being and caregiver general 
health 
 0.39 0.11 <0.001*** 
Caregiver general health and pwAMD well-
being 
 0.18 0.12 0.14 
IADL and DLTV  0.70 0.06 <0.001*** 
IADL and pwAMD general health  -0.45 0.10 <0.001*** 
DLTV and pwAMD general health  -0.39 0.10 <0.001*** 
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Residual variances 
CRA  0.65 0.09 <0.001*** 
Caregiver well-being  0.35 0.07 <0.001*** 
pwAMD hours of care received  0.52 0.09 <0.001*** 
Caregiver hours of care provided  0.48 0.08 <0.001*** 
pwAMD well-being  0.38 0.07 <0.001*** 
Caregiver general health  0.69 0.09 <0.001*** 
R-square     
CRA  0.36 0.09 <0.001*** 
Caregiver well-being  0.65 0.07 <0.001*** 
pwAMD hours of care received  0.48 0.09 <0.001*** 
Caregiver hours of care provided  0.52 0.08 <0.001*** 
pwAMD well-being  0.62 0.07 <0.001*** 
Caregiver general health  0.31 0.09 <0.001*** 
*p<0.05, ** p<0.001, ***p<0.001. a DLTV is the Daily Living Tasks Dependent on Vision scale. Scale ranges from 22 to 88 where 
higher scores indicate poorer visual function. b IADL is the Instrumental Activities of Daily Living scale. Scale ranges from 0 (no 
disability) to 8 (high disability). c Self-rated health is measured using a single item. Higher scores indicate better health. d Hours-of-
care is measured using a 4-point ordinal scale where higher scores indicate more care is received by the pwAMD/caregiver 
provides more care per week.  eCRA is the Caregiver Reaction Assessment. The total scale ranges from 1 to 5, where higher scores 
indicate more negative impact of providing support. f General well-being is on a scale of 0 to 48 where higher scores indicate 
better well-being.  
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Figure 7.1 Initial path model of the impact of receiving and providing support for age-related macular degeneration showing significant 
pathways. DLTV denotes the Daily Living Tasks dependent on Vision scale. IADL is Instrumental Activities of Daily Living. CRA is the Caregiver Reaction 
Assessment. 
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The impact of the ‘stressors’ 
The three ‘stressors’ included in the model (pwAMD visual functioning, difficulties with 
IADLs and pwAMD health) all significantly correlated with each other.  Although all 
three were predicted to affect caregiver and pwAMD primary appraisals of 
giving/receiving support, only difficulties with IADL were significantly associated with 
pwAMD and caregivers’ appraisal of the amount of help they received or provided.  
Similarly, although all three ‘stressors’ were hypothesised to explain caregivers’ 
secondary appraisal of the impact of providing support (i.e. their CRA scores), only 
pwAMDs’ general health was significantly associated with this appraisal.  
Of the outcomes, pwAMD ‘stressors’ were all hypothesised to predict pwAMDs’ well-
being. Poorer pwAMDs’ level of visual functioning and poorer pwAMD general health 
predicted poorer pwAMD well-being. In this sample of pwAMD receiving support for 
AMD, difficulties with IADL were not significantly associated with pwAMDs’ well-being. 
Of the impacts of the ‘stressors’ on caregiver outcomes, pwAMDs’ level of visual 
functioning did not directly predict caregivers’ well-being. Additionally pwAMDs’ 
health did not directly predict caregivers’ general health.  
Impact of primary appraisals ‘hours of care provided/ received’ 
Both pwAMDs’ and caregivers’ appraisals of the amount of support received/ provided 
were hypothesised to predict caregivers’ secondary appraisal of the impact of 
providing support (their CRA scores), however neither pathway was significant.  
PwAMDs’ appraisal of the amount of care they received was predicted to affect their 
well-being. This relationship was significant in the multivariable analysis of the 2013 
survey findings presented in Chapter 4. It was also significant in the bivariate analysis 
presented in this chapter (Table 7.9). However in bivariate analysis, only the pairwise 
comparison between those pwAMD who reported receiving the least amount of care 
for AMD (the ‘fewer than 7 hours of care a week’ group) and those who received the 
most amount of help (the ‘more than 35 hours of care a week’ group) was significant. 
In multivariate analyses presented in Table 7.12 and Figure 7.1, the relationship was 
not significant.  
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Caregivers’ appraisal of the amount of care they provided was hypothesised to impact 
on their well-being and general health, however neither relationship was found to be 
significant in the multivariate model. 
There was a significant correlation between pwAMDs’ and caregivers’ appraisals of the 
amount of help they receive/ provide.  
Impact of secondary appraisal using the ‘Caregiver Reaction Assessment’ 
The SEM found that caregivers’ CRA scores predicted their own outcomes (i.e. their 
well-being and general health), but not the pwAMDs’ outcome (well-being).  
The present model explained around 35.5% of the variance in CRA scores (R2 = 0.355), 
indicating that there were factors not included in the present model that could be used 
to predict caregiver reactions towards providing support. The only significant predictor 
of CRA scores included in the model was pwAMDs’ general health.   
Outcomes 
The predictors of pwAMD and caregiver outcomes are described above. Briefly, 
pwAMDs’ well-being was predicted by their level of visual functioning (i.e. their DLTV 
score) and their general health, but not by their difficulties with IADL. Neither their 
primary appraisal of the amount of care they receive, nor their caregiver’s CRA score 
were significantly related to their well-being. 
There were no significant indirect pathways between pwAMDs’ DLTV scores and their 
well-being (see Table 7.13). Neither pwAMDs’ nor caregivers’ primary appraisals of the 
amount of care received/provided nor caregivers’ CRA score acted as mediators. There 
was a similar pattern for the relationship between pwAMDs’ health and their well-
being. Only the direct pathway was significant, and not the indirect pathway via 
primary appraisals or CRA scores.  
There were no significant direct or indirect pathways from pwAMDs’ IADL scores to 
their well-being scores (via the mediators of pwAMDs’ and caregivers’ primary 
appraisals of the amount of care received/ provided or caregivers’ CRA score). 
Caregiver well-being and general health were directly predicted by CRA scores, but not 
caregivers’ primary appraisal of the amount of support they provide to the pwAMD nor 
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the pwAMD ‘stressors’. Additionally there were no significant indirect pathways from 
pwAMDs’ IADL or DLTV scores to caregivers’ well-being or health. However there was a 
significant indirect pathway from pwAMDs’ health to caregiver well-being via 
caregivers CRA score. Additionally, pwAMDs’ health indirectly affected caregivers’ 
health via caregivers’ CRA score. 
Caregiver and pwAMD well-being were significantly correlated, as predicted. 
Caregivers’ well-being and their health were also correlated. There was no significant 
association between pwAMDs’ well-being and caregivers’ health.   
The present model explained approximately 64.9% of the variance in caregivers’ 
wellbeing (R2 = 0.649), 61.6% of the variance in pwAMDs’ well-being (R2 =0.616), and 
31.2% of the variability in caregivers’ health (R2 = 0.312) (all significant at ps<0.01). 
Together with the model fit statistics, this indicates that the model fitted the data 
reasonably well, however there was a substantial amount of the variance in caregivers’ 
health that could not be explained by the model.  
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Table 7.13. Indirect pathways for initial model.  
 
Model 
pathways 
  Standardised 
path 
coefficients  
Standard 
error 
p 
value 
 
Effects from 
DLTV to 
pwAMD well-
being 
 Total effect -0.33 0.10 0.002** 
 Total indirect 
effect 
-0.04 0.03 0.26  
 Direct effect -0.29 0.10 0.005** 
Indirect effects      
pwAMD well-being → CRA → DLTV  -0.03 0.03 0.30  
 pwAMD well-being → pwAMD help 
received → DLTV 
 -0.002 0.01 0.88  
 pwAMD well-being → CRA → pwAMD 
help received → DLTV 
 0.000 0.004 0.96   
 pwAMD well-being → CRA → Caregiver 
help provided → DLTV 
 -0.01 0.01 0.47  
Effects from 
IADL to 
pwAMD well-
being 
 Total effect -0.19 0.11 0.07  
  Total indirect 
effect 
-0.04 0.07 0.60  
  Direct effect -0.16 0.12 0.19  
 Indirect effects      
 pwAMD well-being → CRA → IADL  -0.01 0.03 0.77  
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 pwAMD well-being → pwAMD help 
received → IADL 
 -0.01 0.06 0.88  
 pwAMD well-being → CRA → pwAMD 
help received → IADL 
 -0.001 0.02 0.96  
 pwAMD well-being → CRA → Caregiver 
help provided → IADL 
 -0.02 0.02 0.42  
Effects from 
pwAMD 
health to 
pwAMD well-
being 
 Total effect 0.43 0.08 0.00*** 
  Total indirect 
effect 
0.06 0.04 0.11  
  Direct effect 0.36 0.08 0.00*** 
 Indirect effects      
 pwAMD well-being → CRA → pwAMD 
health 
 0.06 0.04 0.12  
 pwAMD well-being → pwAMD help 
received → pwAMD health 
 0.001 0.005 0.88  
 pwAMD well-being → CRA → pwAMD 
help received → pwAMD health 
 0.000 0.001 0.96  
 pwAMD well-being → CRA → Caregiver 
help provided → pwAMD health 
 0.002 0.004 0.56  
Effects from 
DLTV to 
Caregiver well-
being 
 Total effect -0.15 0.13 0.26  
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  Total indirect 
effect 
-0.17 0.11 0.13  
  Direct effect 0.02 0.09 0.80  
 Indirect effects      
 Caregiver well-being → CRA → DLTV  -0.14 0.11 0.22  
 Caregiver well-being →  Caregiver help 
provided → DLTV 
 -0.01 0.02 0.55  
 Caregiver well-being → CRA → pwAMD 
help received → DLTV 
 -0.001 0.02 0.96  
 Caregiver well-being → CRA → 
Caregiver help provided → DLTV 
 -0.02 0.03 0.42  
Effects from 
IADL to 
Caregiver well-
being 
 Total effect -0.15 0.12 0.22  
  Total indirect 
effect 
-0.15 0.12 0.22  
 Indirect effects      
 Caregiver well-being → CRA → IADL  -0.04 0.13 0.77  
 Caregiver well-being →  Caregiver help 
provided → IADL 
 -0.03 0.05 0.52  
 Caregiver well-being → CRA → pwAMD 
help received → IADL 
 -0.004 0.08 0.96  
 Caregiver well-being → CRA → 
Caregiver help provided → IADL 
 -0.07 0.08 0.36  
Effects from 
pwAMD 
 Total effect 0.29 0.09 0.001** 
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health to 
Caregiver well-
being 
  Total indirect 
effect 
0.29 0.09 0.001** 
 Indirect effects      
 Caregiver well-being → CRA → pwAMD 
health 
 0.27 0.09 0.001** 
 Caregiver well-being →  Caregiver help 
provided →  pwAMD health 
 0.004 0.01 0.61  
 Caregiver well-being → CRA → pwAMD 
help received →  pwAMD health 
 0.000 0.01 0.96  
 Caregiver well-being → CRA → 
Caregiver help provided →  pwAMD 
health 
 0.01 0.02 0.54  
Effects from 
DLTV to 
Caregiver 
health 
 Total effect -0.10 0.06 0.09  
  Total indirect 
effect 
-0.10 0.06 0.09  
 Indirect effects      
 Caregiver health → CRA → DLTV  -0.06 0.05 0.25  
 Caregiver health →  Caregiver help 
provided →  DLTV 
 -0.03 0.03 0.30  
 Caregiver health → CRA → pwAMD 
help received →  DLTV 
 0.000 0.01 0.96  
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 Caregiver health → CRA → Caregiver 
help provided →  DLTV 
 -0.01 0.01 0.44  
Effects from 
IADL to 
Caregiver 
health 
 Total effect -0.14 0.08 0.07  
  Total indirect 
effect 
-0.14 0.08 0.07  
 Indirect effects      
 Caregiver health → CRA → IADL  -0.02 0.06 0.77  
 Caregiver health →  Caregiver help 
provided →  IADL 
 -0.09 0.06 0.16  
 Caregiver health → CRA → pwAMD 
help received →  IADL 
 -0.002 0.04 0.96  
 Caregiver health → CRA → Caregiver 
help provided →  IADL 
 -0.03 0.04 0.38  
Effects from 
pwAMD 
health to 
Caregiver 
health 
 Total effect 0.31 0.10 0.003** 
  Total indirect 
effect 
0.14 0.06 0.02*  
  Direct effect 0.17 0.11 0.12  
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 Indirect effects      
 Caregiver health → CRA → pwAMD 
health 
 0.12 0.06 0.03*  
 Caregiver health →  Caregiver help 
provided →   pwAMD health 
 0.01 0.02 0.48  
 Caregiver health → CRA → pwAMD 
help received →   pwAMD health 
 0.000 0.003 0.96  
 Caregiver health → CRA → Caregiver 
help provided →   pwAMD health 
 0.01 0.01 0.55  
*p<0.05, ** p<0.001, ***p<0.001.  
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Model development 
The initial model was a good fit with the data and no modification indices were 
produced to suggest that adding or removing pathways might improve the fit of the 
model. Nevertheless, in the initial model there were 16 non-significant pathways (see 
Table 7.12 or Figure 7.1). A more parsimonious model might be explained by removing 
non-significant pathways. It is normally considered good practice for one to take into 
account the previous literature before removing pathways, however since there was 
no relevant dyadic model that could be used to inform decisions, all 16 non-significant 
pathways were removed. A pathway was added between pwAMD health and caregiver 
well-being in order to compare the direct and indirect effects between these two 
variables given that the initial model found a significant indirect effect for pwAMD 
health on caregiver well-being via caregivers’ CRA score.  
The revised model is shown in Figure 7.2 with the standardised path coefficients. 
Examination of the fit indices indicated the revised model fitted the data fairly well (χ2 
(22)= 35.22, p = 0.04, CFI= 0.96, RMSEA= 0.09, SRMR= 0.14), although not as well as 
the initial model. Most standardised path coefficients were significant at p<0.001. The 
exceptions were for the correlations between caregiver well-being and pwAMD well-
being (p=0.01), and between caregiver well-being and caregiver health (p=0.001). The 
only insignificant pathway was the test of a direct effect between pwAMD health and 
caregiver well-being added into this second model (p=0.64), but the indirect effect via 
caregivers’ CRA scores remained significant (p<0.001). Matching the initial model, the 
indirect effect of pwAMD health on caregivers’ health via CRA scores was significant 
(p<0.001). No modification indices were produced.  
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Figure 7.2 Standardised path coefficients for the re-specification of the initial path model for the impact of receiving and providing 
support for age-related macular degeneration. DLTV denotes the Daily Living Tasks dependent on Vision scale. IADL is Instrumental Activities of 
Daily Living. CRA is the Caregiver Reaction Assessment. 
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The R2 statistics suggest the initial model predicted the variability in the dependent 
variables slightly better than the second model. For instance, the second model 
predicted 25.8% of the variance in CRA scores compared to 35.5% of the variance in 
the initial model. The second model predicted 63.5% of the variability in caregiver well-
being (vs 64.9% in the initial model), 58.5% of the variability in pwAMD well-being (vs 
61.6% in the initial model) and 26.8% of the variability in caregiver health (vs 31.2% in 
the initial model). The second model also had poorer model fit statistics than the initial 
model. Thus although the second model included only the significant pathways from 
the initial model, the initial model still fitted the data better.  
DISCUSSION 
The results from the 2013 survey (presented in Chapter 4) suggested that the 
relationship between the amount-of-care-received and the well-being of the pwAMD, 
after adjusting for severity of vision loss (using registration status and patient-reported 
change in vision status since diagnosis), was counterintuitive: well-being deteriorated 
as the amount of care received for AMD increased. This second study included a more 
detailed measure of ability to carry out vision-dependant tasks (the DLTV) as an 
indicator of present level of VI. The SEM found that pwAMD well-being was 
significantly associated with difficulties carrying out vision-dependent tasks, but not 
with the amount of care received. There was also no significant indirect effect of level 
of visual functioning on pwAMD well-being via the amount of care they received. Thus 
when visual functioning was used instead of registration status and change in vision 
status since diagnosis, receiving more care for AMD was no longer associated with 
poorer well-being. Therefore this thesis took an important step forward by including 
visual functioning to investigate if the relationship between receiving more care for 
AMD and poorer well-being persisted after controlling for the impact of present level 
of VI. 
Model summary 
Supporting the theoretical underpinnings of the Yates et al. (1999) Stress Process 
model, the ‘stressor’ of difficulties with IADL predicted both pwAMDs’ and caregivers’ 
primary appraisals of the number of hours of care they reported receiving or providing. 
In this multivariable analyses with all three ‘stressors’ included, the other variables 
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classified as ‘stressors’ (pwAMDs’ DLTV score and general health) were not associated 
with these primary appraisals. This is particularly surprising for the DLTV score as 
participants were asked to indicate the amount of help they received or provided for 
AMD and thus one might expect a significant association with this condition-specific 
‘stressor’. However it may be that pwAMD receive help with the tasks of daily living 
included in the IADL measure (e.g. preparing meals, getting to places beyond walking 
distance), but are less likely to receive help with some of the more specific vision-
dependent tasks included in the DLTV (e.g. enjoying the scenery if out for a drive or 
distinguishing a person’s features across the street). 
PwAMDs’ health was measured using a single-item asking participants to rate their 
general health on a scale from 1 to 7 where 1 is ‘extremely bad’ and 7 is ‘excellent’. In 
contrast to the DLTV and the IADL, this measure did not assess pwAMDs’ level of 
functioning, thus we might expect a poorer association with the appraisals of the 
amount of help received/ provided.  
Both the models tested in the present study (Figures 6.1 and 7.2) add to the Yates et 
al. (1999) model by including both pwAMD and caregiver primary appraisals of the 
number of hours of support received/provided. It is interesting to note that they were 
both predicted by the same ‘stressor’ (IADL) and not by others (DLTV score and general 
health). The R2 statistics showed a reasonable amount of the variability in pwAMDs’ 
appraisals (48.1%) and caregivers’ appraisals (52.0%) could be explained by the model, 
but there is still a moderate amount left unexplained. Perhaps a measure that 
specifically assesses the amount of help provided for AMD might predict these primary 
appraisals better, however none currently appear in the literature. 
The amount of help received and provided for MD was not related to the well-being of 
the pwAMD or to caregiver well-being, caregiver health or caregiver reactions towards 
providing support. These findings contradict the theoretical underpinnings of the Yates 
et al. (1999) stress model. One might question the usefulness of these primary 
appraisal measures given their inability to predict secondary appraisals or the 
outcomes in the present model. However it may that these primary appraisals are 
useful in predicting pwAMD secondary appraisals of the impact of receiving support 
(not measured in this study), and thus should not be immediately discounted. 
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Poorer general health in pwAMD (but not difficulties with vision-dependent or 
everyday tasks) predicted more negative caregiver reactions to providing support. This 
indirectly predicted poorer caregiver well-being and general health. Although 
caregivers were asked to complete the CRA to investigate ‘how providing care for your 
friend or family member with a macular condition has affected you, your family and 
your daily routine’ (emphasis added), caregivers may not have considered only the 
aspects of providing support related to the AMD, but rather the impact of providing 
support for the person in general, thus taking into account other reasons for providing 
support such as other medical conditions or general frailty. Indeed in the preliminary 
analyses, there was a moderate correlation between the total CRA score with the 
number of other conditions the pwAMD had (rs = 0.29, p<0.05). It is interesting to note 
that poorer pwAMD general health predicted more negative caregiver reactions to 
providing support whereas pwAMDs’ level of visual functioning or their difficulties with 
tasks of everyday living did not. This finding suggests that targeting the general health 
of pwAMD in interventions may be effective at reducing caregiver ‘burden’ and 
consequently improve caregiver well-being and health alongside pwAMD well-being. 
Caregiver reactions towards providing support (their CRA score) predicted their 
general health. In line with stress process models, pwAMD health was predicted to act 
as a ‘stressor’ and predict the caregiver outcome of general health. However a 
significant direct effect for this was not found. Instead there was an indirect 
relationship between pwAMD and caregiver health via caregivers’ CRA scores. The 
findings suggest that poorer pwAMD health predict more negative caregiver reactions 
to providing support which in turn predict poorer caregiver health. It is worth noting 
that the CRA contains an ‘impact on health’ subscale. There is a strong correlation 
between this subscale of the CRA and caregivers’ general health (rs = -0.69, p<0.001). 
Thus although the CRA asks about the impact that caregiving specifically has on one’s 
health, there is an indication that there may be some overlap between this and 
caregivers’ ratings of their general health that might account for the significant 
relationship between CRA total scores and caregiver health.  
As predicted, caregivers’ reactions towards providing support to the pwAMD were 
predictive of their well-being. Similar to the findings above, CRA scores mediated the 
relationship between pwAMDs’ health and caregivers’ well-being. Thus poorer 
 313 
 
pwAMDs’ health predicted poorer caregivers’ reactions to providing support (i.e. 
higher caregiver ‘burden’) which predicted poorer caregiver general health and lower 
caregiver well-being.  
In this sample of 72 dyads of pwAMD and their caregivers, caregiver outcomes (well-
being and general health) were predicted by the impact of providing support for the 
pwAMD, however this was influenced by pwAMD general health rather than pwAMD 
level of visual functioning or difficulties with tasks associated with everyday living. 
PwAMDs’ well-being was predicted by their general health and the impact of vision 
loss on tasks dependent on vision but not with how much difficulty they had with tasks 
of everyday living. Caregiver ‘burden’ did not predict pwAMD well-being. Neither 
pwAMD nor caregiver outcomes were affected by the amount of care for AMD they 
reported receiving/providing.  
Contrary to expectations, pwAMDs’ difficulties with vision-dependent tasks were not 
significantly associated with caregivers’ reported hours-of-care-provided, caregiver 
‘burden’ or caregiver well-being. There may be other aspects of living with AMD that 
impact on the caregiver. Indeed part of the shared residual covariance between 
pwAMDs’ and caregivers’ well-being might be explained by factors associated with 
AMD that affect both pwAMD and their caregivers (or by shared factors unrelated to 
AMD). Some of the caregivers in this study reported having to give up work or reduce 
their working hours in order to provide care to the pwAMD. Some pwAMD reported a 
change in registration status since the 2013 survey; most were registered as SI at the 
time of the 2013 survey and were registered as SSI at the time of the second study. 
This might suggest a recent deterioration in vision which could affect both pwAMD and 
caregiver outcomes. The qualitative part of the study may shed some light on factors 
associated with pwAMD and caregiver outcomes that weren’t included in the 
quantitative study. 
It is interesting to note that the measure of vision impairment used in the 2013 survey 
study (registration status) was not associated with caregiver secondary appraisals of 
providing care (their CRA scores) or their outcomes (caregiver well-being and health) in 
the second study. However the DLTV, which measures pwAMDs’ difficulties with 
vision-dependent tasks, was associated with these variables (in bivariate analysis, but 
 314 
 
not multivariate analysis). This may provide further evidence of the suitability of the 
use of the DLTV in the quantitative second study. 
The study findings provide evidence to suggest that caregivers’ ratings of their role as 
enjoyable/rewarding or whether it causes resentment (as measured by the CRA 
esteem subscale), and the overall positive effect caregiving had on their lives were 
unrelated to reports from the pwAMD about their level of difficulty with tasks, their 
general health or the amount of help they received. This suggests that these ‘stressors’ 
and ‘primary appraisal’ aren’t taken into account when appraising the positive aspects 
of providing care. Caregivers’ appraisal of the overall positive impact of providing 
support was significantly associated with higher well-being and a lower total CRA score 
(indicating less negative impact of caregiving or ‘burden’). There were no other 
variables that significantly correlated with positive appraisals and could be used to 
help predict caregivers’ overall positive appraisal of providing care (e.g. age, gender, 
pwAMD/caregiver relationship type). These findings add to the small amount of data 
on positive appraisals of providing care for someone with AMD in the literature. The 
qualitative study will explore both positive and negative appraisals in more detail.  
Whilst caregivers’ positive appraisals of the impact of providing care were unrelated to 
the ‘stressors’ and ‘primary appraisal’ used in the present study, negative appraisals of 
caregiving were associated with these factors. This suggests that caregivers may not 
take into account pwAMD level of functioning when appraising the positive impact of 
providing support on their lives, but they do take this into account when thinking of 
the negative impact of providing support. Thus highlighting perhaps, an important 
distinction that needs to be made when assessing caregiver reactions to providing 
support. The correlation between the single-items measuring positive and negative 
appraisals of caregiving was moderate but not large. This suggests these two 
subjective appraisals may be constructs that are similar but assess different aspects of 
the caregiver’s situation.  
The analyses of the 2013 survey data controlled for pwAMD gender. Indeed the 
multivariate analyses presented in Chapter 4 found that men with MD were more 
likely to report better well-being, but there was no sex difference in generic or MD-
specific QoL. Unfortunately the small sample in the present study meant that the 
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gender of the pwAMD or caregiver could not be included in the SEM. The present 
study included more men with MD than the 2013 survey sample used in the 
multivariate analyses presented in Chapter 4. There was almost an even balance of 
gender in the second study (51% male, 49% female) whereas in the 2013 study, men 
made up 35% of the sample. It is likely that the views of men with MD are 
overrepresented in the present study when compared to the 2013 survey study. 
However the well-being of the sample included in the quantitative second study was 
not significantly different to the well-being of those included in the 2013 survey 
findings.   
There was a strong, but not a perfect correlation between pwAMDs’ and caregivers’ 
appraisals of the amount of help they received/provided. Caregivers’ appraisal of the 
amount of care they provided was related to some of their outcomes, whereas 
pwAMDs’ appraisal was not related to caregiver outcomes (e.g. for caregiver well-
being and caregiver general health- see Table 7.9). Therefore it was considered 
important to include both in the SEM on these data-driven grounds, in addition to 
including these on theoretical grounds in order to test a dyadic model. The SEMs 
presented in Figures 6.1 and 7.2 were repeated with either the pwAMD hours-of-care-
received variable or caregiver hours-of-care-provided variable (not both). The direct 
and indirect pathways showed similar results to the model presented in Figure 6.1 in 
this chapter (which included both pwAMD and caregiver primary appraisals). However 
the model fit statistics showed a slightly poorer fit to the data. For example, when the 
model shown in Figure 6.1 was run with only pwAMD hours-of-care-received included, 
the model fit statistics were (χ2 (4)= 8.20, p = 0.09, CFI= 0.98, RMSEA= 0.12, SRMR= 
0.03). Model fit statistics for the model including only caregiver reported hours-of-
care-provided were: (χ2 (4)= 5.50, p = 0.24, CFI= 0.99, RMSEA= 0.07, SRMR= 0.02). Thus 
the original SEM results (including both pwAMD and caregiver primary appraisals) are 
presented in this chapter2.  
                                                          
2 Three indices were used to evaluate the fit of the model: chi-square χ2 with an insignificant p 
value (p>0.05); a comparative fit index (CFI) value of above 0.95; and a root mean square error 
of approximation (RMSEA) value of less than 0.05, were considered to be indicative of good 
model fit (Hooper et al., 2008). SRMR (standardised root mean square residual) values below 
0.08 suggest an adequate model fit (Hu & Bentler, 1999). The initial model showed a 
satisfactory fit to the data (χ2 (7)= 8.77, p = 0.27, CFI= 0.99, RMSEA= 0.06, SRMR= 0.02). 
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The average CRA total score was much lower than that seen in the study of caregivers 
who take patients with wet AMD to treatment (mean of 2.4 vs 3.2, respectively; Gohil 
et al. (2015)). Mean scores on all subscales of the CRA but caregiver esteem, were 
lower in the present study: self-esteem (mean for Gohil et al. study= 2.0, mean for 
present study= 2.0), impact on finances (mean for Gohil et al. study= 3.9, mean for 
present study= 2.1), impact on health (mean for Gohil et al. study= 2.9, mean for 
present study= 2.4), impact on schedule (mean for Gohil et al. study= 3.3, mean for 
present study= 3.0), and lack of family support (mean for Gohil et al. study= 3.8, mean 
for present study= 2.3). Indeed, Gohil et al. (2015) concluded that caregivers of people 
who assisted pwAMD with travelling to treatment for AMD reported high levels of 
burden, and this was said to be comparable to studies of caregivers who take patients 
to treatment for atrial fibrillation (Coleman et al., 2012). In the present study, 17% of 
pwAMD reported they were currently receiving eye injections as treatment for AMD. 
Whilst the lower average CRA scores in the present study for caregivers of people 
receiving treatment and those not receiving treatment may suggest that caregivers of 
people not receiving treatment may experience lower burden, future research would 
need to confirm this. Caregivers of those receiving treatment may indeed experience 
higher burden as a result of providing care, however they may also be more hopeful of 
a positive outcome.  
Gohil et al. (2015) reported that child or sibling caregivers of people with wet AMD 
receiving treatment had higher CRA scores than friends or spouse caregivers. They 
suggested this may be because child or sibling caregivers were younger and more likely 
to be employed with a greater potential of disruption to their daily routine. In the 
present study, although the mean CRA total scores for adult-offspring caregivers were 
higher than spouse caregivers, this difference was not statistically significant (see Table 
7.6). Adult-offspring caregivers tended to score higher on all subscales apart from the 
‘impact on health’ subscale (although these differences weren’t significant). There 
were also no significant differences between the caregiver relationship types on any 
other caregiver secondary appraisal measures. This is despite the adult-offspring 
caregivers being younger than spouse caregivers in the present study. Gohil et al. 
(2015) suggestion that adult-offspring caregivers might perceive greater burden as a 
result of conflicting commitments whilst providing care, is supported by role theories 
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in the caregiver ‘burden’ literature. This suggests that stress occurs due to ‘role 
overload’ (where individuals lack the time and resources to fulfil obligations associated 
with each of their roles, (Goode, 1960, as cited in Bastawrous, 2013), or ‘role conflict’ 
(when the expectations of the various roles an individual holds become incompatible, 
Biddle, 1986). The qualitative study will investigate differences in pwAMD/caregiver 
relationships further. 
Perhaps there were no significant differences between caregiver relationship types in 
this study because adult-offspring caregivers had adapted to the caregiving role. Any 
difficulties caregivers had with managing the support they provide around other 
commitments may be managed better given time to adjust to the role. In the present 
study there were no significant differences in how long caregivers had been providing 
support to the pwAMD between spouse and adult-offspring caregivers. The majority of 
adult-offspring caregivers (76%) reported providing support for ‘more than 5 years’ 
and thus may have had time to adapt to the role and had perhaps taken the decision 
to reduce other role commitments. Caregivers in the Gohil et al. (2015) study were on 
average five years younger than those in the present study (average age of caregivers 
in the Gohil et al. (2015) study was 56 years for adult-child caregivers, and 74 years for 
spouse caregivers, compared with 61 years and 79 years in the present study, 
respectively). Younger caregivers may be juggling more roles and responsibilities and 
thus experience greater caregiver burden. An alternative interpretation may be that 
the CRA measure did not effectively assess the impact that providing support had on 
the sample of caregivers of pwAMD in the present study. There may be aspects of 
providing care for AMD that are specific to the caregiver relationship type. This will be 
investigated in the qualitative study that follows. 
CRA subscale scores indicate that the sample of caregivers of pwAMD in the present 
study had lower negative impacts on their health, finances, schedule, esteem and 
family support than caregivers of people with multiple sclerosis (Forbes et al., 2007). 
Partners of people with rheumatoid arthritis (RA) reported more negative impacts on 
their schedule, family and finances than the caregivers in the present study, but lower 
impacts on their health and esteem (Jacobi et al., 2003). Partners of patients with 
colorectal cancer reported lower negative impacts of providing care across all 
subscales than the sample in the present study (Nijboer, Triemstra, Tempelaar, 
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Sanderman, & van den Bos, 1999). Similar to partners of patients with RA, the 
caregivers in the present study reported the most negative impact on the schedule 
subscale (Jacobi et al., 2003). The subscale least impacted by caregiving was impact on 
caregiver self-esteem. Of course it is important to note that in addition to the different 
medical conditions, there are other factors associated with well-being and appraisals 
of providing care that varied between these studies (e.g. gender, age, type of patient-
caregiver relationship), so one should be wary of making direct comparisons across 
studies. 
Bivariate analyses in the present study found no significant differences in pwAMD QoL 
(general or MD-specific) or well-being between those whose spouse was their 
caregiver and those whose adult-offspring was their caregiver. This is supported by the 
results from multivariate analysis of the 2013 survey responses presented in Chapter 4 
which found that the type of pwAMD/caregiver relationship was not associated with 
pwAMD QoL or well-being. The qualitative study findings may add to this finding of 
lack of differences in pwAMD outcomes between spouse pairs and adult-
offspring/parent pairs.  
Gopinath et al. (2015) found caregivers who perceived the pwAMD was ‘highly 
dependent’ on them were more likely to report caregiver distress. Caregiver distress 
was measured by caregiver self-reports of feeling down, sad, frustrated, isolated and/ 
or pessimistic as a result of providing care. The present study included validated 
measures of caregiver ‘burden’ and well-being. There was evidence to support the 
findings of Gopinath et al. (2015): there was a large significant correlation between 
care-recipient dependency (using the same measure used in the Gopinath et al., 2015 
study) and the total CRA score (see Table 7.8). There was also a significant correlation 
between care-recipient dependency and caregiver well-being (see Table 7.8). Higher 
pwAMD dependency on the caregiver was associated with caregivers reporting a 
greater negative impact of providing support and poorer well-being. 
To the author’s knowledge, this is the first study to use the W-BQ16 in pwAMD and the 
first to use the W-BQ12 or W-BQ16 to measure well-being in caregivers. The low 
number of missing data suggest that respondents felt the items on the measure were 
acceptable. Whilst the W-BQ12 has been evaluated for use in pwAMD (Mitchell & 
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Bradley, 2001), further work is needed to carry out full psychometric evaluation of the 
W-BQ16 in this sample. The shorter version of the W-BQ16 (the W-BQ12) has been 
used more widely. W-BQ12 scores are provided in Table 7.11 for comparison with 
other groups. The sample of pwAMD receiving support for AMD in the present study 
reported lower mean general well-being scores (mean=21.21) than: pwAMD who 
completed the W-BQ12 in the 1999 survey (mean= 22.40) (Mitchell & Bradley, 2001), 
adults with growth hormone deficiency (mean= 22.53) (McMillan, Bradley, Gibney, 
Russell-Jones, & Sönksen, 2006), and women who have experienced pregnancy loss 
(mean=21.68) (Koch, Santos, & Santos, 2012). The poorer well-being of pwAMD in the 
present study than these other groups may demonstrate the impact that AMD or 
receiving care for AMD has on well-being. However, as noted above, there are other 
factors that differ between these studies and may affect well-being (such as 
differences in age or gender) so one should be wary of making direct comparisons 
across studies. Since there are no previous studies with caregivers that have included 
the Well-Being measure, there were no data available for comparison. Caregivers had 
slightly better well-being than pwAMD in this study (mean=23.23).  
STRENGTHS AND LIMITATIONS 
Importantly, this is the first study to investigate the impact of providing support for 
AMD using a dyadic perspective, including both pwAMD and caregiver factors as 
outcomes and controlling for the non-independence between dyads. To the 
knowledge of the researcher, this is the first study in the AMD literature to do this.  
The use of SEM over ordinary regression analysis in this study, had several advantages. 
First it allowed all pathways in the model to be assessed simultaneously. Secondly, for 
dyadic analysis specifically, it controlled for non-independence of the pwAMD and 
caregiver by the correlation of errors between their dependent variables. It also 
allowed for the testing of indirect and direct effects. 
The present study includes both psychological and physical health outcomes for 
caregivers, which is important as focusing on only one outcome may lead to the 
mistaken conclusion that some people are not affected by the caregiving role (Pearlin, 
1989).  It investigates the predictors of these, as well as of caregiver ‘burden’, thus 
adding to the literature which has only examined caregiver ‘burden’ as an outcome 
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(Gohil et al., 2015), or caregiver distress and changes to retirement or lifestyle plans 
(Gopinath et al., 2015). It also used validated measures to assess caregiver reactions to 
providing support (the Caregiver Reaction Assessment) and well-being (the W-BQ 16). 
However one must approach the findings with caution. A number of caveats must be 
noted. First, one must be aware of the increased risk of type I error occurring in the 
results of the bivariate analyses since corrections were not applied following multiple 
testing. (See Chapter 2 for the reasoning behind not applying corrections.) Thus these 
results should only be taken as indicative of associations between variables where they 
exist rather than definitive. 
Second, structural equation modelling is generally a large-sample technique (see 
discussion of sample size in Chapter 6). Only the variables that were pertinent to 
analyses were included, and other variables such as gender that were not included, 
could be tested with larger samples.  
All variables included in the model were treated as continuous variables. However 
both the variables for general health and ‘hours of care received/ provided’ could be 
considered to be ordinal. General health was measured using a 7-point Likert scale, 
whilst ‘hours of care received/ provided’ used was measured using an ordered 4-point 
scale. It has been suggested that treating ordinal variables as if they were normally 
distributed interval-scaled variables is more realistic if they contain at least 5 possible 
values, and are at least ‘nearly normal’ (Blunch, 2008). This would be appropriate for 
the general health variables, but not for the hours of care variables used in the present 
study. Given that preliminary analyses found non-linear trends for the pwAMD and 
caregiver ‘hours of care received/ provided’ variable with several other variables (e.g. 
DLTV total scores), it might be particularly important for this variable to be considered 
as ordinal (or categorical) in future replications of this study.  
Other limitations to this study should be noted. The initial model fitted the data well, 
however there was still a moderate amount of variability in the dependent variables 
that remained unexplained by the model (i.e. caregiver reactions to providing support, 
amount of support provided/ received, pwAMD and caregiver well-being and 
caregivers’ health). There may be other factors not measured in this study that help 
predict these variables. Nevertheless, this study provides the beginnings of a picture 
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for how these variables interact to predict pwAMD and caregiver outcomes. The 
findings of the qualitative study may help to provide a more comprehensive picture.   
The direction of relationships between variables in the SEM were based on the 
directions between variables in a model described in the caregiver literature (Yates et 
al., 1999 stress process model). There are currently no models in the literature that 
describe the dyadic impact of providing support for AMD. Therefore the assumptions 
made about the direction of relationships may not be accurate. For instance, stress 
process models suggest that patient’s health is a ‘stressor’ and is predictive of 
caregiver outcomes such as their health. This direct relationship was not significant in 
the present study, although an indirect relationship via caregiver ‘burden’ (CRA scores) 
was significant. Future models might treat both pwAMD and caregiver health as 
outcomes. Longitudinal work might help to explain the relationship between variables 
such as patient and caregiver health, e.g. to see if they are directly or indirectly related 
or if the relationship between them is reciprocal.  
Previous research on the impact of providing support for someone with AMD has 
focused on the experiences of people who support someone living with wet AMD (e.g. 
Gohil et al., 2015; Gopinath et al., 2015; Varano et al., 2015, 2016; Vukicevic et al., 
2016). The present study has added to this research literature by including the 
experiences of caregivers of people with dry AMD. Around 40% of the pwAMD 
included in this second study reported having dry AMD at the time of the 2013 survey 
(however this may have turned to wet AMD since then and we did not include a 
question on what type of AMD the pwAMD had in this second study). This percentage 
is lower than the number of people with dry AMD in the UK population. It is estimated 
that only 10-15% have wet AMD, with the rest having dry AMD (Bonastre et al., 2002). 
Therefore although this study includes a broader range of caregivers of pwAMD, it is 
likely that the experiences of caregivers of people with wet AMD may be over-
represented.  
Non-responders to the second study had poorer general health at the time of MSQ 
2013 completion than responders. Health status may have changed in the two years 
following the 2013 survey (when participants were asked to complete the second 
study), however the most common reason for non-response stated by non-responders 
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to the second study who returned paperwork was ‘poor health’. Therefore it is 
possible that those in better health are over-represented in this study. However there 
were no significant differences in general health status between those who took part 
in the second study and the 2013 MSQ respondents who were included in the analyses 
examining the impact of care on QoL and well-being presented in Chapter 4. 
Furthermore pwAMD health was included in the multivariate analyses reported in this 
chapter. 
The SEM included a measure of caregivers’ ‘secondary appraisal’ of the impact of 
providing support but not a pwAMD ‘secondary appraisal’ of the impact of receiving 
support. At the time of designing the study, the author could not find a standardised 
measure assessing patients’ perceptions of receiving support. The research literature 
in the vision loss field has focused on the concept of overprotection as a negative 
impact of receiving support however other negative impacts and indeed, positive 
impacts of receiving support have yet to be investigated in detail. Including a measure 
of the ‘secondary appraisal’ of receiving support might be a mediator for the 
relationship between pwAMD’s primary appraisal of the amount of help received and 
their well-being. This may help to explain the non-significant pathway between the 
amount-of-care-received variable and well-being in the present study. It would also be 
interesting to examine how pwAMD and caregiver secondary appraisals of 
receiving/providing support impact on each other’s outcomes and if the effects are 
equal. This would involve testing for actor and partner effects, which can be 
investigated using the Actor-Partner Interdependence Model (APIM) as a framework 
(Cook & Kenny, 2005).  Perceptions of the support received will be investigated in the 
qualitative study that follows. 
One must note that the secondary appraisal measure for caregivers included in this 
study was not AMD-specific although it has been used previously in studies assessing 
caregiver ‘burden’ in caregivers of people with wet AMD (Gohil et al., 2015). The 
internal consistency of the measure, which indicates how well the items on the 
measure fit together conceptually, was measured using Cronbach’s alpha coefficient. 
The present study reported an alpha of 0.92 which is above the minimal 0.90 level 
recommended for instruments already in use (Bland & Altman, 1997; DeVon et al., 
2007). In the present study, the CRA total scores were strongly correlated with other 
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similar measures, as would be expected. For instance, there was a strong, significant 
correlation between CRA scores and caregiver well-being, indicating that a greater 
negative impact of providing care was associated with poorer well-being. This provides 
evidence of concurrent validity of the CRA in this sample of caregivers of pwAMD. 
There were some missing data on the subscales, for instance, the ‘family support’ scale 
had six missing data. This may indicate that this group of caregivers were unable or 
unwilling to answer the items on this subscale. In the present study, caregivers were 
asked on the questionnaire if providing care impacted on any other areas of their lives 
not asked about in the CRA. Additionally they were asked if they found any of the 
questions on the CRA particularly difficult to answer or if they felt the question did not 
apply to them. Unfortunately, a lack of time meant that these responses have yet to be 
analysed but analysis of this data would provide insight into the whether this group of 
caregivers of pwAMD found the items on the CRA applicable to their experiences and 
acceptable (they were willing to answer the questions). 
Summary 
The SEM tested in this chapter provides support for the proposed dyadic model of the 
impact of providing and receiving support for AMD (see Figure 6.1). The model 
suggests there are different predictors of what might be considered the more 
objective measures of support (i.e. the ‘primary appraisals’ of the amount of help 
pwAMD reported receiving and caregivers reported providing), from those predicting 
more subjective appraisals of help provided (caregiver reactions to providing support), 
and pwAMD and caregiver outcomes (well-being and health). The results from the 
2013 survey suggested that receiving care for AMD was associated with poorer well-
being, whilst controlling for registration status and change in vision status since 
diagnosis as indicators of level of VI. The present study measured the impact of VI by 
examining the impact that AMD had on vision-dependent tasks. When this measure 
was used, receiving more care for AMD was not associated with poorer pwAMD well-
being.  The qualitative study that follows will examine pwAMD/ caregiver dyad 
experiences in more detail to add to the quantitative study findings.  
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Chapter 8:  
The impact of providing and receiving support for AMD: Results and Discussion of 
the qualitative study. 
Results 
Eight pwAMD/ caregiver pairs were interviewed. Four were spouse pairs (including two 
husband with AMD/ wife caregivers pairs, and two wife with AMD/ husband caregiver 
pairs). The four remaining pairs were adult-offspring/ parent pairs. Three caregivers 
were the daughter of the pwAMD, one was the son. All adult-offspring caregivers were 
supporting their mother with AMD. 
Three key themes were identified: (a) Managing independence, (b) Accepting the ‘new 
normal’, and (c) External support. Whilst these three themes were identified in the 
transcripts of spouse pairs and adult-offspring/parent pairs, there were important 
differences in their descriptions of their experiences, and therefore they will be 
presented separately. Tied to this was the view that spouse pairs were experiencing 
the impact of providing and receiving support for AMD in ‘partnership’ with one 
another, whilst adult-offspring/parent pairs described ‘looking after mother.’ This cut 
across all aspects of their experiences and is reported as the overarching theme: 
“Managing the changes: living with AMD in partnership vs looking after mother”, 
which will be discussed after presenting the themes.  
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ANALYSIS OF THE THEMES IDENTIFIED AMONGST SPOUSE CAREGIVER/ PERSON 
WITH AMD PAIRS3 
Theme 1: Managing independence 
Vision loss caused by AMD led to changes in, or loss of, previously-enjoyed activities. 
The emotional consequences of this was noted in the pairs. Caregivers were aware of 
the distress, frustration and sadness this caused, and empathised with their partner.  
He does get frustrated and it has been times when he’s at the beginning he was 
very depressed, obviously. Because you know a major part of his activities in his 
life have been robbed from him and that lasted quite a while. (Participant 121a, 
wife of husband with AMD) QUOTE 1 
Some pairs felt this resulted in the pwAMD losing confidence in their ability to carry 
out activities. Pair 121 and 121a illustrate how low confidence/ self-efficacy resulted in 
the pwAMD feeling dependent on their caregiver, and this caregiver reported feeling 
more restricted.  
I still get by because I’ve got my dear wife doing anything that I wish I could be 
able to do. (Participant 121, husband with AMD) QUOTE 2 
…he doesn’t like me to go out on my own because he thinks that if anything 
happens to me, he’ll be absolutely lost and I’m restricted in as much as I can’t 
do as much as I would like to do independently anymore. (Participant 121a, wife 
of husband with AMD) QUOTE 3 
 
The majority of pairs described pwAMDs’ determination to continue with activities as 
normal. PwAMD described their spouses encouraging them to continue with activities 
independently and caregivers noted being aware of not overly restricting the pwAMD 
(i.e. giving them the choice of whether they would like help instead of stepping in to 
help straight away).  
                                                          
3 ‘…’ indicates quotation beginning mid-sentence or speech omitted. 
Material within square brackets has been added by the author for clarification. 
Underlined text indicate an emphasis in speech.  
Material within rounded brackets indicates where the audio recording wasn’t clear and so a 
best guess was made as to what was said.  
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I mean he’s not an invalid by any means and he doesn’t um, doesn’t like me 
barging in and saying ‘oh let me do that’ (laughs). Um (pause) yeah, he gets 
very cross about things like that…He likes to plod on and um, do it himself if he 
can. (Participant 28a, wife of husband with AMD) QUOTE 4 
 
This required a balancing act for pair 121 and 121a, as the caregiver reported wanting 
to encourage her husband to continue to try things independently but also being 
aware that pushing too much might affect his confidence.  
Yeah I have asked him to do things and once he says I can’t do it, I don’t ask him 
anymore…Then I think well there’s no point in making him er frustrated and feel 
inadequate so I won’t ask him to do that anymore. (Participant 121a, wife of 
husband with AMD) QUOTE 5 
 
Pairs recognised the importance of maintaining confidence in the pwAMDs’ abilities to 
prevent over-reliance on the caregiver and to maintain individual independence. Only 
caregivers reported concern over their potential to provide too much help to the 
pwAMD; no pwAMD reported receiving too much help.  
Pairs engaged in a variety of strategies to help the pwAMD continue with activities.  
This included acquiring low-vision aids (LVAs) and doing activities together. 
Environmental barriers (e.g. unreadable bus numbers, poor lighting), problems with 
reading material (e.g. very small writing), problems with LVAs (e.g. lack of interest in 
talking book topics), day-to-day differences in vision, as well as negative past 
experiences (e.g. getting lost when out and about) were barriers to doing activities 
independently. Furthermore, having left a long time between a previous perceived 
unsuccessful attempt and further attempts at carrying out an activity, was also cited as 
a barrier. Caregivers provided support and encouragement to push past these barriers, 
for example: 
… he [husband] would encourage me to go in to town by myself if I wanted to 
because many time[s] he said there’s no reason why you can’t try anyway and 
he’d help me to get on the bus... But he thinks that it would be a good thing for 
me and I think it would be a good thing for him as well that I go a bit further 
away than the area where we live. (Participant 128, wife with AMD) QUOTE 6 
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Safety concerns were raised. All pwAMD who drove reported giving up driving due to 
concerns over their own and other peoples’ safety. This restricted their ability to get 
out and about which had a knock-on effect on their freedom and independence. They 
noted a reliance on others for lifts. Getting out and about independently was limited to 
local areas where pairs were familiar with the roads and knew where to cross safely.  
I like to be independent if I can be... You know, for instance crossing roads and 
things like that, as I say, I go out alone but only in my local area. I wouldn’t go 
anywhere strange. If I’m in my local area I know where the traffic is coming 
from and where best to cross the road and so on. (Participant 81, wife with 
AMD) QUOTE 7 
Doing activities together had a dual purpose. First caregivers could take over the more 
risky activities whilst still completing the activity together. Secondly it meant that any 
non-serious mistakes or mishaps could be averted (e.g. putting in wrong ingredients 
whilst cooking). When pwAMD were aware of mistakes they had made by accident, 
pairs who described using humour found this was a helpful coping strategy.  
…when she gets things wrong, either she sees something wrong or something 
like that we have a really good laugh about it. You’ve got to be able to laugh 
and that really does help. (Participant 81a, husband of wife with AMD) QUOTE 
8 
Otherwise, caregivers reported not drawing attention to mistakes with the presumed 
purpose that the pwAMDs’ confidence would be protected.  
I don’t really want to interfere with her pulling things up and doing the wrong 
thing. Cos it doesn’t matter a great deal in the garden does it…whether she 
makes a mess of things or not. (Participant 128a, husband of wife with AMD) 
QUOTE 9 
 
Theme 2: Accepting the ‘new normal’ 
It was notable that spouse pairs spoke about the help received and provided being an 
accepted part of their marriage together. Pairs spoke of the reciprocal nature of 
providing support throughout their marriage and in particular, how the pwAMD had 
provided support to the caregiver when needed. Thus providing support for AMD was 
also seen as a way of providing support within their partnership. For instance, 
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participant 121a talked about how her husband had provided her with support whilst 
she was going through treatment for cancer: 
He used to take me to the hospital and cos I, when I after I’d had the 
radiotherapy I couldn’t, I couldn’t move my arms very much and very tired when 
I came back. Yes he supported me then and um I’ve gotta support him now. 
That’s what a partnership’s all about isn’t it? (Participant 121a, wife of husband 
with AMD) QUOTE 10 
Pairs reported providing support to the pwAMD for other illnesses and medical 
conditions in addition to AMD. These were sometimes reported to have a greater 
impact on the pwAMD’s quality of life than the AMD, and caregivers reported greater 
difficulty providing support for these conditions. 
So I think deafness is her biggest problem, more than sight because any sight 
problems she has I can deal with, I can do whatever it is for her, you know. But I 
can’t hear for her. (Participant 81a, husband of wife with AMD) QUOTE 11 
Co-morbidities were therefore sometimes used as a frame of reference that affected 
pairs’ perceptions of the help received or provided for AMD. 
Many pairs reported viewing the diagnosis of AMD as part of the process of ageing and 
them ‘both growing old’ together and thus may be a somewhat expected change in 
their lives.  
I feel fine. As I say, it’s just one of the things that happens…neither of us are as 
fit as we would like to be, as we used to be, by any means but we are both, I’m 
nearly 80 and [husband] is [a similar age] um, and you do slow down. And er, if 
you have a good marriage, a happy marriage, you just, you just carry on and er 
make the best of it. (Participant 28a, wife of husband with AMD).  QUOTE 12 
 
But I suppose we looked at it both in the same way really, we thought it’s part 
of getting old you know (laughs). (Participant 81a, husband of wife with AMD) 
QUOTE 13 
 
Living together in partnership meant that AMD affected both the pwAMD’s and their 
caregiver’s activities. This affected activities for leisure as well as household tasks.  
…life has been reduced by half in our, you know our activities. (Participant 121a, 
wife of husband with AMD) QUOTE 14 
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Whilst limitations were noted, they were mainly viewed as part of living with AMD in 
partnership and were generally accepted. There was some evidence that pairs used 
positive reinterpretation of the limitations on activities caused by sight loss. 
I think even if she hadn’t had AMD we’d probably be doing pretty much the 
same things as we do now anyway. We like walking… we can still manage a bit 
of that. So we go to the places we like. Yeah I, not a huge impact on our way of 
life probably… (Participant 81a, husband of wife with AMD) QUOTE 15 
 
Changes in activities that required the greatest adjustment tended to be those 
resulting from changes in established roles within the partnership. These were 
sometimes specific to traditional gender roles within a household. For instance, wives 
became the main driver in the household since male pwAMD had stopped driving. 
Whilst male pwAMD reported having enjoyed driving and thus experienced a great loss 
since having to stop, their wives who were less familiar with driving reported more 
anxiety and perhaps a lack of confidence in this task.  
I wouldn’t say I’m a confident driver because I’ve always had my husband to do 
the driving er but I’ve had to steel myself for long journeys um on the motorway 
and it’s not something I enjoy (Participant 121a, wife of husband with AMD) 
QUOTE 16 
 
Men reported doing household tasks they ‘don’t normally do’ including cooking and 
sewing. They reported some trepidation about doing these activities, however wives 
reported they completed the tasks adequately. Doing these tasks in partnership, with 
the caregiver following the pwAMDs’ instructions, was commonplace, as illustrated by 
pair 128a and 128:  
…day to day I find myself doing things that I don’t normally do…cooking for 
example, and er um er household repairs and er sewing (laughs) would you 
believe? (both laugh). Which I’m no good at but I have to assist – not a question 
of doing it, I just have to follow instructions. (Participant 128a, husband of wife 
with AMD) QUOTE 17 
…the sewing is very good, he’s very good at threading needles (laughs) and he’s 
got, he learned how to sew buttons and things like that. (Participant 128, wife 
with AMD) QUOTE 18 
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These changes in roles and responsibilities generally led to only minor changes in roles 
for female caregivers (apart from becoming the main driver);   
 I provide all the domestic support but that’s not particularly because of the 
macular, I would be doing it anyway, most of it anyway. Um (pause). No, just, 
just help him when he can’t see very well and um, and I say driving because he’s 
not allowed to do that. (Participant 28a, wife of husband with AMD) QUOTE 19 
However male caregivers now took on more of the household responsibilities. Both 
the wives with AMD and their husbands reported these tasks were considered part of 
providing support for AMD. For instance participant 81a described how he considered 
cooking and cleaning as part of the support he provides to his wife: 
Well it [the amount of time I spend helping my wife with AMD per week] varies 
a lot but it’s pretty simple really. I mean, every day we have a routine like 
everybody I guess. I get up and make breakfast and all that sort of thing. Um 
and then we, we always go out every day, regardless. We never stay in all day 
and er but then of course there’s things like sometimes we eat out at lunchtime 
but we always have a dinner in the evening – well I do that. Then at the 
weekends I do the traditional Sunday roast, you know and all that kind of thing. 
And so, on the cooking side that’s pretty straightforward, um and on the 
household side I have a routine again of doing all of the housework on Sunday 
morning while [my wife’s] at church. So she hasn’t got to sit there and watch 
me. (Participant 81a, husband of wife with AMD) QUOTE 20 
 
Male caregivers generally reported accepting these changes in roles and 
responsibilities. Whilst these changes were ‘not expected’, they also reported reasons 
why these new responsibilities were benefitting them, including keeping them 
‘healthy’ by ‘having something to do’, giving them exercise, easing them into 
retirement and preventing them from focusing on their own ‘worries’ by forcing them 
to think of others. There was evidence they used benefit finding and positive reframing 
as coping strategies.  
… I never thought that at the end of the, when I got older that I would suddenly 
end up doing this…I have no complaints and absolutely she’d do twice as much 
for me so it’s never been an issue at all. You do what you have to do. And I don’t 
mind it, and I - actually the way to not mind it is to enjoy it, which I do. 
(Participant 81a, husband of wife with AMD) QUOTE 21 
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Theme 3: External support 
The majority of the time, pairs reported managing the impact of AMD together in 
partnership. However there were occasions when outside help was required. This 
happened when pairs didn’t have the skills, knowledge, tools or physical ability to do 
particular tasks themselves. It included, for instance, help with home maintenance and 
repairs as well as everyday tasks around the home. However there were barriers to 
receiving help. Getting help from outside the pair involved putting their trust in 
strangers. Pairs reported that this was a barrier to seeking help, for instance, with 
getting a cleaner to help with household tasks.  
…people are urging her [my wife] to get in a cleaner but I’m not keen on getting in 
a cleaner to do things…I don’t like people coming into my house and knowing, 
looking everywhere and examining everything and (pause) which a cleaner should 
do. I’m not keen on that. (Participant 128a, husband of wife with MD) QUOTE 22 
 
Others had sought practical help but had unsatisfactory experiences which resulted in 
a distrust of services. Pair 121 reported feeling that the practical help they sought had 
‘taken advantage of’ the pwAMD’s sight loss and consequently did a ‘very sloppy’ job, 
which led to the pwAMD feeling helpless and frustrated.  
…out of everything I think that if we had more practical help we’d be a lot 
happier. He [husband] would certainly too because he feels that he can’t do it, 
somebody else comes and does it, doesn’t do the job properly and that’s when it 
gets to him and he says if only I had my sight, you know, I’d be able to do this. 
(Participant 121a, wife of husband with AMD) QUOTE 23 
 
Pairs also reported unsatisfactory experiences with eye care professionals. Reasons for 
unsatisfactory experiences included being given the diagnosis of AMD in an uncaring 
manner and not being given enough information and support.  
… that was how I found out and this guy was, this medic that I saw was 
pathetic. His diagnosis was right but the thought that he had of how I might 
feel, looking after me and the caring… was zero. (Participant 28, husband with 
AMD) QUOTE 24 
 
Similarly, participant 121a reported being disappointed with the lack of attention paid 
to the patient perspective when they were given the news that treatment for AMD 
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was no longer effective.  The consultant who had been seeing them through the 
treatment did not deliver the news themselves. The pair perceived this as them being 
‘brushed aside’ by the consultant ‘because she couldn’t do any more for us’. This lack of 
continuity with seeing the same consultant was seen as being ‘heartless’ and led to the 
pair feeling ‘disappointed’ and ‘unhappy’ with the healthcare system.  
…we were the last to be seen and on that last appointment the consultant who 
had been seeing us all the way through gave the job to somebody else who we 
had never seen to tell us there was nothing else that could be done….I thought 
that was very heartless. Very heartless. You know at least, to be told by someone 
that was familiar with you, that had seen you through your treatment, and then 
that you knew, would have been much better…. I felt we’d just been brushed 
aside because she couldn’t do any more for us…  (Participant 121a, wife of 
husband with AMD).  QUOTE 25 
Caregivers sometimes reported acting as advocates for the pwAMD when they had 
negative experiences. For instance, following the above experience, participant 121a 
wrote to the consultant to say ‘how disappointed and upset we were that she hadn’t 
spared us the time’. Similarly, participant 121a reported taking on an advocacy role 
when dealing with people who had completed poor practical work in their home: 
I do get a bit feisty when I have to support him and that’s the only way round it I 
have to make sure that you know he’s not taken advantage of. (Participant 
121a, wife of husband with AMD). QUOTE 26 
 
Difficulties arose when pwAMD made attempts to seek outside help which were 
hindered by other peoples’ perception that help was not needed. For instance, 
participant 28 reported trying to access LVAs from a charity, only to be told that his 
sight loss was ‘not quite bad enough’ to access help. However others reported 
receiving more satisfactory help from charities in the form of LVAs, counselling by 
telephone, and up-to-date information on research into treatments for AMD. 
Pairs mentioned receiving only occasional help from their adult-offspring. There were 
several reasons for this. Pairs perceived themselves to still be in the role of caregiver to 
their adult-offspring (they saw themselves in the traditional roles of parents and 
children, or felt they could not break the traditional roles since their adult-offspring 
was perceived to be in poorer health). Furthermore some pairs perceived their adult-
offspring had too many other responsibilities to be able to provide support. Lastly, 
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pairs felt that their adult-offspring were unaware of the consequences of sight loss and 
thus perhaps did not perceive they needed help, as illustrated below by participant 
121a: 
…I think they [my children] don’t realise that er how difficult life is sometimes 
for us and we don’t tell them but they certainly don’t realise it. How can they? I 
mean they’ve never been in that same position it’s difficult for them to, to 
know. (Participant 121a, wife of husband with AMD) QUOTE 27 
 
No pwAMD reported receiving too much help from adult-offspring. However, caregiver 
81a noted how offers of help from outside the pair were received gratefully, but could 
sometimes be considered over-helping. It could be inferred that this happened 
because people outside the pair do not see the day-to-day limitations posed by AMD 
which provides a guide to knowing how much help to provide.  
P: Well my daughter’s very sympathetic…They don’t fully understand the impact I 
don’t think but then they’re not living with it every day. Not because they don’t, 
they’re not unsympathetic, it’s because they don’t realise in certain instances just 
what the limitations are. 
R: Mm. So can you give me maybe an example of what kind of things that they 
think wouldn’t be affected? 
P: Well it’s a bit I think over the top sometimes you know, I somet’, we visit one 
daughter and she makes her husband sort of take hold of [wife’s name] arm, 
march her down the steps, and across the paths and holds the car door open, as if 
she can’t find her own way back to the car, you know. She finds that a little bit 
irritating which I would as well. But you can’t say anything because it’s meant 
well of course.  
 (Participant 81a, husband of wife with AMD) QUOTE 28 
 
On the whole, pairs reported being satisfied with the amount of help provided by their 
adult-offspring. However there were occasions when pairs reported struggling on their 
own (e.g. if the caregiver was taken ill and someone was needed to provide additional 
support to the pair). Others reported researching professional services for emergency 
cover in case they fell ill in the future. None reported having talked to their children 
about this, reinforcing the idea that pairs either preferred or felt the need to keep the 
provision of care within the boundaries of their partnership as much as possible.  
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… I can’t think that I would want any help from anybody. An emergency is always 
a bit of a worry, you know if I broke a leg and had to go to hospital, then that 
emergency situation like that is a worry. But there are, there are institutions 
which do help in that case. Which I have contacted, yeah. (Participant 128a, 
husband of wife with AMD) QUOTE 29 
 
Meeting other people who had experienced sight loss acted as a source of inspiration 
for pwAMD. This challenged their own preconceptions about the skills and abilities of 
people living with sight loss.  
… it’s amazed me what some blind people do. (Participant 28, husband with 
AMD) QUOTE 30 
 
PwAMD reported benefitting from attending local groups by sharing their experiences 
and this led to them feeling they were ‘not alone, you know, suffering from this 
horrible thing’.  
I like to chat and um, so I go to that group... you meet other people and you 
know that everybody there is suffer from macular so it’s something that I’ve 
been going for oh a number of years as well. I like to go to these meetings 
because you feel that you’re not alone, you know, suffering from this horrible 
thing. (Participant 128, wife with AMD) QUOTE 31 
 
Thus whilst pairs reported mostly coping together with AMD in partnership, some 
pwAMD noted the benefits of meeting people outside the pair, who had experienced 
sight loss.  
Meeting other people with sight loss who were widowed led pairs to report being ‘very 
lucky’ to have each other as a source of support and solace in living with AMD. 
I mean I’m just fortunate that I’ve still got my husband because lots of women 
of my age are widows and it must be a great deal more difficult for them. And I 
think because I’ve got him, my life hasn’t changed so much, it has changed of 
course but you know, it could have been, it could be much worse. (Participant 
81, wife with AMD) QUOTE 32 
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ANALYSIS OF THE THEMES IDENTIFIED AMONGST ADULT- OFFSPRING 
CAREGIVER/PARENT WITH AMD PAIRS 
Theme 1: Managing independence 
Similar to the experiences of spouse pairs, individuals with AMD in adult-offspring/ 
parent pairs reported the negative impact that AMD had on hobbies, their ability to 
carry out everyday activities, and the resulting frustration and sadness they felt as they 
dealt with this loss. Their adult-offspring caregivers were empathetic to these losses.  
… thinking of all the disabilities, you know like accidents and losing an arm or a 
leg, I think I could cope with any of that but I could not cope with being blind, 
really couldn’t, cos I’ve seen what it does, you know. It is really difficult... Oh 
yeah, when you see the effect it has on their quality of life and how they have to 
make their lifestyle so different. (Participant 37a, daughter of mother with 
AMD) QUOTE 33 
Some caregivers reported building up a frame of reference of how much they believed 
their mother could and could not see.  
I mean, when she tells me what she can and can’t see I’m quite amazed really. 
Sometimes, because she’ll say ‘oh what’s that’ beside her and I think how on 
earth have you seen that (laughs). But it’s just the light catching something or 
suddenly she’ll see it whereas actually her field of vision is very, very limited… 
(Participant 19a, daughter of mother with AMD) QUOTE 34 
Caregivers were trying to make sense of the extent of their mother’s sight loss. They 
used this to build their understanding of how much help their mother required. 
Sometimes there were conflicts in this frame of reference, as illustrated in the quote 
above, and this resulted in some confusion over the extent of their mother’s 
limitations.  This led to difficulties when caregivers felt their mother asked for more 
help than needed. One daughter described how her mother asked for help but was still 
able to do things independently, which led to confusion and feeling that her mother 
might sometimes exaggerate her limitations in order to receive her help. 
Yeah, well this is the strange thing, you know. When she needs to go to the 
doctors she walks down to the village on her own, on a Monday to the club she 
walks on her own, on a Friday afternoon she walks on her own and I often think, 
well if she can do that on her own (laughs) why is she always saying to me ‘oh 
can you just do this?’ you know. I mean I know she knows the area and she 
knows the path but it just seems sometimes I wonder if she exaggerates a bit, 
you know? (Participant 37a, daughter of mother with AMD) QUOTE 35 
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Generally, pwAMD reported wanting to remain as independent as possible, and tried 
things alone before seeking assistance. Some caregivers reported that this meant they 
felt their mothers were reluctant to ask for help and thus reported having to pick up 
on what their mother may need help with rather than being asked directly. A barrier to 
this was if pairs did not live together and thus caregivers could not see the day-to-day 
impact of sight loss. 
Caregivers sometimes reported helping in secret. For example, one daughter reported 
she believed that sight loss caused by AMD was the reason for her mother’s kitchen 
becoming dirtier over time. She described cleaning her mother’s kitchen when her 
mother had gone upstairs. This was possibly to avoid seeming critical, reducing the 
impact on her mother’s self-efficacy and to enable her mother to continue living 
independently. 
… Just pick up odd things so that I think oh I think she probably needs more help 
with that now. I mean I must admit you see um you know I notice like the 
kitchen isn’t as clean as it used to be, things like that so she wouldn’t see all 
that... And I would have thought oh I’m sure if she realises they were grubby 
she’d be very upset about it… I don’t mention it to her but if she’s upstairs doing 
something then I’ll get a cloth out …But again you see it’s hard because she, she 
is so independent. (Participant 1a, daughter of mother with AMD) QUOTE 36 
 
Caregivers reported finding ways to enable their mother to continue with hobbies or 
activities. This often involved doing the activity together, with the caregiver doing the 
part of the activity that was more risky to the person with sight loss or carrying out the 
initial part of the task that required sight.  
… I’ve got her some really thick, chunky knitting needles. And then I cast on 
some stitches, like 20 or 30 stitches, and then she’ll sit there and knit until the 
big ball, the big ball of wool’s gone and I make them into blankets for cats. So 
she thinks she’s making things that are needed and then, cos you know what I 
mean, you know, she doesn’t know when she drops a stitch or anything so 
there’s the odd hole here and there, so I mean they couldn’t be given away to 
anybody but I say to her ‘right, there’s another pussy blanket’ you know. 
(laughs) So she’s quite pleased that she’s still doing that. (Participant 37a, 
daughter of mother with AMD) QUOTE 37 
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Caregivers also provided aids to help their mother live independently as much as 
possible. Some pwAMD only reported using these when perceived as necessary. There 
was some indication that caregivers provided aids before they were required by their 
mother.  This was not perceived negatively by the pwAMD.  
She uses a stick outside but she doesn’t use a stick in the house and we bought 
her a sort of pushing pusher trolley thing, she won’t have anything to do with 
that. (Participant 19a, daughter of mother with AMD) QUOTE 38 
 
Pairs reported coping with non-serious mistakes and mishaps related to the AMD with 
humour. Some pwAMD reported ‘not letting on’ about mistakes they had made. 
Reasons for hiding mistakes were to avoid embarrassment and not wanting to burden 
the caregiver. Trips and falls were a constant worry. One pair struggled to come to an 
agreement on the best way to manage this. There were indications that the pwAMD 
had difficulty accepting changes in their life that might help to prevent falls, whilst the 
caregiver reported feeling frustrated that changes could not be made.  
But see the trouble is, where she can’t see, she’s walking, always walking into 
things and hurting herself so we’re always running to and fro the minors unit to 
get dressings done or stitches done or bruises and bangs on her head 
done…(Participant 37a, daughter of mother with AMD) 
Well, I keep saying to her, you know-also to cut down on weeding and 
gardening- what I said to her is why don’t I put all the pots in to the flowerbed 
so then all the area of the garden is clear… I try and make alterations, you know 
for safety and then the answer always is ‘oh no, daddy did that’ or ‘daddy put 
that there’ or ‘daddy built that’ so she won’t let me make any alterations. It’s so 
frustrating you know. (Participant 37a, daughter of mother with AMD) QUOTE 
39 
 
Theme 2: Accepting the ‘new normal’ 
Within the theme ‘accepting the ‘new normal’’, spouse pairs described providing care 
to one another as part of their marriage and living in partnership together. For adult-
offspring/ parent pairs, caregiving for AMD typically began when the pwAMD’s 
 338 
 
husband had died. A central theme present in caregivers’ accounts was adjusting to 
the perceived responsibility they had for the pwAMD or ‘looking after their mother’. 
For some, this was unexpected and overwhelming.  
…my Dad died [over ten] years ago and so everything basically came to- down 
on me after that (laughs). And I mean everything. (Participant 37a, daughter of 
mother with AMD) QUOTE 40 
Feeling that they were responsible for their mother was woven into various aspects of 
their lives. For instance, one daughter felt a responsibility for keeping her mother 
company, and reported feeling pressured to take her mother out and about with her 
whenever she went out. This restricted her freedom.  
But I have thought that ever since my father died because I mean that was over 
10 years ago, because he would take her everywhere…but I have noticed that 
she’s more my responsibility now for her happiness of going out etc. (Participant 
1a, daughter of mother with AMD) QUOTE 41 
…cos I know when she’s away, it’s an absolute relief. All that is gone from my 
mind, I think oh if I want to go to [town] I can because she’s not around, so I 
don’t have to lie to her (Participant 1a, daughter of mother with AMD) QUOTE 
42 
 
PwAMD reported requiring assistance for travelling to unfamiliar places and places 
further afield. The reasons for this included them not being able to drive to places 
beyond walking distance, needing guidance in unfamiliar environments, and requiring 
help for activities that involved reading including entering PIN numbers and reading 
labels. The majority of pwAMD reported a reduced social circle due to family and 
friends of similar age or older having died. Participant 37a reported how her mother 
was no longer able to go out on group trips because her sight loss meant that an 
increased risk of falls made her ‘too much of a liability’ for insurance purposes. These 
factors meant that pwAMD mainly relied on their adult-offspring to get out and about.  
There appeared to be some gender differences in caregivers’ perceptions of providing 
care. The one son who took part in this study, had a stoic approach to the reasons why 
he provided care as well as the provision of care which could indicate acceptance of his 
role.   
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…it’s what sons are for really (Participant 120a, son of mother with AMD). QUOTE 
43 
 
Female caregivers were more likely to report more numerous impacts of providing 
support and difficulties fitting caregiving into their lives.   
There were differences between pwAMDs’ and caregivers’ perception of the adult-
offspring’s reaction to taking on the caregiver role. PwAMD were matter of fact about 
the situation. For instance participant 1 reported her daughter had ‘taken it in her 
stride’. There were some indications that pwAMD had not thought about the 
implications providing care had on their adult-offspring, or perhaps, that they 
preferred not to think about this.  
I suppose you could say in one way I’m a bit of a tie in that respect aren’t I? … I 
try not to be, but um you know she, she does um - I don’t go to the doc very 
often I’m glad to say or the hospital but I would be dependent entirely on her if I 
did. (Participant 19, mother with AMD) QUOTE 44 
Some pwAMD discussed ways in which they provided help to their adult-offspring 
(either now or in the past), perhaps as a way to emphasise the reciprocal nature of 
providing support in their relationship.  
… my daughter’s husband had a stroke [number] years ago…I feel that I am able 
to be a bit of company for her you know at times. I always know when there’s 
trouble, she opens my door and comes down. So I’m hoping and I don’t honestly 
think I’ve made her life worse. (Participant 19, mother with AMD) QUOTE 45 
I try to help them. Sometimes they forget things – mind you I do as well, my god 
I do, but I try to diplomatically (laughing) suggest something or other you know. 
I, the main thing is not to interfere but if you remember something and they’ve 
forgotten it, you know you think well it’s stupid, why the hell don’t you say 
something but on the other hand you think you’re interfering you know! 
(Participant 19, mother with AMD) QUOTE 46 
Caregivers and pwAMD referred to this as ‘looking after’ each other, however it was 
accepted that this was now weighted more heavily in terms of the adult-offspring 
providing help to their mother.  
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Two of the four pairs interviewed lived together. For participant 19 who lived with her 
daughter and son-in-law, it was important to her to emphasise that she ‘was invited, I 
didn’t ask to come’. This suggests a concern about being a burden on her daughter and 
son-in-law. She emphasised how well the situation had worked and her aim to remain 
independent: 
They’ve been extremely good and it’s worked very well. I made sure I wouldn’t 
be ‘and my mother came too’ you know I’m up here, I’ve got my talking books 
which are my saviour. Absolutely. I listen to those and I’m quite happy. 
(Participant 19, mother with AMD). QUOTE 47 
 
Indeed her daughter (participant 19a) echoed the positive relationship she had with 
her mother:  ‘I wouldn’t want anyone else to look after her’. She acknowledged that 
having separate spaces in the house for each of them was ‘the secret of it working’ and 
contributed to this positive evaluation of them living together. Of the pairs who didn’t 
live together, the caregivers reported having thought about this potentiality and had 
discussed it with their partner or siblings. Whilst this was considered the next step if 
sight deteriorated further, there were barriers to this, for example, if they reported 
relationship strains with their mother.  
It appeared that many pairs did not discuss the impact providing care had on the 
caregiver, thus mothers were unaware of them. Occasionally, when such matters were 
discussed, solutions (if possible) were found.  
… she goes to [place] every Sunday and most Sundays I’ve picked her up. But 
then some Sundays I’ve been working so it’s quite a rush for me… I have really 
resented that but I have found out now, that these people that come and collect 
her will bring her home if I’m working, so that’s such, that’s a huge relief …so 
that’s been a great help but she didn’t say that until recently… (Participant 1a, 
daughter of mother with AMD) QUOTE 48 
 
However in some cases, even when matters were discussed caregivers still reported 
feeling concerned, showing that the issue was unresolved despite communication. One 
caregiver suggested she used positive reinterpretation to cope:  
Sometimes I just wish I could do things a bit more quietly in the morning rather 
than race around trying to do everything to get there at whatever time it is. And 
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she [mother] just says to me ‘tell what time you’re coming, it doesn’t matter’ 
but sometimes in the morning you can’t always, you know, things happen in the 
morning... and that starts my day off, sometimes, a bit fraught. I try and, I know 
she needs to know that and it gives me a deadline to work to I suppose. 
(Participant 19a, daughter of mother with AMD) QUOTE 49 
 
Caregivers reported several ways in which providing care impacted on their lives, 
including their health, their finances, social life, relationships with other family 
members, plans for the future and employment. These were discussed in terms of 
managing their wants and needs with the responsibility they had for their mother. 
Some caregivers reported difficulty accepting these changes in their lives.  
Two caregivers who were still working described difficulty getting time off work to take 
their mother to medical appointments for AMD. There were differences in caregivers’ 
appraisals of the difficulties in getting ‘time off’. The son who took part in this study 
reported being ‘a little bit miffed’ towards his employer as he perceived that caregiving 
should come first.  
My mother’s welfare, whether it’s to do with eyes, or to do with her medical 
condition at the moment, is more important, than any erm objectives or ticking 
boxes (Participant 120a, son of mother with AMD). QUOTE 50 
 
A female caregiver described guilt and difficulty managing these competing priorities. 
She reported not wanting to ‘take advantage’ of her employer by taking time ‘off’ for 
appointments.  
But I mean because I work part time it, it is easier – I found when I was working 
full time the pressure was great because I’d have to um request the days off 
that she went down to [hospital], you know monthly, um and sometimes I’d 
think well I might not be able to get this day off and she’d say ‘well you’ll just 
have to tell them, you’ll just have to tell them’. I said look it’s not a quite like 
that mum, so, so that did worry me and also because I had to use up some of 
my annual leave because I didn’t work so many weekends meant I didn’t have 
the days off in the week. So then I was using up my annual leave and I was 
feeling resentful of that. (Participant 1a, daughter of mother with AMD) QUOTE 
51 
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…I don’t like to take advantage, I’m all you know even when I was working full 
time in the [company] I felt I sort of gave them my first um priority as it were. 
(Participant 1a, daughter of mother with AMD) QUOTE 52 
 
These differences in reactions to taking time ‘off’ work to accompany their mother to 
medical appointments between the son and the daughter caregivers, may indicate 
gender differences in caregivers’ perception of this situation. Participant 37a felt that 
providing care prevented her from entering employment and that this had affected her 
finances and social life. 
As discussed above, pwAMD viewed their caregiver’s reaction to providing care as 
something the caregiver got on with. Whilst they recognised that the help received 
from their adult-offspring was needed and therefore accepted, they also wished to 
remain as independent as possible.  
Theme 3: External support 
As discussed above, adult-offspring caregivers’ feelings of responsibility for their 
mother brought significant changes to their lives, occasionally resulting in stress and 
resentment of the situation. They sometimes found it difficult to discuss the impact 
with their mother, and thus their mother was unaware of the impact. It was generally 
the caregivers who sought outside help when needed (as opposed to pwAMD). When 
outside help was required, pairs reported difficulty putting their trust in others. 
External support was required for cover when the caregiver needed to be away from 
home (e.g. to go on holiday or to visit an ill relative), and for ‘at home’ medical help for 
other medical conditions. This distrust of others was also reflected in caregivers’ 
concerns about the future living circumstances of the pwAMD- many reported a 
distrust of care homes. These concerns highlighted the feeling of responsibility 
caregivers had over their mother’s welfare.  
…I think when you get very old to be uprooted and put in to some kind of 
institutionalised situation is very, very difficult. And I don’t know, I would hate 
it, it may happen to me one day, I suppose. But I think you’re relying on people 
that you don’t know, I would be quite worried about it. You can’t, you do trust 
when you’re older, you’re quite vulnerable to people. (Participant 19a, daughter 
of mother with AMD) QUOTE 53 
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When non-relatives (who were perceived as not having an obligation to provide help) 
offered help, some caregivers reported difficulty accepting help and handing over 
responsibility for their mother to others. Participant 1a reported she didn’t want to 
‘abuse’ the help provided as she didn’t want them to get ‘fed up’ of providing help to 
her mother. 
Some caregivers reported difficulty getting help from others. Male relatives (spouses, 
brothers) of the daughter caregivers were reported to provide occasional support. For 
participant 37a, she attributed this to a ‘typical sort of son attitude’ where ‘as long as 
he knew I was around he did basically nothing’. In contrast, others reported being 
more satisfied with the small amount of help provided by spouses or brothers, as they 
perceived this was the most care they could provide (e.g. some had their own health 
problems, others lived further away).  
R: Does he [brother] come up and help with the day-to-day things at all or? 
P: No cos he’s such a, such a distance away. 
R: Right yeah. I mean how do you feel, would you prefer that he did a bit more 
or? 
P: No, no I’m quite happy with the way things are because I do know that if we 
hit like a crisis or something then he would do his utmost to come up and help. 
(Participant 1a, daughter of mother with AMD) QUOTE 54 
 
There were difficulties receiving help from health and social services. Some pairs 
described anger and resentment at having to pay for services needed for the 
treatment and care of the pwAMD, with the underlying message that this help must 
not be perceived by the ‘outside’ to be needed if it had to be paid for. Participant 120 
reported of charities, ‘I don’t bother them anymore than I can possibly help…’- 
highlighting the different expectations pairs had of services from the charity and the 
health and social care sector. 
Pairs described a lack of continuity from services for AMD and this led to them feeling 
abandoned. Participant 19a described help from the NHS as ‘very reactive, not at all 
proactive so they don’t offer any help’. A couple of pairs reported receiving unexpected 
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and unexplained one-off visits from health and social care services only to find they 
were never contacted again.  
A lack of information about AMD within health and social care services as well as 
within the general public led participant 120 to report ‘you get very, very little 
information about eye problems. They will publicise everything, every medical condition 
under the sun, but you very rarely hear anything about eyes’ QUOTE 55. She also 
reported having received ‘no help, outside help, whatsoever’. These factors 
contributed to her perception that pwAMD had been forgotten about.  
Caregivers reported that the fact they were providing care for their mother meant that 
formal services perceived their mother was not in need of any additional help.  
… a few years ago, out of the blue, er mother had a phone call from social 
services that (hesitation) took both of us completely by surprise. And this person 
for some reason best (hesitation) I’ll explain, decided to pick a fight for no 
apparent reason…And she turned round and said ‘oh you’ve got a son’… And I 
just don’t know where that came from… And as I (stutter) and I was saying, I 
thought charming I thought these people were supposed to help! … But anyway 
that’s my job at the moment. (Participant 120a, son of mother with AMD) 
QUOTE 56 
 
P: The doctor is aware of the situation but I think he feels, probably quite 
rightly, that I am at home all day and I do a good job of looking after my Mum 
and more people, more needy who perhaps live on their own are less well off or 
whatever, who are more deserving of the care of the overstretched 
professionals. 
R: How do you feel about that though?…. 
P: Well, I probably agree with him. I try not to bother him unless it’s something 
important.(Participant 19a, daughter of mother with AMD) QUOTE 57 
 
The lack of help from social and healthcare services because caregivers were around to 
help their mothers provoked different reactions from these caregivers. Participant 19a 
was more likely to agree with the conclusion that others who were coping alone were 
‘more deserving of the care of the overstretched professionals’. However the male 
 345 
 
caregiver (participant 120a) felt abandoned by these services that were ‘supposed to 
help’.  
 
Overarching theme bringing together the spouse pairs and adult-offspring/parent 
pairs: “Managing the changes: living in partnership vs looking after mother” 
Transcending the aforementioned themes and bringing together the findings from 
spouse and adult-offspring/parent pairs was the concept of managing the changes 
brought about by the onset of receiving and providing support for AMD through ‘living 
in partnership’ with one another (spouse pairs) or ‘looking after mother’ (adult-
offspring/parent pairs).  
Spouse pairs lived together with AMD in partnership. They were together at diagnosis, 
sought information together on AMD, developed strategies for coping together, and 
caregivers were aware of the pwAMDs’ changes in sight having been together since 
diagnosis. In comparison, adult-offspring caregivers generally had little recall of the 
diagnosis and only started providing care when their father had died. It is mentioned in 
both the spouse pair and adult-offspring/parent pair narratives that adult-offspring 
struggled to determine the appropriate amount of support to provide, perhaps 
because they were less aware of the pwAMD’s limitations because they hadn’t always 
been in close proximity to each other (e.g. see QUOTES 27, 28, 34, 35, 36).  
Living in partnership meant that the limitations posed by AMD affected the spouse 
caregiver as well as the pwAMD, particularly in terms of the established roles within 
the pair such as being the main driver and being the person who undertook most of 
the domestic tasks. These changes in roles and responsibilities were handled together 
within their partnership whilst also trying to maintain the independence of the 
pwAMD. Adult-offspring/parent pairs spoke less about promoting the confidence of 
the pwAMD and providing encouragement, perhaps because they viewed providing 
help as part of looking after their mother. For instance, whilst a husband caregiver 
(participant 128a) reported not wanting to tell his wife that she was pulling up flowers 
instead of weeds because he considered this was ‘not important’ (QUOTE 9), a pwAMD 
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(participant 37) whose daughter was her primary caregiver reported that her daughter 
informed her when such mistakes were made:   
… there’s so many things I can’t do in the garden now. I go out there, I thought 
I’ll try and do some weeding, but if [daughter] standing there next to me of 
course I’m pulling out rather flower plants as well as weeds you see (Participant 
37, mother with AMD) 
The close relationship between spouses may mean they have a greater understanding 
of their partner’s feelings and do not want to upset their partner and affect their 
confidence. They may also perceive a greater risk to their relationship if pointing out 
mistakes was perceived as criticising their spouse. 
The spouses who took part in this study saw each other as equals and ‘partners’ and 
thus tried to manage household tasks together. Whilst the majority of pwAMD seemed 
to be proactive in providing help in the home, one pwAMD required more 
encouragement. Their caregiver reported a strategy of only asking the pwAMD to help 
with household tasks once, with the purpose of preventing them from getting 
frustrated and protecting their confidence by not asking them several times (QUOTE 
5).  In contrast, for adult-offspring/parent pairs who lived together, the caregiver 
tended to take over the household tasks completely.  
Whilst the care provided between spouses was seen as part of their partnership/ 
marriage together, the responsibility adult-offspring caregivers felt they had for their 
mother was not already built into their lives. The newfound responsibility adult-
offspring caregivers felt they had for their mother was reflected in various aspects of 
their lives, and some caregivers reported more difficulty adjusting and ‘accepting the 
‘new norm’’ than others. Adult-offsprings’ other responsibilities (e.g. looking after 
their spouse or their own children, employment) were highlighted by spouse pairs as 
reasons for receiving occasional help from their children. Adult-offspring who were the 
primary caregivers in this study also reported difficulties fitting in these competing 
responsibilities around caregiving. 
The concept of spouse pairs coping with AMD together in partnership whilst adult-
offspring caregivers had the responsibility of looking after their mother also 
transcended the theme of ‘external support’. Adult-offspring caregivers reported 
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needing help from others as they were managing competing responsibilities, whilst 
spouse pairs only reported requiring help in an emergency situation. Despite both 
pairs describing receiving little help from health and social care services, adult-
offspring/ parent pairs were more likely to report feeling abandoned by these services. 
Both spouse and adult-offspring/parent pairs reported difficulties putting their trust in 
other people to provide services needed (e.g. QUOTES 22, 26, 53). 
Adult-offspring/parent pairs reported a lack of communication between them 
regarding: the impact of providing support on the adult-offspring caregiver, and 
pwAMD limitations and need for help (e.g. QUOTE 36). PwAMD were hesitant to tell 
their adult-offspring about mistakes and falls, perhaps as they didn’t want to be a 
burden to their adult-offspring. 
…cos I hate having to take up her time the way I do but when she says ‘why do 
you sound like that?’ she knows when I’ve hurt myself, even if, when I haven’t 
told her you know… She’ll say ‘Why do you sound like that, what have you 
done?’ I said ‘oh well’ you know then I have to own up then when I’ve had a fall 
or injured my leg. (Participant 37, mother with AMD). 
 
The narratives from spouse pairs suggested they had difficulty with the changing of the 
traditional parent child roles within their relationship. This was seen as a reason why 
they received only occasional help from their adult-offspring. The adult-offspring 
/parent narratives echoed some of this; some pairs reported that the pwAMD was 
‘independent’, and didn’t ask for help. This meant that the adult-offspring caregiver 
often had to keep a look out for what help might be needed. In some cases, caregivers 
described their mother as ‘stubborn’ because they refused to make changes that might 
benefit them (e.g. moving plant pots to somewhere where they were less likely to be 
tripped over) (QUOTE 39). This suggests that parents may have difficulty accepting 
changes and accepting help from their adult-offspring (indeed they may not perceive 
this as help).  
The adult-offspring caregivers spoke about ‘looking after my mother’ and equally, their 
mother spoke about ‘being looked after’. Instead of pwAMD becoming dependent 
when their adult-offspring takes over their care, they report being determined to 
remain as independent as possible.  Thus instead of adult-offspring/parent pairs using 
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the term ‘caring for’ the pwAMD, the term ‘looking after’ was an alternative phrase to 
show that the support received and provided was more supervisory, less clinical and 
was considered part of their family relationship.  
 
DISCUSSION 
The overall aim of the mixed-methods study (presented in Chapter 7 and the present 
chapter) was to explore the impact of receiving and providing support for AMD. A 
dyadic approach was used for both the quantitative and qualitative studies to take into 
account the interactive relationship between the support recipient and provider.  
HOW THE QUALITATIVE FINDINGS HELP EXPLAIN AND ADD TO THE QUANTITATIVE 
FINDINGS 
Key research question: Why did the amount of care received by pwAMD predict 
pwAMD well-being in the first study (the Macular Society 2013 survey) but not the 
quantitative part of the second study (the pwAMD/caregiver study)? How can the 
qualitative study help to explain this finding? 
In the quantitative second study, pwAMD difficulties with vision-dependent tasks was 
used as a measure of the impact of VI instead of registration status and patient-
reported change in vision status since diagnosis (which were used in the first study). 
This may more precisely reflect the pwAMD’s experience of VI. When pwAMD 
difficulties with vision-dependent tasks were included in the model, the amount of 
care received for AMD was no longer associated with pwAMD well-being.  The 
qualitative data reflect the quantitative study findings. PwAMD discussed the impact of 
vision loss on changes to everyday tasks and their previously-enjoyed hobbies. This 
resulted in frustration and sadness which impacted on their well-being.  
Whilst the majority of pairs felt the pwAMD was determined to remain independent 
and tried to continue with their activities, it was noted that sometimes low self-
efficacy and other barriers (e.g. problems with LVAs, small writing in books and on 
food labels) prevented pwAMD from completing tasks independently, and this was 
when help was provided for vision-related tasks. Thus the qualitative findings suggest 
that it is a combination of the degree of sight loss as well as other factors such as self-
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efficacy, the determination to remain independent, and the availability of aids that 
determines pwAMD need for help with vision-related tasks. This may help to explain 
why difficulties with vision-dependent tasks were unrelated to the amount of help 
received/ provided in the multivariate analysis as these other factors weren’t taken 
into account. In addition, DLTV scores were not associated with the amount of help 
caregivers reported providing. The qualitative data suggest that some caregivers may 
be unaware of the amount of help needed. Adult-offspring in particular, reported 
uncertainty of their mother’s limitations, difficulty understanding the extent of their 
parent’s sight loss and how much help was needed. Thus the qualitative data provide 
more detail on how vision-dependent tasks affect pwAMD well-being and the amount 
of care received/ provided. 
The qualitative investigation reflected the quantitative study finding that participants 
thought about the help they received/ provided for activities of daily living when 
deciding on the amount of help received/ provided. Many of these tasks (e.g. cooking 
for or with the pwAMD) were built into the everyday lives of spouses or adult-
offspring/parent pairs who lived together.  Since these tasks required little or no 
change to their routine, it might be expected that they would not impact on their well-
being or appraisals of caregiving. However, tasks that fell outside of their ‘norm’ might 
be more likely to impact on these outcomes. Indeed the qualitative results under the 
theme ‘Accepting the ‘new normal’’, show that caregivers reported some anxiety doing 
tasks outside of their established roles and responsibilities (e.g. for women this was 
becoming the main driver, and for men this was having more responsibility for 
domestic tasks such as cooking and sewing). The qualitative investigation highlighted 
that pairs worked together to manage the impact for instance by doing tasks together 
with the pwAMD giving instructions. Since spouse pairs had been living in partnership 
in their marriage together, these changes seemed to be managed easily. In contrast, 
for adult-offspring/parent pairs who lived together, caregivers were more likely to 
report doing all the household tasks. Perhaps this is because pwAMD had moved into 
their adult-offspring’s home and caregivers continued their routine of household 
responsibilities without pwAMD involvement. It should be noted that the discussion of 
how household tasks were negotiated between co-residing pwAMD and adult-
offspring caregivers wasn’t discussed in the interviews, so requires confirmation. For 
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adult-offspring/ parent pairs who didn’t live together, caregivers reported having twice 
as much to do; they were responsible for carrying out activities of daily living (e.g. 
household tasks) for their parent and in their own home, although some activities, 
such as food shopping, were carried out once but involved twice as much work in 
terms of getting food for the pwAMD as well as themselves. Thus whether or not 
pwAMD/ caregiver pairs lived together impacted on whether support tasks were 
carried out in addition to their normal tasks. This might be included in future models to 
see if this affects caregivers’ secondary appraisals or burden of providing care. 
The results presented in this thesis suggest there may be a number of factors that 
affect pwAMD and caregiver appraisals of the amount of help received/ provided. In 
the first study (the 2013 survey), participants in the ‘more than 35 hours of care a 
week’ group were more likely to be male, be married and their primary caregiver was 
more likely to be their wife. In comparison, in the second study there were no 
significant differences in gender or the type of relationship the pwAMD had with their 
caregiver (i.e. spouse or parent) between the ‘hours of care’ groups. There was a 
significant difference in the proportion of pairs who reported living together. All 
pwAMD who reported receiving more than 35 hours of care a week were living with 
their caregiver. This association may be due to these pwAMD requiring more help 
which resulted in them living with their primary caregiver. Alternatively it might be 
that pairs who live together find it difficult to distinguish between the help provided 
for AMD and help provided as part of everyday living. The latter was reflected in the 
qualitative study findings, in particular for spouse pairs who viewed the receipt and 
provision of support as part of their everyday lives.  
The qualitative data provide further explanations for how participants came to decide 
on how much support they receive/ provide and what tasks count as providing care. 
Under the theme ‘accepting the ‘new normal’’, both female pwAMD and their 
husbands reported that the household tasks the husband had taken on since their 
wife’s sight deterioration were considered additional tasks that they wouldn’t 
‘normally’ do. These were more likely to be considered as support for AMD and thus 
be counted as part of the amount of help received/ provided per week than for female 
caregivers who provided domestic responsibilities for their husbands with AMD. All 
spouse pairs in this study reported taking on the traditional roles of husband and wife 
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in their marriage (where men were responsible for earning and women for domestic 
tasks). The age range of spouse pairs was between 77-83 years and this age group may 
be of a generation where this is considered the ‘norm’. Thus there may be gender 
differences in the types of activities considered as support for AMD and this may affect 
the reports of the amount of support provided. 
Both spouse and adult-offspring caregivers reported that the impact of AMD on the 
pwAMD was always in the back of their mind even if they were not providing direct 
support at the time. Concerns over trips and falls were a constant worry. Pairs 
reported the caregiver needing to be on hand to help with situations as they arose 
(e.g. falls or if the pwAMD had put something down and couldn’t remember where 
they left it). The unpredictable nature of the support required made it difficult for pairs 
to decide on how much help they received/provided in quantitative terms (i.e. the 
amount of hours per week they spent receiving/providing support). 
The qualitative data suggest the experience of providing/ receiving support is different 
between spouse and adult-offspring/parent pairs. Whilst similar issues arose in the 
management of providing support for AMD the experiences for spouses and adult-
offspring/parent pairs were notably different in terms of how they adjusted to changes 
in roles and responsibilities, how they managed the independence of the pwAMD and 
that of the caregiver, and their experiences of seeking external support. The 
multivariate findings from the 2013 survey analysis, and bivariate analysis in the 
second quantitative study suggest there were no significant differences between these 
types of pairs in pwAMD or caregiver well-being, health or caregivers’ appraisal of the 
impact of providing support. However the small sample size in the second study 
prevented the inclusion of the type of pwAMD/caregiver relationship in multivariate 
analysis. The qualitative findings suggest it is important to consider these types of pairs 
separately in their experiences of the impact of receiving and providing support for 
AMD. 
The main aim of the present study was to investigate the impact of receiving and 
providing support for AMD. For the spouse pairs interviewed in the qualitative study, 
the focus was instead on how they managed the impact of AMD together, since 
providing support was part of being married. There was a shared impact of AMD on 
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the pairs’ tasks and activities and these were managed together. Providing support 
was seen as part of the reciprocal nature of marriage. Thus the perception that the 
receipt and provision of support was reciprocal was a key appraisal for spouse pairs 
that determined how they coped and accepted this support.  
Difficulties breaking away from the established roles of parent and children were 
mentioned as one of the reasons why the spouse pairs received only occasional help 
from their adult-offspring. There were some indications that pwAMD in this study 
whose primary caregiver was their adult-offspring, still felt the need to provide support 
to their offspring and did this where they could. Being able to provide help to their 
offspring led them to feel that help was reciprocal and reduced their concerns that 
they were a burden. This may contribute to better well-being. However it is possible 
that for other people, the perception that one is a burden in the first place, or 
resentment at feeling the need to provide help in return, may actually contribute to 
poorer well-being. It might be interesting for future research to investigate reciprocal 
support within adult-offspring/ parent with AMD pairs and the impact this has on well-
being. 
PwAMDs’ ratings of their general health predicted their well-being and caregivers’ 
reactions towards providing care (their CRA scores). The quantitative study findings 
suggest pwAMDs’ health is a better indicator of CRA scores than pwAMDs’ level of 
visual functioning, their difficulties with instrumental activities of daily living and the 
amount of help provided/ received. There are few qualitative data to help explain this 
finding, perhaps because providing support for other medical conditions was not the 
focus of the interviews. Nevertheless, spouse pairs reported helping each other in 
partnership with their health conditions. There were indications that pairs compared 
their other health conditions to AMD. For instance participant 81a reported how he 
felt there was little he could do to help his wife with her hearing loss, whereas he felt 
he could do more to help his wife with her sight loss. Thus, for caregivers, feeling able 
to provide help to the pwAMD to help them cope with sight loss may have a positive or 
protective effect on caregivers’ feelings of usefulness and hence well-being.  
The belief that pwAMD were willing to try activities before asking for help was 
important for both pwAMD and caregivers in how they appraised the receipt and 
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provision of support. A determination to manage independently reduced pwAMDs’ 
feelings of guilt that they would burden their caregiver- knowing that they had 
exhausted the options before asking for help. Similarly, caregivers reported feeling 
they were less taken advantage of if they knew the pwAMD was only asking for help 
when needed. The qualitative findings highlight that pwAMD self-efficacy was 
considered an important factor in their determination to carry out activities. Pairs used 
strategies (e.g. doing tasks together, not over-helping the pwAMD, asking the pwAMD 
to try to do an activity only once) to attempt to encourage or maintain confidence and 
prevent the pwAMD feeling frustrated and helpless. In addition, help from outside the 
pair was sometimes considered to be helpful in promoting pwAMD confidence. 
Meeting others who had also experienced sight loss was noted by spouse pairs to be a 
source of inspiration. 
The quantitative study found that caregivers’ reactions towards providing support 
(their CRA scores) did not predict pwAMDs’ well-being. The qualitative findings provide 
some evidence to support this. PwAMD whose spouse was their primary caregiver 
generally reported that the provision of support was an accepted part of their 
marriage and did not mention that caring had produced any major problems for their 
spouse. PwAMD whose primary caregiver was their adult-offspring reported not 
knowing or having thought much about the ways in which caregiving had impacted on 
their caregiver. This lack of awareness may be due to these pairs not having discussed 
the impact. Thus pwAMDs’ well-being might not be related to caregivers’ reactions 
towards providing support if pwAMD were unaware of any impact.  
HOW MIGHT THE MODEL TESTED IN THE QUANTITATIVE STUDY BE MODIFIED 
FOLLOWING THE QUALITATIVE STUDY RESULTS? 
The model may help to explain the impact of the receipt and provision of support for 
AMD better by including factors mentioned above, e.g. type of pwAMD/ caregiver 
relationship and whether the pwAMD lived alone or with their caregiver. In particular 
there are two factors worth highlighting. First, as mentioned above, the impact of AMD 
on ability to carry out previously-enjoyed activities appeared to be related to both 
pwAMD and their caregiver’s well-being. Some of these activities may be captured in 
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the DLTV (e.g. reading newspaper print). However others, such as driving or shared 
activities such as walking and holidays, may be affected and do not appear in the DLTV.  
Second, it is worth considering including a measure of pwAMD self-efficacy in ability to 
carry out vision-related tasks. This factor could be targeted in interventions.  In 
addition, pwAMD confidence to carry out vision-dependent tasks may be related to 
caregiver appraisals of providing support and well-being. 
The model tested in the quantitative study did not include a measure of the perception 
of help received from health and social services or professional services, however the 
qualitative findings suggest this might be useful in understanding the broader context 
of receiving and providing support for AMD. Both the spouse and adult-
offspring/parent pairs reported difficulties getting help when needed. Pairs reported a 
distrust of professional services, for example, for getting practical help around the 
home, and receiving respite help. In addition, a lack of help from others either when 
pairs had sought help and not received it, or by not being offered help, led pairs to feel 
that others did not perceive they required help. This contributed to pairs feeling 
abandoned which may have affected their well-being. This was a particularly poignant 
issue when it came to receiving help from professionals who pairs perceived should be 
providing help (e.g. social care services). Help from charities or from other family 
members was not so expected. The CRA measure used in this study included a subscale 
measuring caregivers’ perception of lack of family support. However there was no 
measure of support from formal services, and this study suggests that this may be 
important in understanding caregiver’s appraisals of providing support.  
There were some similarities and some differences in pwAMD and caregivers’ coping 
strategies. Both reported that using humour when dealing with mistakes caused by 
sight loss was a useful coping strategy. There was some evidence that adult-offspring 
caregivers in particular had difficulties fitting in looking after their mother around their 
other roles and responsibilities. There were indications that caregivers sometimes did 
not discuss the impact of providing care with their mothers. This may have been 
because they wished to protect their mother and this required adult-offspring 
caregivers to suppress their emotions around their mother. Both spouse and adult-
offspring caregivers described ways in which they reinterpreted the changes to find 
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positives, for instance male spouse caregivers reported that providing care had helped 
ease them into retirement. Other positive appraisals of providing support included: 
feeling that they are able to pay back help received in the past from the pwAMD, and 
being able to do something that can help reduce the negative impact that AMD had on 
their loved one. 
The present qualitative study found some indications that adult-offspring caregivers 
had difficulty understanding the pwAMD’s vision loss. Caregivers’ perceptions of the 
pwAMD’s vision loss guided the support they provided. Previous research found that 
spouses of people with Huntingdon’s disease (HD) reported that the person with HD 
experienced more symptoms and less control over the condition, than were self-
reported by the person with HD (Kaptein et al., 2007). This illustrates that people with 
a chronic condition may perceive their condition differently from their caregiver. 
Illness perceptions were found to affect outcomes. Kaptein et al. (2007) reported that 
both the person with HD and their spouse’s illness perceptions correlated with the 
person with HD’s health status (measured using the SF-36). Kaptein et al. (2007) used 
the Illness Perception Questionnaire (IPQ) to assess illness perceptions of the person 
with HD and their spouse. The revised form of the IPQ, the IPQ-R, contains the five 
subscales included in the IPQ (identity, timeline, cause, consequences and 
cure/control), plus two additional subscales (Moss-Morris et al., 2002). These two 
subscales assess participant’s understanding of the condition (the illness coherence 
subscale) and their emotional reactions to the condition (the emotional representation 
subscale). Future research might include the IPQ-R to investigate pwAMD and their 
caregivers’ illness perceptions and how these affect their outcomes. This would involve 
using a re-worded version to assess caregivers’ own representations about the 
pwAMDs’ condition. It would be interesting to see if pwAMD and their caregivers’ 
illness perceptions correlated, for instance, on their understanding of the pwAMD’s 
condition. Based on the qualitative study findings, it might be expected that scores on 
the ‘illness coherence’ subscale might correlate more highly between spouse pairs 
than adult-offspring/ parent pairs. Thus including this measure might help to identify 
differences between these types of pairs.  
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HOW DO THE RESULTS PRESENTED HERE COMPARE WITH OTHER PATIENT AND 
CAREGIVER GROUPS?  
The quantitative study presented in Chapter 7 compared mean well-being (W-BQ12) 
scores of the pwAMD included in this study who received support for AMD with other 
patient populations. PwAMD reported lower well-being than people with adult growth 
hormone deficiency (McMillan et al., 2006) and women who have experienced 
pregnancy loss (Koch et al., 2012). Mean CRA subscale scores were also compared 
across different caregiver populations. The caregivers in this study reported a lower 
negative impact of providing care than caregivers of people receiving treatment for 
wet AMD (Gohil et al., 2015), and caregivers of people with multiple sclerosis (Forbes 
et al., 2007). They also reported less negative impact on their schedule, family and 
finances as a result of caregiving but more impact on health and self-esteem than 
caregivers of people with Rheumatoid arthritis (Jacobi et al., 2003). Of course it is 
important to note that in addition to the different medical conditions, there are other 
factors associated with well-being and appraisals of providing care that varied between 
these studies (e.g. gender, age, type of patient-caregiver relationship), so one should 
be wary of making direct comparisons across studies. 
It is more difficult to compare qualitative findings across different populations since in 
each study there may be different philosophical assumptions that underlie the choice 
of research methods used and how the research is reported, and that comparing 
studies contradicts one of qualitative research’s main strengths which emphasises the 
uniqueness and depth of data. However, meta-ethnography has been used as a form 
of interpretive synthesis to summarise qualitative research studies. It aims to develop 
a theory or a line of argument which integrates and helps to explain the findings from 
separate studies. They are becoming more widespread (e.g. Bennion et al., 2012; 
Greenwood & Mackenzie, 2010), however they tend to be condition-specific. A meta-
ethnographic review of seven qualitative studies on the experiences of caring for 
someone who had experienced a stroke reported ten themes which had been 
identified in the majority of the studies (Greenwood & Mackenzie, 2010). Greenwood 
and Mackenzie (2010) suggested that reports of the experience of caring for a stroke 
survivor focused on change and loss. Changes included changes in roles, relationships 
and responsibilities, whilst losses included losses to former relationships, loss of 
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autonomy and loss of taken-for-granted futures. These changes and losses challenged 
the caregiver’s identity which moved from being that of the partner of the stroke 
survivor, to that of a caregiver. The authors suggested that this reflected a 
‘biographical disruption’, a concept that has previously been used to describe the 
experiences of patients with chronic illness (Bury, 1982). This theory suggests that 
chronic illness disrupts the structures of everyday life, disrupts normal rules of 
reciprocity between the person with the illness and their families, involves growing 
dependency, and leads to re-examination of the expectations and plans held for the 
future (Bury, 1982). That some pairs in the present study reported similar issues such 
as difficulty adjusting to their new roles and loss of independence, suggest that they 
also experienced a biographical disruption and that there are similarities between the 
experiences of both pwAMD and caregivers and those of people with other chronic 
illnesses. Greenwood and Mackenzie (2010) also reported that caregivers used coping 
strategies to attempt to manage these changes. Strategies included those used by the 
pairs in the present study including keeping a sense of humour. The ‘biographical 
disruption’ led to re-evaluation of the lives of caregivers of stroke survivors. There 
were attempts to search for meaning and growth where caregivers identified positive 
outcomes of providing support (Greenwood & Mackenzie, 2010). Similarly, in the 
present study, caregivers used positive reappraisal to re-evaluate how providing 
support had been a positive influence on their life. 
People with other medical conditions and their caregivers have also reported 
difficulties accessing formal services (e.g. Greenwood, Holley, Ellmers, Mein, & Cloud, 
2016; Peters, Fitzpatrick, Doll, Playford, & Jenkinson, 2013). Caregivers’ perception 
that providing care was part of their marriage and feeling that they would be better at 
providing support than others, were reasons for not persisting with efforts to access 
these services (Greenwood et al., 2016). These reasons were also reported by the 
caregivers of pwAMD in the present study. There are differences in the types of help 
needed for different medical conditions. Whilst caregivers of people who had 
experienced a stroke, for example, required help with personal care, this was generally 
not reported as being needed in the sample of pwAMD. Different types of care appear 
to carry with them different requirements. For people who required help with 
personal care, it was important that there was time to build a relationship with the 
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person providing the care (Greenwood et al., 2016). Caregivers in the present study 
reported requiring external help with everyday tasks (particularly in an emergency 
situation if they could not be there to provide care) or with practical tasks around the 
home. Thus it is important to note that different conditions require different types of 
help, and that caregivers and people with the condition may have specific needs 
relevant to these types of support. 
On average, the pwAMD in the present study were diagnosed 14 years ago. Many 
reported feeling abandoned by health and social care services. Apart from seeing ECPs 
at the time of diagnosis or for treatment, many did not report further contact with 
these services. Similarly, a nationwide survey of patients with motor neurone disease, 
Parkinson’s disease and multiple sclerosis found that those diagnosed longer ago 
reported having more difficulty receiving help from health and social care services 
(Peters et al., 2013). This suggests a nationwide problem of lack of continuity of care 
and difficulty accessing services for all medical conditions.  
The author is not aware of any publications synthesising qualitative research on the 
experiences of patient/ caregiver dyads. Research involving dyads provides a more 
detailed view of the shared experience of receiving and providing support. For 
instance, in the present study both pwAMD and their caregivers reported the effect of 
vision loss on pwAMDs’ activities and hobbies, and also shared activities (e.g. walking, 
holidays). Caregivers empathised with the pwAMD and provided help where possible, 
however AMD had meant changes to both of their lives as reflected in the following 
quote from a wife caregiver:   
…life has been reduced by half in our, you know our activities. (Participant 121a, 
wife of husband with AMD) QUOTE 14 
 
AMD has previously been referred to as an ‘invisible disability’ (Mogk, 2008). The lack 
of obvious signs that the pwAMD has a condition causing functional limitations led 
some pwAMD to report feeling that they might be viewed as a fraud (Mogk, 2008).  
Some pwAMD reported concealing their AMD diagnosis to avoid unwanted sympathy 
(Weaver Moore, Constantino, & Allen, 2000).  A lack of communication about the 
extent of sight loss, plus a lack of obvious signs that indicate how much support might 
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be needed may make it difficult for caregivers to know when support is needed. In 
particular, for the adult-offspring caregivers in the present study who were not present 
at diagnosis and were required to provide support suddenly, they also reported 
difficulty knowing the extent of sight loss and how much support was required. They 
were often concerned about over-helping as there was the potential that this might 
increase reliance on them and reduce both the pwAMDs’ and caregivers’ 
independence.  The present qualitative study found caregivers were concerned about 
the impact of sight loss on the pwAMDs’ safety. It may be that not understanding the 
extent of sight loss may increase caregivers’ worry over pwAMDs’ safety if they believe 
their sight loss puts them in danger, and this may contribute to over-helping. Indeed 
Cimarolli et al. (2013) suggested that overprotection may be a particularly salient issue 
for people with VI because of the increased risk of falls and injuries associated with this 
condition.  
The impact of sight loss on shared vision-dependent activities for the pwAMD and 
caregiver, plus caregiver’s knowledge of the pwAMD’s sight loss and concern over 
pwAMD safety, are two ways in which the experiences of pwAMD/caregiver pairs may 
differ from pairs where the caregiver provides support for another reason or condition. 
Future research might directly compare whether the experiences of receiving and 
providing support for AMD is different to that received for other conditions or for old 
age generally. This might provide further evidence for interventions being AMD-
specific. 
IMPLICATIONS FOR THE STUDY FINDINGS IN LIGHT OF THE RESEARCH LITERATURE 
This study adds a dyadic perspective to the experience of living with AMD where 
previous research has focused solely on the impact on the person diagnosed with 
AMD, or on caregivers who support someone diagnosed with wet AMD.  The 
quantitative study provided a model for dyads that extends the models used in 
caregiver burden research. This indicated that for the pairs included in this study, the 
amount of care provided and received is not related to either caregiver appraisals of 
the impact of providing care nor pwAMD or caregiver well-being or caregiver health. 
Additionally there were different predictors for primary and secondary appraisals of 
providing care. However quantitative measures may fail to capture important 
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contextual elements of the dyadic experience and some of the measures used were 
limited in not being specific to AMD. The qualitative study provided evidence that 
reflects and adds to the quantitative study findings. The combined findings provide 
information on how interventions may be targeted to help pairs living with AMD.  
Previous research has found a strong relationship between loss of vision-related 
functional ability and symptoms of depression (e.g. Casten, Rovner, Leiby, and Tasman 
(2010); Cimarolli et al. (2016)). The present study findings support this relationship, 
and add to this by highlighting the emotional impact this has on those close to the 
pwAMD. This supports the findings from Strawbridge et al. (2007) who found that VI 
negatively impacted spouses’ depression, physical functioning, well-being and marital 
quality. Cimarolli et al. (2016) suggested that for people with VI the distress resulting 
from loss of activities can lead to a vicious cycle whereby the decreased motivation 
resulting from depressive symptoms leads to less engagement in previously-enjoyed 
activities and this further exacerbates depressive symptoms. The qualitative study 
suggested that the pwAMD and their caregivers who took part in the study had 
created ways of managing the impact of AMD together. Pairs engaged in a variety of 
strategies to continue with activities with the aim of maintaining the pwAMDs’ self-
efficacy and independence.  
Self-efficacy is the core component of social cognitive theory and is defined as a 
person’s belief in his or her ability to succeed in a particular situation (Bandura, 1977). 
According to social cognitive theory, self-efficacy can be affected by four sources of 
information. These include: successful accomplishments of the task, vicarious 
experiences of observing other people succeeding, verbal persuasion that the person 
has the capability to perform successfully, and the person’s perception of their level of 
physiological arousal from which they use to judge their level of anxiety and 
vulnerability to stress. Aspects of these were apparent in the qualitative results. 
Caregivers provided encouragement to the pwAMD, previous successful or 
unsuccessful attempts contributed to whether the pwAMD felt they could successfully 
accomplish a task, and meeting others who had sight loss was seen as a source of 
inspiration. Pairs reported using their own strategies to manage the pwAMDs’ self-
efficacy. Caregivers used humour to laugh off mistakes and make light of the situation 
with the aim of preventing this from impacting on the pwAMDs’ confidence. Spouse 
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caregivers reported avoiding pointing out mistakes that were perceived to be 
unimportant.  
The theme of ‘maintaining independence’ described the strategy that pwAMD and 
their caregivers commonly adopted by asking for or providing support only when 
needed. The concept of overprotection or over-helping has been described in the 
literature and has been linked to negative outcomes in people who have experienced 
vision loss (e.g. Cimarolli (2006)). Thompson et al. (2002) found overprotection 
resulted from caregiver resentment and patient dependency. Cimarolli and Boerner 
(2005) reported negative aspects of receiving support for people of working age with 
VI, including people underestimating or overestimating their capabilities and thus 
providing too much or too little help. However in the present qualitative study, it was 
mainly caregivers who reported concerns about over-helping the pwAMD rather than 
the other way round. The present study provides the caregivers’ perspective to 
Cimarolli and Boerner (2005) findings. As suggested by Cimarolli et al. (2013), and 
corroborated by this study, is the concern of an increased risk of falls for pwAMD. One 
caregiver in the present qualitative study reported being concerned about low pwAMD 
self-efficacy, and perceived that providing support would prevent this from getting 
worse by protecting the pwAMD from experiencing failure. Thus instead of 
overprotection being due to caregiver resentment or hostility, this study suggests that 
it might stem from either empathy for the pwAMD, low pwAMD self-efficacy or 
concern over pwAMD safety, however it must be noted that no pwAMD reported a 
perception of receiving too much help from their caregiver. 
Reports of over-helping related to family members outside of the pair. It was 
suggested that this was due to them not knowing the limitations posed by AMD. Since 
such instances only happened occasionally and were perceived as being ‘meant well’, 
the perception that this was ‘irritating’ was not mentioned to these family members. 
Similarly, adult-offspring caregivers reported being unsure of their mother’s 
limitations. This affected their perception of the amount of help to provide.   
There have been some promising results for self-management interventions designed 
to increase the functional abilities of people with low vision and decrease depression, 
however the majority have only found short-term positive effects (for a review see 
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Cimarolli et al., 2016). Such interventions include teaching problem-solving techniques 
to remove barriers to activity engagement, training in the use of optical and assistive 
devices (LVAs), and the teaching of orientation and mobility skills. The majority of 
interventions, however, are designed solely for the person with low vision. The results 
presented here suggest that it may be beneficial to include the caregiver in such 
programmes in order to support the person with low vision. Having the support of the 
caregiver may act as a boost to encourage longer term effects by reinforcing what was 
learnt and reminding pwAMD to apply it in the future.  
There are few reported evaluations of support groups for caregivers of adults with VI 
(e.g. Cimarolli, Sussman-Skalka, & Goodman, 2004; Larizza et al., 2011). One 
programme has been found to increase the caregivers’ understanding of their visually 
impaired partners’ vision (improved understanding of what their partner can see or 
do), improve their certainty about when, how and how much help to provide, improve 
their ability to talk openly about stressful situations that arise because of vision 
problems, and reduce the caregivers’ negative appraisal of their role (Cimarolli et al., 
2004). The intervention covered areas highlighted as important in the qualitative 
findings from the present study including: understanding your partner’s vision loss, 
exploring emotional issues, getting around safely and garnering support from family 
and friends. Unfortunately, the support program was not found to increase caregivers’ 
life satisfaction or depression. The authors attributed this to a ceiling effect- 
participants reported high levels of life satisfaction and low depression at the 
beginning of the program. The authors did not assess changes in the visually impaired 
person’s outcomes and suggested that this would help to highlight the wider benefits 
of the programme including how the support programme for caregivers affects the 
person with vision loss.   
The acceptability of interventions for caregivers of people with VI would need to be 
evaluated. The present qualitative study suggested that some pairs appeared to prefer 
to manage AMD within their pair and this may act as a barrier to engagement. Indeed 
previous research has found that spouse caregivers are less likely than other types of 
caregivers to have any informal helpers or to use service programmes designed to 
relieve caregiver burden (Pinquart & Sörensen, 2011). It may be that the limited use of 
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helpers from outside the marital dyad reflect the desire of couples to manage as an 
independent unit.  
The present study adds to the small amount of literature that observes differences 
between spouse and adult-offspring caregivers, particularly those using qualitative 
approaches. Pinquart and Sörensen (2011) conducted a meta-analysis of quantitative 
studies of caregivers of people with dementia or who were physically frail, and found 
that spouses reported more depressive symptoms than adult-offspring caregivers, and 
this was partially explained by spouses providing more care.  In contrast, Chappell, 
Dujela, and Smith (2014) found adult-offspring caregivers of older adults with 
dementia reported more subjective burden than spouse caregivers. The bivariate 
analysis in the present quantitative study suggested no significant differences between 
spouse and adult-offspring caregivers for outcomes including well-being and reactions 
to providing support. However the qualitative study findings suggest similarities and 
differences in providing care for AMD between spouse and adult-offspring/parent 
pairs. Whilst similar issues were raised in managing the impact of AMD, maintaining 
the independence of the pwAMD and obtaining external support, there were 
differences in how pairs adjusted to providing support. It has been reported elsewhere 
that spouses view caregiving as normative and part of their marriage vows whilst 
adult-offspring caregivers view caregiving as an addition to their lives and experience a 
reversal of the traditional parent and child roles (Bastawrous, 2013; Lee & Smith, 
2012). The qualitative study adds to this the ways in which adult-offspring/parent pairs 
were similar to and different from spouse pairs (as highlighted under the overarching 
theme). One of the key differences was that some adult-offspring caregivers reported 
difficulty adjusting to the new responsibility they felt they had for their parent, which 
could be seen to represent a change to traditional parent and child roles.  
It is possible that caring for a pwAMD brings with it a condition-specific sense of 
responsibility. Sight loss can present barriers to social interaction (for example, 
pwAMD report difficulty recognising faces, Bennion et al., 2012). Communication 
theory suggests that sight loss may lead to difficulties picking up on non-verbal 
communication (NVC) (Heine & Browning, 2002).  In addition, the parents with AMD in 
the qualitative study reported a small social circle due to friends and family of a similar 
age having died. All pwAMD in the current study were unable to drive and relied on 
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their caregiver to take them to places. These factors might suggest that pwAMD have a 
reduced social circle and this may put pressure on their relationship with their 
caregiver. Indeed one adult-offspring caregiver in the present study reported that this 
led to an unwanted responsibility of having to take her mother out with her whenever 
she went out. Sight-specific reasons for difficulty communicating with others might 
undermine pwAMDs’ confidence interacting with others. Not being able to see NVC 
and not being able to see what is going on around them, may potentially lead to 
pwAMD having difficulty putting trust in others. Indeed one pair in this study reported 
having felt that people who had been in their home to do practical work had ‘taken 
advantage of’ the pwAMD’s sight loss and consequently done a ‘sloppy’ job. These 
factors may play a part in leading caregivers of pwAMD to feel more responsible for 
the pwAMD than for someone without AMD. These hypothesised relationships would 
need to be tested in future research.  
The present study also added the perspective of parents with AMD and the 
expectations they had of their adult-offspring. Spouse pairs reported difficulty moving 
away from parent and child roles and reported this was a barrier to receiving help from 
their adult-offspring. For pwAMD whose primary caregiver was their adult-offspring, 
they reported providing help to their children- either financially or through practical or 
emotional means (e.g. being a ‘listening ear’, QUOTE 45). This reduced their concerns 
that they would become a burden. According to exchange theory, individuals are 
motivated to maintain a balance in how much support is received and provided 
(Walster, Berscheid, & Walster, 1973, 1978). Interventions may benefit from guiding 
pwAMD to identify ways in which they can provide help to their caregiver. 
The present study findings suggest some agreement with gender role norms and 
expectations reported in the caregiver literature. In the qualitative study, daughters 
reported taking on the primary caregiver role over their male relatives such as their 
brothers. In agreement with past research (e.g. Leopold, Raab, & Engelhardt, 2014), 
this was primarily due to being in closer proximity to their mother, however one 
participant suggested this might be due to the expectation that the female relative 
should take on the role. This assumption that the daughter would be the primary 
caregiver is echoed in findings reported elsewhere (e.g. for a discussion of different 
perspectives behind gender norms and taking on the caregiver role, see Bastawrous et 
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al., 2014). Prior gender experiences of providing care to children may mean that 
providing care to a parent is seen as an extension of these skills and thus women may 
be expected to be more competent caregivers. Since current society suggests women 
are expected to provide care, and that this may form part of their identity as a woman, 
to ask for help may be perceived by women as a disruption to this identity (Feld, 
Dunkle, Schroepfer, & Shen, 2010). Thus they may be more likely to provide care 
alone. There were mixed findings in the present study. Whilst one daughter in this 
study reported asking for help from her brother for any type of caregiver activity, two 
others reported only asking for help with practical tasks from their husbands or 
brothers. When it came to getting help from formal services, one daughter reported 
having accepted the lack of provision of help due to her availability as a caregiver (as 
opposed to having no caregiver), whereas the one male caregiver in the present study 
did not accept this as an adequate reason for not receiving help. According to gender-
roles, male caregivers (sons) may perceive themselves not to have the skills or abilities 
to care and thus would prefer receiving more help. This may be the reason why the 
male caregiver required help, however he was also the only caregiver who was 
employed full-time and this may be the reason why help was required.  Thus the 
gender differences noted in this study are speculative and may be due to differences in 
gender roles or other socio-demographic factors.  
Included in the Stress Process Model proposed by Pearlin et al. (1990) are the use of 
coping resources as mediators between stressors and outcomes. The present study 
provides evidence to suggest that pairs engaged in the use of several coping strategies 
to manage the impact of AMD. Of particular note is the use of positive reappraisal and 
benefit finding. These emotion-focused coping strategies may be useful when dealing 
with unmodifiable stressors and uncontrollable events for which problem-focused 
coping is unlikely to be helpful (Lazarus & Folkman, 1984). Caregivers reported using 
this strategy to manage the uptake of new domestic tasks, to adjust to changes in roles 
and responsibilities and to manage competing responsibilities. Guided positive 
reappraisal has been found to lower depression, but not reduce overload or burden in 
a group of caregivers of people with Alzheimer’s disease, compared to a 
psychoeducation control group (Cheng et al., 2014). This intervention used a similar 
strategy to those used in cognitive-behavioural interventions by teaching caregivers 
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the interconnectedness of their thoughts, emotions and behaviours and how 
modifying one’s thoughts might improve well-being directly or indirectly through 
behaviour change.  
The quantitative and qualitative study findings highlight that AMD is often managed 
alongside other medical conditions. The quantitative study findings suggest that 
targeting the general health of pwAMD in interventions may be effective at reducing 
caregiver ‘burden’ and consequently improve caregiver well-being and health 
alongside pwAMD well-being. The findings also suggest that it may be more important 
for interventions to focus on caregiver appraisals of providing support than the 
amount of support provided. 
Participants in the present qualitative study reported unsatisfactory experiences with 
health and social care services. In particular, a lack of information and support 
provision at diagnosis echoes the findings from the first study (the 2013 survey) 
presented in this thesis. One pair also reported a lack of support and understanding of 
the patient perspective when being told that treatment would no longer be effective 
for AMD. Bennion et al. (2012) reported that AMD patients felt let down by the NHS 
because of a lack of treatment for (some types of) AMD, and they also had a distrust of 
the NHS, for example, because of a belief that past medical procedures had caused 
their AMD. They suggested that the negative views of the NHS that were reported to 
be held by pwAMD could impact on their future engagement with the service. This 
may be important for people diagnosed with early AMD which could turn to wet AMD. 
Seeking help quickly for changes in vision may be important for saving sight and a 
potential barrier to early help-seeking may be a feeling of disengagement from the 
health services. 
The present qualitative study found a disparity in the amount of external help received 
from different services. Some pairs reported receiving sufficient information and help 
from charities (such as the Macular Society) and local blind associations through the 
provision of LVAs and telephone counselling. However there was a reluctance to use 
these services too much because of their charitable status. Pairs were more likely to 
report dissatisfaction with social services who were expected to help. The availability 
of the caregiver to provide help to the pwAMD was seen as a hindrance to receiving 
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help from social services. Some pairs reported dissatisfaction with the lack of help 
offered.  
 
Unfortunately, it appears that the lack of support from social services is likely to get 
worse. England remains one of the few major advanced countries that has not 
reformed the way it funds long-term care in response to the needs of an ageing 
population (Humphries, Thorlby, Holder, Hall, & Charles, 2016). A recent report from 
the King’s Fund (Humphries et al., 2016) suggests that access to social care has 
reduced considerably over the past decade, so that by 2010, 90% of local authorities 
were limited to providing help to those with ‘substantial’ or ‘critical’ needs only 
(Fernandez, Snell, Forder, & Wittenburg, 2013). The pressure on families to provide 
care to older people will undoubtedly increase in the future with an ageing population 
stretching public funding on the adult social care system. Some of the caregivers who 
took part in interviews suggested that taking on the caregiver role and the tasks 
associated with providing support to the pwAMD (e.g. cooking, sewing) were 
unexpected. The lack of public awareness of AMD, as mentioned by a participant in the 
qualitative study, and in previous research (Cimarolli et al., 2012), suggests that people 
may be unprepared for managing care for someone with AMD in the future. Thus it 
may be important for the general public to be informed about AMD and made aware 
of this increasing pressure on them to provide care in the future. 
 
Alternatively, more innovative approaches are being put forward to enable older 
people to live independently for longer. In 2011 a number of cities around the world, 
including Manchester and Newcastle, signed the ‘Dublin Declaration for Age Friendly 
Cities’. This declaration sets priorities for cities to work towards meeting the topics set 
out in the World Health Organisation’s (WHO) Guide for Age Friendly Cities (WHO, 
2007). This includes adapting or maintaining elements of the physical and social 
environment to recognise the importance this has on people’s quality of life. Of 
particular importance is including the voices of older people in initiatives to improve 
their neighbourhoods and thereby increasing their participation and empowerment in 
developing their neighbourhood. Age UK (a UK-based national charity) argue that local 
government investing in better neighbourhoods, for instance by repairing uneven 
pavement to prevent falls, may be a key factor that enables older people to feel 
 368 
 
confident to go out into their neighbourhoods (AgeUK, 2013). This may prevent the 
need to use NHS and social care services and enable older people to live alone instead 
of going into residential care, which ultimately would save on the cost of social care. 
They argue that the benefits of investing in age-friendly neighbourhoods are not yet 
recognised by local or national government. The findings of the present study suggest 
that pwAMD and their caregivers are concerned about the safety of the pwAMD. 
PwAMD reported being limited to walking alone in their local areas due to finding 
comfort in the familiarity of the area (e.g. knowing where to cross the road safely). 
Others cited environmental barriers such as unreadable bus numbers as reasons for 
not using public transport and going further afield. Therefore this study provides 
evidence to suggest that pwAMD might benefit from the development of age-friendly 
neighbourhoods, and should be involved in consultations for neighbourhood 
improvements.  
In a similar vein is the development of ‘Cohousing communities’ which are created and 
run by their residents (see ‘http://cohousing.org.uk/’). Residents own a private 
household but have shared areas, such as for cooking and washing. They share 
activities and support one another. Another initiative called ‘Homeshare’ matches 
elderly and vulnerable people with younger people who are willing to offer help in 
exchange for cheap accommodation in the older person’s home (see 
‘http://homeshare.org/programmes-worldwide/united-kingdom/’). These strategies 
could enable individuals with AMD to live independently and reduce a reliance on a 
primary caregiver. There have been some evaluative studies of such programmes in 
the UK (O'Shea, 2012; Thornton, 1995). Coffey (2010) evaluated a Homeshare pilot 
programme in three areas of the UK (Oxfordshire, West Sussex and Wiltshire). The 
homeowners reported that sharing their home with a ‘housesharer’ allowed them to 
gain independence, provided companionship, increased confidence (e.g. for walking 
independently) and reduced worries about  being alone if they fell over or had an 
accident. ‘Housesharers’ reported benefits included: cheap accommodation, 
companionship, language and cultural education and an increased awareness of the 
challenges experienced by the homeowner. The evaluation included QoL and health 
status measures (the WHOQOLBREF and EQ-5D). Unfortunately there were too little 
data at follow-up to examine improvements in QoL over time.   
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COMMENTS ON THE MEASURES USED IN THE QUANTITATIVE STUDY 
The qualitative findings provide some suggestions for how the measures used in the 
quantitative study could be adapted to be relevant to the study of dyads of pwAMD 
and their caregivers. 
A potential way to make the CRA more relevant for caregivers of pwAMD could be to 
adjust the measure to allow caregivers to rate the importance of each item to their 
lives, following the design features of the MacDQoL (Mitchell et al., 2005). This would 
indicate which questions and subscales have a bigger impact on their lives. On 
analysing the interview data, it seems that for many of the interviewees (particularly 
adult-offspring caregivers), caregiving for AMD impacted heavily on their schedule as 
they tried to manage competing responsibilities. Although there were generally high 
scores for the ‘impact on schedule’ subscale in the quantitative study findings, the 
overall CRA score is quite low, perhaps due to averaging this score out with the other 
subscales which tended to have lower scores (such as ‘impact on health’). This masks 
the impact that caregiving has on their schedule. If one could state the importance of 
the items on this subscale, then the overall CRA score might more accurately reflect 
the burden felt by caregivers. Indeed rating the importance of items on the CRA might 
help to highlight which items are more relevant for spouse or adult-offspring 
caregivers. 
Large-scale studies would need to test and validate this adapted version of the CRA 
with importance ratings. If most caregivers of pwAMD agreed on the relative 
importance of items, then they could be weighted for general use. If there are 
differences (for example between spouse and adult-offspring caregivers as described 
above), then each respondent would need to rate each item and individual weightings 
would need to be used. 
The qualitative study highlighted the emotional impact of difficulties with performing 
activities because of sight loss. Providing emotional support to the pwAMD was not 
measured in the quantitative study. Both the qualitative and quantitative study 
suggest that participants consider everyday tasks when deciding on how much support 
they receive or provide. It may be important to ask specifically about provision of 
emotional support as this type of support doesn’t appear to be considered when 
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deciding on the amount of support received/ provided. Providing emotional support 
may also impact on caregiver secondary appraisals of providing care, and pwAMD and 
caregiver well-being.  
STRENGTHS AND LIMITATIONS OF THE STUDY AND IDEAS FOR FUTURE RESEARCH 
As mentioned in Chapter 7, the results from the SEM are limited based on the small 
sample size used. Thus the results are only suggestive of possible relationships 
between the quantitative measures used and would benefit from the study being 
repeated using a larger sample.  
There are several limitations to the study in common with the 2013 survey. First, both 
quantitative studies used questionnaires to collect data. In the second study, pwAMD 
were offered the opportunity for telephone completion, and three participants took 
this up. It is likely that some of the respondents who completed a paper version 
received help with questionnaire completion from someone else, however we did not 
ask if they received help in the second study and so we do not know the percentage 
who received this. It is possible that the answers from respondents who had assistance 
with questionnaire completion may not be a true reflection of their experiences. For 
instance, pwAMD well-being scores may be higher if they preferred their caregiver to 
be unaware of the true extent of their level of stress and negative well-being. Similarly, 
for dyads who completed their respective questionnaires at the same time, caregivers 
may not have wanted the pwAMD to be aware of low well-being and high perceived 
‘burden’ resulting from caregiving. The author received anecdotal evidence for this 
when she was arranging interviews with participants for the qualitative study. A 
caregiver stated that she felt her answers weren’t very accurate because she 
completed the questionnaire with her mother present and didn’t want her to know her 
‘true’ answers. Thus this may limit the validity of the questionnaire findings. In 
addition, in the present dyadic study, despite assurances of participant confidentiality, 
it is possible that the interview respondents were worried about their answers getting 
back to the other member of their pair and this may have affected their responses. 
Secondly, this sample of pwAMD who were members of the Macular Society at the 
time of the first survey, may be more informed by the Macular Society about their 
AMD than the general AMD population, and would have had access to support from 
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the Macular Society. Data was not available to see how long pwAMD had been 
members of the Macular Society. However since they had all been members at the 
time of the 2013 survey (end of 2013), and data collection for the second study took 
place at the end of 2015, it can be deducted that they had all at least known about the 
Macular Society for at least two years (whether they had discontinued membership 
since 2013 is unknown). Thus they had had the opportunity to access help from the 
Macular Society if needed.  
One possibility is that caregivers who were the most overloaded or over-burdened 
didn’t feel they had the time to complete the survey or take part in the interviews, and 
thus the caregiver experiences reported in the present study may not be 
representative of the population of caregivers of pwAMD. The CRA scores reported in 
the quantitative study may be an underestimation of the ‘burden’ faced by the 
population as a whole. Equally, it may be that caregivers who felt the most impact of 
providing support were more likely to volunteer as they felt able to contribute 
meaningfully to the research, would want to progress the research field to benefit 
caregivers or may want the opportunity to ‘offload’ and thus taking part may be 
considered therapeutic.   
The ‘ideal’ sample size for use in interview research continues to be debated (see 
Chapter 6 for a discussion). It is difficult to know when ‘saturation’ has been reached, 
and the author could not be sure that enough data were collected to allow the topic to 
be explored fully. Also, the qualitative study did not include pairs consisting of 
daughters and fathers, whose experiences may differ from those included in the 
interview study here. Indeed, it would be interesting to investigate the issue of 
‘gendered roles’ in these pairs. Only 6% (n=4) of respondents were father- daughter 
pairs, and in the one pair that volunteered for interview the pwAMD had another 
serious medical condition (cancer). It was felt that to include this pair might bias the 
results. This perhaps mirrors the percentage of father-daughter pairs in the population 
of pwAMD, since AMD is more common in women than men and women tend to 
outlive men (so male pwAMD may be more likely to receive support from their wives). 
Thus the findings reported here may reflect the AMD populations’ demographics and 
thus be generalisable to the majority of this population.  
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The qualitative study indicated that there may be gender-specific responses to 
providing care (e.g. accepting the lack of help from formal services). However, as 
mentioned above, the study included only one male son caregiver and so larger studies 
would need to be carried out to see if these findings are generalisable.   
The pairs included in the qualitative study reported having received or provided 
support for AMD for more than five years and thus they may have had time to develop 
the strategies to cope with the impact of providing and receiving support. Future 
research might see how pwAMD/caregiver dyads who have been providing support for 
AMD for a shorter duration are managing this change. 
It is important to note that AMD is a degenerative condition and the qualitative 
findings illustrate the dynamic nature of living with AMD and sight loss. This is 
illustrated in the qualitative study through within- and between-pair comparisons (i.e. 
participants reflected on their own experiences since diagnosis and pairs differed in 
their time since diagnosis, pwAMDs’ visual function scores etc.). This is a strength of 
the study as it allows us to generalise the results to the experiences of pairs at 
different stages. Though the results may be considered to be limited because they do 
not look at any particular stage in detail, and pairs may differ in their ability to cope at 
different stages. Thus a longitudinal study which follows up pairs over time may 
provide more reliable data on how pairs manage with providing support for AMD at 
different stages of this degenerative condition.  
The qualitative study used separate interviews with caregivers and pwAMD. The 
researcher noted in her reflective notes how one person in a pair tended to be more 
verbose than the other, and that by having separate instead of joint interviews, this 
may have enabled the quieter of the pair to have their say. However there may have 
been benefits to using joint interviews including insights into how pairs discussed and 
managed AMD together. Additionally, since both members of the pair are present in 
joint interviews, this would overcome the issue of internal confidentiality. However 
joint interviews may have prevented participants from talking about the negative 
aspects of receiving or providing care that participants would prefer to be hidden from 
their counterpart. 
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The researcher took the approach of using thematic analysis to describe patterns in 
the data for all pairs interviewed. An alternative approach may be to focus on 
individual pairs. This was the approach taken by Burton et al. (2015) who focused on a 
married couple both living with AMD. They used interpretative phenomenological 
analysis (Smith, Flowers, & Larkin, 2009) to conduct an in-depth analysis of 
participants’ responses in order to understand their lived experience of living with 
AMD together. In addition, the guidelines for qualitative dyadic analysis suggested by 
Eisikovits and Koren (2010) could be used to help investigate features of ‘togetherness 
and separateness’ within pairs- a feature lost by using thematic analysis across more 
than one pair. A broader approach was taken in the current study so that results would 
reflect a wider variety of dyads’ experiences and thus would have more 
generalisability. Also internal confidentiality issues prevented the presentation of 
detailed analysis and quotes from each member of the pair. 
A key strength of this study was the use of a variety of research methods and analysis 
(i.e. mixed methods, dyadic methods and analysis, and structural equation modelling) 
that had relevance to the study of dyads and provided a more thorough exploration of 
the impact of receiving/providing support for AMD than has been used in previous 
studies focusing on either the pwAMD or the caregiver. In addition, the separation of 
the qualitative findings for spouse and adult-offspring/parent pairs, provided 
information on the differences between these pairs and gave some insight into 
changes in caring responsibilities as people get older. 
Another strength of this study is the use of validated questionnaires to assess well-
being and QoL. Previous studies including caregivers of people with wet AMD have 
relied on creating their own (untested) instruments to measure caregiver outcomes 
(e.g. Gopinath et al., 2015).  
Lastly, the researcher noted only a small amount of research on dyadic analysis and in 
particular, the considerations that should be taken into account when using mixed 
methods. Further research could address this issue, particularly as the study of 
patient/caregiver dyads becomes more relevant in the future as the population ages 
and research is needed to determine ways to support dyads. 
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The present study focused on pwAMD who receive support however research is also 
needed to support those who are coping without a caregiver and the factors that lead 
to pwAMD requiring informal care. 
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Chapter 9: General discussion 
The main research questions for this thesis were: 
1. To investigate whether healthcare experiences of patients with age-related 
macular degeneration have improved since a similar survey was carried out in 
1999. To determine whether significant improvements have been made since 
publication of the 1999 survey results in 2002, and/ or the Royal College of 
Ophthalmologists (RCOphth, 2009) management guidelines in 2009. 
2. To examine other sources of information and support used by people with 
AMD (pwAMD) after the diagnostic consultation, in particular support from 
friends and family. 
3. To explore the impact of receiving and providing care for AMD from the 
perspectives of pwAMD and their caregivers.  
The studies that investigated these research questions used a pragmatic mixed-
methods approach. This chapter will summarise the research findings and consider the 
implications of the research. A discussion of the limitations of the findings and possible 
avenues for future research are also included.  
Overview of findings 
Healthcare experiences – changes since 1999 
The Macular Society 2013 survey (MSQ 2013) formed the first study of the thesis. This 
nationwide survey was sent to 4000 members of the Macular Society and received a 
39% response rate (n=1571). The results of this 2013 survey, presented in Chapter 3, 
showed that people diagnosed with AMD since the 1999 survey, reported better 
experiences at diagnostic consultation. They were significantly more likely to be given 
the name of their macular condition, report that the HCP who diagnosed them was 
interested in them as a person, and report overall satisfaction with the diagnostic 
consultation. Within the 2013 sample, there were gradual trends of improvement over 
time in: provision of written information, Macular Society information and receiving 
appropriate help, support and advice at the time of diagnosis. In regard to the 
RCOphth guidelines, whilst overall satisfaction with the diagnostic consultation 
significantly improved following their publication in 2009, nine other areas of 
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information and support provision remained low and did not significantly improve. 
There were no significant improvements associated with publication of the 1999 
survey results in 2002. The top two reasons for dissatisfaction with the diagnostic 
consultation reported by the 1999 sample remained the same for the 2013 sample: a 
lack of information and advice given (e.g. on the condition, prognosis, further support) 
and poor attitude of the HCP who diagnosed them (they were seen as dismissive, 
patronising or unfeeling). 
Sources of information and support used by people with AMD 
The 2013 survey respondents reported lower levels of help and support from GPs than 
did the 1999 respondents. In addition, 39% reported their GP was ‘not at all well-
informed’ about their macular condition. The 2013 survey respondents reported a 
need for information and support in several areas following diagnosis, but felt that 
they were not offered the information and support they required. Needs included 
access to psychological support and to a low-vision clinic.   
Receiving informal care, support or assistance for AMD 
Chapter 4 described the investigation of the receipt of support for AMD from family 
and friends. Of the 2013 survey respondents, 53% reported receiving care because of 
their AMD. Respondents who received care for AMD reported poorer QoL (both 
general and MD-specific) and well-being. Receiving more care for AMD (measured in 
number of hours per week) was associated with poorer well-being and MD-specific 
QoL, but not general QoL. These relationships were found despite controlling for the 
respondent’s degree of visual impairment (VI) using registration status and self-
reported change in vision status since diagnosis (whether vision was better, the same 
or worse). 
The impact of receiving and providing care for AMD 
Subsequent studies (Chapters 6 to 8) used a mixed-methods approach to examine 
possible reasons for the relationship between receiving care for AMD and poor well-
being. Previous research has neglected to take into account the close relationship 
between pwAMD and their caregivers (see literature review in Chapter 5). Unique to 
this area of research, the aim of the subsequent studies was to explore the impact of 
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receiving and providing support for AMD using a dyadic perspective. The second 
quantitative study (Chapter 7) built on the 2013 survey findings by asking participants 
about the difficulty they had with carrying out vision-related tasks instead of using 
registration status and change in vision status since diagnosis as measures of VI. 
PwAMD’s level of visual functioning, measured using the DLTV, may more accurately 
reflect the pwAMD’s experience of VI. Structural equation modelling examined 
predictors of well-being of the pwAMD and their caregiver, caregiver general health 
and caregiver reactions towards providing support.  When the DLTV measure was used 
as a measure of VI, the amount of help received for AMD was no longer associated 
with pwAMD well-being, nor was it associated with caregiver well-being or health. 
PwAMD who reported their vision caused them more difficulty carrying out vision-
dependent tasks and who reported poorer general health, were more likely to report 
poorer well-being. Caregivers who reported greater negative impact of providing 
support, reported poorer well-being and health, however, caregiver reactions towards 
providing care did not impact on pwAMD well-being. Poorer pwAMD general health 
(but not difficulties with vision-dependent tasks or tasks associated with daily living) 
predicted more negative caregiver reactions to providing support. PwAMD general 
health indirectly predicted caregiver well-being and health via caregiver reactions to 
providing support.  The amount of support received and provided was mainly 
determined by the level of difficulty pwAMD had with carrying out everyday tasks 
(IADLs), but not with more specific vision-dependent tasks nor their general health 
status. 
The qualitative third study was designed to explore the experiences of 
pwAMD/caregiver dyads in more depth, and to help explain and elaborate on the 
second quantitative study findings. Chapter 8 reports the findings from qualitative 
interview data with eight dyads. Four pairs were spouses (for two pairs the husband 
had AMD, and for the other two pairs the wife had AMD). Of the remaining pairs, three 
caregivers were daughters and one was a son. All adult-offspring caregivers were 
providing support for their mother with AMD. The findings highlight the similarities 
and differences between pwAMD/caregiver pairs where the caregiver is the spouse of 
the pwAMD, and those where the caregiver is the adult-offspring of the pwAMD.  
Three themes were identified: (a) Managing independence, (b) Accepting the ‘new 
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normal’, and (c) External support. Whilst these three themes were identified in the 
transcripts of spouse pairs and adult-offspring/parent pairs, there were important 
differences in the descriptions of their experiences, and their results were therefore 
presented separately. Tied to this was the view that spouse pairs were experiencing 
the impact of providing and receiving support for AMD in ‘partnership’ with one 
another, whilst adult-offspring/parent pairs described ‘looking after mother’. This cut 
across all aspects of their experiences and was reported as the overarching theme; 
“Managing the changes: living with AMD in partnership vs looking after mother”.  
The theme ‘managing independence’ described the impact that vision loss had on 
pwAMD activities and hobbies. Vision loss impacted on activities the pairs shared 
together. Pairs discussed strategies they used to maintain the pwAMD’s confidence in 
continuing with activities, thus enabling continued independence for the pwAMD and 
reducing reliance on the caregiver which impacted on the caregiver’s own 
independence. There were indications that adult-offspring caregivers had more 
difficulty determining the appropriate amount of support to provide. “Accepting the 
‘new normal’” described how pairs had adapted to receiving and providing support for 
AMD. For spouse pairs, the majority spoke about providing and receiving support as an 
accepted part of their marriage together. Changes to established roles within the pair 
required the greatest adjustment (e.g. becoming the main driver). Adult-offspring 
caregivers tended to report more difficulty fitting the provision of care into their lives 
around their other responsibilities. Both spouse and adult-offspring/ parents pairs 
reported difficulty accessing external support from formal services (health and social 
care) and from family and friends (discussed under the theme ‘External support’). 
Due to the small sample size of 72 dyads, the second quantitative study was unable to 
take into account the type of pwAMD/ caregiver relationship in multivariate analysis. 
However the qualitative third study highlights that the type of pwAMD/caregiver 
relationship is important for understanding how pwAMD and their caregivers adapt to 
living with AMD.  
The third theme highlighted in the qualitative study, ‘External support’, reflected 
findings from study 1 which describe the lack of information and support provided to 
pwAMD at diagnosis and beyond. 
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Practical and theoretical implications 
Before discussing the findings any further it is important to be mindful of the current 
squeeze on NHS and social care services in England. Furthermore, this pressure is only 
likely to increase with the rising older population at risk of developing AMD. Thus, 
where possible, suggestions for interventions that use existing resources (e.g. medical 
training, use of voluntary sector services) have been focused on here. 
Information and support provision in healthcare 
Patient experiences are an important indicator of the quality of healthcare. The results 
from the 2013 survey and the qualitative study suggest there is considerable room for 
improvement in information and support provision in the diagnostic consultation and 
thereafter. It is a concern that the RCOphth 2009 guidelines, which contain 
recommendations for what information and support should be provided in diagnostic 
consultations, were not associated with significant improvements in many areas of 
information and support. The 2002 publication of the 1999 survey results was also not 
associated with improvements suggesting that such publications alone are not enough 
to promote changes in practice.  
Many respondents reported seeing their GP about their AMD, however several felt 
their GP was uninformed about their AMD or was not helpful or supportive. Whilst 
referral via a GP is no longer needed for diagnosis, the GP has a key role in the 
management of AMD. For instance, they act as a ‘gatekeeper’ for access to further 
support (e.g. referral to an eye specialist for registration as SI or SSI which may lead to 
benefits for the pwAMD). PwAMD may find it easier to access an appointment with 
their GP than with an eye specialist. There is the potential for GPs to provide important 
information and support for pwAMD after diagnosis. Study 1 found that, compared 
with the 1999 survey, fewer of the 2013 survey respondents who had experienced 
visual hallucinations reported that they had been to see a HCP about hallucinations. 
Without the knowledge that sight loss can cause visual hallucinations (also known as 
Charles Bonnet Syndrome or CBS), pwAMD may attribute the hallucinations to a 
serious mental illness such as dementia. It may thus be worthwhile to educate GPs 
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about CBS and ask them to discuss this with their patients who have AMD. Such 
explanations could prevent unnecessary worry arising from attributing the symptoms 
to an alternative cause.  
The multivariable analysis in Study 1 included several socio-demographic, eye- and 
health-related factors linked to patient experiences. Women were found to be less 
likely than men to report receiving information and support for five aspects of 
healthcare. Older respondents were more likely to report not receiving information at 
diagnosis on what to do if they experience a sudden deterioration in vision. This study 
did not examine whether differences in reported information and support provision 
were due to differences in patient characteristics (e.g. expectations) or differential 
treatment from HCPs (perhaps resulting from sex-role stereotypes (women are more 
likely to get upset) or ageist beliefs (older people won’t recall the information 
provided)). Nevertheless, an awareness of the differences should prompt HCPs to 
check these particular ‘at risk’ groups have received and understood important 
information and take home written information for later reference. HCPs should be 
trained to self-reflect on their interactions with patients; to check that they have 
provided information and support to everyone regardless of age or gender.  
Respondents who were registered as SI or SSI at the time of survey completion were 
more likely to report not having received, at time of diagnosis, information on what to 
do if they experience a sudden deterioration in vision. This suggests that lack of such 
information at diagnosis may cause subsequent sight loss sufficient to warrant 
registration. 
The Macular Society produce a ‘Guide to AMD’ leaflet which contains information 
pertinent to the RCOphth guidelines. If these leaflets were handed to pwAMD and 
their caregivers, this could be a relatively simple way of providing this information to 
pwAMD. Leaflets could be given in consultations by HCPs or by eye clinic staff, or by 
volunteers post-consultation. Some pwAMD report having difficulty reading written 
information so the leaflet is likely to be more effective if the HCP or volunteer explains 
the information in the leaflet and highlights important points (e.g. to seek help 
immediately if the pwAMD experiences a sudden deterioration in vision).  
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It may be the case that ophthalmologists, optometrists and GPs do not see providing 
information and support as part of their role in the management of AMD. The results 
suggest that information given early on, may lead to better outcomes, e.g. as above, 
the 2013 survey respondents who reported not receiving information at diagnosis on 
what to do if they experience a sudden deterioration in vision were more likely to be 
registered as SI or SSI, thus demonstrating the importance of providing this 
information. Medical training should emphasise the benefits of providing information 
and support to patients, not only in terms of improving eye-related outcomes, but also 
in terms of improving patient experience. It has been suggested that examining how 
illness is represented in various art forms (e.g. novels, poems, movies or paintings) 
might help sensitise medical students and HCPs into humanising medical care (Kaptein, 
Meulenberg, & Smyth, 2013). There are some depictions of AMD in art, e.g. the 
painting ‘Eyes’ by Cecil Riley illustrates the painter’s visual hallucinations caused by his 
AMD (Riley, 2008). The painting of a series of eyes depict the visual hallucinations of 
eyes that floated across his vision. The use of vision simulators during medical training 
could facilitate a better understanding of AMD and its effect on functioning. 
Additionally, qualitative research provides rich, detailed accounts of patient’s and 
caregiver’s experiences that could be used to convey the impact of AMD to medical 
students and HCPs. For example, the HealthTalk online website 
(http://www.healthtalk.org/) includes short films of interviews with people with a 
range of conditions and their caregivers. The films are organised into themes based on 
the issues relevant to the patients and caregivers. The interviewees explain their 
experiences, in their own words. It is difficult not to be moved on hearing their 
experiences.  Some of the short films have been developed into teaching resources for 
HCPs (see http://www.healthtalk.org/peoples-experiences/improving-health-care). 
These films were designed to trigger discussion and debate about patients and 
practice.  Similar films including pwAMD and their caregivers could be used to illustrate 
the issues found in this thesis and be geared towards service improvement, for 
instance, highlighting the impact of lack of information and support provision at 
diagnosis and beyond. These films could be incorporated into medical training to help 
‘humanise’ patient care.  
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The 2013 survey findings and interviews with pwAMD/caregiver dyads suggest that 
many are not receiving further information and support after being seen by a ECP at 
diagnosis. Previous studies have also found that people with VI aren’t given access to 
support services after diagnosis (Hodge et al., 2015; Thetford et al., 2009, 2011). There 
is evidence to show that registration doesn’t necessarily mean that people with VI are 
directed to the services and benefits they are entitled to (Hodge et al., 2015). Previous 
research has highlighted that pwAMD have different information and support needs at 
different stages, e.g. during treatment, or based on their type of AMD (wet or dry) 
(Burton et al., 2013). The qualitative study presented in Chapter 8 provides the 
perspective of pwAMD/caregiver pairs and showed that AMD impacts on those around 
the pwAMD as well as the pwAMD. This shared impact led to support needs including: 
household tasks both routine and for maintenance and repairs, plus respite for the 
caregiver as well as emergency cover. There appeared to be different support needs 
for pwAMD/caregiver pairs who were spouses and pairs where the caregiver was the 
adult-offspring of the pwAMD. For example, adult-offspring caregivers were more 
likely to report requiring respite help as they were managing competing 
responsibilities, whilst spouse pairs were more likely to only require help in an 
emergency situation.  There were barriers to receiving and asking for help including: 
difficulty putting trust in others (e.g. for respite help or cleaning), and friends and 
family not being aware of the impact of vision loss or of providing care and therefore 
not offering help.   
As noted in the paragraph above, the qualitative study showed that AMD impacts on 
the caregiver as well as the pwAMD. Under the theme ‘External support’ presented in 
the qualitative study, some caregivers noted negative interactions with HCPs. In 
particular, one caregiver described how she and her husband with AMD felt they had 
been ‘brushed aside’ by a consultant when treatment for AMD was no longer effective. 
Such experiences fuel negative perceptions of the NHS and may lead to disengagement 
with it. Caregiver’s and pwAMD’s lives are interwoven and as such, caregivers are in a 
strong position to inform health and social care professionals about the consequences 
of negative interactions and experiences with health and social services. This may be 
particularly important for pairs where sight loss has led to depression in pwAMD, and 
they may not feel able to advocate for themselves. Therefore their caregivers might be 
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able to represent the views of these pairs where the pwAMD may be less likely to put 
their views across.  
On a practical level, health and social care services need to be aware that unexpected 
and unexplained one-off visits from professionals who never call again, cause not only 
confusion in pwAMD and their caregivers but also contribute to a sense of 
abandonment from these services. Informing pwAMD and their caregivers about home 
visits in advance will give them time to prepare questions beforehand to make sure 
that such ‘one-off’ visits are beneficial. 
Another key finding of the present research was the importance of emotional support 
at initial diagnosis and the potential lack of this type of support. For example whilst 
30% of respondents to the 2013 survey reported that they would have like to have 
been offered psychological support at the time of diagnosis, only 2% reported ever 
being offered such support. Almost one in ten of the 2013 sample reported they would 
have liked to have been offered psychological support at the time of survey 
completion. This shows the initial emotional impact of diagnosis of AMD and the on-
going support needed. Eye clinics and GPs could easily be made aware of this need for 
emotional support and signpost appropriately.  
Since 74% of the 2013 survey respondents, who were all members of the Macular 
Society at the time of survey completion, reported not being told about the Macular 
Society at diagnosis, this suggests that they found out about the Macular Society 
through other means. Indeed, 82% of respondents reported not being given other 
contacts for help and support at the time of diagnosis. This evidence adds to previous 
research showing people with VI are required to be proactive in seeking further 
information (Burton et al., 2013). 
Further information may be obtained through attending local support groups. The 
qualitative study presented in this thesis indicated the benefits of attending these 
groups for the pwAMD in this study, including that meeting others with sight loss was 
used as a source of inspiration and motivation in managing the impact of VI.  If ECPs in 
diagnostic consultations were to signpost pwAMD routinely to these groups and 
explain the benefits of attending, then pwAMD would not feel abandoned after 
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diagnosis, they would be able to receive further important information on their AMD 
and they’d be able to build rapport with other people in a similar situation.  
Awareness of the similarities and differences between pwAMD/caregiver pairs who are 
spouses and those who are adult-offspring/parent pairs 
Whilst the quantitative studies (presented in Chapters 4 and 7) found no significant 
differences between pairs who were spouses or adult-offspring/ parent pairs in QoL or 
well-being, the qualitative study highlighted the similarities and differences between 
these types of pairs in managing the impact of sight loss. It may be important to take 
into account such differences when designing interventions. For instance, whilst for 
spouse pairs the provision and receipt of support for AMD was an accepted part of 
their marriage together, for adult-offspring/ parent pairs, caregivers reported more 
difficulty fitting caregiving into their lives and help from others was more likely to be 
needed. Additionally, adult-offspring caregivers were more likely to report difficulty 
understanding the extent of their parent’s vision loss. They may benefit from 
interventions designed to improve understanding of the pwAMD’s vision loss (e.g. 
Cimarolli et al., 2004). The use of vision simulators could facilitate a better 
understanding of AMD and its effect on functioning. 
The importance of taking into account the dyad 
As far as the author is aware, the current research is the first in this area to explore the 
interactive relationship between the care recipient and provider within 
pwAMD/caregiver pairs. The quantitative study found that pwAMD general health 
predicted caregiver reactions to providing support. There was an indirect relationship 
between pwAMD health and both caregiver well-being and caregiver health, via 
caregiver reactions to providing care. However pwAMD difficulties with vision-
dependent tasks, everyday tasks or the amount of help the caregiver provided to the 
pwAMD did not predict these caregiver outcomes. By taking into account pwAMD and 
caregiver factors and by treating the dyad as the unit of analysis, this study has been 
able to indicate which factors may be useful for targeting in interventions.  For 
instance, the results suggest that it may be useful to target pwAMD general health in 
order to reduce caregivers’ negative reactions to providing care.  
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The addition of a qualitative methods approach provided a deeper understanding of 
how pairs managed the impact of AMD together. Previous self-management 
interventions for people with VI have targeted the patient only and have had limited 
long-term effects (for a review see Cimarolli et al., 2016). Such interventions include 
teaching problem-solving techniques to remove barriers to activity engagement, 
training in the use of optical and assistive devices (LVAs), and the teaching of 
orientation and mobility skills. The qualitative findings suggest that having the 
caregiver present to support the pwAMD may act as a boost to encourage longer term 
effects by reinforcing what was learnt and reminding them to apply it in the future. 
Using a qualitative approach allowed specific issues related to the shared experience 
of living with AMD to be recognised, which could be targeted in interventions. One 
important concern was that of safety. For example, several respondents expressed 
concerns about pwAMD not being able to see obstacles that might cause them to trip 
or fall, or that they might have an accident using kitchen appliances. This issue could 
be addressed by having facilitated discussion about changes needed to prevent 
accidents, particularly as the findings indicated that tension might arise if one member 
of the pair is reluctant to make changes. Facilitated discussion could perhaps happen in 
local support groups. Other interventions might include: advice on LVAs that can 
reduce the risk of accidents, and referral to vision rehabilitation support who can come 
to the home and provide help and advice on changes to improve safety. 
Additionally, the pairs reported that vision loss from AMD had impacted on more than 
practical day-to-day living but also on their shared activities. These activities could be 
targeted in interventions, such as local support groups. Discussions might include how 
AMD has affected the activity and developing a plan for how the pwAMD and caregiver 
might jointly overcome the obstacles that prevent them from carrying out the activity 
or find substitute activities that better suit. 
Lastly, the recent IVAN trial comparing the efficacy of two anti-VEGF treatments 
(ranibizumab and bevacizumab) for wet AMD primarily investigated changes in 
corrected distance visual acuity (using VAlogMAR) (Chakravarthy et al., 2013). Changes 
in visual function (using reading index, contrast sensitivity and near visual acuity) and 
the pwAMD’s QoL (using the MacDQoL) were also investigated. The findings of the 
pwAMD/ caregiver study presented in this thesis indicate that AMD is not experienced 
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in isolation and caregivers are likely to be affected by treatment. For instance, 
stabilisation or an improvement in visual acuity may impact on the activities the 
pwAMD is able to do, thus maintaining their independence and reducing reliance on 
their caregiver. This may lead to a reduction in the amount of help provided, which 
could have subsequent impacts on various aspects of the caregivers’ and pwAMDs’ 
QoL (e.g. employment, social life) and health. Shared activities may be able to be 
continued for longer. The risk of trips and falls may reduce, as well as the subsequent 
need for hospitalisation, thus reducing the impact on health and social services. Long-
term evaluations might investigate whether treatment leads to the pwAMD being able 
to stay in their home for longer (as opposed to entering residential care), and the 
resulting impact on both pwAMD and their caregiver’s QoL.   
Designing a model to understand the impact of receiving and providing support 
A review of the literature could not find a model that proposed a way of examining the 
experience of living with AMD using a dyadic perspective. The Yates et al. (1999) 
stress-process model was used as a starting point in the second quantitative study, 
however the original model focuses on caregiver outcomes. PwAMD well-being was 
added as an outcome in the study presented in this thesis. As a result of the qualitative 
findings, I have suggested a variety of possible modifications to the model (see 
discussion section in Chapter 8). This thesis provides an important first step in 
assessing the experience of receiving and providing support for pwAMD/caregiver 
pairs. 
By using a sequential mixed-methods approach to study the impact of receiving and 
providing support for AMD, this thesis has used the qualitative findings to suggest how 
the quantitative measures used in the second quantitative study may be adapted to be 
relevant to pwAMD and their caregivers. For instance, the CRA measure used to 
investigate caregiver reactions to providing support could be adapted to allow the 
participants to rate the importance of each item to their lives, following the design 
features of the MacDQoL measure of the impact of macular disease on QoL (Mitchell 
et al., 2005). This would indicate which items and subscales have a bigger impact on 
their life. The qualitative study highlighted differences between spouse and adult-
offspring caregivers in their experiences of providing support; however the mean total 
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CRA scores were not significantly different between these types of caregivers. The 
adapted CRA measure with importance ratings may reveal where priorities differ for 
spouse or adult-offspring caregivers.  In particular, the qualitative findings suggested 
that providing care may impact more heavily on adult-offspring caregivers’ schedule 
and the adaptation proposed may help to show this. 
A model of Health-related Quality of Life 
The results of the studies reported in this thesis may provide evidence that could be 
used to inform the development of a disease-specific Health-related Quality of Life 
(HRQoL) model for AMD. This can be used to understand where intervention may be 
appropriate and the impact this is likely to have on outcomes that are important to the 
patient. For example, the most widely reported model of HRQoL, proposed by Wilson 
and Cleary (1995), suggested that functional status and general health perceptions are 
associated with overall QoL. The second quantitative study reported in this thesis 
found that pwAMDs’ difficulties with visual functioning and their perception of general 
health were associated with their well-being, and therefore provides evidence to 
support these relationships in pwAMD. This suggests that an intervention to improve 
pwAMD’s general health or level of visual functioning may lead to improvements in 
their well-being. In addition, Wilson and Cleary’s (1995) model also suggested that 
characteristics of the individual’s environment, such as interactions with healthcare 
providers and support received from family and friends, may affect the individual’s 
perceptions of their symptoms, functional status, general health perceptions and 
overall quality of life. However the authors did not provide detail on how these 
characteristics may affect these outcomes. Whilst the first study in this thesis 
examined the information and support received in the diagnostic consultation, it did 
not go beyond this to understand how this might affect QoL. Evidence from qualitative 
interviews with pwAMD and their caregivers found that they were disappointed with 
the lack of support received from health and social services. As suggested in Chapter 8, 
it may be useful for the dyadic model to include a measure of the perception of help 
received from health and social services in order to understand how these factors 
might impact on outcomes. The impact of healthcare experiences on outcomes such as 
visual functioning, general health and QoL remain to be tested formally.   
 388 
 
Impact 
A potential way in which to train ECPs to provide much-needed information and 
support in consultations may be through professional meetings or training courses. 
The author and Professor Clare Bradley attended ‘The Elizabeth Thomas seminar for 
Macular Disease’ organised by the RCOphth in October 2016. This annual seminar is 
attended by ophthalmologists with varying amounts of experience in providing eye 
care. Some are more experienced and are involved in the supervision and training of 
less experienced ophthalmologists. The author and Professor Bradley presented the 
findings on healthcare experiences from this thesis (presented in Chapter 3), and 
emphasised that information pertinent to the RCOphth guidelines (RCOphth, 2009) are 
included in the leaflet produced by the Macular Society called ‘Guide to AMD’. An 
impact questionnaire completed by ophthalmologists before the presentation found 
that over half of the ophthalmologists in attendance reported that they ‘always’ gave 
the leaflet to pwAMD.  Of those who reported not already ‘always’ giving this leaflet to 
pwAMD, all but one ophthalmologist changed their response in the post-talk 
questionnaire to say that they would now give the leaflet to pwAMD ‘all the time’. 
Thus professional seminars for ECPs may be another route in which to improve 
awareness of patient experiences. The use of post-talk questionnaires may facilitate 
ECPs to question their current practice, thus potentially leading them to make 
informed decisions about how they might change their future consultations with 
pwAMD and how they might train less experienced ECPs to do the same. 
Limitations of the thesis  
First, the participants with AMD who participated in all three studies presented in this 
thesis were members of the Macular Society at the time of the 2013 survey 
completion. One might question the representativeness of the sample. Individuals may 
have joined the Macular Society because they had unsatisfactory experiences in their 
diagnostic consultations and sought information and support elsewhere. Conversely, 
this sample may have received information about the Macular Society in the diagnostic 
consultation more often than the general AMD population and thus be more satisfied. 
Macular Society members may be more informed about AMD than the wider 
population of pwAMD, and may have accessed support from the Macular Society. This 
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may have reduced the need for support from elsewhere (e.g. from family and friends, 
formal services). Thus caution should be applied when generalising the thesis findings 
to all pwAMD including those who are not members of the Macular Society. 
Caregivers who didn’t volunteer to take part in the second quantitative study and 
qualitative third study may be the most overloaded or over-burdened and didn’t feel 
they had the time to complete the survey or take part in the interviews. Therefore the 
caregiver experiences reported in these studies may not be representative of the 
population of caregivers of pwAMD. Equally, it may be that caregivers who felt the 
most impact of providing support were more likely to volunteer as they felt able to 
contribute meaningfully to the research, would want to progress the research field to 
benefit caregivers or may want the opportunity to ‘offload’ and thus taking part may 
be considered therapeutic.  There are other factors that might affect the 
generalisability of the caregivers included in the qualitative study, and are described in 
Chapter 8. For example, of the eight caregivers who took part in the qualitative 
interviews, four of them were spouses of the pwAMD and were retired. The other four 
were adult-offspring caregivers; two of which were still working (one part-time, one 
full-time). This small number of caregivers who were still working may be an 
underrepresentation of caregivers of pwAMD who are employed, however since there 
have been no previous studies on caregivers of pwAMD (including people with wet and 
dry AMD), the proportion of caregivers in work is not known. 
The results of the model presented in the second quantitative study (in Chapter 7) are 
limited by the small sample size used. The results are only suggestive of possible 
relationships between the quantitative measures used. The small sample also meant 
that other factors that may have been relevant to studying the impact of receiving and 
providing support for AMD, including gender of the pwAMD and their caregiver and 
the type of pwAMD/ caregiver relationship, could not be included in the model for 
reasons discussed in Chapter 6. 
In the two quantitative studies included in this thesis, the measure of general health 
used was a 7-point single-item self-assessment of general health, designed for the 
present study based on the generic QoL item from the MacDQoL. This single-item was 
used because the focus of the 2013 survey was to investigate experiences of living with 
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a macular condition rather than general health, and to avoid licensing costs associated 
with using a validated questionnaire. The single-item was quick to administer, however 
there were limitations to what could be inferred from the research findings. For 
instance, in the second quantitative study, pwAMD general health was associated with 
caregiver reactions to providing support and pwAMD well-being. Using a more detailed 
measure of health status, such as the SF-36 (Jenkinson, Stewart-Brown, Petersen, & 
Paice, 1999), may provide more information on which aspects of health (e.g. physical 
functioning, pain) impact on these outcomes.  
This is the first study to use the 16-item version of the Well-being questionnaire (W-
BQ16) with pwAMD and their caregivers. A lack of time meant that the W-BQ16 could 
not be psychometrically evaluated in these samples. However the 12-item W-BQ has 
previously been used and validated for pwAMD (Mitchell & Bradley, 2001). The second 
quantitative study is the first study to use the CRA in a sample of caregivers of people 
with wet and/or dry AMD. Internal consistency of the CRA was good however full 
psychometric evaluation of these measures is needed to assess the acceptability, 
validity and reliability of these measures in this population. 
The survey methodology used in the quantitative studies presented in this thesis 
assessed the participants’ self-report of several of the key variables included the 
analyses including their well-being, quality of life, general health, vision status and 
experiences of healthcare. Common method variance states that variance in these 
factors may be due to the measurement method (i.e. self-report) rather than the 
construct of interest. Thus the relationships found (or not found) between variables 
may be due to an alternative explanation than the one hypothesised. Podsakoff, 
MacKenzie, Lee & Podsakoff (2003) summarised potential sources of common method 
biases. These included, for instance, common rater effects which refers to any artificial 
covariance between variables measured in the study being due to the same person 
providing the responses for two or more variables of interest being correlated in the 
study. Some of the issues of using self-report measures have been mentioned earlier in 
this thesis. For example in Chapter 8, some pwAMD and their caregivers reported 
completing questionnaires together and this may have led to them completing their 
responses in what they perceived to be a socially acceptable manner if they did not 
want the other person in the pair to know their true feelings. Thus caregivers’ and 
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pwAMDs’ well-being and caregivers’ reactions to providing care may have been 
artificially high/positive. The use of an alternative methodology in the form of 
qualitative interviews conducted separately with patients and their caregivers may 
have helped to ameliorate the effect of social desirability affecting participant’s 
responses, thus increasing the validity of their interview responses. It was important to 
measure the participant’s own appraisal of some of the variables included in the 
studies presented in this thesis, including their well-being and reactions to providing 
care. However one might control for the effects of common method variance, where 
feasible, by collecting the measures of variables from different sources, for instance, 
by using clinician reports of the participants’ visual acuity or general health. Time 
limitations in the studies presented in this thesis meant that these variables were 
unable to be collected using this method. 
Recommendations for future research 
The findings from the first quantitative survey highlight that pwAMD are not receiving 
information and support needed to manage their condition. The reasons why they are 
not receiving this are unknown. Future research might investigate the reasons why 
ophthalmologists, optometrists and GPs might not be providing this information. An 
observational study might investigate the interaction between the pwAMD and HCP in 
the consultation. This would provide objective evidence about what information and 
support was provided in the consultation, and also look at how the information was 
conveyed; in particular, whether HCPs showed empathy with the pwAMD and whether 
they were sensitive to the information and support needs of the pwAMD. This research 
method could also be used to see if the gender differences found in provision of 
information and support in the first quantitative study were replicated and whether 
the HCP provided less or different information to women and to older people 
compared with that provided to men and younger people. If pwAMD and HCPs were to 
consent to the consultation being videotaped and used, there is the potential for these 
videos to be used in training HCPs. Follow-up interviews after the consultation could 
help to highlight whether pwAMD and HCPs were satisfied with the consultation and 
identify potential areas for improvement. Involving both HCPs and pwAMDs in working 
together towards service improvement might lead to better engagement with the 
research, and ultimately more patient-centred care.    
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The first quantitative study found that receiving care for AMD was associated with 
poorer QoL and well-being, despite controlling for degree of visual impairment. This 
study used registration status and pwAMD-reported change in vision status since 
diagnosis as measures of degree of VI. The second quantitative study used pwAMDs’ 
self-reported level of visual functioning as the measure of VI (the DLTV). When this 
more detailed measure of visual impairment was used, the amount of care received for 
AMD was not associated with pwAMD well-being. It would be informative to repeat 
the first study using a more detailed measure of visual impairment (such as the DLTV) 
to see if receiving care for AMD (vs not receiving care) is still associated with poorer 
well-being.  The qualitative data suggest that pwAMD appreciate, and perhaps rely on 
the help provided by their caregiver and believe that pwAMD who don’t have this 
support may be struggling;  
I mean I’m just fortunate that I’ve still got my husband because lots of women 
of my age are widows and it must be a great deal more difficult for them. And I 
think because I’ve got him, my life hasn’t changed so much, it has changed of 
course but you know, it could have been, it could be much worse. (Participant 
81, woman with AMD) 
 
It would be useful to investigate how people who do not have access to this support 
manage living with AMD, what can be done to support pwAMD living independently, 
as well as the factors that lead to pwAMD needing support.  
 
Overall summary 
The main survey in Chapter 3 reported a disappointing degree of improvement in 
information and support provision in the diagnostic consultation for pwAMD. Overall 
satisfaction with the diagnostic consultation improved in the time following 
publication of the RCOphth 2009 guidelines, however nine other areas of information 
and support provision didn’t, nor was there any improvement associated with the 
publication of the 1999 survey results in 2002. Satisfaction with GPs was also low. 
Subsequent studies established that pwAMD, when they are not seen in the eye clinic 
for diagnosis or treatment, have little contact with health and social services for AMD-
related support. Support came mainly from family and friends. Previous research has 
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neglected to take into account the close relationship between pwAMD and their 
caregivers, and the considerable impact that vision loss has on the lives of both 
pwAMD and their caregiver. The rising population of older people at risk of AMD will 
put further pressure on overstretched health and social care services, and there is 
likely to be increased reliance on the caregiving of family and friends. Studies in this 
thesis have used dyadic methods to provide evidence-based suggestions for how 
pwAMD and their caregivers can be supported to manage the impact of AMD.  There is 
a profound need for training ECPs on the importance of giving information and support 
in diagnostic consultations, and signposting to further support. Now is the time to 
create a co-ordinated network of information and support, designed by health and 
social care services working in partnership with pwAMD and caregivers.  
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Appendix 1: Search strategy for narrative literature review presented in Chapter 1. 
The electronic databases searched were Web of Science and Google Scholar. 
Reference lists from the resources found were checked for relevant references and 
experts in the field were contacted for additional sources of information. 
Although the review did not endeavour to be systematic in nature, several key words 
were used to retrieve relevant articles for discussion. The important key words 
included: 
  ‘AMD’, ‘age-related macular degeneration’, ‘age related macular 
degeneration’ 
 ‘vision impairment’, ‘vision loss’, ‘low vision’ 
Electronic database searches were not limited by year of publication in order to 
maximise the literature that would be included in the review to understand how 
knowledge and theory on this topic has changed over time. Only articles published in 
the English language were included. Literature using either or both qualitative and 
quantitative methods were included. Review articles were included. 
The author critically appraised the literature but did not use specific criteria to 
evaluate the quality of included studies which are recommended for use when 
conducting a systematic review (e.g. CASP checklist (Critical Appraisal Skills 
Programme, 2013); The Quality Assessment Tool for Quantitative Studies (Effective 
Public Health Practice Project, 1998)). 
Thus it is acknowledged that by using a narrative review method instead of systematic 
review methodology, relevant articles may have been missed in the search (systematic 
reviews typically run searches in several electronic databases) and that studies of poor 
quality may have been included. All included literature has been assigned the same 
level of quality. 
 
 
 
 
 
 
 
 
 
 
    The Macular Disease (MD) Society Questionnaire 
 
 
 
This questionnaire is designed to find out about the  
experiences and views of people with MD. 
 
Please place a cross in the ‘Yes’, ‘No’ or ‘Don’t Know’  
boxes or write in the reply boxes.  If any reply boxes  
are too small for your complete answer, please  
continue on the blank sheet of paper at the back of the 
questionnaire, indicating the question number you are  
responding to.  Please also write any further  
information you would like to give on the extra sheet(s). 
 
 
 
1. Had you heard about MD before your own condition 
was  diagnosed? Yes     No  
 
 
2.  Do you know of any other members of your family who  
 have or had MD? Yes     No            Don’t  
            know 
 
 
 If ‘Yes’, please state in box their relationship to you  
 (e.g. mother, brother etc.) and approximate age of onset 
 if known.  
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3. Before your MD was diagnosed had you experienced  
 any of the following conditions or circumstances? 
 
a. Other eye disease e.g.   
    Glaucoma, cataracts…………… Yes    No 
 
  
If ‘Yes’, please describe 
  
 
  
 
  
 b. Injury to head or eyes.………….Yes      No 
 
 If ‘Yes’, please describe 
 
 
  
 
  
 c. Diabetes………………………….. Yes    No 
 
 d. High blood pressure ……………Yes             No 
            
e. Stroke…………………………….. Yes             No 
 
       If ‘Yes’ to and of the above (a, b, c, d, e) please note any 
medication taken in ‘f’ below. 
 
  f. Frequent use of any medication 
     (e.g. aspirin, sleeping pills)..…..Yes    No 
  
If ‘Yes’, please list 
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 g. Smoking……………….…………. Yes          No 
  
 h. Living and/or working in   
           smoky atmospheres due to  
           others smoking…………………..Yes          No 
 
i. Drinking alcohol…………………   Yes         No 
         
    If ‘Yes’, please state the drink you then preferred 
    e.g. red wine, beer, lager, whisky. 
 
      
 
 
 
 j. Stress or bereavement………..  Yes    No 
 
      k. Working and/or living in   
     hot temperatures/climate……… Yes  No 
 
      l. Frequent or lengthy         
 exposure to sun…………………  Yes  No 
    
      m. Other notable conditions/circumstances prior to  
      developing MD (please state in box). 
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4.  
 
 
a. how was your MD described to you? (please state) 
 
 
 
 
 
 
b. were you given the name of this condition? Yes        No 
      
c. were you told of any possible cause of this condition? 
Yes           No 
 
   If ‘Yes’, please state 
 
 
 
 
d. did you feel that the Eye Specialist who diagnosed your  
MD was interested in you as a person?   Yes     No   
 
e. did you feel that the interview with the Eye Specialist was 
satisfactory?   Yes   No 
 
If ‘No’, please state why you felt dissatisfied 
 
 
 
 
 
 
 
 
 
 
When your MD was first diagnosed:  
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For questions 5 and 6 please circle one number where 
‘3’ indicates ‘very’ and ‘0’ indicates ‘not at all’. 
 
 
 
 
 
 
 
5. Around the time you were first                      
    diagnosed with MD, to what extent                          
    was your General Practitioner                   very              not at all 
    well informed about MD? ………………… 3 2 1 0 
 
6. To what extent has your General                   
Practitioner been helpful and      very              not at all 
supportive? …………………………………  3 2 1 0 
 
7. Were you ever told by an Eye Specialist, G.P. or Optometrist 
(Optician) that ‘Nothing can be done’ to help with your MD? 
    Yes          No  
 
      If ‘Yes’, how did you react to being told  
 
‘Nothing can be done’  ? Please answer ‘Yes’ or ‘No’ to  
 each of a, b, c, d, e, f.  Did you feel: 
 
a) resigned ………………… Yes    No  
 
b) shocked/sick/panic…… Yes     No 
         
c) helpless…………………. Yes    No 
 
d) angry…………………….. Yes    No 
 
e) anxious or depressed… Yes    No 
 
f) suicidal………………….. Yes    No 
 
g) other, please state 
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8. Were you ever told by an Eye Specialist, G.P. or Optometrist   
(Optician) that you will not go completely blind because  
    of your MD?   Yes    No  
 
  If ‘Yes’, how did you react to being told  
 
 ‘you will not go completely blind’ ? Did you feel: 
 
a) relieved…………Yes   No 
 
b) other, please state 
 
 
 
 
9. Have you had any eye treatments or operations e.g. laser 
    operation, operation to remove cataracts, treatment for  
glaucoma?  Yes     No 
 
If ‘Yes’, please state which treatments or operations you have 
had: 
 
 
 
 
 
 
10.  Has your Eye Specialist, G.P. or Optometrist suggested that  
some eye treatments/operations may do more harm than  
good?   Yes        No 
 
If ‘Yes’, which treatment was felt possibly to be harmful? 
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11.  Have you experienced any worsening of vision following a  
 treatment or operation?  Yes    No   
 
 If ‘Yes’, please state the treatment or operation  
 
 
 
 
 
 
12.  Have you found any improvement in vision since diagnosis 
 of  MD?    Yes     No     Don’t  
           know 
 If ‘Yes’, to what do you attribute the improvement? 
 
 
 
 
 
 
 
13.  Have you been told that MD is part of the ageing process? 
 Yes No 
  
 If ‘Yes’, by whom? (Eye Specialist, G.P., Optometrist, etc) 
   
 
 
 
 
 
14. Did you see your Eye Specialist privately or on the N.H.S.? 
 
 N.H.S. only    
 
 Private only  
 
 Both private and N.H.S. 
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15.  After diagnosis of MD, did your Eye Specialist, G.P. or  
Optometrist recommend regular eye tests in case other 
 conditions developed? Yes         No 
 
16. Were you given any information about the MD society or  
      local self-help groups?   Yes     No 
 
    If ‘Yes’, please state who gave you the information.     
    
 
 
 
 
 
 
17. Are you a member of a local MD self-help group? 
 Yes  No 
 
18.  Were you able to get more information about your MD  
 after diagnosis?  Yes    No 
  
If ‘Yes’, where did you find this information? 
 
 
 
 
 
 
19. Have you experienced any vision changes that have caused 
you concern? E.g. pulsating lights, flashes, shimmering  
light, hallucinations such as animal, human or plant forms, 
changing coloured patterns, blurred vision, difficulty seeing 
depth or seeing at night.  Yes    No  
 
If ‘Yes’, please state  
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19 continued: 
 Have you talked about these experiences with your Eye 
Specialist, G.P. or Optometrist?    Yes    No 
 
 Were you told of any possible causes of these experiences?   
Yes     No  
  
     If ‘Yes’, please state  
 
 
 
20. Would you be prepared to keep a diary/record of your MD 
condition?    Yes   No  
 
 
 
The MD Society has funded this survey and funds other 
research. There are many other possible areas of research 
which you might wish to see funded. 
 
 
21. How important to you are each of the following broad  
 research areas? Please circle one number for each scale  
 where 3 = very important and 0 = not important.  
 
 Causes and prevention of MD……….. 3 2 1 0 
 
 
 New treatments ………………………… 3 2 1 0 
 
 
 Low vision aids for people with MD… 3 2 1 0 
 
 
 Improving care and support of  
  people with MD………………………….. 3 2 1 0 
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21 continued:  
Please add any specific suggestions for research you would like  
to see carried out. 
 
 
 
 
 
 
22. In general, my quality of life is:  
 
 excellent………………….. 
 very good………………… 
 good………………………. 
 neither good nor bad…... 
 bad……………………….... 
 very bad………………….. 
 extremely bad………….... 
 
23. If I did not have MD, my quality of life would be: 
 
 very much better………….. 
 much better ……………….. 
 a little better ………………. 
 the same…………………… 
 a little worse……………….. 
 much worse………………... 
 very much worse………… 
For items 22 and 23 please cross one of the 7 boxes offered 
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24.  
 
 
 
                                                                               all             not 
                                                                                the time           at all 
 a) I have crying spells or feel like it ………………… 3 2 1 0 
 
 b) I feel downhearted and blue………………… ……. 3 2 1 0 
 
 c) I feel afraid for no reason at all…………………… 3 2 1 0 
 
 d) I get upset easily or feel panicky………………… 3 2 1 0 
 
 e) I feel energetic, active or vigorous………………. 3 2 1 0 
 
 f) I feel dull or sluggish……………………………...... 3 2 1 0 
 
 g) I feel tired, worn out, used up or exhausted…… 3 2 1 0 
 
 h) I have been waking up feeling fresh  
     and rested…………………………………………….. 3 2 1 0 
  
 i) I have been happy, satisfied, or pleased  
with my personal life……………………………...... 3 2 1 0 
 
j) I have lived the kind of life I wanted to………...... 3 2 1 0 
 
 k) I have felt eager to tackle my daily tasks 
    or make new decisions…………………...... 3 2 1 0 
       
l) I have felt I could easily handle or cope  
   with any serious problem or major  
   change in my life…………………………………...... 3 2 1 0 
 
 
Please circle a number on each scale to indicate how 
often each phrase has applied to you in the past few 
weeks:  3 = ‘all the time’, 0 =’not at all’. 
 
Please make sure that you have considered each of  
   the 12 statements and have circled a number for each. 
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25.Have you been to a Low Vision Clinic?  Yes        No 
 
 
26. Have you been visited at home by a rehabilitation officer?  
Yes         No 
 
 
27. Have you been shown how to use low vision aids?  
      Yes          No 
 
28. Have you found low vision aids useful? Yes           No 
 
      If ‘Yes’, please note below which aids you have found useful. 
 
 
 
 
  
 
 
 
 
If there are any low vision aids you have tried but did not  
find to be useful, please note which aids they were and  
why they were not useful. 
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29. 
 
 
 
 
 
 
 
 a) Date of birth  _ _ / _ _ / _ _      
 
 
 
 b) Sex:  Male        Female 
 
 
 c) Which form of MD do you have? Please indicate below for     
each eye.  
 
 Left eye:  Wet     Dry           Don’t       None  
                                                              know 
    Any other conditions 
    
 
        
 Right eye: Wet     Dry   Don’t         None  
               know 
    Any other conditions 
  
    
 
d) Dates of diagnosis of MD  
 
 Left eye _ _ / _ _ / _ _         Right eye _ _ / _ _ / _ _ 
 
 
  
Please fill in the dates as accurately as you can. 
These dates are important. 
 
 
 
 
 
Please give the following details about yourself 
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e) Dates of onset of MD (your estimate) 
 
 Left eye _ _ / _ _ / _ _   Right eye _ _ / _ _ / _ _ 
 
 
 
f) Are you registered as blind or partially sighted?  Yes        No 
If ‘Yes’, please give date or dates below 
 
 date registered as partially sighted  _ _ / _ _ / _ _ 
 
 date registered as blind _ _ / _ _ / _ _ 
 
 
g) Before MD was diagnosed, did you need to wear glasses? 
 
 for reading?    Yes      No 
 
 for distance?   Yes      No  
 
h) Which hand do you prefer to use for writing?   
Right        Left 
        
    
 
i) Some children are made to use their right hand despite a left- 
hand preference. Did this apply to you?  Yes          No  
 
 
j) Please state in the boxes your occupation: 
 
 before diagnosis 
 
 
 
 after diagnosis      
 
 
 
 now 
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Please cross one of the 5 boxes offered 
 
If you have had any changes of occupation were they: 
 
  due to MD?    Yes          No 
 
  due to other factors?   Yes         No 
 
 
k)  Please state in the boxes your main interests and activities: 
 
 before diagnosis 
 
 
 after diagnosis  
 
 
 now   
 
 
   If you have had any changes in activities or interests were  
   they: 
   due to MD?   Yes           No  
    
   due to other factors?   Yes           No  
 
l) Do you live alone?   Yes         No  
 
m) Do you have defective hearing?   Yes     No   
 
n) General health 
 
    In general, would you say your health is:  
 
        Excellent    Very good      Good             Fair             Poor   
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o)  Skin colour 
 
Please circle a number to indicate depth of your skin colour  
where 1 is lightest (eg white European) and 5 is darkest (eg 
black African).  
 
 Light      Dark  
            1       2        3        4        5 
 
 
 
p) Eye Colour 
 
Please cross a box to describe the colour of your  
eyes or describe in your own words. 
 
 
    Blue          Green      Hazel           Brown          Grey 
 
Other (please state)   
 
 
  Please circle a number to indicate the depth of your  
   eye colour. 
 
  
    Light                 Dark     
        1      2      3      4      5 
 
q) Did someone else help you to complete this questionnaire? 
Yes  No  
 
If ‘Yes’, please state relationship to helper e.g. husband, 
daughter, friend etc 
 
 
 
 
r) Today’s date  _ _ / _ _ / _ _ 
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Thank you very much for your help 
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Dear Society Member,
We would like to invite you to participate in a survey that 
is being carried out by The Macular Society and Royal 
Holloway, University of London. Please read the following 
information and discuss it with others if you wish. 
Please contact the researchers using the contact details  
on page 4 if there is anything that is not clear or if you 
would like more information. 
This research has been approved by the ethics committee  
of Royal Holloway, University of London.
What is the purpose of the survey?
This survey covers many aspects of living with macular 
conditions including experience of diagnostic consultations, 
rehabilitation services and satisfaction with treatment.  
A similar survey was completed by Macular Society members 
in 1999 and this survey will tell us how the experiences of 
people with macular conditions have changed since then. 
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The results will help us provide support for people with  
macular conditions and help plan future research. You will be 
able to read summaries of the results in Sideview and Digest.
Who have we asked to participate? 
We have invited randomly selected members of the 
Macular Society, who joined between 2000 and 2013, to 
participate in the survey. We wish to include members who 
have any type of macular condition, are aged over 18 and 
who currently live in the UK. 
What will I need to do?
You will need to tick or write down the answers that apply 
to you. If the reply boxes are too small, you can use the 
continuation sheets at the end of the booklet but please  
include the question number with your response.
If you can complete the survey yourself or have 
someone who can help you then please return it to us 
in the freepost envelope provided as soon as possible.  
If you would prefer to have the questions read to you, 
please ring the number on page 4. An interviewer will 
contact you to arrange a convenient time to complete 
the survey with you over the phone.
Some people may find recalling their past experiences 
uncomfortable. The Macular Society helpline is available 
to you if needed. The helpline number is 0300 3030 111.
Do I have to take part? 
No, you do not have to fill in the survey. Choosing not to 
will not disadvantage you in any way. If anything is not 
clear, or if you have any questions, please contact us on 
the phone number on page 4. 
If you do not wish to take part,  we would appreciate it if you 
could fill in the form headed ‘Reasons for not taking part’ 
and return it to us in the freepost envelope provided and we 
will not trouble you again.
If you decide to take part, please be aware that you do not 
have to answer every question.  You can leave it blank or 
give your reasons for not answering if you wish. 
How will we maintain your privacy  
and confidentiality?
The answers you give will be treated in complete confidence. 
All data will be collected and stored in accordance with the 
Data Protection Act 1998. Reports from the project will  
summarise information, but will not identify individuals.  
If you would prefer to answer the survey over the telephone 
with the researcher, the phone call will be audio-recorded 
and your responses will then be written onto a survey. The 
audio-recording will be stored confidentially and destroyed 
once the results are published. 
All surveys will be given an ID number and will be anonymous. 
If you provide your name and contact details, these will be 
separated from your responses and put in a secure computer 
database to which only the researchers will have access. 
What do I do next? 
If you want to take part, please sign and date the consent 
form attached to the survey. This will be separated from 
your responses when they are received. Please continue on 
to the next pages of the survey and ensure you take rest 
breaks when needed.
Thank you
2 3
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4Research Group:
Ms Emily Boxell   PhD Researcher
Professor Clare Bradley  Professor of Health Psychology
Contact details:
Health Psychology Research Unit,
Orchard Building,
Royal Holloway, University of London.
Egham, Surrey
TW20 0EX.
email:  
emily.boxell.2013@rhul.ac.uk
c.bradley@rhul.ac.uk  
(please include ‘Macular Society Survey’ in the subject line)
N.B. You may wish to keep this information sheet for reference. 
For enquiries please telephone: 
01784 443718    or    01784 443714 
Contact details
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This study has been approved by the Royal Holloway,  
University of London Ethics Committee.
Thank you for considering taking part in this research. If you have  
any questions, please contact the researchers before you decide  
whether to take part (contact details are on page 4 of the 
Information for Participants).
Please tick below to show you agree with the following statements:
• I have read the information sheet about this study.
• If I had any questions, I have had the opportunity to ask  
these questions (using the contact details) and I have  
received satisfactory answers to these questions.
• I understand that I am free to withdraw from the study  
at any time, without giving a reason.
I agree to participate in this study ................. Yes        No 
Name of participant
Signature         
Date
Please check that you have ticked the ‘Yes’ or ‘No’ box and  
have signed and dated this form. Thank you.
NB: This Consent form will be detached and stored separately  
from the responses you provide.
Participant Consent Form
fo
r o
ffi
ce
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Your macular condition 
 1. Do you have age-related macular degeneration (AMD)?  
Yes  %    (if ‘yes’ please go to Q2)     No  
%
     
 
If ‘no’ write the name of your macular condition in the box below  
and go to Q3.
       
 2a). If you have AMD, which form do you have?  
 •  Left eye    Wet        Dry        Don’t know        None  
   •  Right eye    Wet        Dry        Don’t know        None   
 2b). If you have AMD, do you know what stage it is at now?  
 •  Left eye    Early/     Advanced     Don’t know     None  
           Intermediate
   •  Right eye  Early/     Advanced     Don’t know     None  
            Intermediate
3.  Dates (approximate) of diagnosis of your macular condition:  
a) Left eye   _ _ / _ _ / _ _     b) Right eye   _ _ / _ _ / _ _ 
The Macular Society  
Survey 2013
This survey is designed to find out about the experiences and views of 
people with any type of macular condition. If you do not have a macular 
condition, please return this uncompleted survey in the envelope provided. 
Please tick the relevant boxes or write in the reply boxes. There are 
two blank pages at the end if you run out of space. 
Please do not write on this page – thank you.
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 4. Had you heard of macular conditions 
  before your own condition was diagnosed? ....... Yes        No   
 5. Around the time of diagnosis, had you 
experienced stress or bereavement?.................... Yes        No   
 6. Apart from your macular condition,  
do you/did you have any other eye  
disease e.g. glaucoma, cataracts? ........................ Yes        No   
 
If ‘yes’ describe the condition and dates of any major treatment:
 7a). How was your macular condition first noticed?
   
    •  By my optician at a routine eye test appointment:  
      Yes  %  (if ‘yes’ please go to Q8a on page 6)      No  
%
     
    •  I noticed the symptoms myself and sought medical help:  
      Yes  %  (if ‘yes’ please go to Q7b on page 5)      No  
%
      
    •  Someone else first noticed the signs of my macular condition:  
      Yes  
%
      No  %  (if ‘no’ please go to next option below) 
 
      If ‘yes’ please describe what happened below and then go to 
      Q7b on page 5. 
    •  Other, please state below:
7b).   I first sought help from a: 
 
   GP        Optician        Hospital Eye Clinic   
 
   Other, please state: 
 
 
 
 
 
   Please describe the symptom that led you to seek help:
7c). Once symptoms were noticed, how quickly did you seek advice from 
a healthcare professional (GP, optician, hospital doctor)?
   
    •  Same or next day .........................   (please go to Q8a on page 6)  
   •  2 to 6 days .....................................   
   •  1 week to 1 month ......................   
   •  More than 1 month .....................   
   •  Can’t remember ...........................   
   •  N/A ..................................................  
7d). If your appointment with a healthcare professional about early 
symptoms was delayed for more than 2 days, please state reasons 
why below:
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 8a). Who first diagnosed your macular condition? Please tick one box 
from the list below:
  
    •  hospital eye specialist ...................................     
   •  optician ............................................................   
   •  GP ......................................................................   
   •  don’t know ......................................................   
   •  other, please state:
8b). Did you feel that this healthcare professional (who first diagnosed 
your macular condition), was interested in you as a person? 
  Yes        No  
8c). Overall, did you feel that the diagnostic consultation with this 
healthcare professional was satisfactory? 
  Yes        No  
  Please explain why below:
 8d). Were you given the name of your condition at the time  
of diagnosis?  
Yes  
%
      No  %  (if ‘no’ please go to Q8e)    
  If ‘yes’, what name was given for your eye condition at the  
time of diagnosis? Please tick one or more of the following:
  
    •  macular degeneration (MD) ..................................     
   •  age-related macular degeneration (AMD) ........   
   •  juvenile macular degeneration ...........................   
   •  wet AMD ...................................................................   
   •  dry AMD ....................................................................   
   •  don’t recall ...............................................................   
   •  other (please state in box) e.g. retinitis pigmentosa,  
      cone dystrophy, rod dystrophy, Stargardt’s disease:
 
 
 8e). Were you given any written information about your macular  
condition at the time of diagnosis? 
  Yes        No  
8f). Were you given any information around the time of diagnosis  
about what to do if you were to have a sudden deterioration  
in your vision? 
  Yes        No  
8g). Do you feel you were given appropriate support, help or advice  
at the time of diagnosis? 
  Yes        No  
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8h). Were you given information about the Macular Society  
(or the Macular Disease Society, as it was previously called)  
at the time of diagnosis? 
  Yes        No  
8i). Were you given any other contacts for help and support at  
the time of diagnosis? 
  Yes        No  
  If yes, please state:
8j). Around the time of diagnosis, were you given information about  
the likely progress of your macular condition? 
  Yes        No  
8k). If at initial diagnosis only one eye was affected, were you given 
  information about how your second eye might be affected in   
the future? 
  Yes        No  
If your macular condition was initially diagnosed by a hospital eye
specialist please go to Q9a.
 9. If your condition was not initially diagnosed by a hospital eye  
specialist, have you been to see a hospital eye specialist about  
your macular condition since diagnosis?  
Yes  
%
      No  %  (if ‘no’ please go to Q10 on page 10)    
  If ‘yes’, please tick one or more reasons why you have  
been to see a hospital eye specialist from the list below: 
  
    •  for confirmation of diagnosis ................................     
   •  for low-vision service referral ...............................   
   •  for a certificate of visual impairment .................   
   •  for monitoring vision ..............................................   
   •  for treatment ...........................................................   
   •  other, please state below: 
 9a). Did you see your eye specialist privately or on the NHS?
  
   •  NHS only .........................................     
   •  private only ...................................   
   •  both private and NHS .................. 
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For questions 10 and 11 please circle one number where ‘3’  
indicates ‘very’ and ‘0’ indicates ‘not at all’. If you did not
discuss your macular condition with your GP, please circle 
N/A for not applicable.
 10. Around the time you were first  
diagnosed with your macular 
  condition, to what extent was      not 
your GP well-informed about         very         at all 
your condition? ......................................... 3  2  1  0   N/A
 11. To what extent has your GP  
been helpful and supportive  
about your macular condition? ............. 3  2  1  0  N/A
 12. Were you ever told by a healthcare professional that 
‘Nothing can be done’ to help with your macular condition?  
Yes  
%
      No  %  (if ‘no’ please go to Q13 on page 11)    
 12a). If ‘yes’, which healthcare professional told you this?  
Please tick from the list below: 
  
    •  hospital eye specialist .........................     
   •  nurse .......................................................   
   •  optician ...................................................   
   •  GP .............................................................   
   •  eye clinic liaison officer .......................   
   •  other, please state:
 12b). How did you react to being told, ‘Nothing can be done’?
  Please answer ‘yes’ or ‘no’ to each of a,b,c,d,e, and f. 
  Did you feel:
                  Yes     No
    a)   resigned ...............................................         
   b)   shocked/sick/panic ............................         
   c)   helpless ................................................         
   d)   angry ....................................................         
   e)   anxious or depressed ........................         
   f)   suicidal ..................................................         
   g)   other, please state below:
 13. Were you ever told by a healthcare professional that ‘You will  
not go completely blind’ because of your macular condition?  
Yes  
%
      No  %  (if ‘no’ please go to Q14 on page 12)    
13a). If ‘yes’, who told you this? Please tick from the list below: 
  
    •  hospital eye specialist .........................     
   •  nurse .......................................................   
   •  optician ...................................................   
   •  GP .............................................................   
   •  eye clinic liaison officer .......................   
   •  other, please state:
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13b). How did you react to being told, ‘You will not go completely 
blind’? Did you feel:
         Yes     No
    a)   relieved .......................................         
   b)   alarmed ......................................         
   c)  other, please state below: 
 14. Have you been told that your macular condition is part of
  the ageing process?  
Yes  
%
      No  %  (if ‘no’ please go to Q15)    
14a). If ‘yes’, who told you this? Please tick from the list below: 
  
  •  hospital eye specialist .........................     
•  nurse .......................................................   
•  optician ...................................................   
•  GP .............................................................   
•  eye clinic liaison officer .......................   
•  other, please state:
 15. Were you told by a healthcare professional, around the  
time of diagnosis, of the possibility of experiencing visual  
hallucinations as a side effect of sight loss? 
  Yes        No 
 16. In the past 12 months, have you seen an eye specialist or 
optician about your macular condition?
  
    •  Yes ............................................................   
   •  No, and I haven’t needed to ..............   
   •  No, but I needed to ..............................   
   If you ticked ‘No, but I needed to’ please give reasons for your 
   response below: 
 
 
 
 
 
 
For questions 17 and 18, please tick one of the boxes offered. 
 17. In general, my present quality of life is: 
  
    •  excellent ..................................................     
   •  very good ...............................................     
   •  good ........................................................   
   •  neither good nor bad ...........................   
   •  bad ...........................................................   
   •  very bad ..................................................   
   •  extremely bad ....................................... 
 18. If I did not have a macular condition, my quality of life would be: 
  
    •  very much better ..................................     
   •  much better ...........................................   
   •  a little better ..........................................   
   •  the same ................................................     
   •  worse ...................................................... 
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 19. Please circle one number on each scale, from 3 (all the time)  
to 0 (not at all), to indicate how often you feel each statement 
has applied to you in the past few weeks: 
                all                          not 
                       the time            at all 
  a)  I have crying spells or feel like it ..................... 3 2  1   0 
 
b)  I feel downhearted and blue ........................... 3 2  1   0 
 
c)  I feel afraid for no reason at all ....................... 3 2  1   0 
 
d)  I get upset easily or feel panicky .................... 3 2  1   0 
 
e)  I feel energetic, active or vigorous ................. 3 2  1   0 
 
f )  I feel dull or sluggish ......................................... 3 2  1   0 
 
g)  I feel tired, worn out, used up  
     or exhausted ........................................................ 3 2  1   0 
 
h)  I have been waking up feeling fresh 
     and rested ............................................................. 3 2  1   0 
 
i )  I have been happy, satisfied or pleased 
     with my personal life .......................................... 3 2  1   0 
 
j )  I have lived the kind of life I wanted to ......... 3 2  1   0 
 
k)  I have felt eager to tackle my daily tasks 
     or make new decisions ...................................... 3 2  1   0 
 
l )  I have felt I could easily handle or cope 
     with any serious problem or major 
     change in my life ................................................. 3 2  1   0
 
Continued on next page . . .
                  all                          not 
                       the time            at all
           m)  I feel that too many demands are  
      made on me ......................................................... 3 2  1   0 
  n)  I feel frustrated by obstacles which 
        occur in my life ...................................................... 3 2  1   0 
 
o)  I have too many problems to cope with ......... 3 2  1   0 
 
p)  I feel stressed ........................................................ 3 2  1   0 
 20. Do you feel that your well-being has been affected by 
  anything in particular in the past few weeks, e.g. any
  other health conditions, bereavement, retirement? 
  Yes        No 
  If ‘yes’ please state:
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Questions 21 to 24 ask about any treatment you may 
have had for your macular condition.
 21. Have you had any treatment for your macular condition, now or  
in the past?  
Yes  
%
      No  %  (if ‘no’ please go to Q25 on page 17)    
  If ‘yes’, please tick all the treatments you have had  
from the list below: 
  
  •  injections into the eye (also called anti-VEGF 
    injections, e.g. Avastin, Lucentis or Eylea) .................     
•  laser treatment ................................................................   
•  photodynamic therapy ...................................................   
•  radiation therapy .............................................................   
•  intraocular lens implant .................................................   
•  other, please state below:
 22. What was your most recent treatment? Please state below:
  
  a)  Name of treatment:
 
  b)  Date of last treatment:   _ _ / _ _ / _ _ 
 
c)  Date of last follow-up appointment:   _ _ / _ _ / _ _
23. How satisfied/dissatisfied were you with this treatment overall? 
  
    •  satisfied ..................................................     
   •  slightly satisfied ....................................   
   •  neither satisfied nor dissatisfied .......   
   •  slightly dissatisfied ..............................     
   •  dissatisfied ............................................. 
  Please give reasons for your response in the space below:
 24. Did you feel involved in the decision-making about this treatment? 
  
    •  Yes, and I wanted to be .......................     
   •  Yes, but I didn’t want to be .................   
   •  No, but I wanted to be .........................   
   •  No, and I didn’t want to be .................   
 25. Since diagnosis, can you see: 
  
    •  better ..................................     
  •  the same ............................   
  •  worse .................................. 
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The next questions are on the support you have received after diagnosis.
26. Are you a member of a local support group for people with 
macular conditions? 
  Yes        No  
 27. Were you able to get more information about your macular  
condition after diagnosis?  
Yes  
%
      No  %  (if ‘no’ please go to Q28)    
  If ‘yes’, where did you find this information?  Please state below: 
 28. Have you attended a low-vision clinic?
  a)   Yes     (if ‘yes’ please go to Q28c)      No    
b)   If ‘no’ would you like to attend a low-vision clinic? 
   Yes        No      Please now go to Q29 on page 19.
 28c). Please rate your overall satisfaction/dissatisfaction with the  
low-vision clinic: 
  
    •  satisfied ....................................................................     
   •  slightly satisfied ......................................................   
   •  neither satisfied nor dissatisfied .........................   
   •  slightly dissatisfied .................................................     
   •  dissatisfied ............................................................... 
 28d). Please give reasons for your overall satisfaction/ dissatisfaction with 
the low-vision clinic.
 29. Have you ever been shown how to use low-vision aids? 
a)   Yes         No    
b)   If ‘no’ would you like to be shown how to use them? 
   Yes         No  
 30. Have you ever found low-vision aids (including electronic aids) useful? 
a)   Yes         No  
  Please use the space below for comments on the pros and cons of 
specific low-vision aids:
 
 30b). Have any particular low-vision aids or techniques helped you  
continue with work or leisure activities? If so, please describe:
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 31. Have you heard of eccentric viewing? (techniques which help make 
the most of your remaining peripheral vision) 
  Yes        No  
 32. Have you ever been trained in eccentric viewing?   
Yes  
%
      No  %  (if ‘no’ please go to Q33)    
  If ‘yes’, how useful did you find the eccentric viewing 
training? 
  
  •  very useful ....................................     
•  moderately useful .......................   
•  slightly useful ...............................   
•  not at all useful ............................  
 33. Have you ever had a home assessment done by a rehabilitation  
officer? (i.e. someone who assessed your home environment and 
provided advice to improve your daily living e.g. on lighting issues, 
mobility within the home.)  
a)   Yes        No    
b)   If ‘no’ would you like to have a home assessment done? 
   Yes        No  
 34. Have you ever been offered psychological support from the hospital 
or eye clinic? 
  a)   Yes        No    
b)   If ‘no’ would you like/have liked to receive psychological support 
  •  now? .............................................Yes        No   
 
•  at the time of diagnosis?..........Yes        No  
 35. Do you feel you have a need for services that have not been offered 
to you? 
Yes        No  
  If ‘yes’ please comment below:
36. Do you have one or more friends or family members who provide 
unpaid care, support or assistance to you because of your  
macular condition?  
Yes  
%
      No  %  (if ‘no’ please go to Q37 on page 22)    
  If ‘yes’, please state:  
•  their relationship to you, e.g. husband, daughter, friend:  
 
 
 
 
 
•  the average hours per week in total they spend helping you: 
     Fewer than 7 hours per week ............     
   7 to 14 hours ..........................................   
   15 to 35 hours ........................................   
   More than 35 hours per week ............. 
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Question 37 is on experiences of visual hallucinations. These 
might appear as patterns, faces, people, plants, trees, animals or 
other objects. This condition is called Charles Bonnet Syndrome 
and is a common side effect of sight loss. If needed, contact the 
Macular Society for more information on 0300 3030 111 after 
completing this questionnaire.
 37a). Since the diagnosis of your macular condition, have you  
experienced any visual hallucinations (i.e. seeing things  
that other people cannot see)?  
Yes  
%
      No  %  (if ‘no’ please go to Q38 on page 23)    
  If ‘yes’, please describe:
 37b). Have you talked about the visual hallucination(s) with a   
healthcare professional, e.g. an eye specialist, GP or optician?  
Yes  
%
      No  %  (if ‘no’ please go to Q38 on page 23)
37c). Were you told of any possible cause of these visual hallucination(s)?  
Yes  
%
      No  %  (if ‘no’ please go to Q38 on page 23)    
  If ‘yes’, please state cause below:
 38. Around the time of diagnosis of your macular condition, were any 
of the following recommended to you?  
 38a). Having regular eye tests (at least every two years):
     •  Was this recommended around the time of diagnosis?   
        Yes        No  
     •  If ‘yes’ by whom?         
       eye specialist        optician        other  
     •  To what extent do you have eye tests at least every two years?         
        not at all       sometimes       mostly       all the time   
 38b). Eating a diet rich in fruit and vegetables, oily fish and eggs:
     •  Was this recommended around the time of diagnosis?   
        Yes        No  
     •  If ‘yes’ by whom?         
       eye specialist        optician        other  
     •  To what extent do you have a diet rich in fruit, vegetables, oily 
        fish and eggs now?         
        not at all       sometimes       mostly       all the time   
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38c). Protecting your eyes from bright sunlight:
     •  Was this recommended around the time of diagnosis?   
        Yes        No  
     •  If ‘yes’ by whom?         
       eye specialist        optician        other  
     •  To what extent do you protect your eyes from bright sunlight?         
        not at all       sometimes       mostly       all the time   
 38d). Taking nutritional supplements (such as vitamins, minerals and  
antioxidants):
     •  Was this recommended around the time of diagnosis?   
        Yes        No  
     •  If ‘yes’ by whom?         
       eye specialist        optician        other  
     •  To what extent do you take nutritional supplements regularly now?  
        not at all       sometimes       mostly       all the time   
     •  Which nutritional supplements do you take (if any)?  
 38e). Monitoring your own vision (especially the better eye) using an 
Amsler grid and/or any straight line in your environment e.g. a window:
    •  Was this recommended around the time of diagnosis?   
       Yes        No  
    •  If ‘yes’ by whom?         
       eye specialist        optician        other  
    •  To what extent do you monitor your vision now?         
       not at all     daily     weekly     monthly     yearly   
 38f). At the time of diagnosis of your macular condition, did you smoke?
  •  Yes  
%
      No  %  (if ‘no’ please go to Q39) 
  •  If ‘yes’, were you recommended to stop smoking by your eye 
      specialist, GP or optician (in relation to your macular condition)? 
    Yes        No  
  •  Do you smoke now?  
    Yes        No  
39). Please state below any other recommendations and the extent  
to which you follow them:
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 40. Have you ever felt that you have been treated differently from a 
person who doesn’t have a macular condition? This could be at 
work, at home, with family or friends etc., and could be in a positive 
or negative way. 
Yes        No    
If ‘yes’, please give example/s and indicate if positive or negative:
 41. Are you registered as severely sight impaired (blind) or  
sight impaired (visually impaired)?
 41a). Yes  
%
      No  %  (if ‘no’ please go to Q41c on page 27)    
  If ‘yes’, please give date or dates below:
 41b). •  date registered as sight impaired      _ _ / _ _ / _ _   
 
•  date registered as severely sight impaired      _ _ / _ _ / _ _
  Please now go to Q42 on page 27.
 41c). If you have not registered as severely sight impaired (blind)  
or sight impaired, please tick the reason(s) why below:
  
    •  I haven’t been offered registration ......................................     
   •  I was offered registration but declined ...............................     
   •  I was offered registration and it is being processed ........   
   •  Other, please state below:
 
  
 42. Please give the following details about yourself:
 42a). Date of birth     _ _ / _ _ / _ _  
 42b). Sex:   Male        Female  
 42c). Please indicate your ethnic group below:
  
    •  White ................................................................     
   •  Asian/Asian British ........................................     
   •  Black/Black British .........................................   
   •  Chinese ............................................................   
   •  Other, please state below:  
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42d). Is English your first language? 
Yes        No  
  If ‘no’ please rate your fluency in English on the scale below  
by putting a cross on the number that applies to you:
 42e). Age at leaving full time education:       years
42f). Please state in the boxes your occupation.
42g). If you have had any changes of occupation, were they due 
to the macular condition? 
Yes        No  
  If ‘no’, please state reason(s):
42h). Please state in the box below your main interests and activities:
42i). Have you needed to change your activities or interests because of 
your macular condition? 
Yes        No  
  Please give any comments below:
28 29
  
very 
  basic 1 2 3 4 5 6 7
  
very 
  fluent
before onset of symptoms of macular condition:
after diagnosis:
now:
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30 31
 43. How comfortable do you feel using a computer? 
  
    •  very comfortable ...............     
   •  comfortable ........................   
   •  not at all comfortable ......   
44. Do you live alone? ....................................Yes        No   
45. Do you have any loss of hearing? .........Yes        No   
 46. In general, my health is: 
  
  •  excellent ..............................     
•  very good .............................   
•  good ......................................   
•  neither good nor bad ........     
•  bad ........................................   
•  very bad ...............................     
•  extremely bad ..................... 
47. Did someone else help you to complete this questionnaire? 
Yes        No  
48. Today’s date:     _ _ / _ _ / _ _  
 This section will be detached from the survey so that  
 it remains anonymous.
         49. Please write your postcode in the box below: 
                  
        Thank you – your contribution is greatly appreciated.
fo
r o
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ce
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Please do not write on this page – thank you.
32 33
Thank you for taking part in this survey. Please write down your 
contact details below if you are willing to be contacted if we need 
more information about your replies. 
Name
 
Telephone         
 
Postal address
 
Email address
Would you be happy to be put on a database of people willing to  
be invited to participate in future research? (You would be under  
no obligation to take part). 
 
•  Yes, I am willing to be invited ..............     
•  No, I don’t wish to be invited................  
Your contact details
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This page has been left blank for continuation. 
Please note the question number with your responses.
34 35
The research team at Royal Holloway, University of London may  
be conducting some research on the experiences of carers of 
people with macular conditions in the future. If you have a carer 
who may be interested in receiving an invitation to participate in 
this research, please provide their contact details below (they 
would be under no obligation to take part). 
Name
 
Telephone         
 
Postal address
 
Email address
Research team:  
Ms Emily Boxell, PhD Researcher 
Prof Clare Bradley, Professor of Health Psychology  
Health Psychology Research Unit, Royal Holloway,  
University of London. TW20 0EX
Telephone: 01784 443718 or 01784 443714
Carer’s contact details
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This page has been left blank for continuation. 
Please note the question number with your responses.
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Appendix 4: Table 1. Comparison of questions included in the 1999 Macular Disease Society Questionnaire (MDSQ 1999) and 2013 Macular Society survey (MSQ 
2013). Questions are in numerical order as they appear in the MSQ 2013. *indicates which questions were used/ selected in the analyses reported in this thesis.  
 
Row 
number 
MDSQ 
1999 
question 
number 
MSQ 
2013 
question 
number 
MDSQ 1999 question 
wording 
MSQ 2013 question 
wording (changes are 
marked in italics) 
Reason for any changes or for addition/ removal of this 
question 
General modification made in the MSQ 2013: “MD” (macular disease) in the MDSQ 1999 changed to 
“macular conditions” for all 2013 survey questions. The 
term ‘macular conditions’ is more commonly used now. 
 
1*Used to 
select 
participants 
with AMD 
for 
analyses 
reported in 
Chapters 3 
and 4, and 
to assist 
participant 
selection in 
the follow-
on study.  
29c (see 
below) 
1 (See below.) Do you have age-related 
macular degeneration 
(AMD)? Y/N 
If ‘no’ write the name of 
your macular condition in 
the box below and go to 
Q3: [free-text box 
response] 
The author felt that q29c used in the MDSQ 1999 could be 
made clearer to ascertain whether the respondent had 
AMD (the most common macular condition) or another 
type of macular condition. In the modified version, only 
respondents who reported having AMD would be directed 
to answer further questions about the type and stage of 
AMD they had (which is only relevant for people with 
AMD) (q2a and b).  
 
2*results 
reported in 
chapter 3  
29c 2a) Which form of MD do you 
have? Please indicate below 
for each eye. 
 
 Left eye  
Wet 
Dry 
If you have AMD, which 
form do you have? 
 
 
 Left eye  
Wet 
Dry 
(See 1 above.) 
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Row 
number 
MDSQ 
1999 
question 
number 
MSQ 
2013 
question 
number 
MDSQ 1999 question 
wording 
MSQ 2013 question 
wording (changes are 
marked in italics) 
Reason for any changes or for addition/ removal of this 
question 
Don’t know  
None 
Any other conditions [free-
text response box] 
 Right eye 
Wet 
Dry 
Don’t know  
None 
Any other conditions [free-
text response box] 
 
Don’t know  
None 
 
 
 Right eye 
Wet 
Dry 
Don’t know  
None 
 
3 - 2b) - If you have AMD, do you 
know what stage it is at 
now? 
 
 Left eye  
Early/ intermediate 
Advanced 
Don’t know  
None 
 
 Right eye 
Early/ intermediate 
Advanced 
Don’t know  
(See 1 above.) 
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Row 
number 
MDSQ 
1999 
question 
number 
MSQ 
2013 
question 
number 
MDSQ 1999 question 
wording 
MSQ 2013 question 
wording (changes are 
marked in italics) 
Reason for any changes or for addition/ removal of this 
question 
None 
 
4*results 
reported in 
chapter 3  
29d 3 Dates of diagnosis of MD 
 
 
 Left eye  _ _ / _ _ / _ 
_ 
 Right eye _ _ / _ _ / _ 
_ 
Dates (approximate) of 
diagnosis of your macular 
condition: 
a) Left eye _ _ / _ _ / _ _ 
b) Right eye _ _ / _ _ / _ _ 
 
To explore the impact of the RCOphth guidelines for AMD 
published in February 2009, and the publication of the 
MDSQ 1999 results in July 2002, a new variable was 
created based on the 2013 survey respondents’ date of 
diagnosis (before or after each of these dates). 
 
Also used to create new variable for age at diagnosis which 
was used for participant selection (see Figure 2.1 in 
Chapter 2). 
  
5 1 4 Had you heard about MD 
before your own condition 
was diagnosed? Y/N 
Had you heard of macular 
conditions before your own 
condition was diagnosed? 
Y/N 
“MD” (macular disease) changed to “macular conditions” 
for all 2013 survey questions. The term ‘macular 
conditions’ is more commonly used now and the term 
‘disease’ avoided by the Macular Society. 
  
6 3j 5 Before your MD was 
diagnosed had you 
experienced any of the 
following conditions or 
circumstances? 
… 
Around the time of 
diagnosis, had you 
experienced stress or 
bereavement? Y/N 
The 1999 survey had a question covering the length of two 
pages that asked about possible risk factors for MD 
(question 3a-m). In the 2013 survey, these were reduced 
to two questions (question numbers 5 and 6). Since the 
1999 survey there have been many well-designed studies 
that have investigated risk factors for macular conditions 
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Row 
number 
MDSQ 
1999 
question 
number 
MSQ 
2013 
question 
number 
MDSQ 1999 question 
wording 
MSQ 2013 question 
wording (changes are 
marked in italics) 
Reason for any changes or for addition/ removal of this 
question 
j) stress or bereavement 
(Y/N) 
in great detail (e.g. see Chakravarthy et al., 2010; Guymer 
& Chong, 2006; Tomany et al., 2004). This was not a 
primary aim of the present study. Thus these 1999 survey 
questions (q3b-i, k-m) were removed from the 2013 
survey.  
 
7 3a & 9 6 3. Before your MD was 
diagnosed had you 
experienced any of the 
following conditions or 
circumstances? 
a) Other eye disease e.g. 
glaucoma, cataracts (Y/N) 
If ‘yes’, please describe [free-
text box response] 
 
9. Have you had any eye 
treatments or operations e.g. 
laser operation, operation to 
remove cataracts, treatment 
for glaucoma? Y/N 
If ‘yes’, please state which 
treatments or operations you 
have had: [free-text box 
response] 
Apart from your macular 
condition, do you/ did you 
have any other eye disease 
e.g. glaucoma, cataracts? 
Y/N 
-If ‘yes’ describe the 
condition and dates of any 
major treatment: [free-text 
box response] 
The MSQ 2013 included one question that asked about 
other eye conditions and treatments for these conditions. 
As above, the primary aim of the MDSQ 1999 question was 
to investigate the presence/ treatment for other eye 
conditions as a risk factor for the respondent’s macular 
condition. This was not a primary aim of the MSQ 2013 
study.  
The MSQ 2013 question was included to have this 
background information from the respondent. For 
instance, q7 below asked about seeking help for symptoms 
of the macular condition. It was hypothesised that having 
another eye condition may have affected help-seeking. 
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Row 
number 
MDSQ 
1999 
question 
number 
MSQ 
2013 
question 
number 
MDSQ 1999 question 
wording 
MSQ 2013 question 
wording (changes are 
marked in italics) 
Reason for any changes or for addition/ removal of this 
question 
8 - 7a) - How was your macular 
condition first noticed? 
 By my optician at a 
routine eye test 
appointment: Y/N 
 I noticed the symptoms 
myself and sought 
medical help: Y/N 
 Someone else first 
noticed the signs of my 
macular condition: Y/N  
If ‘yes’ please describe 
what happened below and 
then go to Q7b on page 5. 
 Other, please state 
below [free-text 
response box] 
Based on the literature review discussed in chapter 1, gaps 
in the literature were identified and as a result, these 
newly-designed questions were included in the survey. (At 
the time of designing the 2013 survey, there were no 
relevant questionnaires available that had been designed 
and evaluated to measure this topic in people with 
macular conditions.) 
 
9 - 7b) - I first sought help from a: 
 GP 
 Optician 
 Hospital Eye Clinic 
 Other, please state: 
[free-text response 
box] 
 
As above. 
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Row 
number 
MDSQ 
1999 
question 
number 
MSQ 
2013 
question 
number 
MDSQ 1999 question 
wording 
MSQ 2013 question 
wording (changes are 
marked in italics) 
Reason for any changes or for addition/ removal of this 
question 
Please describe the 
symptom that led you to 
seek help: [free-text 
response box] 
10 - 7c) - Once symptoms were 
noticed, how quickly did 
you seek advice from a 
healthcare professional 
(GP, optician, hospital 
doctor)? 
 Same or next day 
 2 to 6 days 
 1 week to 1 month 
 More than 1 month 
 Can’t remember 
 N/A 
 
As above. 
 
11 - 7d) - If your appointment with a 
healthcare professional 
about early symptoms was 
delayed for more than 2 
days, please state reasons 
why below: [free-text 
response box] 
As above. 
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Row 
number 
MDSQ 
1999 
question 
number 
MSQ 
2013 
question 
number 
MDSQ 1999 question 
wording 
MSQ 2013 question 
wording (changes are 
marked in italics) 
Reason for any changes or for addition/ removal of this 
question 
12*results 
reported in 
chapter 3 
- 8a) - Who first diagnosed your 
macular condition? Please 
tick one box from the list 
below: 
 Hospital eye specialist 
 Optician 
 GP 
 Don’t know 
 Other, please state: 
[free-text response 
box] 
This question was added to the 2013 survey to clarify who 
diagnosed the respondent’s macular condition. Since the 
1999 survey, optometrists have been able to give a 
diagnosis to the patient. The other response options were 
included to check whether respondents had seen an ECP 
or someone else about their macular condition.   
 
13*results 
reported in 
chapter 3 
4d 8b) When your MD was first 
diagnosed: 
Did you feel that the Eye 
Specialist who diagnosed 
your MD was interested in 
you as a person? 
Y/N 
Did you feel that this 
healthcare professional 
(who first diagnosed your 
macular condition), was 
interested in you as a 
person? 
Y/N 
 
The wording was changed from ‘eye specialist’ (in the 1999 
survey) to ‘healthcare professional’ (in the 2013 survey) to 
reflect the fact that optometrists can now diagnose 
macular conditions (whereas in 1999 this was not the case) 
and some respondents may only have seen their 
optometrist (or GP which is less likely but still possible), 
and may not have received a formal diagnosis from an 
ophthalmologist. 
14*results 
reported in 
chapter 3 
4e 8c) When your MD was first 
diagnosed: 
Did you feel that the 
interview with the Eye 
Specialist was 
satisfactory? 
Overall, did you feel that 
the diagnostic consultation 
with this healthcare 
professional was 
satisfactory? 
Y/N 
As above. 
In the MDSQ 1999, respondents were asked to provide 
reasons for dissatisfaction with the consultation only. The 
MSQ 2013 used a modified version of this question which 
asked respondents to provide reasons for dissatisfaction or 
satisfaction with the diagnostic consultation. 
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Row 
number 
MDSQ 
1999 
question 
number 
MSQ 
2013 
question 
number 
MDSQ 1999 question 
wording 
MSQ 2013 question 
wording (changes are 
marked in italics) 
Reason for any changes or for addition/ removal of this 
question 
Y/N 
If ‘no’, please state why you 
felt dissatisfied: [free-text 
response box] 
Please explain why below: 
[free-text response box] 
 
15*results 
reported in 
chapter 3 
4b 8d) When your MD was first 
diagnosed: 
b) Were you given the name 
of this condition?  
Y/N 
Were you given the name 
of your condition at the 
time of diagnosis?  
Y/N 
If ‘yes’, what name was 
given for your eye condition 
at the time of diagnosis? 
Please tick one or more of 
the following: 
 Macular 
degeneration (MD) 
 Age-related 
macular 
degeneration 
(AMD) 
 Juvenile macular 
degeneration 
 Wet AMD 
 Dry AMD 
 Don’t recall 
Sub-question asking respondents to report what name 
they were given for their macular condition at the time of 
diagnosis was added to see if this had changed since 
diagnosis (i.e. using the response to q2a of the 2013 
survey, we could see if dry AMD at diagnosis had changed 
to wet AMD since diagnosis, for example). Also used to 
investigate if HCPs were giving the name of the exact type 
of macular condition at the time of diagnosis. 
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Row 
number 
MDSQ 
1999 
question 
number 
MSQ 
2013 
question 
number 
MDSQ 1999 question 
wording 
MSQ 2013 question 
wording (changes are 
marked in italics) 
Reason for any changes or for addition/ removal of this 
question 
 Other (please state 
in box) e.g. retinitis 
pigmentosa, cone 
dystrophy, rod 
dystrophy, 
Stargardt’s disease: 
[free-text response 
box] 
16*results 
reported in 
chapter 3 
- 8e) - Were you given any written 
information about your 
macular condition at the 
time of diagnosis? 
Y/N 
New question designed to assess the incorporation of the 
RCOphth 2009 guidelines on AMD into practice, and focus 
on information and support provision around the time of 
diagnosis. 
17*results 
reported in 
chapter 3 
- 8f) - Were you given any 
information around the 
time of diagnosis about 
what to do if you were to 
have a sudden 
deterioration in your 
vision? 
Y/N 
As above. 
 
18*results 
reported in 
chapter 3 
- 8g) - Do you feel you were given 
appropriate support, help 
or advice at the time of 
diagnosis? 
Y/N 
As above. 
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Row 
number 
MDSQ 
1999 
question 
number 
MSQ 
2013 
question 
number 
MDSQ 1999 question 
wording 
MSQ 2013 question 
wording (changes are 
marked in italics) 
Reason for any changes or for addition/ removal of this 
question 
19*results 
reported in 
chapter 3 
16 8h) Were you given any 
information about the MD 
society or local self-help 
groups? 
Y/N 
If ‘yes’, please state who gave 
you the information. [free-
text response box] 
Were you given 
information about the 
Macular Society (or the 
Macular Disease Society, as 
it was previously called) at 
the time of diagnosis? 
Y/N 
 
This question was modified slightly in order to investigate 
if this information was given in the diagnostic consultation 
specifically. Designed to assess the incorporation of the 
RCOphth 2009 guidelines on AMD into practice. 
Sub-question was removed as this question followed the 
other 2013 survey questions on experiences within the 
diagnostic consultation. Respondents had indicated in an 
earlier question which HCP had first diagnosed their 
macular condition (q8a). 
 
20*results 
reported in 
chapter 3 
- 8i) - Were you given any other 
contacts for help and 
support at the time of 
diagnosis? 
Y/N 
If yes, please state: [free-
text response box] 
 
New question designed to assess the incorporation of the 
RCOphth 2009 guidelines on AMD into practice, and focus 
on information and support provision around the time of 
diagnosis. 
21*results 
reported in 
chapter 3 
- 8j) - Around the time of 
diagnosis, were you given 
information about the 
likely progress of your 
macular condition? 
Y/N 
  
As above. 
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Row 
number 
MDSQ 
1999 
question 
number 
MSQ 
2013 
question 
number 
MDSQ 1999 question 
wording 
MSQ 2013 question 
wording (changes are 
marked in italics) 
Reason for any changes or for addition/ removal of this 
question 
22 - 8k) - If at initial diagnosis only 
one eye was affected, were 
you given information 
about how your second eye 
might be affected in the 
future? 
Y/N 
As above. 
23 - 9 - If your condition was not 
initially diagnosed by a 
hospital eye specialist, have 
you been to see a hospital 
eye specialist about your 
macular condition since 
diagnosis? 
Y/N 
If ‘yes’, please tick one or 
more reasons why you 
have been to see a hospital 
eye specialist from the list 
below: 
 For confirmation 
of diagnosis 
 For low-vision 
service referral 
 For a certificate of 
visual impairment 
This question was added based on a suggestion from the 
Macular Society. Staff from the society were concerned 
that there may be people with macular conditions who are 
diagnosed in primary care or in the community and have 
not been seen in a hospital setting, and thus may be 
missing out on information and support or perhaps 
treatment. This question was added to investigate this and 
to determine the reasons why patients had been seen in 
the hospital. 
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Row 
number 
MDSQ 
1999 
question 
number 
MSQ 
2013 
question 
number 
MDSQ 1999 question 
wording 
MSQ 2013 question 
wording (changes are 
marked in italics) 
Reason for any changes or for addition/ removal of this 
question 
 For monitoring 
vision 
 For treatment 
 Other, please state 
below: [free-text 
response box] 
24 14 9a) Did you see your eye 
specialist privately or on the 
N.H.S.?  
 N.H.S. only 
 Private only 
 Both private and 
N.H.S. 
Did you see your eye 
specialist privately or on 
the NHS? 
 NHS only 
 Private only 
 Both private and 
NHS 
No change. 
25*results 
reported in 
chapter 3 
5 and 6 10 and 
11 
For questions 5 and 6 please 
circle one number where ‘3’ 
indicates ‘very’ and ‘0’ 
indicates ‘not at all’.  
5. Around the time you were 
first diagnosed with MD, to 
what extent was your General 
Practitioner well informed 
about MD?............................ 
 
Very                          not at all      
3             2           1            0            
For questions 10 and 11 
please circle one number 
where ‘3’ indicates ‘very’ 
and ‘0’ indicates ‘not at 
all’. If you did not discuss 
your macular condition 
with your GP, please circle 
N/A for not applicable.  
10. Around the time you 
were first diagnosed with 
your macular condition, to 
what extent was your GP 
In the 1999 survey, missing data on responses to the two 
GP questions were considerable. Many wrote on the 
survey that they had not seen their GP about their macular 
condition (Mitchell, Bradley, Anderson, Ffytche, & Bradley, 
2002).  A “not applicable” option was therefore added in 
the 2013 survey to investigate how many had not visited 
their GP about their AMD. 
 
“MD” (macular disease) changed to “macular conditions” 
for all 2013 survey questions. The term ‘macular 
conditions’ is now preferred by the Macular Society. 
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MDSQ 
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MDSQ 1999 question 
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question 
 
6. To what extent has your 
General Practitioner been 
helpful and supportive? 
………………………………………. 
 
Very                          not at all      
3             2           1            0            
 
well-informed about your 
condition?............................ 
 
Very                 not at all      
3         2        1        0        N/A 
 
11. To what extent has 
your GP been helpful and 
supportive about your 
macular condition? …………. 
 
Very              not at all      
3        2       1       0           N/A 
 
26 7 12 Were you ever told by an eye 
specialist, G.P. or optometrist 
(optician) that ‘Nothing can 
be done’ to help with your 
MD? 
Y/N 
If ‘yes’, how did you react to 
being told, ‘Nothing can be 
done’? Please answer ‘yes’ or 
‘no’ to each of a,b,c,d,e, f. Did 
you feel: 
a) Resigned Y/N 
Were you ever told by a 
healthcare professional 
that ‘Nothing can be done’ 
to help with your macular 
condition? 
Y/N 
12a) If ‘yes’, which 
healthcare professional told 
you this? Please tick from 
the list below: 
 Hospital eye 
specialist 
The MDSQ 1999 question was modified to account for the 
fact that healthcare professionals other than the eye 
specialist, GP or optometrist may have told respondents 
that ‘nothing can be done’ for their macular condition. The 
sub-question was added to investigate which healthcare 
professionals this was. 
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Reason for any changes or for addition/ removal of this 
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b) Shocked/ sick/ panic 
Y/N 
c) Helpless Y/N 
d) Angry Y/N 
e) Anxious or depressed 
Y/N 
f) Suicidal Y/N 
Other, please state; [free-text 
response box] 
 Nurse 
 Optician 
 GP 
 Eye clinic liaison 
officer 
 Other, please state: 
[free-text response 
box] 
12b) How did you react to 
being told, ‘Nothing can be 
done’? Please answer ‘yes’ 
or ‘no’ to each of a,b,c,d,e, 
and f. Did you feel: 
a) Resigned Y/N 
b) Shocked/ sick/ 
panic Y/N 
c) Helpless Y/N 
d) Angry Y/N 
e) Anxious or 
depressed Y/N 
f) Suicidal Y/N 
g) Other, please state 
below; [free-text 
response box] 
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MDSQ 
1999 
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wording 
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27 8 13 Were you ever told by an eye 
specialist, G.P. or optometrist 
(optician) that you will not go 
completely blind because of 
your MD? Y/N 
If ‘yes’, how did you react to 
being told, ‘You will not go 
completely blind’? Did you 
feel: 
a) Relieved Y/N 
b) Other, please state: 
[free-text response 
box] 
Were you ever told by a 
healthcare professional 
that ‘You will not go 
completely blind’ because 
of your macular condition? 
Y/N 
13a) If ‘yes’, who told you 
this? Please tick from the 
list below: 
 Hospital eye 
specialist 
 Nurse 
 Optician 
 GP 
 Eye clinic liaison 
officer 
 Other, please state: 
[free-text response 
box] 
13b) How did you react to 
being told, ‘You will not go 
completely blind’? Did you 
feel: 
a) Relieved Y/N 
b) Alarmed Y/N 
As above. 
‘Alarmed’ was added to the MSQ 2013 question to 
investigate alternative reactions to being told that one will 
not go completely blind. It was hypothesised that whilst 
some people might be relieved that they will not go 
completely blind, others may not have considered that 
their macular condition would lead to severe vision loss 
and therefore this statement might be considered 
alarming.  
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c) Other, please state 
below: [free-text 
response box] 
28 13 14 Have you been told that MD 
is part of the ageing process? 
Y/N 
 
If ‘yes’, by whom? (Eye 
specialist, G.P., Optometrist, 
etc) [free-text response box] 
 
Have you been told that 
your macular condition is 
part of the ageing process? 
Y/N 
 
14a) If ‘yes’, who told you 
this? Please tick from the 
list below: 
 Hospital eye 
specialist 
 Nurse 
 Optician 
 GP 
 Eye clinic liaison 
officer 
 Other, please state: 
[free-text response 
box] 
 
Tick list provided for more straightforward data entry (only 
responses to the ‘other’ response category in the 2013 
survey question required coding). The same tick list was 
provided as that used in the previous two questions (q12 
and 13), as it was hoped that respondents might be 
familiar with the content and order of the list of healthcare 
professionals, and that this might make the question easier 
to complete. 
29*results 
reported in 
chapter 3 
- 15 - Were you told by a 
healthcare professional, 
around the time of 
New question designed to assess the incorporation of the 
RCOphth 2009 guidelines on AMD into practice, and focus 
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MDSQ 
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wording 
MSQ 2013 question 
wording (changes are 
marked in italics) 
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diagnosis, of the possibility 
of experiencing visual 
hallucinations as a side 
effect of sight loss?  
Y/N 
on information and support provision around the time of 
diagnosis. 
30*results 
reported in 
chapter 3 
- 16 - In the past 12 months, 
have you seen an eye 
specialist or optician about 
your macular condition? 
 Yes 
 No, and I haven’t 
needed to 
 No, but I needed to 
If you ticked ‘No, but I 
needed to’ please give 
reasons for your 
response below: [free-
text response box] 
Question included to investigate gaps in support 
provision/ need for help and support. 
31*results 
reported in 
chapter 3 
and 
chapter 4 
22 & 23 17 & 18 In general, my quality of life 
is:  
Excellent/ very good/ good/ 
neither good nor bad/ bad/ 
very bad/ extremely bad. 
 
If I did not have MD, my 
quality of life would be: 
In general, my present 
quality of life is:  
Excellent/ very good/ 
good/ neither good nor 
bad/ bad/ very bad/ 
extremely bad. 
 
These questions on quality of life appear in the MacDQoL 
(Mitchell et al., 2005). The changes to the MD-specific item 
reflect changes made to this item in the MacDQoL since 
1999 (see Mitchell & Bradley, 2004). In particular, the 
number of positive response options for the MD-specific 
item was reduced from three to one (from ‘a little worse, 
much worse and very much worse’ to ‘worse’). This change 
was made because few people use this end of the scale, as 
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question 
Very much better/ much 
better/ a little better/ the 
same/ a little worse/ much 
worse/ very much worse.  
If I did not have a macular 
condition, my quality of life 
would be: 
Very much better/ much 
better/ a little better/ the 
same/ worse. 
it would indicate benefits of having a macular condition, 
which are usually perceived as being few if any.  
The wording of the question stem for the general QoL item 
has not changed since the design of the Audit of Diabetes 
Dependent quality of life (ADDQoL) questionnaire (Bradley 
et al., 1999), on which the MacDQoL is based. It is not 
known why the 1999 survey question omitted the word 
‘present’ from this item. 
 
32*results 
reported in 
chapter 3 
and 
chapter 4 
24 (a-l) 19 (a-p) W-BQ 12 W-BQ 16 The longer version of this Well-Being Questionnaire (which 
includes a stress subscale) was used so that psychometric 
evaluation of this measure for people with AMD could be 
carried out. (Psychometric evaluation of the W-BQ 12 for 
people with macular conditions was carried out using data 
from the 1999 survey (Mitchell & Bradley, 2001)). The W-
BQ16 has already been validated (along with other 
condition-specific subscales making up the W-BQ28) for 
use with patients with diabetes (Speight, Khagram, & 
Davies, 2012). 
 
33 - 20 - Do you feel that your well-
being has been affected by 
anything in particular in the 
past few weeks, e.g. any 
other health conditions, 
We anticipated that they may be other factors not 
measured in the survey questions that may affect 
respondent’s well-being. This question asked if they felt 
anything in particular had affected their well-being in the 
past few weeks (which is the time period over which 
respondents are asked to consider their well-being). 
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bereavement, retirement? 
Y/N 
 
If ‘yes’, please state: [free- 
text response box] 
 
34 9 21 Have you had any eye 
treatments or operations e.g. 
laser operation, operation to 
remove cataracts, treatment 
for glaucoma? Y/N 
If ‘yes’, please state which 
treatments or operations you 
have had: [free-text box 
response] 
Have you had any 
treatment for your macular 
condition, now or in the 
past? 
Y/N 
 
If ‘yes’, please tick all the 
treatments you have had 
from the list below: 
 Injections into the 
eye (also called 
anti-VEGF 
injections, e.g. 
Avastin, Lucentis or 
Eylea) 
 Laser treatment 
 Photodynamic 
therapy 
 Radiation therapy 
The 2013 survey was changed to include separate 
questions on treatment for macular conditions and other 
eye conditions. The updated question here was modified 
to focus specifically on treatment for macular conditions. A 
tick list was provided as a prompt and for more 
straightforward data entry. 
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 Intraocular lens 
implant 
 Other, please state 
below: [free-text 
response box] 
35 - 22 - What was your most recent 
treatment? Please state 
below: 
a) Name of 
treatment: [free-
text response box] 
b) Date of last 
treatment: 
 _ _ / _ _ / _ _ 
c) Date of last follow-
up appointment:  
_ _ / _ _ / _ _ 
This question was added to the MSQ 2013 to investigate 
whether respondents have received treatment for their 
macular condition and what this treatment is. They were 
asked dates of last treatment/ follow-up to investigate 
how long ago they had been seen and if their sight had 
been monitored recently. This question was included to 
investigate impact of treatment on patient-reported 
outcomes such as well-being and quality of life as well as 
visual outcomes (e.g. registration status).  
36 - 23 - How satisfied/ dissatisfied 
were you with this 
treatment overall?  
 Satisfied 
 Slightly satisfied 
 Neither satisfied 
nor dissatisfied 
 Slightly dissatisfied 
Question was added to investigate respondents’ 
satisfaction with recent treatment.  
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 Dissatisfied 
Please give reasons for 
your response in the space 
below: [free-text response 
box] 
37 - 24 - Did you feel involved in the 
decision-making about this 
treatment? 
 Yes, and I wanted 
to be 
 Yes, but I didn’t 
want to be 
 No, but I wanted to 
be 
 No, and I didn’t 
want to be 
 
Question was added to investigate whether respondents’ 
felt they had a say/ role in deciding whether they wanted 
treatment, and if they preferred to be involved in the 
decision-making process for treatment or not. 
Based on the literature review discussed in chapter 1, gaps 
in the literature were identified and as a result, this newly-
designed question was included in the survey. (At the time 
of designing the 2013 survey, there were no relevant 
questionnaires available that had been designed and 
evaluated to measure this topic in people with macular 
conditions.) 
 
38*results 
reported in 
chapter 4 
12 25 Have you found any 
improvement in vision since 
diagnosis of MD? 
Yes/ No/ don’t know 
 
If ‘yes’, to what do you 
attribute the improvement? 
[free-text response box] 
Since diagnosis, can you 
see: 
 Better 
 The same 
 Worse 
 
The MDSQ 1999 question was modified in order to find out 
if respondents’ felt that their vision had remained the 
same or had become worse since diagnosis (a response of 
‘no’ to the 1999 question does not tell us whether vision 
had remained the same or deteriorated, however a ‘yes’ 
answer tells us that sight has improved). The sub-question 
was removed from the 2013 survey as part of prioritising 
questions of relevance to the aims of the 2013 survey. 
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39*results 
reported in 
chapter 3 
17 26 Are you a member of a local 
MD self-help group? Y/N 
Are you a member of a 
local support group for 
people with macular 
conditions? Y/N 
“MD” (macular disease) changed to “macular conditions” 
for all 2013 survey questions. The term ‘macular 
conditions’ is preferred by the Macular Society now. 
‘Support group’ used instead of ‘self-help’ group as this 
terminology is more commonly used now (e.g. by the 
Macular Society). 
 
40*results 
reported in 
chapter 3 
18 27 Were you able to get more 
information about your MD 
after diagnosis? Y/N 
-If ‘yes’, where did you find 
this information? [free-text 
box response] 
Were you able to get more 
information about your 
macular condition after 
diagnosis? Y/N 
-If yes, where did you find 
this information? Please 
state below.  [free-text box 
response] 
“MD” (macular disease) changed to “macular conditions” 
for all 2013 survey questions. The term ‘macular 
conditions’ is more commonly used now. 
 
41*results 
reported in 
chapter 3 
 
25 28 a) & 
b)  
Have you been to a low vision 
clinic? Y/N  
Have you attended a low-
vision clinic? Y/N 
-if ‘no’ would you like to 
attend a low-vision clinic? 
Y/N 
Sub-question included to investigate gaps in support 
provision/ need for help and support. 
42*results 
reported in 
chapter 3 
- 28c) - Please rate your overall 
satisfaction/ dissatisfaction 
with the low-vision clinic: 
Satisfied/ slightly satisfied/ 
neither satisfied nor 
Question added to investigate respondents’ satisfaction 
with the low-vision clinic. Question adapted from the 
MacSSQ (Mitchell & Bradley, 2009, 2011). 
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dissatisfied/ slightly 
dissatisfied/ dissatisfied. 
43 - 28d) - Please give reasons for 
your overall satisfaction/ 
dissatisfaction with the 
low-vision clinic. [free-text 
response box] 
Question added to investigate respondents’ reasons for 
dis/satisfaction with the low-vision clinic.  
44 27 29 Have you been shown how to 
use low vision aids? Y/N 
Have you ever been shown 
how to use low-vision aids? 
Y/N 
-If ‘no’ would you like to be 
shown how to use them? 
Y/N 
Sub-question included to investigate gaps in support 
provision/ need for help and support. 
45 28 30 Have you found low vision 
aids useful? Y/N 
-If ‘yes’, please note below 
which aids you have found 
useful.  [free-text box 
response] 
-If there are any low vision 
aids you have tried but did 
not find to be useful, please 
note which aids they were 
and why they were not 
useful. [free-text box 
response] 
Have you ever found low-
vision aids (including 
electronic aids) useful? 
Y/N 
-Please use the space below 
for comments on the pros 
and cons of specific low-
vision aids: [free-text box 
response] 
 
Two sub-questions were combined to save space. Included 
the term ‘electronic aids’ in the 2013 survey as a prompt 
for respondents to report these (if they were used). 
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46 - 30b) - Have any particular low-
vision aids or techniques 
helped you continue with 
work or leisure activities? If 
so, please describe: [free-
text response box] 
 
This question was added to focus on whether respondents 
were able to continue with leisure and/or work activities at 
the time of survey completion, and which low-vision aids 
or techniques had helped them to continue with these.  
 
47 - 31 - Have you heard of 
eccentric viewing? 
(techniques which help 
make the most of your 
remaining peripheral 
vision) Y/N 
 
In addition to the questions on low-vision aids, this 
question was added to investigate other strategies 
respondents’ might use for managing the effects of vision 
loss. 
 
48 - 32 - Have you ever been trained 
in eccentric viewing? Y/N 
-If ‘yes’, how useful did you 
find the eccentric viewing 
training? 
Very useful/ moderately 
useful/ slightly useful/ not 
at all useful.  
See above. Question added to investigate whether 
respondents had been trained in eccentric viewing and 
whether or not they had found it useful. 
49 26 33 a) & 
b) 
Have you been visited at 
home by a rehabilitation 
officer? Y/N 
Have you ever had a home 
assessment done by a 
rehabilitation officer? (i.e. 
someone who assessed 
Brief explanation provided in the 2013 survey in case 
respondents weren’t aware of the role of a rehabilitation 
officer. 
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your home environment 
and provided advice to 
improve your daily living 
e.g. on lighting issues, 
mobility within the home.) 
Y/N 
If ‘no’ would you like to 
have a home assessment 
done? Y/N  
Sub-question included to investigate gaps in support 
provision/ need for help and support. 
50*results 
reported in 
chapter 3 
- 34 a) & 
b) 
- Have you ever been offered 
psychological support from 
the hospital or eye clinic? 
Y/N 
-If ‘no’ would you like/ 
have liked to receive 
psychological support: 
Now? Y/N 
At the time of diagnosis? 
Y/N 
As reported in the literature review in chapter 1, many 
people experiencing vision loss have poor mental health. 
This question was added to investigate whether 
respondents had ever been offered/ received 
psychological support for their macular condition.  
 
Sub-question included to investigate gaps in support 
provision/ need for help and support. 
51 - 35 - Do you feel you have a 
need for services that have 
not been offered to you? 
Y/N 
-If ‘yes’ please comment 
below (free-text response 
box) 
Question included to investigate whether respondents had 
any need for help and support that was not already 
covered in the previous questions. 
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52*results 
reported in 
chapter 4 
- 36 - Do you have one or more 
friends or family members 
who provide unpaid care, 
support or assistance to 
you because of your 
macular condition? Y/N 
-If ‘yes’, please state: 
 Their relationship to 
you, e.g. husband, 
daughter, friend: (free-
text response box) 
 The average hours per 
week in total they 
spend helping you: 
Fewer than 7 hours per 
week/ 7 to 14 hours/ 15 to 
35 hours/ more than 35 
hours per week.  
Based on the literature review discussed in chapter 1, gaps 
in the literature were identified and as a result, these 
newly-designed questions were included in the survey. (At 
the time of designing the 2013 survey, there were no 
relevant questionnaires available that had been designed 
and evaluated to measure this topic in people with 
macular conditions.) 
  
 
53*results 
reported in 
chapter 3 
19 37a-c) Have you experienced any 
vision changes that have 
caused you concern? E.g. 
pulsating lights, flashes, 
shimmering light, 
hallucinations such as animal, 
human or plant forms, 
changing coloured patterns, 
Question 37 is on 
experiences of visual 
hallucinations. These 
might appear as patterns, 
faces, people, plants, trees, 
animals or other objects. 
This condition is called 
Charles Bonnet Syndrome 
1999 survey question was modified for the 2013 survey to 
focus on the specific vision change of interest to the 
present study (experiencing visual hallucinations).  
It is possible that respondents may not have had 
knowledge of Charles Bonnet Syndrome before reading 
this survey. The Macular Society contact phone number 
was provided for information and support. 
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blurred vision, difficulty 
seeing depth or seeing at 
night. 
Y/N 
If ‘yes’, please state. [free-
text response box] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Have you talked about 
these experiences with 
your eye specialist, GP or 
optometrist? 
        Y/N 
 
 
and is a common side 
effect of sight loss. If 
needed, contact the 
Macular Society for more 
information on 0300 3030 
111 after completing this 
questionnaire.  
 
37a) Since the diagnosis of 
your macular condition, 
have you experienced any 
visual hallucinations (i.e. 
seeing things that other 
people cannot see)?  
Y/N 
If ‘yes’, please describe: 
[free-text response box] 
 
37b) [If ‘yes’ to q37a] Have 
you talked about the visual 
hallucination(s) with a 
healthcare professional, 
e.g. an eye specialist, GP or 
optician? 
Y/N 
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Row 
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MDSQ 
1999 
question 
number 
MSQ 
2013 
question 
number 
MDSQ 1999 question 
wording 
MSQ 2013 question 
wording (changes are 
marked in italics) 
Reason for any changes or for addition/ removal of this 
question 
 
 Were you told of any 
possible causes of these 
experiences? 
Y/N 
If ‘yes’, please state. [free-
text box response] 
37c) [If ‘yes’ to q37b] Were 
you told of any possible 
cause of these visual 
hallucination(s)? 
Y/N 
If ‘yes’, please state cause 
below: [free-text response 
box] 
 
54 15 38a) After diagnosis of MD, did 
your eye specialist, G.P. or 
optometrist recommend 
regular eye tests in case other 
conditions developed? 
Y/N 
Around the time of 
diagnosis of your macular 
condition, were any of the 
following recommended to 
you? 
a) Having regular eye 
tests (at least every 
two years): 
 Was this recommended 
around the time of 
diagnosis? Y/N 
 If ‘yes’ by whom? 
Eye specialist/ optician/ 
other (free-text 
response box) 
Based on the literature review discussed in chapter 1, gaps 
in the literature were identified and as a result, these new 
questions were included in the survey.  
 
Questions 38a-f were designed based on 
recommendations stated in the RCOphth 2009 guidelines 
for information that should be communicated to patients 
with AMD around the time of diagnosis.  
These recommendations include ways in which people 
with macular conditions can self-manage their condition 
(e.g. monitoring eyesight for sudden changes in vision).  
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Row 
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MDSQ 
1999 
question 
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MSQ 
2013 
question 
number 
MDSQ 1999 question 
wording 
MSQ 2013 question 
wording (changes are 
marked in italics) 
Reason for any changes or for addition/ removal of this 
question 
 To what extent do you 
have eye tests at least 
every two years? 
Not at all/ sometimes/ 
mostly/ all the time 
55 - 38b) - Around the time of 
diagnosis of your macular 
condition, were any of the 
following recommended to 
you? 
b) Eating a diet rich in 
fruit and vegetables, 
oily fish and eggs: 
 Was this recommended 
around the time of 
diagnosis? Y/N 
 If ‘yes’ by whom? 
Eye specialist/ optician/ 
other (free-text 
response box) 
 To what extent do you 
have a diet rich in fruit, 
vegetables, oily fish 
and eggs now? 
Not at all/ sometimes/ 
mostly/ all the time 
As above. 
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MDSQ 
1999 
question 
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MSQ 
2013 
question 
number 
MDSQ 1999 question 
wording 
MSQ 2013 question 
wording (changes are 
marked in italics) 
Reason for any changes or for addition/ removal of this 
question 
56 - 38c) - Around the time of 
diagnosis of your macular 
condition, were any of the 
following recommended to 
you? 
c) Protecting your eyes 
from bright sunlight: 
 Was this recommended 
around the time of 
diagnosis? Y/N 
 If ‘yes’ by whom? 
Eye specialist/ optician/ 
other (free-text box) 
 To what extent do you 
protect your eyes from 
bright sunlight? 
Not at all/ sometimes/ 
mostly/ all the time 
As above. 
57 - 38d) - Around the time of 
diagnosis of your macular 
condition, were any of the 
following recommended to 
you? 
d) Taking nutritional 
supplements (such as 
As above. 
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number 
MDSQ 
1999 
question 
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MSQ 
2013 
question 
number 
MDSQ 1999 question 
wording 
MSQ 2013 question 
wording (changes are 
marked in italics) 
Reason for any changes or for addition/ removal of this 
question 
vitamins, minerals and 
antioxidants): 
 Was this recommended 
around the time of 
diagnosis? Y/N 
 If ‘yes’ by whom? 
Eye specialist/ optician/ 
other (free-text box) 
 To what extent do you 
take nutritional 
supplements regularly 
now? 
Not at all/ sometimes/ 
mostly/ all the time 
 Which nutritional 
supplements do you 
take (if any)? 
 
58 - 38e) - Around the time of 
diagnosis of your macular 
condition, were any of the 
following recommended to 
you? 
e) Monitoring your own 
vision (especially the 
better eye) using an 
As above. 
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MDSQ 1999 question 
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marked in italics) 
Reason for any changes or for addition/ removal of this 
question 
Amsler grid and/ or any 
straight line in your 
environment e.g. a 
window: 
 Was this recommended 
around the time of 
diagnosis? Y/N 
 If ‘yes’ by whom? 
Eye specialist/ optician/ 
other (free-text box) 
 To what extent do you 
monitor your vision 
now? 
Not at all/ daily/ weekly/ 
monthly/ yearly 
 
59 3g 38f) Before your MD was 
diagnosed had you 
experienced any of the 
following conditions or 
circumstances? 
g. smoking  
Y/N 
 
f) At the time of diagnosis 
of your macular 
condition, did you 
smoke? 
Y/N 
If ‘yes’, were you 
recommended to stop 
smoking by your eye 
specialist, GP or optician (in 
As above. 
 
(Note that in the 1999 survey, the question was included 
mainly to investigate possible causes of AMD. In the 2013 
survey the primary purpose was to find out if respondents 
had been recommended to stop smoking after diagnosis to 
help protect against further deterioration in vision.) 
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wording 
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marked in italics) 
Reason for any changes or for addition/ removal of this 
question 
relation to your macular 
condition)? 
Y/N 
Do you smoke now? 
Y/N 
60 - 39) - Please state below any 
other recommendations 
and the extent to which 
you follow them: [free-text 
response box] 
As above. 
61 - 40) - Have you ever felt that you 
have been treated 
differently from a person 
who doesn’t have a 
macular condition? This 
could be at work, at home, 
with family or friends etc., 
and could be in a positive 
or negative way. 
Y/N 
If ‘yes’, please give 
example/s and indicate if 
positive or negative: [free-
text response box] 
 
Based on the literature review discussed in chapter 1, gaps 
in the literature were identified and as a result, this newly-
designed question was included in the survey. (At the time 
of designing the 2013 survey, there were no relevant 
questionnaires available that had been designed and 
evaluated to measure this topic in people with macular 
conditions.) 
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wording 
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Reason for any changes or for addition/ removal of this 
question 
62*results 
reported in 
chapter 3 
and 4 
29f 41 a-c) Are you registered as blind or 
partially sighted? 
Y/N 
 
 
 
If ‘yes’, please give date or 
dates below 
 Date registered as 
partially sighted 
 _ _ / _ _ / _ _ 
 Date registered as 
blind 
               _ _ / _ _ / _ _ 
41 a) Are you registered as 
severely sight impaired 
(blind) or sight impaired 
(visually impaired)? 
Y/N 
 
41b ) If ‘yes’, please give 
date or dates below: 
 Date registered as 
sight impaired 
 _ _ / _ _ / _ _ 
 Date registered as 
severely sight 
impaired  
_ _ / _ _ / _ _  
 
41c) If you have not 
registered as severely sight 
impaired (blind) or sight 
impaired, please tick the 
reason(s) why below: 
 I haven’t been 
offered registration 
 I was offered 
registration but 
declined 
Differences in the wording of the 1999 and 2013 survey 
questions reflect changes in terminology used since 1999.  
 
Sub-question included to investigate gaps in support 
provision/ need for help and support. 
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question 
 I was offered 
registration and it 
is being processed 
 Other, please state 
below: [free-text 
response box] 
 
63*results 
reported in 
chapter 3 
and 4 
29a 42a Date of birth _ _ / _ _ / _ _ Date of birth _ _ / _ _ / _ _ No change. 
(Used to create new variables for age at the time of survey 
completion and age at first diagnosis.) 
64*results 
reported in 
chapter 3 
and 4 
29b 42b  Sex: Male/ Female Sex: Male/ Female No change. 
65*results 
reported in 
chapter 3 
29o 42c Skin colour 
Please circle a number to 
indicate depth of your skin 
colour where 1 is lightest (eg 
white European) and 5 is 
darkest (eg black African). 
 
Light           Dark 
  1    2  3   4   5 
Please indicate your ethnic 
group below: 
 White 
 Asian/ Asian British 
 Black/ Black British 
 Chinese 
 Other, please state 
below: [free-text 
response box] 
The 1999 survey question asked about depth of skin colour 
(which has been investigated as a risk factor for AMD).  
The 2013 survey question asked about ethnicity instead. 
The response options are typical of those included in other 
surveys, so it was perceived that respondents would be 
familiar with this type of question and that this would be 
easier to complete for the respondents, and provide data 
that could be compared with other research findings/ 
studies using these response options.  
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66 - 42d - Is English your first 
language? 
Y/N 
 
If ‘no’ please rate your 
fluency in English on the 
scale below by putting a 
cross on the number that 
applies to you:  
 
Very basic             Very 
fluent 
          1   2  3  4  5  6  7   
Used as part of selection criteria- for respondents whose 
first language was not English and who rated their fluency 
in English as below 7, the hard copy survey responses were 
read and checked to see if they were able to understand 
and respond to the survey questions without difficulty.  
 
67 - 42e - Age at leaving full time 
education: _ years 
Included as a way of estimating socio-economic status 
(SES). 
68 29j 42f Please state in the boxes your 
occupation: 
 Before diagnosis 
[free-text response 
box] 
 After diagnosis [free-
text response box] 
 Now [free-text 
response box] 
 
Please state in the boxes 
your occupation. 
 
Before onset of symptoms 
of macular condition: [free-
text response box] 
After diagnosis: [free-text 
response box] 
 
Now: [free-text response 
box] 
This question was used to investigate if participants had 
changed their occupation due to the symptoms of the 
macular condition. The 2013 survey question was modified 
to account for possible delays to diagnosis meaning that 
the respondent may have changed occupation after onset 
of symptoms, but before diagnosis.  
Page 496
 
 
 
 
 
Appendix 4: Table 1. Comparison of questions included in the 1999 Macular Disease Society Questionnaire (MDSQ 1999) and 2013 Macular Society survey (MSQ 
2013). Questions are in numerical order as they appear in the MSQ 2013. *indicates which questions were used/ selected in the analyses reported in this thesis.  
 
Row 
number 
MDSQ 
1999 
question 
number 
MSQ 
2013 
question 
number 
MDSQ 1999 question 
wording 
MSQ 2013 question 
wording (changes are 
marked in italics) 
Reason for any changes or for addition/ removal of this 
question 
69 - 42g - If you have had any 
changes of occupation, 
were they due to the 
macular condition?  
Y/N 
If ‘no’, please state 
reason(s): 
 [free-text response box] 
See above. This question was added to confirm whether or 
not the participant had changed occupation because of 
their macular condition. Sub-question added to investigate 
other reasons for change in occupation. It was 
hypothesised that some respondents may have changed 
occupation due to their macular condition AND other 
factors. These factors might be related to the macular 
condition. They would be able to state this in the free-text 
response box if applicable.  
 
70 29k 42h Please state in the boxes your 
main interests and activities:  
 
 Before diagnosis 
[free-text response 
box] 
 After diagnosis [free-
text response box] 
 Now [free-text 
response box] 
 
Please state in the box 
below your main interests 
and activities: [free-text 
response box] 
 
Changes were made to make the questions more focused. 
Information on hobbies before and after diagnosis were 
not felt to be a priority for the 2013 survey. 
 
71 29k 
continued 
42i If you have had any changes 
in activities or interests were 
they: 
Due to MD? Y/N 
Due to other factors? Y/N 
Have you needed to change 
your activities or interests 
because of your macular 
condition?  
Y/N 
See above. 
The MSQ 2013 question was reworded to ask whether 
changes were due to the macular condition. This was the 
main focus of interest (i.e. not whether they had needed 
to change activities due to other factors). Respondents 
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question 
Please give any comments 
below: 
[free-text response box] 
could give more information in the free-text response box 
(e.g. if they felt that changes in activities were due to their 
macular condition AND other factors). 
72 - 43 - How comfortable do you 
feel using a computer? 
 Very comfortable 
 Comfortable 
 Not at all 
comfortable 
This question was included to find out how many 
people with macular conditions are able to use a 
computer. This was included because a potential line 
of future research may be to use online survey 
methodology or for delivering online interventions for 
people with macular conditions.  
 
73*results 
reported in 
chapter 4 
29l 44 Do you live alone? 
Y/N 
Do you live alone?  
Y/N 
 
No change. 
74 29m 45 Do you have defective 
hearing? Y/N 
Do you have any loss of 
hearing? 
Y/N 
Modified to reflect current terminology used for hearing 
loss.  
 
75*results 
reported in 
chapter 3 
and 4 
29n 46 General health. Please cross 
one of the 5 boxes offered. 
In general, would you say 
your health is: 
 Excellent 
 Very good 
 Good 
 Fair  
 Poor  
In general, my health is: 
 Excellent 
 Very good 
 Good 
 Neither good nor 
bad 
 Bad 
 Very bad 
 Extremely bad 
1999 survey question used response options from the 36-
item Short Form Health Survey (SF-36) (Ware & 
Sherbourne, 1992). To avoid license costs, it was decided 
to re-design the 2013 survey question response options. 
They were changed to the response options used in the 
general QoL item from the MacDQoL.  
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76 29q 47 Did someone else help you to 
complete this questionnaire? 
Y/N 
If ‘yes’, please state 
relationship to helper e.g. 
husband, daughter, friend etc  
[free-text response box] 
Did someone else help you 
to complete this 
questionnaire? 
Y/N 
The 2013 survey omitted the sub-question used in the 
1999 survey in order to keep the number of questions to a 
minimum. 
77*results 
reported in 
chapter 3 
and 4 
29r 48 Today’s date: _ _ / _ _ / _ _ Today’s date: _ _ / _ _ / _ _ No change.  
(Used to create new variable for age at the time of survey 
completion.) 
78 - 49 - Please write your postcode 
in the box below: [free-text 
response box] 
 
Included as a way of estimating socio-economic status 
(SES). 
 
MDSQ 1999 questions removed from the 2013 survey 
79 2 - Do you know of any other 
members of your family who 
have or had MD? 
Yes/ No/ Don’t know 
 
If ‘yes’, please state in box 
their relationship to you (e.g. 
mother, brother etc.) and 
- Removed from 2013 survey because this question was 
included in the 1999 survey to investigate genetic/ family 
causes for MD. There has since been well-designed studies 
designed to examine genetic causes. This question was 
removed because investigating the information and 
support available/ provided to people with AMD were the 
main reasons for the present study, not investigating the 
causes of macular conditions.  
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question 
approximate age of onset if 
known.  
[free-text response box] 
 
80 3 - Before your MD was 
diagnosed had you 
experienced any of the 
following conditions or 
circumstances? 
 
a. Other eye disease 
e.g. Glaucoma, 
cataracts  
Y/N 
If ‘yes’, please 
describe 
[free-text response 
box] 
b. Injury to head or eyes 
Y/N 
If ‘yes’, please 
describe 
[free-text response 
box] 
c. Diabetes 
Y/N 
d. High blood pressure 
- Similar to above. 
Removed from 2013 survey because this question was 
included in the 1999 survey to investigate causes for MD. 
There has since been studies designed to examine causes. 
This question was removed because investigating the 
information and support provided to people with AMD 
were the main reasons for this study, not investigating the 
causes of macular conditions.  
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Y/N 
e. Stroke 
Y/N 
If ‘yes’ to any of the above 
(a,b,c,d,e) please note any 
medication taken in ‘f’ below. 
 
f. Frequent use of any 
medication (e.g. 
aspirin, sleeping pills) 
Y/N 
If ‘yes’, please list 
[free-text response 
box] 
 
g. smoking  
Y/N 
h. living and/or working 
in smoky 
atmospheres due to 
others smoking  
Y/N 
i. drinking alcohol 
Y/N 
If ‘yes’, please state 
the drink you then 
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question 
preferred e.g. red 
wine, beer, lager, 
whisky. 
[free-text response 
box] 
j. stress or 
bereavement 
Y/N 
k. working and/or living 
in hot 
temperature/climate 
Y/N 
l. frequent or lengthy 
exposure to the sun 
Y/N 
m. Other notable 
conditions/ 
circumstance prior to 
developing MD 
(please state in box) 
[free-text response 
box] 
 
81 4a - When your MD was first 
diagnosed: 
 
- The responses to this question were not reported in the 
published paper of the 1999 survey results (Mitchell et al., 
2002) nor the author’s thesis (Mitchell, 2003). Thus it was 
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How was your MD described 
to you? (please state) 
[free-text response 
box] 
 
removed from the 2013 survey as there were no data 
available for comparison. It was also perceived that the 
free-text responses would take a long time to analyse with 
the risk that the information may not be useful 
(particularly if responses could not be compared with the 
MDSQ 1999 responses).  
82 4c - Were you told of any possible 
cause of this condition?  
Y/N 
If ‘yes’, please state 
[free-text response 
box] 
 
- Same as above. 
83 10 - Has your eye specialist, G.P. 
or optometrist suggested that 
some eye treatments/ 
operations may do more 
harm than good? 
Y/N 
If ‘yes’, which treatment was 
felt possibly to be harmful? 
[free-text response 
box] 
 
 
- Since 1999, there have been major advancements in 
treatment. For wet AMD, anti-VEGF injections have been 
shown to be effective in preventing vision loss and have a 
low risk of adverse events (see chapter 1 for summary). 
There is currently no effective treatment for dry AMD. 
 
This question was removed as part of prioritising questions 
of importance and relevance to the study aims. 
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84 11 - Have you experienced any 
worsening of vision following 
a treatment or operation? 
Y/N 
If ‘yes’, please state the 
treatment or operation. 
[free-text response 
box] 
- See above. 
85 12 - Have you found any 
improvement in vision since 
diagnosis of MD? 
Y/N/ Don’t know 
 
If ‘yes’, to what do you 
attribute the improvement? 
[free-text response box] 
- See above. 
86 20 - Would you be prepared to 
keep a diary/ record of your 
MD condition? 
Y/N 
- This question was removed as part of prioritising questions 
of importance and relevance to the study aims. 
87 21 - The MD Society funded this 
survey and funds other 
research. There are many 
other possible areas of 
research which you might 
wish to see funded. 
- In order to keep the length of the survey down, this 
question on preferences for future research topics was 
removed.  
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Appendix 4: Table 1. Comparison of questions included in the 1999 Macular Disease Society Questionnaire (MDSQ 1999) and 2013 Macular Society survey (MSQ 
2013). Questions are in numerical order as they appear in the MSQ 2013. *indicates which questions were used/ selected in the analyses reported in this thesis.  
 
Row 
number 
MDSQ 
1999 
question 
number 
MSQ 
2013 
question 
number 
MDSQ 1999 question 
wording 
MSQ 2013 question 
wording (changes are 
marked in italics) 
Reason for any changes or for addition/ removal of this 
question 
 
How important to you are 
each of the following broad 
research areas? Please circle 
one number for each scale 
where 3= very important and 
0= not important.  
 
 Causes and 
prevention of 
MD……… 3 2 1 0 
 New treatments…3 2 
1 0 
 Low vision aids for 
people with MD……..3 
2 1 0 
 Improving care and 
support of people 
with MD ………  3 2 1 0  
 
Please add any specific 
suggestions for research you 
would like to see carried out. 
[free-text response 
box] 
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Appendix 4: Table 1. Comparison of questions included in the 1999 Macular Disease Society Questionnaire (MDSQ 1999) and 2013 Macular Society survey (MSQ 
2013). Questions are in numerical order as they appear in the MSQ 2013. *indicates which questions were used/ selected in the analyses reported in this thesis.  
 
Row 
number 
MDSQ 
1999 
question 
number 
MSQ 
2013 
question 
number 
MDSQ 1999 question 
wording 
MSQ 2013 question 
wording (changes are 
marked in italics) 
Reason for any changes or for addition/ removal of this 
question 
88 29e - Dates of onset of MD (your 
estimate) 
 Left eye _ _/_ _/ _ _ 
 Right eye _ _ /_ _/ _ _ 
 
- The MSQ 2013 included a question on the date of 
diagnosis of the respondents’ macular condition (see row 
4, q3). Date of onset was not needed. This question was 
removed as part of prioritising questions of importance 
and relevance to the study aims. 
89 29g - Before MD was diagnosed, 
did you need to wear glasses? 
 For reading?  Y/N 
 For distance?  Y/N 
- Removed from 2013 survey because this question was 
included in the 1999 survey to investigate causes for MD. 
There have since been studies designed to examine 
causes. This question was removed as part of prioritising 
questions of importance and relevance to the study aims. 
90 29h - Which hand do you prefer to 
use for writing? 
Right/ left 
 
- As above. 
91 29i - Some children are made to 
use their right hand despite a 
left-hand preference. Did this 
apply to you? 
Y/N 
- As above. 
92 29p - Eye colour 
Please cross a box to describe 
the colour of your eyes or 
describe in your own words. 
Blue/ Green/ Hazel/ Brown/ 
Grey 
Other (please state) 
- As above. 
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Appendix 4: Table 1. Comparison of questions included in the 1999 Macular Disease Society Questionnaire (MDSQ 1999) and 2013 Macular Society survey (MSQ 
2013). Questions are in numerical order as they appear in the MSQ 2013. *indicates which questions were used/ selected in the analyses reported in this thesis.  
 
Row 
number 
MDSQ 
1999 
question 
number 
MSQ 
2013 
question 
number 
MDSQ 1999 question 
wording 
MSQ 2013 question 
wording (changes are 
marked in italics) 
Reason for any changes or for addition/ removal of this 
question 
[free-text response box] 
 
Please circle a number to 
indicate the depth of your 
eye colour. 
 
Light                                   Dark 
1           2         3        4          5 
 
MD= macular disease, AMD= age-related macular degeneration, MDSQ 1999= Macular Disease Society 1999 Questionnaire, MSQ 2013= Macular Society 2013 
survey, GP= general practitioner, HCP= healthcare professional, ECP= eye care professional, SES= socio-economic status.  
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Appendix 5: Covering letter for MSQ 2013. 
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Appendix 6: Reply slip- reasons for not taking part in the MSQ 2013. 
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 Appendix 7: Detailed description of codes for reasons for satisfaction and 
dissatisfaction with the diagnostic consultation (responses from the MSQ 2013). 
 
Reasons for dissatisfaction with the diagnostic consultation:  
Lack of information or advice, including written information:  
About condition, about prognosis, adjustment, low-vision aids, self-help groups, 
counselling, no referral to Low Vision Clinic/after care, information is not satisfactory 
(e.g. “written information only”).  Include no help provided for the future and no 
explanation of what the future might bring.  Include that information was not given in 
an appropriate format (e.g. written information given when participant couldn’t see). 
Include comments relating to participant having to ask the healthcare professional 
(HCP) to write down the information, or comments on not being able to remember all 
that they were told (which suggests they needed information in a format that they 
could take away with them).  
Include not being told diagnosis or name of condition under separate category of 
“macular condition not named.” 
Example from 2013 survey:  
“I was not warned that my second eye could be affected at a later date” 
“…just said I had AMD and that’s it.” 
Specialist’s/ healthcare professional’s attitude:  
Healthcare professional was described as being: dismissive, patronising, brusque, 
unfeeling, uninterested in patient/condition, used jargon, talked to colleagues whilst 
ignoring the patient, made patient feel of no consequence because of their age, matter 
of fact, brief, given no option/encouragement. Include information given in a blunt/ 
uninterested manner. 
Example from 2013 survey:  
“Made no attempt to reassure me…very curt and abrupt”  
Told nothing could be done:  
Code as this if the respondent had written exactly this or very similar.  
Example from 2013 survey:  
“I was told that I would go completely blind in that eye and nothing could be done” 
Discharged after consultation:  
No follow-up given, include had to ask for a referral or follow-up.  
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Example from 2013 survey:  
“No follow-up given” 
No opportunity for questions: 
Example from 2013 survey:  
“Very abrupt manner when questioned” 
Macular condition not named:  
Include not being told diagnosis or name of condition.   
Example from 2013 survey:  
“Did not give a name to my condition” 
Problems with management:  
Delay in getting appointments, paperwork/correspondence lost, seeing different 
doctors, doctor was not a macular specialist, delay in referral to social services, 
problems with test/ equipment and comments related to length of time taken to run 
the tests. Include aspects of the clinic experience such as staff not introducing 
themselves. Include not seeing eye specialist and sent letter with results in post 
instead. Include costs related to receiving a diagnosis, comments relating to location of 
eye clinic and/or difficulty getting to the clinic, diagnosis given by a non-specialist e.g. a 
nurse rather than a ECP (if respondent indicated they were dissatisfied with this).  
Example from 2013 survey:  
“Lost notes on two sessions” 
Wanted second opinion:  
Example from 2013 survey:  
“Had a second opinion at XXX” 
Lack of time with consultant:  
Example from 2013 survey:  
“Given short shift by the consultant”  
Negative comment on treatment received:  
Include cost of treatment, having to pay for private treatment, healthcare professional 
recommended treatment that was unsuccessful, had to make a quick decision about 
treatment.  Include unhappy about having treatment. Include that respondent said 
they didn’t receive treatment when it was possible to have it. Include comments on 
not being informed about side effects of treatment.  
Example from 2013 survey:  
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“It was in the early days of treatment and it wasn’t available on the NHS”  
“Performed thermal laser treatment and failed to warn me about the difficulty of 
walking afterwards”. 
Shocked by what they were told: 
Example from 2013 survey:  
“In all a very frightening experience”  
Delay to diagnosis:  
Include misdiagnosis before eventual correct diagnosis and problems with diagnosis.  
Include if respondents have written something that eludes to a late diagnosis, for 
example if they wrote that treatment would not be helpful as they were diagnosed too 
late.  
Example from 2013 survey: 
“Not given diagnosis for a long while”  
Caused a delay to receiving treatment: 
Include comments that mention that the diagnosis was made too late so that 
treatment was not viable, or that delays for other reasons caused a delay to treatment.  
Example from 2013 survey: 
“I saw XXX at XXX who said it was far too late to treat my AMD. Optician should have 
bypassed GP.”  
 
Competence of healthcare professional (poor): 
Include comments based on the professional’s incompetence including: lack of 
knowledge, making mistakes, not understanding urgency, misdiagnosis. Comments 
should mention the HCP specifically.  
Example from 2013 survey:  
“Did not know a lot at first” 
“I rather feel GP did not understand about urgency” 
 
Reasons for satisfaction with the diagnostic consultation:  
Diagnosis made or confirmed: 
Comments indicating participant was pleased that something was being done about 
their symptoms/ their diagnosis. Include comments that they were “finally” diagnosed, 
or were pleased to have the diagnosis confirmed.  
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Examples from 2013 survey:  
“Pleased something being done, I had not imagined it” 
“Consultant confirmed diagnosis.” 
Information or advice was provided:  
Information about: diagnosis, prognosis, adjustment, low-vision aids, self-help groups, 
counselling, nutrition, how to check eyes for deterioration, about the Macular Society, 
referral to LVC/aftercare was provided. Also include provided with information about 
treatment, and future outlook. Include comments on being told what activities 
respondent would still be able to do (if this was interpreted positively by the 
respondent). Include given information about how to check eye/s and what to do if 
they notice changes in vision.  
Examples from 2013 survey:  
“The consultant explained everything” 
“…told I would still be able to cook, go for walks” 
Specialist’s or healthcare professional’s attitude:  
Polite, kind, interested in patient’s condition, encouraging, pleasant, sympathetic. 
Made patient feel comfortable. Took an interest in patient. Include descriptions where 
HCP took account of patient’s feelings.  
Example from 2013 survey:  
“He took an interest in me” 
Prevention of delay: 
Include comments relating to help was provided quickly e.g. appointments were 
received quickly in the post, paperwork/correspondence prompt, fast referrals.  
Put any comments that relate to something that prevented a delay to diagnosis or 
treatment in here.  
Example from 2013 survey: 
“Received prompt help” 
“Referred to hospital immediately” / “Optician sent me straight to an eye centre” 
Referred to or within a hospital: (if respondent indicated that they were satisfied 
with this) 
Comments related to being referred to hospital by an optician or GP, or from one 
hospital specialist to another specialist within the same hospital or to a different 
hospital. 
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Example from 2013 survey:  
“Referred me to eye specialist” 
“Local hospital consultant referred me to Bristol eye clinic” 
Referred to GP: (if respondent indicated that they were satisfied with this) 
Example from 2013 survey:  
“She referred me to GP” 
Treatment received or information on treatment:  
Positive comment about treatment, e.g. treatment was effective. Or participant 
indicated in the first part of the question that they were satisfied with the 
consultation, and then wrote that they received treatment (so assume they were 
satisfied because they had received the treatment). Include comments related to 
respondents saying they were happy with the team that delivered the treatment.  
Example from 2013 survey:  
“Receiving Lucentis Injections”  
Competence of healthcare professional (good): 
Positive comments on professional’s competence including being an expert, 
knowledgeable or being professional.  
Example from 2013 survey:  
“She was an expert in the area” 
Follow-up offered/ received: 
Include if respondent was offered regular appointments to monitor condition. Include 
if respondent was told to come back if their condition worsens (comment must show 
that participant was satisfied with this action/advice).  
Example from 2013 survey:  
“Come back if there was further deterioration” 
“I had a six month repeat consultation” 
Thorough examination:  
Healthcare professional took their time, was careful, carried out many tests to confirm 
diagnosis. Include that respondent was satisfied with the eye test.  
Example from 2013 survey:  
“Thorough examination included laser scans” 
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Appendix 8: Search strategy for narrative literature review presented in Chapter 5. 
The electronic databases searched were Web of Science and Google Scholar. 
Reference lists from the resources found were checked for relevant references and 
experts in the field were contacted for additional sources of information. 
Although the review did not endeavour to be systematic in nature, several key words 
were used to retrieve relevant articles for discussion. The important key words 
included: 
  ‘caregiver’, ‘carer’, ‘caregiving’, ‘caring’ ,‘care recipient’ 
 ‘AMD’, ‘age-related macular degeneration’, ‘age related macular degeneration’ 
 ‘burden’, ‘stress’ , ‘well-being’ 
 ‘vision impairment’, ‘vision loss’, ‘low vision’ 
 ‘social support’ 
 ‘dyad’, ‘couple’ 
The author searched other electronic resources, including the Carers UK website, for 
information on the impact of caring on the general UK population.  
Electronic database searches were not limited by year of publication in order to 
maximise the literature that would be included in the review to understand how 
knowledge and theory on this topic has changed over time. Only articles published in 
the English language were included. Literature using either or both qualitative and 
quantitative methods were included. Review articles were included. 
The author critically appraised the literature but did not use specific criteria to 
evaluate the quality of included studies which are recommended for use when 
conducting a systematic review (e.g. CASP checklist (Critical Appraisal Skills 
Programme, 2013); The Quality Assessment Tool for Quantitative Studies (Effective 
Public Health Practice Project, 1998)). 
Thus it is acknowledged that by using a narrative review method instead of systematic 
review methodology, relevant articles may have been missed in the search (systematic 
reviews typically run searches in several electronic databases) and that studies of poor 
quality may have been included. All included literature has been assigned the same 
level of quality. 
Appendix 9: Questionnaire package sent to people with AMD in the 
quantitative second study: INFORMATION SHEET, QUESTIONNAIRE 
BOOKLET, REPLY SLIP, CHANGE OF CONTACT DETAILS SLIP. 
 
                                                                                               
 
Information for participants 
 
Dear (Enter name), 
 
We would like to invite you to participate in a research study 
that is being carried out by Royal Holloway, University of 
London with the support of the Macular Society. Please read 
the following information and discuss it with others if you wish.  
 
Please contact the researchers using the details at the end of 
this letter if there is anything that is not clear or if you would 
like more information. This research has been approved by 
the ethics committee of Royal Holloway, University of London. 
 
What is the purpose of this research? 
  
There has been very little previous research looking at the 
experiences of people who support someone living with 
macular degeneration. The results of the Macular Society 
2013 Survey (also carried out by us) found that 54% of 
respondents reported that someone provided unpaid care, 
support or assistance to them because of their macular 
condition. Of these, 47% reported receiving support for 7 
hours or more a week. However, little is known about the 
impact of providing this support on the carers themselves or 
those with macular conditions who they care for.   
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We recognise that this is an important topic that needs to be 
researched in order to provide support and develop services 
that may be needed, to help inform Macular Society 
campaigns, and to inform future research. 
 
Who have we asked to participate?  
 
We asked members of the Macular Society, who completed 
the Macular Society 2013 survey to write their name and 
contact details, and that of their carer’s, at the end of the 
survey if they were interested in taking part in this research.  
 
If you are not interested in research participation, we 
apologise for troubling you. We would be grateful if you could 
contact us (using the contact details below or by returning the 
enclosed reply slip), so that we know not to contact you again.  
 
If you would like to take part, are aged over 18 and currently 
live in the UK, please carry on reading below.  
 
What will I need to do? 
 
Enclosed in the envelope with this information sheet, you will 
find a consent form and some questionnaires. These 
questionnaires ask about your current well-being, your quality 
of life and the impact your macular degeneration has on 
carrying out everyday tasks. There is also another short 
questionnaire which contains some questions about you (e.g. 
age, gender), your macular condition, general health, and on 
the support you receive. 
 
Once you have read this information sheet, and if you would 
still like to take part, please sign the consent form, complete 
the questionnaires, and return them to us in the stamped 
addressed envelope. This should all take around 30 minutes 
to complete. If you would like help completing the 
questionnaires, you can phone the lead researcher who will 
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go through them with you over the phone at a time convenient 
to you (01784 443718).   
 
The second part of the research study, which you can choose 
to take part in if you wish, will include a one-to-one telephone 
interview with the lead researcher. The interviews will be at a 
time and date convenient to you.  
 
The interview will include questions on your experiences since 
diagnosis, your well-being and the things that may affect your 
well-being, including your experiences of receiving support 
because of the macular degeneration. We anticipate that the 
interviews will last between 30-60 minutes. 
 
Some people may find recalling these experiences 
uncomfortable. The Macular Society helpline is available to 
you if needed. The helpline number is 0300 30 30 111. 
 
Please note, that you can take part in the first part of the 
research study (the postal questionnaires) without completing 
the telephone interview, if you wish.  
 
Do I have to take part?  
 
No, you do not have to take part. Choosing not to will not 
disadvantage you in any way. If anything is not clear, or if you 
have any questions, please contact us at the email address or 
phone number below.  
 
If you do not wish to take part,  please fill in the reply slip and 
return it to us in the stamped addressed envelope provided so 
we know not to trouble you again. 
 
If you decide to take part, please be aware that you are not 
agreeing to answer every question.  You can opt not to 
answer specific questions or in the case of the paper 
questionnaires, leave it blank.  
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If you agree to being contacted about taking part in the 
telephone interview, please tick the relevant box and write 
your contact number on the consent form in the space 
provided. 
 
How will we maintain your privacy and confidentiality? 
 
The answers you give will be treated in complete confidence.  
All data will be collected and stored in accordance with the 
Data Protection Act 1998. Reports from the project will 
summarise information, but will not identify individuals. You 
will be able to read summaries of the results in Sideview 
which all members of the Macular Society receive and/or 
Digest which is sent to members who indicate that they wish 
to receive it.  
 
All questionnaires will be given an ID number and will be 
anonymous. If you provide any identifiable information, this 
will be separated from your responses and put in a secure 
computer database to which only the researchers will have 
access.  
 
Telephone interviews will be audio-recorded and then 
transcribed. An ID number will be used on the transcript in 
place of your actual name. The audio-recording and 
transcribed interview will be stored confidentially and 
destroyed once the results are published.  
 
What do I do next?  
 
If you want to take part, please complete the consent form 
and questionnaires and return them in the stamped addressed 
envelope provided. Alternatively, phone 01784 443718 for 
telephone completion. 
 
If we have incorrect contact details stored for you, please 
complete the change of contact details slip stating your 
correct details.  
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 We appreciate the time you have taken to read this 
information sheet, and look forward to receiving your reply. 
 
 
Thank you. 
 
 
 
  
Research Group: 
 
  Ms Emily Boxell                  PhD Researcher 
  Professor Clare Bradley     Professor of Health Psychology 
  Mrs Janet Bayfield             Administrator 
 
Contact details: 
Health Psychology Research Unit, 
Orchard Building, 
Royal Holloway, University of London. 
Egham, Surrey.  
TW20 0EX. 
 
email: emily.boxell.2013@rhul.ac.uk;   
  c.bradley@rhul.ac.uk;   
  janet.bayfield@rhul.ac.uk. 
(please include “Supporter  research”  in the subject line)        
 
Telephone: 01784 443718 or 01784 443714 or 
01784 443915 
 
N.B. You may wish to keep this information sheet for 
reference. Please use this phone number to contact us with 
any queries.  
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Participant ID number: 
1 
 
 
                                                     
Participant consent form. 
This study has been approved by the Royal Holloway, 
University of London Ethics Committee. 
Thank you for considering taking part in this research. If you 
have any questions, please contact the researchers before you 
decide whether to take part (contact details overleaf). 
Please tick below to show you agree with the following 
statements: 
 
 I have read the information sheet about this study… 
 
 
 
 If I had any questions, I have had the opportunity to 
ask these questions (using the contact details 
overleaf) and I have received satisfactory answers 
to these questions……………………………………... 
 
 
 I understand that I am free to withdraw from the 
study at any time, without giving a reason………….. 
 
 
I agree to participate in this study…………Yes          No 
 
Would you be interested in being contacted about taking part in 
the one-to-one telephone interviews as described in the 
information sheet? 
Yes  No  
If yes, please state your preferred contact number below:  
 
(Landline preferable)………………………………………………. 
P.T.O. to sign and date this form. 
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Participant ID number: 
2 
 
 
Name of participant….  
 
Signature ……………. 
 
Date…………………… 
 
Please check that you have ticked the ‘Yes’ or ‘No’ box and 
have signed and dated this form. Thank you. 
  _____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ 
Research Group: 
  Ms Emily Boxell                  PhD Researcher 
  Professor Clare Bradley     Professor of Health Psychology 
  Mrs Janet Bayfield             Administrator 
 
Contact details: 
Health Psychology Research Unit, 
Orchard Building, 
Royal Holloway, University of London. 
Egham, Surrey. TW20 0EX. 
 
email: emily.boxell.2013@rhul.ac.uk;   
  c.bradley@rhul.ac.uk;   
  janet.bayfield@rhul.ac.uk. 
(please include “Supporter research”  in the subject line)        
 
Telephone: 01784 443718 or 01784 443714 or 
01784 443915 
NB: This Consent form will be stored separately from the 
responses you provide. 
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Participant ID number: 
 
3 
 
 
  
 
Activities of Daily Living 
 
 
This questionnaire asks about your current experience carrying out 
tasks associated with everyday living. Please indicate how much 
difficulty you have carrying out each of the tasks below by circling a 
number on the scale. The 4-point scale ranges from being able to 
perform the task with; “no difficulty”, “with difficulty, but without 
help”, “with help” or “unable to perform task.” 
 
 
 
 
How much difficulty do you 
have…? 
No 
difficulty 
With 
difficulty 
but 
without 
help 
With    
help 
Unable   
to 
perform 
task 
1. Preparing meals ........................................ 1 2 3 4 
2. Grocery shopping ...................................... 1 2 3 4 
3. Managing one’s own money ..................... 1 2 3 4 
4. Using a telephone ..................................... 1 2 3 4 
5. Heavy housework ..................................... 1 2 3 4 
6. Light housework ........................................ 1 2 3 4 
7. Getting to places beyond 
walking distance ....................................... 1 2 3 4 
8. Taking medications ................................... 1 2 3 4 
 
 
Thank you. 
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Participant ID number: 
 
4 
 
 
  
 
Daily living tasks dependent on vision (DLTV) 
 
Please circle one number on each scale, from 4 (no difficulty) to 1 
(cannot see to do), to indicate how much difficulty your vision causes 
you when doing the following tasks: 
 
How much difficulty do you 
have…? 
No 
difficulty 
A little 
difficulty 
A lot of 
difficulty 
Cannot 
see to do 
1. distinguishing a person’s 
features across the room .......................... 4 3 2 1 
2. noticing objects off to either 
side ........................................................... 4 3 2 1 
3. watching TV programmes ......................... 4 3 2 1 
4. seeing steps and using them .................... 4 3 2 1 
5. enjoying the scenery if out for 
a drive ....................................................... 4 3 2 1 
6. reading road signs or street 
names ....................................................... 4 3 2 1 
7. distinguishing a person’s 
features across the street ......................... 4 3 2 1 
8. recognising seasonal changes 
in the garden ............................................. 4 3 2 1 
9. distinguishing a person’s 
features at arm’s length ............................ 4 3 2 1 
Continued on the next page… 
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Participant ID number: 
 
5 
 
How much difficulty do you 
have…? 
No 
difficulty 
A little 
difficulty 
A lot of 
difficulty 
Cannot 
see to do 
10. pouring yourself a drink ............................. 4 3 2 1 
11. cutting up food on your plate ..................... 4 3 2 1 
12. cutting your finger nails ............................. 4 3 2 1 
13. using kitchen appliances ........................... 4 3 2 1 
14. adjusting to darkness after 
being in the light ........................................ 4 3 2 1 
15. adjusting to the light after 
being in the dark ....................................... 4 3 2 1 
 
How confident do you feel in 
your ability to walk around…? 
 
Extremely 
 
Somewhat 
 
Barely 
 
Not at all 
16. in your immediate 
neighbourhood .......................................... 4 3 2 1 
17. outside your immediate 
neighbourhood .......................................... 4 3 2 1 
 
 
With your near glasses on how 
much difficulty do you have…? 
No 
difficulty 
A little 
difficulty 
A lot of 
difficulty 
Cannot 
see to do 
18. reading normal sized 
newspaper print ........................................ 4 3 2 1 
19. reading newspaper headlines ................... 4 3 2 1 
20. reading correspondence, e.g. 
bills, letters, cards ..................................... 4 3 2 1 
21. signing documents, e.g. 
cheques .................................................... 4 3 2 1 
22. identifying money from purse 
or wallet ..................................................... 4 3 2 1 
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Participant ID number: 
 
6 
 
 
 
How would you rate…? Excellent Good Fair Poor 
23. your overall distance vision ....................... 4 3 2 1 
24. your overall near vision, i.e. 
for close work ............................................ 4 3 2 1 
 
 
Questions on driving 
 
 
25. Have you ever driven a car? 
 
  
Yes  No  please go to question 28, next page.   
26. Do you currently drive? 
 
  
Yes  please go to question 27. No     
26a). If no, have you stopped driving because of your macular          
condition or for another reason? 
 
 Mainly because of your 
macular condition………….. 
  
please go to question 28. 
 
 Partly because of your 
macular condition and partly 
other reason(s)…………….. 
  
 
please state reason(s) in the 
box below and then go to 
question 28. 
 Mainly other reason(s)……...  please state reason(s) in the 
box below and then go to 
question 28. 
 Please state reason(s) below:  
  
  
Continued on next page… 
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Participant ID number: 
 
7 
 
 
27. (For those who currently drive.)  
 
Thinking about the impact of your macular condition on your vision, 
would you feel able to: 
 
a) drive to familiar places in daylight? 
 
Yes  No  
 
b) drive to familiar places in the dark? 
 
Yes  No  
 
 
c) drive to unfamiliar places in daylight? 
 
Yes  No  
 
 
d) drive to unfamiliar places in the dark? 
 
Yes  No  
 
 
 
28. Does your caregiver currently drive? 
 
    please continue onto the next page. 
 
 
28a). If yes, does your caregiver drive you to places? 
 
Yes  No  
 
 
 
 
Thank you. Please continue onto the next page. 
Yes  No  
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Participant ID number: 
 
MacDQoL © Prof Clare Bradley: 1.7.00. Standard UK English (rev 3.11.05)   
Health Psychology Research, Dept of Psychology, Royal Holloway, University of London, Egham, Surrey, TW20 0EX, UK. 
 
 
l) In general, my present quality of life is: 
   
  excellent ............................. 
  
 
   
  very good ............................   
   
  good ....................................   
   
  neither good nor bad .........   
   
  bad.......................................   
   
  very bad ..............................   
   
  extremely bad .....................   
 
 
 
 
 
 
 
 
 
 
8 
This questionnaire asks about your quality of life – in other words how 
good or bad you feel your life to be.  Please put an “X” in the box that 
best indicates your response for each item.  What we would like to know 
is how you feel about your life now. 
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Participant ID number: 
 
MacDQoL © Prof Clare Bradley: 1.7.00. Standard UK English (rev 3.11.05)   
Health Psychology Research, Dept of Psychology, Royal Holloway, University of London, Egham, Surrey, TW20 0EX, UK. 
 
 
 
 
 
 
Thank you. Please continue onto the next page. 
 
 
 
 
 
 
 
 
 
 
9 
Now we would like to know how your quality of life is affected by your 
macular disease (MD), which includes macular degeneration, and can 
cause loss of central vision. 
Il) If I did not have MD, my quality of life would be: 
   
  very much better ................ 
  
 
   
  much better .........................   
   
  a little better ........................   
   
  the same ..............................   
   
  worse ...................................   
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Well-being Questionnaire (W-BQ16) 
 
Please circle one number on each scale, from 3 (all the time) to 0 (not 
at all), to indicate how often you feel each statement has applied to 
you in the past few weeks. 
 
  all 
the time 
  not  
at all 
1. I have crying spells or feel like it ............... 3 2 1 0 
2. I feel downhearted and blue ...................... 3 2 1 0 
3. I feel afraid for no reason at all ................. 3 2 1 0 
4. I get upset easily or feel panicky ............... 3 2 1 0 
5. I feel energetic, active or vigorous ............ 3 2 1 0 
6. I feel dull or sluggish ................................. 3 2 1 0 
7. I feel tired, worn out, used up or 
exhausted ................................................. 3 2 1 0 
8. I have been waking up feeling fresh 
and rested ................................................. 3 2 1 0 
9. I have been happy, satisfied or 
pleased with my personal life .................... 3 2 1 0 
10. I have lived the kind of life I wanted 
to ............................................................... 3 2 1 0 
11. I have felt eager to tackle my daily 
tasks or make new decisions .................... 3 2 1 0 
12. I have felt I could easily handle or 
cope with any serious problem or 
major change in my life ............................. 3 2 1 0 
Continued on the next page… 
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  all 
the time 
  not  
at all 
13. I feel that too many demands are 
made on me .............................................. 3 2 1 0 
14. I feel frustrated by obstacles which 
occur in my life .......................................... 3 2 1 0 
15. I have too many problems to cope 
with ............................................................ 3 2 1 0 
16. I feel stressed ........................................... 3 2 1 0 
 
Please make sure that you have considered each of the 16 statements 
and have circled one number in response to each statement. 
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Additional questions 
 
1. Please give the following details about yourself: 
 
a) Marital status:  
 Married/ living with partner…  
 Widowed……………………..  
 Divorced……………………..  
 Separated……………………  
 Single…………………………  
 Civil partnership……………..  
 
b) Employment status: 
 Employed, full time……………………….  
 Employed, part time……………………...  
 Self-employed……………………………. 
 Looking after family and/ or home …….. 
 Retired …………………………………….  
 Seeking work/ unemployed…………….. 
 Disabled or too ill to work……………..... 
 Student…………………………………….  
 Other……………………………………….  
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c) Highest level of education qualification obtained: 
 
 Degree or higher degree…………………………………….  
 Higher education qualification below degree level ….……  
 A levels or equivalent………………………………………..  
 O level or GCSE or equivalent …………………………….  
 Still studying………………………………………………….  
 No formal qualifications……………………………………..  
 Other, please state below:…………………………………. 
……………………………………………………………….. 
 
2. Do you have one or more friends or family members who 
provide unpaid care, support or assistance to you because 
of your macular condition?  
Yes              No  
a) Who is the person who most often provides help, 
support or assistance to you? 
 
Please state their name, and their relationship to you (e.g. 
daughter, husband, neighbour).   
 
Name:……………………………………………………….. 
 
Relationship to you: ………………………………………. 
b) Please tick how many hours per week this person 
spends helping you (on average): 
 
 Fewer than 7 hours per week……...  
 7 to 14 hours………………………...  
 15 to 35 hours……………………….  
 More than 35 hours per week……..  
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c)  Does anyone else provide you with assistance 
(because of your macular condition)? 
Yes           No  
If yes, please state their name(s) and relationship(s) to 
you: 
 
 
 
 
 
 
 
3. Have you ever had treatment for your macular 
condition? 
Yes           No   please go to question 4, next page. 
If ‘yes’, are you currently receiving treatment? 
Yes           No   please go to question 4, next page. 
If ‘yes’, please state the name of this treatment. If you 
are receiving eye injections, please state the name of 
the injection if known: 
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4. Are you registered as severely sight impaired (blind) or 
sight impaired (visually impaired)? 
 no……………………………………………………………...  
 yes, I am registered as sight impaired…………………....  
 yes, I am registered as severely sight impaired (blind)…  
 
5. In general, my health is:  
 excellent………………………  
 very good……………………..  
 good…………………………..  
 neither good nor bad……….  
 bad……………………………  
 very bad……………………...  
 extremely bad……………….  
 
6. Do you have (or have you had) any of the following 
medical conditions? Please tick all that apply. 
 Diabetes…………………………………………………….  
 Stroke……………………………………………………….  
 Heart attack/ heart disease……………………………….  
 Kidney disease…………………………………………….  
 Asthma/ lung disease……………………………………..  
 Other serious/ long-term condition (s) (please state) …  
…………………………………………………………………… 
Continued on next page… 
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7. Today’s date:    _ _ / _ _ / _ _ 
 
 
End of questionnaire. Thank you for your participation.  
 
If you are interested in being contacted about taking part in a 
one-to-one telephone interview as part of this research, please 
make sure you tick the relevant box on the consent form.  
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Appendix 10: Questionnaire package sent to caregivers in the quantitative 
second study: INFORMATION SHEET, QUESTIONNAIRE BOOKLET, REPLY 
SLIP, CHANGE OF CONTACT DETAILS SLIP. 
 
                                                                                               
 
Information for participants 
 
Dear (Enter name), 
 
We would like to invite you to participate in a research study 
that is being carried out by Royal Holloway, University of 
London with the support of the Macular Society. Please read 
the following information and discuss it with others if you wish.  
 
Please contact the researchers using the details at the end of 
this letter if there is anything that is not clear or if you would 
like more information. This research has been approved by 
the ethics committee of Royal Holloway, University of London. 
 
What is the purpose of this research? 
  
There has been very little previous research looking at the 
experiences of people who support someone living with 
macular degeneration. The results of the Macular Society 
2013 Survey (also carried out by us) found that 54% of 
respondents reported that someone provided unpaid care, 
support or assistance to them because of their macular 
condition. Of these, 47% reported receiving support for 7 
hours or more a week. However, little is known about the 
impact of providing this support on the carers themselves or 
on those with macular conditions who they care for.   
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We recognise that this is an important topic that needs to be 
researched in order to provide support and develop services 
that may be needed, to help inform Macular Society 
campaigns, and to inform future research. 
 
Who have we asked to participate?  
 
We asked members of the Macular Society, who completed 
the Macular Society 2013 survey to write their name and 
contact details, and that of their carer’s, at the end of the 
survey if they considered that they might be interested in 
taking part in this research.  
 
If you are not interested in research participation, we 
apologise for troubling you. We would be grateful if you could 
contact us (using the contact details below or by returning the 
enclosed reply slip), so that we know not to contact you again.  
 
We are specifically interested in looking at the experiences of 
those who are the primary caregiver of someone with macular 
degeneration, and who are not fomally paid a salary for this 
role (although they may be receiving Carer’s allowance or 
other benefits). If this is you, and you are aged over 18 and 
currently live in the UK, please carry on reading below.  
 
What will I need to do? 
 
Enclosed in the envelope with this information sheet, you will 
find a consent form and some questionnaires. These 
questionnaires ask about your current well-being and the 
impact of providing care to someone with macular 
degeneration. There is also another short questionnaire which 
contains some questions about you (e.g. age, gender), your 
general health, and on the support you provide.  
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Once you have read this information sheet, and if you would 
still like to take part, please sign the consent form, complete 
the questionnaires, and return them to us in the stamped 
addressed envelope. This should take around 30 minutes to 
complete. If you would like help completing the 
questionnaires, you can phone the lead researcher who will 
go through them with you over the phone at a time convenient 
to you (01784 443718).   
 
The second part of the research study, which you can choose 
to take part in if you wish, will include a one-to-one telephone 
interview with the lead researcher. The interviews will be at a 
time and date convenient to you.  
 
The interview will mainly look at your experiences of providing 
support to someone with macular degeneration.There will be 
questions on the impact of providing this support, and on the 
factors that might help or hinder the ability to provide this 
support. We anticipate that the interviews will last between 30-
60 minutes. 
 
Some people may find recalling these experiences 
uncomfortable. The Macular Society helpline is available to 
you if needed. The helpline number is 0300 30 30 111. 
 
Please note, that you can take part in the first part of the 
research study (the postal questionnaires) without completing 
the telephone interview, if you wish.  
 
Do I have to take part?  
 
No, you do not have to take part. Choosing not to will not 
disadvantage you in any way. If anything is not clear, or if you 
have any questions, please contact us at the email address or 
phone number below.  
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If you do not wish to take part, please fill in the reply slip and 
return it to us in the stamped addressed envelope provided so 
we know not to trouble you again. 
 
If you decide to take part, please be aware that you are not 
agreeing to answer every question.  You can opt not to 
answer specific questions or in the case of the paper 
questionnaires, leave it blank.  
 
If you agree to being contacted about taking part in the 
telephone interview, please tick the relevant box and write 
your contact number on the consent form in the space 
provided. 
 
How will we maintain your privacy and confidentiality? 
 
The answers you give will be treated in complete confidence.  
All data will be collected and stored in accordance with the 
Data Protection Act 1998. Reports from the project will 
summarise information, but will not identify individuals. You 
will be able to read summaries of the results in Sideview 
which all members of the Macular Society receive and/or 
Digest which is sent to members who indicate that they wish 
to receive it.  
 
All questionnaires will be given an ID number and will be 
anonymous. If you provide any identifiable information, this 
will be separated from your responses and put in a secure 
computer database to which only the researchers will have 
access.  
 
Telephone interviews will be audio-recorded and then 
transcribed. An ID number will be used on the transcript in 
place of your actual name. The audio-recording and 
transcribed interview will be stored confidentially and 
destroyed once the results are published.  
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What do I do next?  
 
If you want to take part, please complete the consent form 
and questionnaires and return them in the stamped addressed 
envelope provided. Alternatively, phone 01784 443718 for 
telephone completion. 
 
If we have incorrect contact details stored for you, please 
complete the change of contact details slip stating your 
correct details.  
 
We appreciate the time you have taken to read this 
information sheet, and look forward to receiving your reply. 
 
 
Thank you. 
 
 
 
  
Research Group: 
 
  Ms Emily Boxell                  PhD Researcher 
  Professor Clare Bradley     Professor of Health Psychology 
  Mrs Janet Bayfield             Administrator 
 
Contact details: 
Health Psychology Research Unit, 
Orchard Building, 
Royal Holloway, University of London. 
Egham, Surrey.  
TW20 0EX. 
 
email: emily.boxell.2013@rhul.ac.uk;   
   c.bradley@rhul.ac.uk   
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   janet.bayfield@rhul.ac.uk 
(please include “Supporter  research”  in the subject line)        
 
Telephone: 01784 443718 or 01784 443714 or 
01784 443915 
 
N.B. You may wish to keep this information sheet for 
reference. Please use this phone number to contact us with 
any queries.  
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Participant ID number: 
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Participant consent form. 
This study has been approved by the Royal Holloway, 
University of London Ethics Committee. 
Thank you for considering taking part in this research. If you 
have any questions, please contact the researchers before you 
decide whether to take part (contact details overleaf). 
Please tick below to show you agree with the following 
statements: 
 
 I have read the information sheet about this study… 
 
 
 
 If I had any questions, I have had the opportunity to 
ask these questions (using the contact details 
overleaf) and I have received satisfactory answers 
to these questions……………………………………... 
 
 
 I understand that I am free to withdraw from the 
study at any time, without giving a reason………….. 
 
 
I agree to participate in this study………….Yes         No 
 
Would you be interested in being contacted about taking part in 
the one-to-one telephone interviews as described in the 
information sheet? 
Yes  No  
If yes, please state your preferred contact number below:  
 
(Landline preferable)………………………………………………. 
P.T.O. to sign and date this form. 
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Name of participant….  
 
Signature ……………. 
 
Date…………………… 
 
Please check that you have ticked the ‘Yes’ or ‘No’ box and 
have signed and dated this form. Thank you. 
  _____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ 
Research Group: 
  Ms Emily Boxell                  PhD Researcher 
  Professor Clare Bradley     Professor of Health Psychology 
  Mrs Janet Bayfield             Administrator 
 
Contact details: 
Health Psychology Research Unit, 
Orchard Building, 
Royal Holloway, University of London. 
Egham, Surrey. TW20 0EX. 
 
email: emily.boxell.2013@rhul.ac.uk;   
  c.bradley@rhul.ac.uk;   
  janet.bayfield@rhul.ac.uk. 
(please include “Supporter research”  in the subject line)        
 
Telephone: 01784 443718 or 01784 443714 or 
01784 443915 
NB: This Consent form will be stored separately from the 
responses you provide. 
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The Caregiver Reaction Assessment Instrument 
 
This is a questionnaire which looks at how providing care for your friend or 
family member with a macular condition has affected you, your family and your 
daily routine. Each item is a statement with which you may agree or disagree.  
Beside each statement is a scale which ranges from strongly disagree (1) to 
strongly agree (5).  For each item we would like you to circle a number to show 
how much you disagree or agree with the statement.   
A blank in a sentence refers to the person you are caring for, but please do not 
write any name to keep this anonymous. 
  Strongly 
disagree 
Disagree 
Neither 
agree nor 
disagree 
Agree 
Strongly 
agree 
1. I feel privileged to care for ___. 1 2 3 4 5 
2. Others have dumped caring for ___ 
onto me. 1 2 3 4 5 
3. My financial resources are 
adequate to pay for things that are 
required for caregiving. 
1 2 3 4 5 
4. My activities are centred around 
care for ___. 1 2 3 4 5 
5. Since caring for ___ it seems like 
I’m tired all of the time. 1 2 3 4 5 
6. It is very difficult to get help from 
my family in taking care of ___. 1 2 3 4 5 
7. I resent having to take care of ___. 1 2 3 4 5 
8. I have to stop in the middle of work. 1 2 3 4 5 
9. I really want to care for ___. 1 2 3 4 5 
10. My health has gotten worse since 
I’ve been caring for ___. 1 2 3 4 5 
11. I visit family and friends less since I 
have been caring for ___. 1 2 3 4 5 
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  Strongly 
disagree 
Disagree 
Neither 
agree nor 
disagree 
Agree 
Strongly 
agree 
12. I will never be able to do enough 
caregiving to repay ___. 1 2 3 4 5 
13. My family works together at caring 
for ___. 1 2 3 4 5 
14. I have eliminated things from my 
schedule since caring for ___. 1 2 3 4 5 
15. I have enough physical strength to 
care for ___. 1 2 3 4 5 
16. Since caring for ___, I feel my 
family has abandoned me. 1 2 3 4 5 
17. Caring for ___ makes me feel good.  1 2 3 4 5 
18. The constant interruptions make it 
difficult to find time for relaxation. 1 2 3 4 5 
19. I am healthy enough to care for 
___. 1 2 3 4 5 
20. Caring for ___ is important to me. 1 2 3 4 5 
21. Caring for ___ has put a financial 
strain on the family. 1 2 3 4 5 
22. My family (brothers, sisters, 
children) left me alone to care for 
___. 
1 2 3 4 5 
23. I enjoy caring for ___. 1 2 3 4 5 
24. It’s difficult to pay for ___’s health 
needs and services. 1 2 3 4 5 
 
 
Thank you. 
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Additional questions on the impact of providing care 
 
1. Are there any other areas of your life that you feel have been 
impacted on by providing care for the person with a macular condition 
that were not asked about in these questionnaires? 
 
 
 
 
 
 
 
 
 
 
 
 
2. Were there any questions that you found particularly difficult to 
answer, or that you felt did not apply to you? If so, which question(s)? 
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Please circle a number to show how much you disagree or agree 
with the following statements.  
 
3. In general, I feel that providing care to my relative or friend with a 
macular condition, has a negative impact on me and my life: 
 
Strongly 
disagree 
Moderately 
disagree 
Slightly 
disagree 
Slightly 
agree 
Moderately 
agree 
Strongly 
agree 
1 2 3 4 5 6 
 
 
 
4. In general, I feel that providing care to my relative or friend with a 
macular condition, has a positive impact on me and my life: 
 
Strongly 
disagree 
Moderately 
disagree 
Slightly 
disagree 
Slightly 
agree 
Moderately 
agree 
Strongly 
agree 
1 2 3 4 5 6 
 
 
Please answer the following questions: 
5. In general, my present quality of life is:  
 
  excellent……….…………………….  
  very good..…………………………..  
  good………………………………….  
  neither good nor bad..……………..  
  bad……….…………………………..  
  very bad….………………………….  
  extremely bad….……………….......  
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6. If I did not provide care to my friend or relative with a macular 
condition, my quality of life would be: 
 
 very much better………………….  
 much better………………………..  
 a little better……………………….  
 the same……………………………  
 a little worse……………………….  
 much worse……………………….  
 very much worse………………….  
 
Please continue onto the next page. 
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W-BQ16 © Prof Clare Bradley: 6/96. Standard UK English rev. 14.6.06A  
from the W-BQ12 (rev. 6/96 + instructions rev. 31.1.02) plus the Generic Stress subscale from the W-BQ28 (rev. 3.11.98) 
Health Psychology Research, Dept of Psychology, Royal Holloway, University of London, Egham, Surrey, TW20 0EX, UK. 
Well-being Questionnaire (W-BQ16) 
 
Please circle one number on each scale, from 3 (all the time) to 0 (not 
at all), to indicate how often you feel each statement has applied to 
you in the past few weeks. 
 
  all 
the time 
  not  
at all 
1. I have crying spells or feel like it ............... 3 2 1 0 
2. I feel downhearted and blue ...................... 3 2 1 0 
3. I feel afraid for no reason at all ................. 3 2 1 0 
4. I get upset easily or feel panicky ............... 3 2 1 0 
5. I feel energetic, active or vigorous ............ 3 2 1 0 
6. I feel dull or sluggish ................................. 3 2 1 0 
7. I feel tired, worn out, used up or 
exhausted ................................................. 3 2 1 0 
8. I have been waking up feeling fresh 
and rested ................................................. 3 2 1 0 
9. I have been happy, satisfied or 
pleased with my personal life .................... 3 2 1 0 
10. I have lived the kind of life I wanted 
to ............................................................... 3 2 1 0 
11. I have felt eager to tackle my daily 
tasks or make new decisions .................... 3 2 1 0 
12. I have felt I could easily handle or 
cope with any serious problem or 
major change in my life ............................. 3 2 1 0 
Continued on the next page… 
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W-BQ16 © Prof Clare Bradley: 6/96. Standard UK English rev. 14.6.06A  
from the W-BQ12 (rev. 6/96 + instructions rev. 31.1.02) plus the Generic Stress subscale from the W-BQ28 (rev. 3.11.98) 
Health Psychology Research, Dept of Psychology, Royal Holloway, University of London, Egham, Surrey, TW20 0EX, UK. 
  all 
the time 
  not  
at all 
13. I feel that too many demands are 
made on me .............................................. 3 2 1 0 
14. I feel frustrated by obstacles which 
occur in my life .......................................... 3 2 1 0 
15. I have too many problems to cope 
with ............................................................ 3 2 1 0 
16. I feel stressed ........................................... 3 2 1 0 
 
Please make sure that you have considered each of the 16 statements 
and have circled one number in response to each statement. 
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Additional questions 
 
Demographic questions 
1. Please give the following details about yourself: 
 
a) Date of Birth    _ _ / _ _ / _ _ _ _  
          
b) Highest level of education qualification obtained: 
 
 Degree or higher degree…………………………………….  
 Higher education qualification below degree level ….……  
 A levels or equivalent………………………………………..  
 O level or GCSE or equivalent ……………………………..  
 Still studying…………………………………………………..  
 No formal qualifications………………………………………  
 Other, please state below:…………………………………. 
……………………………………………………………….. 
 
 
c) Sex: Male          Female  
 
d) Marital status:  
 Married/ living with partner……….  
 Widowed……………………………  
 Divorced…………………………….  
 Separated…………………………..  
 Single……………………………….  
 Civil partnership……………………  
Appendix 10: Page 554
Participant ID number: 
11 
 
e) Ethnic group: 
 White British……………..  
 Asian/ Asian British……..  
 Black/ Black British……..  
 Chinese………………….  
 Other, please state below: 
 
…………………………………………………………………… 
f) Employment status: 
 
 Employed, full time……………………….  
 Employed, part time……………………..  
 Self-employed……………………………  
 Looking after family and/ or home …….  
 Retired ……………………………………  
 Seeking work/ unemployed…………….  
 Disabled or too ill to work……………….  
 Student……………………………………  
 Other………………………………………  
 
g) Employment status change, related to caring for person 
with a macular condition: 
 
 Gave up work…………………….  
 Reduced work hours…………….  
 Took paid leave…………………..  
 Took unpaid leave……………….  
 Other (please state): 
………………………………………….. 
 None of the above………………. 
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h) Is English your first language? 
 
Yes          No 
If no, please rate your fluency in English on the scale 
below by putting a cross on the number that applies to 
you: 
Very 
basic 
1 2 3 4 5 6 7 Very 
fluent 
 
 
2. Do you have children? 
Yes           No  
If yes, please state how many and their age(s): 
 
 
 
 
 
Questions about your caregiving role 
3. What relationship are you to the person with a macular 
condition, that you provide support for? (e.g. husband, 
daughter.) 
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4. Please tick how many hours per week you spend helping 
them (on average): 
 
 Fewer than 7 hours per week……...  
 7 to 14 hours………………………...  
 15 to 35 hours……………………….  
 More than 35 hours per week……..  
 
5. How long have you been providing care/ support/ assistance 
to the person with a macular condition, because of this 
condition? 
 
 Less than a year……………..……...  
 Between 1 and 5 years………….....  
 More than 5 years……..……………  
  
6. Did you provide care/ support/ assistance to this person 
before they were diagnosed with a macular condition?  
Yes           No   
If yes, was this for a different medical condition? Please provide 
brief details.  
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7. Does anyone else provide them with assistance (because of 
their macular condition)? 
Yes           No  
If yes, please state their name(s) and relationship to the person 
with the macular condition: 
 
 
 
 
 
 
 
8. Do you live with the person who has a macular condition, 
that you provide care/ support/ assistance for? 
Yes            No  
 
 
9.  How dependent do you feel the person with the macular 
condition has been on you since diagnosis? 
 Not at all dependent……………  
 Somewhat dependent………….  
 Moderately dependent…………  
 Very dependent………………...  
 Extremely dependent…………..  
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General health 
10. In general, my health is:  
 excellent……………………..  
 very good…………………….  
 good………………………….  
 neither good nor bad……….  
 bad……………………………  
 very bad……………………..  
 extremely bad……………….  
 
11. Today’s date    _ _ / _ _ / _ _ 
 
 
 
If you are interested in being contacted about taking part in a 
one-to-one telephone interview as part of this research, please 
make sure you tick the relevant box on the consent form.  
Thank you for your participation 
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 Appendix 11: Interview guide for person with AMD (qualitative 
third study). 
 
Interview questions (with prompts) 
Experiences at diagnosis 
 Tell me about your experience of diagnosis of AMD.  
 When were you diagnosed?  
 How did you feel when you received the diagnosis? 
The impact of having AMD 
 What effect has having AMD had on your life?  
(Prompt: Have there been any particularly difficult times, for you 
because of the macular condition? (further prompts: during 
diagnosis/ treatment, sudden deterioration of eyesight, stopping 
driving etc.)  
 Was there anything that helped or hindered this? 
 
 What effect has AMD had on your (INSERT RELATIONSHIP 
TYPE OF CAREGIVER) life?  
(Prompt: Have there been any particularly difficult times, for them 
because of the macular condition? (further prompts: during 
diagnosis/ treatment, sudden deterioration of eyesight, stopping 
driving etc.)  
 Did anything help with this? 
 How do you feel they cope/d? 
 
 Can you think of anything that could have helped you or your 
(INSERT RELATIONSHIP TYPE) manage the experience at 
diagnosis and any subsequent difficult times better? (prompts: 
outside help, information and support.) 
 
Specific questions on support received (how much, how 
long…) 
 
 How long has your (INSERT RELATIONSHIP TYPE) been 
providing unpaid care for you because of your macular 
condition? 
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 Is this since you were first diagnosed or was this later? 
 If later, what led to them providing care at this later time? 
 Do they, or have they ever provided you with support related to 
another medical condition? 
 You said you receive (INSERT RESPONSE FROM 
QUANTITATIVE SECOND STUDY) hours of support a week. Did 
you find this difficult to estimate? Why or why not? 
 
Now I’m going to ask you about the types of activities your (INSERT 
RELATIONSHIP TYPE) helps you with. Some of them might be 
related to the macular condition, to other health conditions or 
something else, but we can discuss that as we go through them. I 
will read out a list, and please can you answer yes or no as to 
whether they do this. 
 
(Read out each in turn and tick yes or no 
according to whether they report doing this)  
 
 Do they assist you with: 
Yes No 
   
cooking or preparing food   
cleaning   
gardening   
making the bed   
washing / hanging laundry   
reading   
hobbies   
caring for your children or grandchildren 
(check if applicable) 
  
getting dressed   
personal grooming   
travelling/holidays   
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using card machines (ATM’s) and/or entering 
PIN number. 
  
managing your finances   
playing/walking/feeding/ looking after your pet   
getting out and about   
driving you to places   
booking GP or hospital appointments for you   
attending GP or hospital appointments with 
you 
  
climbing stairs   
exercise and/or sport   
shopping   
providing emotional support    
Is there anything else that they do that wasn’t 
included in the list I just read out?  
  
 
The impact of receiving support 
 Do you feel you receive the amount and kind of support or 
assistance you need from them, when you need it? 
o If no, can you explain why? (prompt: do you receive too 
much or too little support?) 
o how do you feel this could be improved? 
 Is there anyone else who provides care/ support/ assistance to 
you? (anyone who helps with any of the activities we went 
through before?) 
 If yes, how do you feel having another person who also 
provides support impacts on you? (prompts: does it make things 
easier or more difficult for you?) 
 How do you think it impacts on your (INSERT 
RELATIONSHIP TYPE)? (prompts: does it make things 
easier or more difficult for them?)  
 If no, how do you feel that affects your relationship with 
(INSERT RELATIONSHIP TYPE), if it does at all? 
Page 564
 Have there been any negative consequences of receiving this 
support? (Prompts: impact on independence, impact on 
relationships etc.) 
 Have there been any positive consequences of receiving this 
support? (Prompts: impact on relationships, practical and 
emotional support received etc.)  
 Do you feel that your relationship with your (INSERT 
RELATIONSHIP TYPE) has changed since they started caring 
for you? (Prompts: how?)  
 Do you think there is anything that could be done to help your 
(INSERT RELATIONSHIP TYPE), provide the support you 
need? (prompts: more outside support, financial support.) 
Quality of life 
The following question asks about your quality of life… 
 In general, would you say that your present quality of life is: 
excellent/ very good/ good/ neither good nor bad/ bad/ very bad/ 
extremely bad.  
 Can you tell me about anything else that you feel affects your 
quality of life and well-being? This could be to do with the 
macular condition, or could be completely unrelated. It could be 
positive, or negative.  
Ending (neutral) question 
 Please could you tell me which type of AMD you have? (i.e. 
wet or dry or both)? 
 
THE CLOSING 
(Summarise the interviewee’s experiences inviting them to correct 
as needed.) 
Is there anything else you would like to add? 
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 Appendix 12: Interview guide for caregivers of people with 
macular degeneration (qualitative third study). 
  
Interview questions (with prompts) 
 How long have you been providing unpaid care for your (INSERT 
RELATIONSHIP TYPE OF PWAMD) because of the macular 
degeneration? 
 Is this since they were first diagnosed or was this later? 
 If later, what led to you providing care at this later time? 
 Do you currently, or have you ever provided them with support 
related to another medical condition? 
We’ve found that some people found it difficult to estimate the 
amount of time they spend helping the person with MD. You said 
you spend (INSERT RESPONSE FROM QUANTITATIVE 
SECOND STUDY) helping (INSERT RELATIONSHIP TYPE).  
Did you find this difficult to estimate? Why?  
Experience of diagnosis 
 Tell me about the experience of diagnosis of AMD.  
 When was your (INSERT RELATIONSHIP TYPE) diagnosed?  
 How did they cope with diagnosis?  
 How did you feel when they were diagnosed? 
Impact of diagnosis 
 What effect has the AMD had on their life? (Prompt: have there 
been any particularly difficult times, for them because of the 
macular condition? (further prompts: during diagnosis/ treatment, 
sudden deterioration of eyesight, stopping driving etc.)) 
 
 What effect has the AMD had on your life? (Prompt: have there 
been any particularly difficult times, for you because of the 
macular condition? (further prompts: during diagnosis/ treatment, 
sudden deterioration of eyesight, stopping driving etc.)) 
 Was there anything that helped or hindered this? 
 
 Can you think of anything that could have helped you or your 
(INSERT RELATIONSHIP TYPE), manage the experience of 
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diagnosis and any subsequent difficult times better? (Prompts: 
outside help, information and support.) 
 
Specific questions on support provided (how much, how 
long…) 
Now I’m going to ask you about the types of support you provide to 
your (INSERT RELATIONSHIP TYPE) because of the macular 
condition. I will read out a list, and please can you answer yes or no 
as to whether you provide this support to them. It might be difficult to 
separate out the help you provide for the macular degeneration with 
help for another health condition or just what you help with 
generally, but we can discuss this. 
 
(Read out each in turn and tick yes or no 
according to whether they report doing this.) 
 
 Do you provide them with help to do: 
Yes No 
   
cook or prepare food   
cleaning   
gardening   
making the bed   
washing / hanging laundry   
reading   
hobbies   
caring for their children or grandchildren   
getting dressed   
personal grooming   
travelling/holidays   
using card machines (ATM’s) and/or entering 
PIN number. 
  
managing their finances   
playing/walking/feeding/ looking after their pet   
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getting out and about   
driving them to places   
booking GP or hospital appointments for them   
attending GP or hospital appointments with 
them 
  
climbing stairs   
shopping   
exercise and/or sport   
providing emotional support   
Is there anything else that you provide help 
with that wasn’t included in the list I just read 
out?  
  
 
The impact of providing support 
 Are their some aspects of care that are more difficult to 
provide than others? 
 
 To what extent do you feel that the care you provide is 
sufficient/ more than sufficient? 
 
 Is there anyone else who provides help/ support/ assistance to 
them? Yes         No 
 If yes, how do you feel having another person who also 
provides support impacts on you? (prompts: does it make 
things easier or more difficult for you?) 
 How do you think it impacts on your (INSERT 
RELATIONSHIP TYPE)? (prompts: does it make things 
easier or more difficult for them?)  
 If no, how do you feel that affects your relationship with 
(INSERT RELATIONSHIP TYPE), if it does at all? 
 
 How do you find that providing this support impacts on you? 
(Prompts: financially, socially, with paid work, with other family 
members, physical/ emotional well-being, health, managing 
your time…) 
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 Have there been specific times when the burden/ pressure on 
you has been greater? Why? 
 Is there anything that helps reduce any negative impact of 
providing this support? (e.g. receiving help from other people, 
spirituality, relaxation time.) 
 Do you feel that you get enough support from others in your 
role as a caregiver? (e.g. friends and family, healthcare 
professionals.) 
 Do you feel that providing the support to your (INSERT 
RELATIONSHIP TYPE) has benefitted you in any way? 
 Do you feel that your relationship with your (INSERT 
RELATIONSHIP TYPE) has changed since you have started 
caring for them? 
 Is there anything that could be done to help you provide the 
support? (Prompt: more outside support, financial support.) 
 In summary, how do you feel about your role as a carer? Is 
there anything else you would like to add to what you have 
already told me? 
Quality of life 
The following question asks about your quality of life… 
 In general, would you say that your present quality of life is: 
excellent/ very good/ good/ neither good nor bad/ bad/ very 
bad/ extremely bad.  
 Can you tell me about anything else that you feel affects your 
quality of life or well-being? This could be to do with caring for 
the person with the macular condition, or could be completely 
unrelated. 
 
THE CLOSING 
(Summarise the interviewee’s experiences inviting them to correct 
as needed.) 
Is there anything else that you would like to add? 
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